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ABSTRACT 
This thesis describes a study of the utilisation of computers by individual 
general practitioners (GPs) in Australia, and compares the practice behaviour 
of GPs who use a computer as a clinical tool, either by prescribing, ordering 
tests, or storing patient data in an electronic medical record format, with those 
who do not use a computer for these functions. 
A survey of individual GP’s use of computers was conducted among 1,336 
GPs who participated in the Bettering the Evaluation and Care of Health 
(BEACH) program between October 2003 and March 2005. The GPs were 
then assigned to groups according to their clinical use (or not) of a computer, 
and were compared on a range of variables including the characteristics of 
the GPs themselves, their practices, their patients, the morbidity they 
managed for their patients, and the managements they provided. Their 
behaviour was also compared, using a set of quality indicators designed for 
use with the BEACH data, and applicable in a primary care setting, to 
determine whether the clinical use of a computer has an affect on the quality 
of care GPs provide to their patients. Finally, GPs who use clinical software 
with embedded pharmaceutical advertising were compared with GPs not 
exposed to advertisements via this media, to determine whether such 
advertising influences the prescribing behaviour of GPs to favour advertised 
brands. 
From 44 quality indicators examined, clinical computer users performed 
‘better’ on four and ‘worse’ on four. For the remaining 36 they exhibited no 
difference. Exposure to pharmaceutical advertising embedded in clinical 
software did not influence the prescribing behaviour of the GPs so exposed. 
Despite the belief espoused in the literature that computer use with improve 
the quality of patient care, I have found no evidence to demonstrate that the 
use of a computer for clinical activity has (as yet) affected, either positively or 
negatively, the quality of care GPs provide to their patients. The current push 
to computerise general practice will mean that this method of assessment will 
be difficult to replicate in the future, given the absence of control groups. 
Other research methods will need to be developed. 
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GLOSSARY OF TERMS AND ABBREVIATIONS 
 
NOTE: The terms below appear in the body of the text. On the first occasion 
of their use in each Chapter they are marked with a dagger symbol (Ŧ) to refer 
the reader here for explanation. The definitions refer to their usage in this 
thesis. 
A1 Medicare items  Medicare item numbers 1, 2, 3, 4, 13, 19, 20, 23, 
24, 25, 33, 36, 37, 38, 40, 43, 44, 47, 48, 50, 51, 601, 602, 720, 
722, 724, 726, 728, 730, 734, 738, 740, 742, 744, 746, 749, 
757, 759, 762, 765, 768, 771, 773, 775, 778, 779, 801, 803, 
805, 807, 809, 811, 813, 815.  
Aboriginal The patient identifies himself or herself as an Aboriginal person. 
Academic detailing  Visits which include face-to-face interaction with 
the intent of changing a provider’s behaviour and his or her 
clinical practice/s. (Albert D, Ahluwalia K et al, 2004)  
Accreditation A process for assessing and recognising the quality of a 
practice against professionally developed and trialled standards.  
ACRRM Australian College of Rural and Remote Medicine – the peak 
professional organisation for rural and remote medicine 
education and training in Australia, the College has approx 
2,000 Fellows and Registrars who practice in regional, rural and 
remote communities throughout Australia.  
Activity level The number of general practice A1 Medicare items 
claimed during the previous 3 months by a participating GP. 
ADGP Australian Divisions of General Practice – the peak national 
body representing 118 Divisions of General Practice and 8 
state-based organisations across Australia. Approx 95% of 
general practitioners are members of a local Division of General 
Practice. Since 2006 now known as Australian General Practice 
Network. 
xiv 
AGPN Australian General Practice Network (Australian Divisions of 
General Practice prior to 2006) 
AGPSCC  Australian General Practice Statistics and Classification Centre, 
known prior to June 2005 (including the time of this study) as the 
General Practice Statistics and Classification Unit (GPSCU) – a 
collaborating unit of the University of Sydney’s Family Medicine 
Research Centre and the Australian Institute of Health and 
Welfare. 
AIHW  Australian Institute of Health and Welfare - Australia's national 
agency for health and welfare statistics and information.  
Allied and other health professionals Those who provide clinical and other 
specialised services in the management of patients, including 
physiotherapists, occupational therapists, dietitians, dentists and 
pharmacists. 
AMA Australian Medical Association – the professional association for 
Australian doctors and medical students, is an independent 
organisation representing more than 27,000 doctors, including 
those salaried or in private practice, general practitioners, 
specialists, teachers, researchers, and doctors in training.  
AMTS Australian Morbidity and Treatment Survey 1990–91. A survey 
of morbidity and management in Australian general practice, 
upon which the BEACH program was based. 
ASGC Australian Standard Geographical Classification – a hierarchical 
classification system consisting of six interrelated classification 
structures. The ASGC provides a common framework of 
statistical geography and thereby enables the production of 
statistics which are comparable and can be spatially integrated.  
ATC Anatomical Therapeutic Chemical Classification. A classification 
system controlled by the World Health Organisation 
Collaborating Centre for Drug Statistics Methodology. It divides 
drugs into different groups according to the organ or system on 
xv 
which they act and/or their therapeutic and chemical 
characteristics.  
BEACH Bettering the Evaluation and Care of Health – the national cross-
sectional survey of general practice activity which formed the 
basis of this thesis. 
BMI Body Mass Index – a measure of overweight or obesity, 
calculated by dividing a person’s weight (in kilograms) by their 
height squared (in m2).  
Brand The marketing name given to a pharmaceutical substance by 
the manufacturer. 
Bulk–billing Allows patients to assign their Medicare rebate directly to the 
treating GP, who accepts the rebate as full payment and 
charges the patient no additional fee 
Category 1 points Points awarded to GPs under the RACGP Quality 
Assurance and Continuing Professional Development Program 
for undertaking activities which explicitly encompass a quality 
assurance learning cycle. 
Category 2 points Points awarded to GPs under the RACGP Quality 
Assurance and Continuing Professional Development Program 
for undertaking any of a variety of educational activities within 
the Category for the purposes of upskilling the individual GP and 
the wider general practice profession, but which do not explicitly 
encompass a quality assurance learning cycle. 
CAPS Coding Atlas for Pharmaceutical Substances – an in-house 
FMRC designed classification with a hierarchical structure 
enabling analysis of medication data at a variety of levels 
including class, group, generic composition and brand name. 
CDSS Clinical decision support systems – software designed to directly 
aid clinical decision-making, in which characteristics of an 
individual patient are matched to a computerised clinical 
knowledge base and patient-specific assessments or 
xvi 
recommendations are then presented to the clinician or the 
patient for a decision. (Sim et al, 2001). Such systems have 
been developed for many clinical issues including alerts, 
reminders for preventive health tasks, advice for prescribing and 
suggestions for active or chronic care issues. (Garg & Tonelli, 
2005). 
Chapters (ICPC-2) The main divisions within ICPC-2. There are 17 chapters 
primarily representing the body systems.  
CHF see Consumer Health Forum.  
Clinical computer use/users A computer is used for clinical functions i.e. 
prescribing, test ordering, medical records, with or without 
internet and/or email. 
CI  Confidence interval. The expected range in which the actual 
population value will be found at a given level of confidence or 
probability. In this thesis 95% CI is used. 
Commonwealth Concession card see Health Care/Benefits Card 
Complaint A symptom or disorder expressed by the patient when seeking 
care. 
Component (ICPC-2) In ICPC-2 there are seven components which act 
as a second axis across all chapters. 
Computer availability A computer is available at the major practice 
address, whether or not it is used by the GP for any purpose. 
Computer use A computer is used by the GP for any function, clinical or 
non-clinical. 
Computerised medical record follow-up questionnaire The 
questionnaire sent to those GPs who reported using the medical 
record function on their clinical software application. The 
BEACH follow-up questionnaire is identified herein as Appendix 
11. 
xvii 
Computerised medical record use The clinical records component of 
their medical software application is used by the GP for storage 
of some or all patient data. In medical record terms: 
 ‘fully computerised’ – the GP used the clinical records 
component of their software to store all patient data including 
externally generated correspondence (included GPs who ticked 
item No.1 on Appendix 11); 
 ‘partially computerised’ – the GP used the clinical records 
component of their software to store a quantity of, but not all, 
patient information. Some patient information was also stored in 
a paper record (included GPs who ticked items No.2 or No.3 on 
Appendix 11). 
Consultation see Encounter (enc) 
Consumer Health Forum  An independent member-based non-
government organisation for health consumers, it provides 
government and policy makers with a consumer perspective on 
health issues and balances the view of health care 
professionals, service providers and industry.  
Detailing See ‘Academic detailing’ 
Diagnosis/problem A statement of the provider’s understanding of a 
health problem presented by a patient, family or community. 
GPs are instructed to record at the most specific level possible 
from the information available at the time. It may be limited to 
the level of presenting signs or symptoms. 
 New problem – the first presentation of a problem, including the 
first presentation of a recurrence of a previously resolved 
problem but excluding the presentation of a problem first 
assessed by another provider. 
 Old problem – a previously assessed problem that requires 
ongoing care. Includes follow-up for a problem or an initial 
xviii 
presentation of a problem previously assessed by another 
provider.  
DoHA Australian Government Department of Health and Ageing. 
DVA Department of Veterans’ Affairs (Australian Government) 
Encounter (enc) Any professional interchange between a patient and a 
GP. This can be: 
‘indirect’ – where there is no face-to-face meeting between the 
patient and the GP but a patient-related service is provided that 
results in information being entered into the patient’s record (e.g. 
renewals for prescriptions or referrals, certificates, case 
conferences) 
 ‘direct – where a face-to-face meeting occurs between the GP 
and the patient. Direct encounters can be further divided into: 
Medicare-claimable 
• A1 items of service: See A1 Medicare items 
  -  Surgery consultations: Encounters identified by 
  any one of MBS item numbers 3, 23, 36, 44. 
  - Home visits: Encounters identified by any one of 
  MBS item numbers 4, 24, 37, 47. 
  - Hospital encounters: Encounters identified by any 
  one of MBS item numbers 19, 33, 40, 50. 
  - Residential aged care facility: Encounters  
  identified by any on of MBS item numbers 20, 35, 
  43, 51. 
  - Other institutional visits: Encounters identified by 
  any one of MBS item numbers 13, 25, 38, 40. 
• Workers compensation: Encounters paid by workers’ 
compensation insurance. 
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• Other paid: Encounters paid from another source (e.g. 
state). 
Encounter form The paper form used as a research tool in the BEACH 
program to enable data collection from 100 patient encounters 
per GP. Each GPs research kit includes 105 encounter forms (5 
spares in case of errors). The encounter form is identified herein 
as Appendix 4. 
FMRC Family Medicine Research Centre – established in August 1999 
to undertake health services research in general practice and 
primary care in Australia. The Centre was formed from the 
Family Medicine Research Unit which has carried out research 
in the Department of General Practice since 1990. The Centre is 
part of the School of Public Health at the University of Sydney. 
Form (of medication) The physical structure of a medication e.g. tablet, 
syrup, capsule, nebule etc. 
FRACGP Fellow of the Royal Australian College of General Practitioners. 
Fully computerised The medical records component of clinical 
software is used for all patient data including externally 
generated correspondence. 
General practitioner (GP)  A medical practitioner who provides primary 
comprehensive and continuing care to patients and their families 
within the community. 
GPCG General Practice Computing Group. The General Practice 
Computing Group (GPCG) is the peak national body for GP 
informatics in Australian general practice. The GPCG is 
auspiced by the Royal Australian College of General 
Practitioners and is a partnership between the Australian 
College of Rural and Remote Medicine, Australian Divisions of 
General Practice, Australian Medical Assoication, Consumers 
Health Forum, Medical Software Industry Association and the 
Rural Doctors Association of Australia. 
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GP Profile questionnaire: The paper form used as a research tool in 
the BEACH program to enable data collection from GP 
participants about themselves and their practices. The GP 
profile questionnaire is identified herein as Appendix 3. 
HbA1c  Haemoglobin, type A1c. 
Health Care/Benefits Card An entitlement card provided by the 
Commonwealth which entitles the holder to reduced cost 
medicines under the Pharmaceutical Benefits Scheme and a 
limited number of other concessions from state and local 
government authorities. Those who qualify are in receipt of a 
pension or allowance administered by the Commonwealth or in 
receipt of an income below the designated threshold for 
qualification.  
ICD International Classification of Diseases. – the international 
standard diagnostic classification for all general epidemiological 
and many health management purposes. 
ICPC International Classification of Primary Care – a classification 
designed to encompass both patients’ reasons for encounter 
(RFEs) and patients’ problems with specificity appropriate to 
primary care. 
ICPC-2 International Classification of Primary Care 2nd edition. 
ICPC-2 PLUS  A clinical terminology classified to the International 
Classification of Primary Care Version 2 (ICPC-2). The ICPC-2 
PLUS terminology provides greater specificity for data input than 
the ICPC-2 classification, with a useable coding system for 
symptoms, diagnoses (problem labels), past health problems 
and the processes of care for use in age-sex disease registers, 
morbidity registers and full electronic health records in primary 
care. It currently contains over 7,000 terms that are commonly 
used in Australian general practice. 
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ICPC Code groups  On occasions variables are analysed at a higher 
level than an individual ICPC-2 or ICPC-2 PLUS code. Where a 
label in a table bears an asterisk (*), multiple codes have been 
grouped together to report at the upper level. A full list of code 
groups from ICPC-2 and ICPC-2 PLUS is available from 
<www.aihw.gov.au/publications/index.cfm/subject/19> 
Medical record The tool used by the GP to store patient information 
incorporating demographic information, patient history, current 
and previous problems managed, current and previous 
prescriptions, investigations, referrals, immunisations. 
Medical record use The clinical records component of medical 
software is use for storage of some or all patient data.  
Medicare Australia’s publicly funded, universal health care system, 
established to provide affordable medical, optometrical and 
hospital treatment. Contributions to the Medicare system are 
based on income and made through taxes and the Medicare 
levy. 
Medicare Australia  An agency of the Australian Government that 
administers health-related programs including Medicare, the 
Pharmaceutical Benefits Scheme (PBS), and others. It is a 
prescribed agency under the Financial management and 
Accountability Act 1997 (Cth) and a statutory agency within the 
Department of Human Services, under the Public Service Act 
1999 (Cth). Prior to 1st October 2005, Medicare Australian was 
known as the Health Insurance Commission. 
Medicare items (of service); item numbers Each professional service 
provided under Medicare has been allocated a unique item 
number. Medicare reimburses expenses related to services 
provided by medical practitioners, and claims are made citing 
the item number for the service. 
xxii 
Medication Includes medication that is prescribed, provided by the GP at 
the encounter, or advised for over-the-counter purchase. 
Medication rates The rate of use of all medications including medications 
that were prescribed, supplied by the GP and advised for over-
the-counter purchase. 
Medication status New: The medication prescribed/provided at the 
encounter/advised is being used for management of the problem 
for the first time.  
 Continued: The medication prescribed/provided at the 
encounter/advised is a continuation or repeat of previous 
therapy for this problem. 
 Old: see Continued. 
Morbidity Any departure, subjective or objective, from a state of 
physiological wellbeing. In this sense, sickness, illness and 
morbid conditions are synonymous. 
Multivariate analyses A statistical analysis technique in which multiple 
variables are analysed separately to determine the contribution 
made by each variable to an observed result. 
NEHTA National e-Health Transition Authority. Established in 2005, to 
develop the specifications, standards and infrastructure 
necessary for an interconnected health sector.  
NESB Non-English-speaking background i.e., a language other than 
English is spoken primarily at home. 
No charge The GP service is provided free with no payment from any 
source. 
Non-clinical computer use/users A computer is used for administrative 
functions, internet and/or email only. The clinical components of 
medical software applications (if installed) such as prescribing, 
test ordering, medical records, are not utilised by the GP in his 
clinical activity. 
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Non-clinical/non-computer users A computer is used for administrative 
functions, internet and/or email only; the clinical components of 
medical software applications (if installed) such as prescribing, 
test ordering, medical records, are not utilised by the GP in his 
clinical activity OR a computer is not used at all for any purpose.  
Non-English speaking background status (NESB) Patients whose primary 
language spoken at home is not English. 
NSAID Non-steroidal anti-inflammatory drug 
OTC Over-the-counter i.e. medications advised for over-the-counter 
purchase. 
Partially computerised The medical records component of clinical 
software is used to store some but not all patient information. 
Patient status The status of the patient to the practice. 
 New patient – This is the patient’s first visit to the practice i.e. 
has not been seen previously at the practice by any of the 
practitioners. 
 Old patient – The patient has been seen at the practice before. 
PBAC Pharmaceutical Benefits Advisory Committee – An independent 
statutory body established in May 1954 under the National 
Health Act 1953, to advise the Australian health minister about 
which drugs and medicinal preparations should be made 
available under the Pharmaceutical Benefits Scheme. No new 
drug may be made available as a pharmaceutical benefit unless 
the committee recommends it.  
PBS Pharmaceutical Benefits Scheme – subsidises the cost of 
necessary and lifesaving medicines for Australian residents. 
PIP  Practice Incentives Program – part of the blended payment 
approach for general practice. Payments made through the 
program are additional to other income earned by GPs and 
practices, such as patient payments and Medicare rebates. 
xxiv 
Precision ratio The ratio of the population proportion (e.g. A1 Medicare 
claims) to the sample proportion (e.g. BEACH A1 item 
encounters). The desired ratio is 1.0, and a ratio of 0.8 or 1.2 is 
20% precision. 
Prescribed/prescribing rates The rate of use of prescribed medications 
(i.e. does not include medications that were GP-supplied or 
advised for over-the-counter purchase). 
Problem managed  see Diagnosis/problem 
Provider A person to whom a patient has access when contacting the 
health care system. 
PSA Prostate specific antigen. 
QA & CPD Quality Assurance and Continuing Professional Development 
Program (QA & CPD) of the Royal Australian College of General 
Practitioners. The QA & CPD Program aims to assist Australian 
GPs maintain and improve the quality of care they provide to 
patients, and promote the highest possible standards of care to 
the community. 
RACGP Royal Australian College of General Practitioners – the peak 
professional organisation for Australian general practitioners, it 
was established to maintain high standards of learning and 
conduct in general practice. Its mission is to benefit communities 
by ensuring high quality clinical practice, education, and 
research for Australian general practice, and supporting current 
and future members in their pursuit of clinical excellence. 
Reason(s) for encounter (RFEs) The subjective reasons given by the 
patient for seeing or contacting the general practitioner. These 
can be expressed in terms of symptoms, diagnoses or the need 
for a service. 
Recognised GP A term used to encompass all categories of GPs who are 
eligible to be included on the vocational register by the HIC (now 
Medicare Australia). Recognised GPs are eligible to use content 
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based consultation items listed in group A1 of the Medicare 
Benefits Schedule (MBS).  
Referral The process by which the responsibility for part or all of the care 
of a patient is temporarily transferred to another health care 
provider. Only new referrals to specialists and allied health 
professionals and for hospital and residential aged care facility 
admissions arising at a recorded encounter are included. 
Continuation referrals are not included. Multiple referrals can be 
recorded at any one encounter. 
Regimen (of medication) The course of therapy which combines the 
strength of product, dose (quantity) and frequency of a 
medication e.g. 2 x 250mg capsules taken twice daily for 5 days. 
RFE(s) Reason(s) for encounter – the subjective reasons given by the 
patient for seeing or contact the general practitioner. The can be 
expressed as symptoms, diagnoses or the need for a service. 
Rubric The title of an individual code in ICPC-2  
RRMA Rural Remote and Metropolitan Areas classification. 
SAND Supplementary Analysis of Nominated Data – the section of the 
BEACH patient encounter form where consultation finishing time 
is recorded for 40 patients by each GP. 
SEIFA Socio-Economic Indexes for Areas – a tool developed by the 
Australian Bureau of Statistics to allow ranking of regions/areas 
as a method to determine the level of social and economic well-
being in that region. 
State government/other paid The encounter is being paid for by the state 
government (eg hospital or other state agency), insurance 
company or other source. It does not include additional cash 
payments made by patients charged through Medicare, but 
would include ‘cash only’ patients eg, overseas travellers. 
xxvi 
Stepwise Procedure  A procedure whereby the ‘best’ subset of predictor 
variables is selected, the criterion of optimality being somewhat 
arbitrary. After each change in the set of variables included in 
the regression, the contribution of each variable is assessed 
and, if the least significant makes insufficient contribution, by 
some criterion, it is eliminated. 
Strength (of medication) The strength of an individual item of a product e.g. 
250mg capsule or 500mg capsule. 
TGA Therapeutic Goods Administration.  
Torres Strait Islander The patient identifies himself or herself as a Torres 
Strait Islander person. 
Type I error  Accepting an alternate hypothesis when the null 
hypothesis is true i.e. accepting that a statistically significant 
difference exists when in reality it does not. 
Type II error  Accepting a null hypothesis when an alternate hypothesis 
is true i.e. accepting that a statistically significant difference 
does not exist when in reality it does. 
Univariate analysis The analysis of a single variable, for purposes of 
description (e.g. averages, or the proportion of cases falling in to 
a given category among the entire sample), as distinct from 
relationships among variables. 
Veterans’ Affairs status The patient is the holder of a Veterans’ Affairs card 
which entitles them to access a range of Repatriation health 
care benefits from the Department of Veterans’ Affairs, including 
access to prescription and other medications under the 
Pharmaceutical Benefits Scheme. Patients may have both 
Veterans’ and Health Care cards. 
Vocationally registered GP Doctors who have been admitted to 
Fellowship of the Royal Australian College of General 
Practitioners (RACGP), and are therefore eligible under the 
Health Insurance Act 1973 to become vocationally registered 
xxvii 
with the Health Insurance Commission. VRGPs are entitiled to 
access to a higher Medicare schedule for the provision of 
medical services. They are required to maintain their vocational 
registration by undertaking professional development activities 
in accordance with the Quality Assurance and Continuing 
Professional Development Program run by the RACGP. 
WHO World Health Organisation. 
Wonca The World Organisation of National Colleges, Academics and 
Academic Associations of General Practitioners, aka the World 
Organisation of Family Doctors. 
Workers’ compensation paid The encounter is claimable through 
workers’ compensation insurance. 
Work-related The symptom or problem has resulted from work-related 
activity or workplace exposure, or a pre-existing condition is 
thought to have been significantly exacerbated by work activity 
or workplace exposure. 
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CHAPTER 1 
 
AIMS OF THIS THESIS AND CANDIDATE’S 
CONTRIBUTION 
1.1 Aims 
• To investigate the availability of computers to general practitioners 
(GPs) at their major practice address, to determine the purposes for 
which these computers are used, and the proportions of individual GPs 
who use their computer for any, or all, of a range of clinical activities.  
• To determine whether individual GPs who use a computer for clinical 
functions differ in their practice behaviour from GPs who do not use a 
computer for clinical activity. 
• To determine, via a set of quality indicators applicable to general 
practice, whether GPs who use a computer for clinical activity differ 
from their non-computerised counterparts in the quality of care they 
provide to their patients. 
• To determine whether advertising embedded in clinical software 
influences the prescribing behaviour of GPs exposed to advertising via 
this medium. 
1.2 Candidate’s contribution 
The candidate was fully involved in all aspects of this study, including 
conceptualising the topic and aims, designing, planning, initiating and 
conducting the research. The candidate selected databases, libraries and 
other sources of information, selected mesh terms and inclusion criteria, and 
planned and undertook a literature search on the topic. Following the literature 
search, the candidate selected the final set of quality indicators appropriate for 
use in primary care that were employed in this study. 
The candidate selected the data collection period, redesigned the GP profile 
questionnaire, designed a follow-up questionnaire for GPs using electronic 
medical records, and submitted these forms for approval to both the BEACHŦ 
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Management Committee and the Ethics Committee of the Australian Institute 
of Health and Welfare. Following Ethics approval (on August 5th 2005) the 
candidate posted the follow-up questionnaires, and entered the data when 
forms were returned. 
Data cleaning and checking was performed by the candidate, assisted by Ms 
Ying Pan (a data analyst at the Centre), under instruction from the candidate. 
The design and performance of analyses for Chapter 4 were undertaken by 
the candidate. Statistical analyses for Chapters 5–7 were determined by the 
candidate with the assistance of Professors Helena Britt (Centre Director) and 
Graeme Miller (Medical Director), and Ms Stephanie Knox (Principal 
Analyst).The majority of analyses were performed by Ms Ying Pan as directed 
by the candidate. Other occasional incidental statistical advice was provided 
by Ms Lisa Valenti (also a data analyst at the centre).  
The preparation and creation of the manuscript, the background and literature 
review, interpretation of results and subsequent discussion presented in this 
thesis are exclusively the work of the candidate. Two papers of which the 
candidate is lead author have emanated from this work. These are ‘The extent 
and utilisation of computerisation in Australian general practice’ (Henderson J, 
Britt H, Miller G. 2006. MJA 185: 84–87) and ‘The effect of advertising in 
clinical software on GP prescribing behaviour’ (Henderson J, Miller G, Pan Y, 
Britt H. 2007. MJA. In press). A list of presentations and reports, and a copy of 
the first of these papers is attached as Appendix 1. The second is in press at 
date of submission. 
1.3 Candidate’s involvement in research leading to this thesis 
The research reported in this thesis was conducted in conjunction with the 
BEACH (Bettering the Evaluation and Care of Health) program, a continuous 
national study of general practice activity in Australia. The candidate has been 
involved with primary care data collection as a member of the BEACH 
research team since joining the program during its first year, in January 1999. 
BEACH is now in its tenth year of data collection and reporting, and during 
these years the candidate has been directly involved with every aspect of the 
3 
program, from recruitment to form design to report writing, and presenting 
results at national and international conferences.  
The candidate updates the design of the BEACH recording form, GP survey 
questionnaire and instruction forms annually, to collect data in areas where 
changes have occurred in general practice e.g., when new Medicare itemŦ 
numbersŦ are introduced for a previously unrecognised service provided by 
GPs, or the increasing involvement of practice nurses over recent years, in 
the performance of procedures previously undertaken solely be the GP. All 
changes are always agreed upon in consultation with the BEACH research 
team and approved by the Management Committee. 
In 2002, the team ran a pilot study of GPs recording their patient encountersŦ 
with their computer, rather than on the structured paper encounter formsŦ. A 
program was designed for loading onto each GP’s Personal Computer, which 
the GPs would keep open on the desktop and would use alternately with their 
clinical software and/or their paper record. The results of this pilot were not 
encouraging – clinically computerised participants found it too time consuming 
to switch between programs, depending on the capacity of their computer 
systems, and they ultimately became selective with the patients they were 
including in the study. Only 23 of the 40 completed the pilot. The team 
concluded that reliable general practice data will only be collectable 
electronically when it can be extracted directly from clinical software.  
Some questions were raised by the pilot, which initiated the candidate’s 
interest in pursuing the topic of this thesis. Firstly, would data collected 
electronically from general practitioners be representative of general practice 
in Australia? Some companies already extract data from patient records of 
GPs who use their clinical software, but all this provides is a sample of the 
activity of the GPs who use a particular software, and with a variety of data 
elements that to do not match the comprehensiveness of data collected 
through BEACH. The second question involved the extent to which GPs were 
using their computers. While over 90% of GPs were reporting using a 
computer in their practice for clinical activity, a relatively small proportion 
appeared to be using it to its maximum capacity. If this was the case, any 
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future introduction of standardised software, data sets, terminologies and 
infrastructure would not improve the prospects for electronic data collection 
from a sample of GPs who were representative of the population of general 
practitioners in Australia. Only GPs who fully utilised their computer as a 
clinical tool would be able to provide comprehensive data. The candidate 
began to interrogate various sources and review literature associated with the 
topic. It became apparent that there was a general perception that general 
practice was ‘computerised’ because so many GPs were now in possession 
of a computer, but nowhere could evidence be obtained of the degree to 
which these computers were being used, or what impact the use of a 
computer was having on the care they provide to their patients. 
Following discussions with the Director and Medical Director involved with the 
BEACH program, the candidate decided to pursue the investigation of 
computer use in general practice, which forms the basis of this thesis.  
 
 
NOTE:  Throughout the remainder of the text an explanation of terms marked 
with a dagger symbol (Ŧ) is provided in the Glossary at the front of this thesis. 
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CHAPTER 2 
 
INTRODUCTION AND BACKGROUND 
2.1 Introduction 
The computer as a tool for organising information became a possibility for 
professionals and individuals when third generation computers (1964–1970) 
replaced magnetic core memory with the integrated circuit. Technologically, 
the fifth generation began in the mid 1970’s with the microcomputer, but the 
real advances occurred following the entry of IBM into the microcomputer 
market. IBM marketed its microcomputers – Personal Computers (or PCs) 
became their trademark – to the business community, with spreadsheet 
programs designed for use on IBM PCs that could perform complex 
mathematical calculations.1  
Areas of the business world, such as banking, were adopting computer 
systems in the pursuit of streamlining procedures and cost efficiencies. Over a 
few decades, the increasing sophistication, power and capacity of computers, 
the growing availability of communication bandwidth, and the decreasing 
costs of storage, hardware and software, has changed the operating 
structure, investment and business processes of every information intensive 
industry, including the health industry.2  
Microcomputers became popular in hospitals, with approximately 75% of US 
community hospitals using them by 1985. Within these institutions, the 
heaviest use of the microcomputer was in health information applications such 
as diagnosis related group (DRG) assignment, abstracting and word 
processing.1 Today tertiary health care facilities use computers at a variety of 
levels, to manage finances, personnel, inpatient admissions and separations, 
bed allocations and theatre lists, and outpatient clinics. Many Australian 
health institutions and providersŦ store patient information electronically, and 
transfer relevant information to clinicians involved in the patient’s ongoing 
care. The internet has provided ready access to the latest clinical guidelines 
and other information to support clinicians in their clinical decision making. It 
has also allowed specialist clinicians at metropolitan locations to ‘consult’ with 
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patients in remote areas hundreds of kilometres away, and clinicians in these 
remote areas to ‘attend’ conferences or lectures, even interactively, through 
videoconferencing. Birth, morbidityŦ and mortality statistics are coded, 
classified, and electronically transferred to relevant data collection agencies. 
Specialists and general practitionersŦ can use clinical software and the 
internet to manage their businesses and their patients. Previously handwritten 
prescriptions, referralŦ letters, requests for pathology or imaging, can now all 
be printed from a computer and in many cases, directly transferred 
electronically to the intended recipient. 
Technological advances have progressed exponentially over a relatively short 
time period, and internationally, stakeholders appear to have adopted the 
stance that computerisation will be the panacea for all short-comings in any 
aspect of health delivery and its management. The international literature 
widely promotes the potential for business applications to manage finances, 
workforce and service planning, and for electronic patient records to provide 
all information required for the ongoing care of a patient. The data obtainable 
from these records would also meet all requirements for public health and 
epidemiological research. The general theme is that all health systems should 
be aiming to realise these potentials. Developed nations such as the United 
States (US), the United Kingdom (UK), Australia, Canada and New Zealand 
‘are adopting health information technology as a tool for rationalizing 
complicated healthcare systems, improving the quality of patient care, 
moderating healthcare costs, and reducing the incidence of adverse events’.3 
Accelerating the adoption of an electronic health information system across 
Australia has become a priority for the Australian Government. In November 
1999, under the guidance of the National Health Information Management 
Advisory Council (NHIMAC), and funded by the Australian Government 
Department of Health and Ageing (DoHAŦ), HealthONLINE was released as 
the strategic framework for health information management and technology 
activities nationally. This project also incorporated HealthINSITE, an internet-
based ‘gateway’ information service to be made available to the public to 
enable informed healthcare decisions. The service aimed to provide high-
quality information from a broad range of ‘approved information partners’.4 
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In 2000, as part of the broader HealthONLINE initiative, the National 
Electronic Health Records Taskforce proposed a national health information 
network called HealthCONNECT. With a consumer’s permission this network 
would facilitate the safe collection, storage and exchange of his/her health 
information between authorised health care providers.5 Trials were 
undertaken in some states and in the Northern Territory. In parallel, the 
proposed medicines component of HealthCONNECT was being field tested in 
Tasmania and Victoria. This component was called MediCONNECT (formerly 
the Better Medication Management System) and was to draw together all 
personal medicines information for an individual held by different pharmacies, 
doctors and hospitals through a secure national electronic system into a 
central file repository under strict privacy guidelines.4 
Although the reasons were not publicly discussed, the HealthCONNECT 
process stalled in 2004, and many of its objectives have now been taken up 
by the National E-Health Transition Authority (NEHTAŦ). NEHTA was 
established in July 2005 by the Australian Commonwealth, State and Territory 
Governments6 to facilitate the adoption of e-health across the health sector. 
NEHTA’s focus is e-health informatics standards and system interoperability.7 
It aims to develop the specifications, standards and infrastructure necessary 
for an interconnected health sector.8 The Council of Australian Governments 
recently approved $130 million to deliver a unique health care identification 
number for every patient and health care professional, and a common 
language for health communications.9 
To realise NEHTA’s objectives, it will be necessary for each sector of the 
Australian health system to adopt a level of computerisation that will allow 
them to interconnect with the whole. Achieving this objective will be a 
challenge given the complex structure of the Australian health system. 
2.2 The Australian Health System – a brief summary 
The Australian health system has a binary structure. The Federal and State 
governments share control and funding of some aspects of the system, while 
being solely responsible for other areas. 
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The Federal government is responsible for national healthcare policy and 
initiatives, and for controlling and managing MedicareŦ, Australia’s publicly 
funded, universal health care system (administered by Medicare AustraliaŦ). 
For patients using hospitals and other health services, Medicare provides for 
free treatment as a public patient in a public hospital, and free or subsidised 
treatment by GPsŦ and specialists (individual clinicians can choose to charge 
more than the Medicare rebate, whereby the patient pays the difference). The 
Federal government is also responsible for the Pharmaceutical Benefits 
Scheme (PBSŦ), a taxpayer funded scheme which provides subsidised 
access to necessary medications, and for controlling the import and supply of 
medicines and medical devices through the Therapeutic Goods Administration 
(TGAŦ). Private health insurance is optional in Australia although tax 
incentives are offered to those who choose to insure themselves privately. It is 
funded and managed by insurance companies, and is regulated by the Private 
Health Insurance Administration Council. The control and partial funding of 
Aged and Community Care facilities is also the responsibility of the Federal 
government, as is the regulation of medical practitioners’ access to Medicare 
payments. 
The Australian Health Care Agreements between the Federal government 
and each State and Territory, provides the basis for the Federal financial 
commitment to public hospital services. The State and Territory governments 
are responsible for the management, partial funding and healthcare delivery 
of public hospitals, and are primarily responsible for the funding and delivery 
of community care services such as mental health, family planning etc. 
Funding for healthcare is shared by both state and federal governments, with 
the Federal government accounting for 46% of expenditure in 2002–03.10  
In 2003 there were 51,819 medical practitioners in Australia working as 
clinicians, and 42% of these were primary care providers. There were 110 
practising primary care practitioners (100 full-time equivalents based on a 45 
hour working week) per 100,000 people.11 General practices operate in a 
variety of business models, from solo practitioners or small partnerships run 
as small businesses or even family businesses, to large practices of 20 or 
more clinicians, all employed by a corporation. About 85% of Australians visit 
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a GP at least once in any given year,12 and they are free to visit multiple GPs 
where services are provided on a fee-for-service basis. General practitioners 
are the ‘gatekeepers’ to the health system,13 as for most Australians the first 
point of contact with the health system is the GP.14 Unless emergency 
treatment is required, where ambulances will take patients directly to 
hospitals, referrals from the GP are required for subsidised access to 
specialists, and thence to public or private hospitals, and day surgery 
facilities. Radiology and pathology services also require GP referral for 
Medicare subsidy, although optometry, physiotherapy and dental are not 
subsidised and therefore do not. Prescription medications are also only 
obtainable through a GP, through a specialist via a GP, or from a hospital 
pharmacy, again accessed via GP referral with the exception of emergency 
treatment. Outside of hospitals, pharmacies are run by private community 
pharmacists.  
The population of Australia in 2003 was 19.9 million people.15 Health 
expenditure as a proportion of gross domestic product (GDP) more than 
doubled over the last four decades of the 20th century, from 4.2% in 1960–61 
to 9.5% in 2002–03, the latter equating to A$72.2 billion.10 The total health 
expenditure for 2004–05 was estimated to be A$87.3 billion.16 During that 
year the primary cost to Medicare for GP services (A1Ŧ and A2 items) was 
over $2 billion.17 Although more recent data are not available, in 2000 
additional secondary costs resulting from GP services (for pathology, imaging, 
referrals to specialists and medications) were over $4 billion.18 
There are several forces driving the increase of healthcare spending in 
Australia. The increased volume and intensity of services and associated 
increased costs is the main driver. Consumer demand and expectation is 
strong, and there is a very high public focus on patient safety and risk 
management. The changing age of the population demographic is another 
driving force – the proportion of people aged 60 years or more will nearly 
double over the next 50 years, from 17.8% to 31.7%. Over the same time 
period, the proportion of the population under 15 years of age will fall from 
19.6% to around 15.0%.19 Associated with this change is an increasing use 
(and cost) of services. Finally there is an ever increasing cost associated with 
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healthcare technology.16 While most of the technology is associated with the 
diagnosis and delivery of health services, a substantial amount is associated 
with information storage and communication. 
In this environment, the computerisation of the health system in Australia is a 
target for the current federal government. Following the implementation and 
evaluation of the local pilots for HealthCONNECT and MediCONNECT, key 
elements have been identified which need to be addressed. These include an 
interoperability framework, health record design, clinical terminologies, clinical 
information standards, healthcare identifiers, privacy and patient consent.3 
While these elements have been publicised as requirements for connecting 
the various independent sectors of the health system to achieve 
interoperability, the readiness of the individual sectors seems to have been 
assumed, and the effects of achieving complete computerisation in order to 
participate in an electronic health network has not been examined for the 
individual sectors. General practice is one such sector.  
2.3 The computerisation of general practice – a brief history 
The Royal Australian College of General Practitioners (RACGPŦ) has been 
actively exploring and advocating the use of computers in general practice 
since the late 1970s,20 and held their inaugural National Computer 
Conference in 1978.21 Through the early 1980s the uptake of computers for 
accounting and practice management increased, but use for clinical 
applications was minimal.22 In July 1985, Medrecord Computer Systems 
proposed to the RACGP that Medrecord computer medical record systems be 
established in 20 representative practices around Australia. As a result of this 
proposal, the College and Medrecord jointly sponsored the Computer 
Assisted Practice Project (CAPP) in 1985.22  
Between 1986 and 1989 the CAP Project oversaw the installation of 
computerised patient record systems in 42 Australian general practices. 
Acceptance of the new technology by doctors, practice staff and patients was 
high. The findings were valuable to the ongoing development of information 
systems, and raised several issues to be addressed throughout the 
development process. These included cost, increased consultationŦ time (in 
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some practices), and the need for: adequate backup routines to protect data; 
improvements in report generation; a standard coding system for use in 
Australia; and data portability across computer systems to enable transfer of 
data to upgraded systems when those in use are superseded. The prime 
issue to be addressed was the development and provision of high quality, 
functional software.22  
Through the 1990’s there was a concerted drive towards computerisation for 
general practice in Australia. Federal Government initiatives, combined with 
those of some state and territory health departments and various groups 
within the profession, have resulted in a dramatic increase in computer useŦ 
by GPs. 
Since the commencement of the Australian General Practice Strategy in 
1989, the (then) Commonwealth Department of Health and Family Services 
has funded a variety of projects aimed to encourage the adoption of electronic 
information systems “to enhance clinical and practice management”.23 A 
major initiative of the Strategy was the establishment of Divisions of General 
Practice with Commonwealth funding in 1992.18 An initiative originally 
conceived from within the profession, divisions are local associations of GPs 
focused on enhancing patient care and health outcomes through collective 
action of GPs at the local level.24 The Divisions operate nationwide under 
guidelines to: represent GPs in their local hospital and community; negotiate 
credentials for GP access to hospitals; organise continuing medical education 
for GPs; implement peer review and quality assurance; facilitate 
undergraduate teaching and vocational training; and to participate in primary 
care research, health promotion and education.25  
The Divisions accelerated the development of information management (IM) 
and information technology (IT) through project funding. The Demonstration 
Practice Grants Program had been announced in 1991, and the Federal 
Government allocated $12 million for 10 demonstration general practice 
divisions and several hundred projects managed by individual GPs.26 A 
considerable number of these were IT demonstration projects, which included 
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trialling the establishment of electronic networks between GPs and other 
areas of the health system.12 
By 1996 the Commonwealth had awarded 95 grants to divisions for short-term 
projects with a strong IT component. A policy change for the Divisions of 
General Practice Program (DGPP) in 1997 resulted in a move away from 
short-term project funding towards longer-term outcomes-based programs 
funded with block grants. Divisions use these grants to provide IM/IT support 
for general practice including provision of information services, educational 
opportunities for GP members, and ongoing support from divisional staff with 
IT expertise. Since the block funding arrangements were initiated there has 
been a 16–fold increase in expenditure on divisional programs with an IM/IT 
focus compared with the earlier short-term project era.21  
In 1998 the General Practice Strategy Review Group (GPSRG) developed 
guidelines to support the development and implementation of IM and IT in 
practices, proposing a principal role for IM/IT in data collection and 
validation.25 The Group outlined the developments undertaken to provide the 
basis for computers to be used routinely as clinical support systems. These 
included the documentation of information flows in general practice; the 
development of standards and codes of practice for clinical coding, privacy of 
medical information, functional specifications for software, technical 
framework for clinical and administrative general practice systems, and 
computerised medical records; the examination in detail of potential benefits 
of electronic prescribing and medicines information; the data requirements of 
forms used in general practice; as well as a range of projects including IT 
demonstrations and trials of networks between GPs and other sectors of the 
health system.25,27  
The GPSRG felt that general practice-related developments in information 
management and information technology were not progressing adequately 
under the Strategy. They included in their vision statement for general 
practice in the 21st century that general practitioners will ‘be assisted in the 
care of patients through utilising advanced technology, electronic 
communication links with providers of health services, and information 
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systems to guide best practice’.27 A series of recommendations resulted, that 
aimed to increase the use of computers and other information systems 
through the provision of incentives to computerise, and funding to promote 
usage, provide training, backup and advice.27 An example of these incentives 
was the announcement by the Health Insurance Commission that all charges 
for computerised prescription paper would be dropped in 1999 following a 
decade of lobbying.18  
In 1997 the RACGP and the AMAŦ collaborated to develop a ‘Strategic 
Framework for Improved Information Management through the use of 
Information Technology in General Practice’ which aimed to promote the 
uptake of information technology in general practice.21 They followed this in 
1998 with a ‘Strategic Framework for Clinical and Administrative General 
Practice Computers’ followed by the publication of Principles for the 
Implementation of Computerisation in General Practice: a plan for the next 
three years. The RACGP also produced the Code of Practice for the 
Management of Health Information in General Practice which provides ‘a 
foundation for the ethical management of information in general practice’.27  
The Practice Incentive Program (PIPŦ) began in July 1998 in response to a 
series of recommendations made by the GPSRG.18 The PIP ‘aims to 
recognise general practices that provide comprehensive, quality care, and 
which are either accredited or working towards accreditationŦ’ against the 
RACGP Standards for General Practice.28 Accreditation is a process for 
assessing and recognising the quality of a practice against professionally 
developed and trialled standards.12 Payments focus on aspects of general 
practice that contribute to quality care, including the use of information 
management/information technology.28  
Financial support through the PIP (since July 1999) has assisted general 
practices to adopt information technology by providing remuneration to 
practices who use prescribing software and have the capacity to send and 
receive electronic clinical information.18 The formula for the IM/IT element has 
three tiers of payment – Tier 1 is for providing data to the Federal 
government; Tier 2 is for the use of bona fide electronic software to generate 
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the majority of prescriptions in the practice; and Tier 3 requires that the 
practice has on site and uses a computer/s connected to a modem to send 
and/or receive clinical information.28 
The General Practice Computing Group (GPCGŦ) was established in 1997, 
initiated jointly be the RACGP and the AMA with funding from the (then) 
Commonweatlh Department of Health and Aged Care to implement and 
oversee the Strategic Framework plans. The GPCG developed the strategic 
framework in 1999, based on the strategies outlined in Principles for the 
Implementation of Computerisation in General Practice29 and the 
recommendations of the GPSRG report.27 It became the peak body for 
general practice computing, providing a strategic and co-operative approach 
to Australian GP informatics,30 and focusing on ‘the effective use of 
information management and technology for clinical and administrative 
purposes’.31 The GPCG operated through a management committee 
comprised of four elected members of the GPCG, stakeholder representatives 
from the RACGP, the AMA, the Rural Doctors Association of Australia 
(RDAA), the (then) Australian Divisions of General Practice (ADGPŦ), the 
Medical Software Industry Association (MSIA), a health consumer and two 
representatives of the General Practice Branch of the (then) Department of 
Health and Aged Care.18 GPCG projects undertaken from 2001 included: 
practical support for GPs via divisions of general practice; the GPCG IT 
Clearinghouse Initiative; the Standards Development Program; the 
Development and Evaluation Program; and the Information Management 
Program.18 The Australian Government Department of Health and Ageing 
(DoHA) announced the withdrawal of funding from the GPCG in April, 2005, 
and to date, it is unclear who will provide the support the GPCG has been 
giving GPs in this area, although Divisions have been assisting in the interim 
period. 
Richards et al (1999),21 reported that the development of information 
management in the Australian health system had been poorly co-ordinated 
since its inception, with initiatives starting at all levels from individual practices 
through to various Branches of the (now) Australian Government Department 
of Health and Ageing (DoHA). Their report highlighted the need for the 
15 
development of national standards, of local and national networks between 
GPs and other health and community services, and of the need for ongoing 
practical training and support for GPs.21  
A considerable amount has been spent on computerising general practice 
over the past three decades, and the Federal government has allocated 
millions more to achieve this goal. The move to computerise seems to have 
advanced from an underlying premise that the use of a computer will improve 
various aspects of management and care. There is a general theme among 
the literature of that period that using a computer will ‘improve’ the 
management of health information by facilitating the provision of information 
needed to assess performance of individual practitioners, to evaluate 
programs, to monitor patient disease and risk management, and to provide 
data for research.  
However, Richards et al (1999) reported that they had found little hard 
evidence that the general use of computers improves efficiency at individual 
practice level. They raised concerns about the lack of evidence that 
computers benefit the health sector generally or that improving outcomes was 
an aim when designing information systems. They also suggested that in the 
business sector information technology costs more through direct and 
opportunity costs than it delivers.21 This view was also raised by Heathfield et 
al (1998), who stated that decision makers in the UK and the US may be 
being ‘swayed by the general presumption that technology is of benefit to 
health care and should be wholeheartedly embraced’ while the evidence to 
either support or oppose this supposition is still scarce.32  
Mitchell & Sullivan (2001) undertook a systematic review of world literature on 
primary care computing from 1980 to 1997.33 Only 89 studies met their 
inclusion criteria and while most of these found some positive effects of 
computerisation in areas such as immunisations, reductions in prescribing 
costs and unnecessary testing, they found only 17 studies researched the 
impact of computers on patient outcomes, a number they concluded 
insufficient to measure whether computers provide real benefits for patients.33 
A search of relevant databases and other sources up to the time of 
16 
commencing this study produced little that could be added to the evidence 
tally for positive or negative impact of computerisation on patient outcomes in 
primary care. 
Nonetheless, few would argue that the potential exists for computerisation to 
achieve the ideal of improved health surveillance and delivery. The ability to 
provide a clearly printed prescription should theoretically reduce medication 
errors caused through illegibility. The storage of complete patient health 
information in one electronic record should improve access to complete and 
timely information when making diagnoses or treatment decisions, preparing 
referrals, ordering tests, or communicating between health care providers. 
Reminders for tests or warnings about medication interactions with other 
medications or contraindicated conditions should help to monitor patient 
conditions and reduce adverse events. This would require that complete data 
be included in the electronic health record (EHR) and that the clinical software 
is able to perform these functions. There is some evidence of these types of 
individual improvements to the quality of care associated with computer use34-
36 but there is also evidence appearing that the computer, while solving 
problems in some areas, is causing or accentuating difficulties elsewhere.37-40 
To what extent individual GPs actually use computers for clinical purposes is 
unknown, as is the effect using computers for clinical purposes has on the 
quality of care provided to patients. In considering how computer use may 
affect the quality of care, evidence is needed in order to determine whether 
there are differences in the behaviour of GPs who use a computer for clinical 
purposes compared with those who do not. Prescribing behaviour is an area 
of particular interest in assessing quality of care. The introduction of 
advertisements embedded in clinical software has provided another avenue to 
promote pharmaceutical products to GPs. This method of advertising has 
caused some controversy, given that it could influence practitioners to 
prescribe a well-promoted product in place of an equally efficacious one, 
which may incur a higher cost to the patient or to the Federal government via 
the PBS. Whether or not this method of promotion affects the prescribing 
behaviour of GPs so exposed, has not yet been measured. 
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In this thesis I will address some of these issues. The specific aims are listed 
in Chapter 1. Each aim is also noted in the Chapter in which it is investigated. 
In Chapter 3 I will described the methodology used in this thesis. In Chapter 4 
I will investigate individual computer use by GPs to determine the extent of 
individual computer use in clinical practice, and what clinical computer 
functions are in use. In Chapter 5 the GPs will be allocated into two groups on 
the basis of whether or not they use a computer as a clinical tool, and 
compare the behaviour of the GP groups to determine any differences in their 
practice behaviour. In Chapter 6, the same GP groups will be compared on a 
set of 34 quality indicators applicable to general practice activity, to examine 
whether or not the use of a computer as a clinical tool has affected the quality 
of care insofar as it can be measured via this method. In Chapter 7 the GPs 
will be reallocated into two groups on the basis of their use of Medical Director 
software, currently the only clinical software on the Australian market which 
has embedded advertising for pharmaceutical products. I will then compare 
the prescribing behaviour for seven advertised products to determine whether 
the continual exposure to advertising through the software affects the 
prescribing decisions of the GPs so exposed. Discussion and conclusions will 
be presented in Chapter 8 and Chapter 9.  
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CHAPTER 3 
 
METHODS 
This thesis is an extension to an ongoing research program called BEACHŦ 
(Bettering the Evaluation and Care of Health). The BEACH program and it’s 
methodology are described in Sections 3.1–3.3. BEACH commenced in April, 
1998 and has continued uninterrupted since that time. Like the program, the 
methodology of BEACH is a continuous, evolving process. For the purpose of 
this extension study, a sub-group of BEACH participants were selected for 
inclusion, and additional methods were applied. Despite its ongoing nature, 
throughout this chapter the methodology of BEACH is described in the past 
tense to explain the process undertaken to collect data for the participants 
involved during the time period applicable to this study. 
The GPsŦ in this study were those who participated in BEACH from mid 
November 2003 to March 2005 (i.e. those GPs who took part in the latter third 
of the 2003–04 BEACH recording year, 28/10/03–29/03/04, and the total of 
the 2004–05 BEACH year, 30/03/04–28/03/05). The participants and time 
period named above are referred to hereafter as ‘participants in this study’ or 
‘during this study period’.  
NOTE: The methodology of BEACH as described below in Section 3.2 is used 
in this thesis. Additional methods designed for, and applied to this study, but 
not generally utilised in the BEACH program are detailed in Section 3.4. An 
explanation of terms marked with the following symbol () has been provided in 
the Glossary at the front of this thesis. 
3.1 An overview of BEACH (Bettering the Evaluation And Care 
of Health) 
Note – the information in this section has been summarised from a number of 
earlier BEACH reports of which the candidate was a co-author. Each section 
is referenced to the report from which the information was extracted and 
abridged.  
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BEACH is a continuous national cross-sectional survey of general practice 
activity. It commenced in April 1998, and is operated by the Australian 
General Practice Statistics and Classification Centre (AGPSCCŦ). The 
AGPSCC is housed within the University of Sydney’s Family Medicine 
Research Centre (FMRCŦ), and is a collaborating unit of the Australian 
Institute of Health and Welfare (AIHWŦ). BEACH is a collaborative study 
between the AIHW and the University of Sydney and is conducted under the 
Australian Institute of Health and Welfare Act 1987.41  
BEACH is supported by a consortium of government departments and 
instrumentalities and the pharmaceutical industry. The program is overseen 
by the BEACH Advisory Board that consists of representatives of the 
AGPSCC, the AIHW, each of the contributing organisations, the Royal 
Australian College of General Practitioners (RACGPŦ), the Australian Medical 
Association (AMAŦ), the Consumers Health Forum (CHFŦ), Australian General 
Practice Network (AGPNŦ) (previously Divisions of General Practice, ADGPŦ), 
and the Australian College of Rural and Remote Medicine (ACRRMŦ).41 
Ethics approval 
All of the research processes used in this thesis were approved by the Human 
Ethics Committee of the University of Sydney and the Ethics Committee of the 
Australian Institute of Health and Welfare. 
3.1.1 Aims 
The BEACH program has three primary aims: 
• to provide a reliable and valid data-collection process for general practice 
which is responsive to the ever-changing needs of information users 
• to establish an ongoing database of GP-patient encounterŦ information 
• to assess patient risk factors and health states and the relationship these 
factors have with health service activity.41 
The BEACH methodology, developed from that utilised in the Australian 
Morbidity and Treatment Survey (AMTSŦ) of 1990–9142, is reported below.  
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3.2 BEACH methods (and utilised in this study) 
A rolling, ever changing, random sample of approximately 1,000 recognised 
GPsŦ participates in the study each year. Each GP records details of 100 
doctor–patient encounters of all types on structured paper forms. As 
previously stated, while the BEACH program continues, the methods used 
during this study period, and applicable to this study’s participants, will be 
reported in the past tense from this point onwards. 
3.2.1 The GP sample frame 
The source population for this study included all recognised GPs who had 
claimed a minimum of 375 general practice Medicare itemsŦ in the most 
recently available three-month Medicare AustraliaŦ (formerly Health Insurance 
Commission, HIC) data period. This equates with a minimum of 1,500 
Medicare claims per year and ensured the inclusion of the majority of part-
time GPs while excluding those who were not in private practice but claimed 
for a few consultationsŦ per year.  
3.2.2 Sample size 
Previous research43 utilising the AMTS42 showed that to achieve the most 
efficient sample of GP–patient encounters in terms of statistical power and 
cost, GPs need only provide information on 100 consecutive encounters and 
that a sample of 1,000 GPs would provide reliable estimates of the most 
frequent problems managed and the most frequently prescribed medications. 
Experience gained through the AMTS also showed that reliable estimates for 
the most frequent management practices are gained for most conditions with 
a sample of this size.41 While BEACH recruits about 1,000 GPs per year, I 
decided to include GP participants from a longer time period as the increased 
sample size would improve the statistical power after analyses and therefore 
the potential for more reliable estimates. 
3.2.3 Drawing the sample 
The Primary Care Division of the Australian Government Department of 
Health and Ageing (DoHAŦ) provided a randomised sample of 1,200 GPs 
every three months throughout the study period, from data supplied to them 
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by Medicare Australia. Data elements about the sampled GPs supplied by the 
Department included: 
• name 
• major practice address 
• contact telephone number 
• age and gender 
• year and country of basic qualification 
• years in general practice 
• number of Medicare claims in the previous 12 months and in the previous 
quarter (also referred to as ‘activity level’Ŧ). 
3.2.4 GP recruitment 
During the data collection period for this study, the randomly selected GPs 
were approached by letter at a rate of 60 per week. The letter outlined the 
study aims and method with particular reference to the time and work each 
doctor would need to contribute. The GPs were also informed about the 
benefits they would receive in return for their participation. A copy of the 
approach letter used for the sample of GPs in this study is attached as 
Appendix 2. 
To maintain GP recognition status (‘vocational registration’) with Medicare 
Australia, GPs are required to undertake quality assurance and continuing 
professional development (QA & CPDŦ) educational activities over a three 
year period called a Triennium. Different activities have varying point values 
and GPs are required to undertake activities over the triennium that total to a 
prescribed number determined by the RACGP. A minimum number of points 
are required for ‘Category 1’ activities, which are educational activities that 
explicitly encompass a quality assurance learning cycle. ‘Category 2’ activities 
are undertaken for the purposes of ‘upskilling’, and are educational activities 
which do not explicitly encompass a quality assurance learning cycle.44 
BEACH qualifies as a QA & CPD activity and each participating GP earns 
clinical audit points towards their QA Category 1 requirements. For the 
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triennium during which these data were collected the GPs were awarded a 
portion (35 points) of their total requirement for Category 1 pointsŦ (60 points) 
on completion of the 100 encounter formsŦ, and a further 15 points for 
completing a follow-up questionnaire on patient smoking behaviour and 
alcohol consumption, six months after the original recording. The GPs also 
received an analysis of their own results compared with those of nine other 
unidentified practitioners who recorded at approximately the same time. 
Comparisons with the national average and with targets relating to the 
National Health Priority Areas were also made.45 The GPs in this study period 
earned a further 15 Category 1 points for completing a short questionnaire 
relating to the analysis of their results. 
Approximately 25 GPs per week were recruited to record over the 66 weeks 
of the study period. GPs were recruited several weeks ahead throughout the 
16 months and constituted a rolling ever-changing sample. 
Approximately 10 days after the approach letter was posted the GP was 
contacted with a follow-up telephone call by a trained recruiter who invited 
them to participate in the study and answered any questions raised by the 
GP. Those who agreed to take part were set an agreed recording date 
approximately two to three weeks ahead. The GP was then allocated an 
individual GP identification number and their details were entered into a 
database for GP participants.41 
3.2.5 Data Collection 
A research pack was sent to the participants about ten days prior to their 
planned recording date. The research pack contained: 
• a pad of 105 recording forms (to allow for some error) (Appendix 3 is a 
single example) 
• a GP profile questionnaireŦ (Appendix 4) 
• a covering letter (Appendix 5) 
• a project information sheet describing the study (Appendix 6) 
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• a detailed set of instructions for completing the patient encounter form with 
a sample of a completed form (Appendix 7) 
• a height and weight measure conversion (to metric) chart (for metric data 
from which body mass index (BMIŦ) can be calculated) (Appendix 8) 
• a pictorial ‘standard drinks’ chart to help patients answer questions on 
alcohol intake (Appendix 9) 
• a reply-paid envelope for return of the completed pad and GP profile  
• two copies of a patient information sheet. (Appendix 10). 
GPs were instructed to have the patient information sheet shown to each 
patient as they entered the waiting room (reception staff usually undertake 
this activity). It summarised the program and gave patients the option of 
having (or not having) the unidentified details of their consultation included in 
the survey by informing the GP of this decision. GPs were only required to 
obtain verbal consent from their patients.  
A telephone reminder was made to each GP participant on the agreed starting 
date to check that the research kit had arrived, to remind them to start, and to 
answer any questions the GP may have had. A ‘free call’ phone number was 
also made available to the GPs to ring the research team about any aspect of 
the study.  
When the 100 forms were completed the GP returned the recording pad with 
the GP survey questionnaire in the reply-paid envelope to the AGPSCC. If a 
pad was not returned within two weeks of the recording commencement date, 
the GP was again contacted by telephone to check on their progress and was 
encouraged to return the pad as soon as possible. Follow-up of non-returns 
continued for five phone calls over ensuing weeks. Where a pad had not been 
returned after three months the GP was considered to have ‘dropped-out’ of 
the program and was so informed.  
3.2.6 Data elements 
BEACH includes three inter-related data collections: patient encounter data; 
patient risk factors and health states (which are not investigated in this thesis); 
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and GP characteristics. An example of the GP-patient encounter form used in 
this study period is attached as Appendix 3. The GP and practice 
characteristics were collected on a questionnaire called a GP profile. The GP 
profile questionnaire used in this study period is attached as Appendix 4. 
Encounter data 
An ‘encounter’ is defined as any professional interchange between a patient 
and a GP. An encounter can be ‘indirect’, where there is no face-to-face 
meeting between the patient and the GP but a patient-related service is 
provided that results in action that should be entered into the patient’s record 
(e.g. renewals for prescriptions or referralsŦ, certificates, case conferences), 
or ‘direct’, where a face-to-face meeting of the patient and the GP occurs (a 
consultation).14 
The consultation/encounter 
Encounter data includes information about the encounter itself. The encounter 
is most often a consultation. Data elements relating to the encounter and 
collected on the patient encounter form (Appendix 3) during this study period 
are shown in Figure 3.1. 
 
Ŧ  
 
 
 
 
 
 
 
 
 Figure 3.1 Data elements collected about the consultation /encounter 
Element  Definition and 
format 
Date   Day, month and 
full year of the en-
counter. Free text. 
Start time / Finish time  Free text; for 40 of 
every 100 patients  
Type of encounter 
  
 Direct (face to face)T  
 Medicare item numberT  
 Workers’ compensation paidT  
 State government / other paidT  
 No chargeT  
 Indirect (patient not seen)T   
Tick box 
Free text  
Tick box 
Tick box 
Tick box 
Tick box 
 T Definition of term available in glossary  
Enables  
measurement 
of change over 
time. Enables  
assessment of 
length of  
consultation. 
Provides view 
of the range 
of GP activity 
regardless of 
source of pay -
ment. 
Enables 
measurement 
of GP work-
load not 
claimable 
through Medi-
care. 
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The patient 
Data elements relating to the patient and collected on the encounter form 
(Appendix 3) included those displayed in Figure 3.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Data elements collected about the patient 
Element  Definition and format 
Age 
 
Day, month and full year of 
patient’s birth. Free text. 
Sex  Tick box for ‘male’ or 
‘female’ 
Status to practiceT  
 
‘New’ patient i.e. the  
patient’s fi rst visit to this 
practice. Yes/No tick box. 
Postcode of residence 
 
Postcode of patient’s home 
address. Free text. 
Health care / Benefits 
cardT  
 Unemployed, pensioner, 
low income earner,  
student. Yes/No tick box. 
Veterans’ Affairs 
statusT  
 Patient holds a  
Repatriation health care 
card. Yes/No tick box. 
Non-English speaking 
background statusT  
 The primary language  
spoken in the patient’s 
home is not English. Yes/
No tick box. 
Aboriginal statusT   The patient identifies  
himself or herself as an 
Aboriginal person. Yes/No 
tick box.  
Torres Strait Islander 
statusT  
 The patient identifies  
himself or herself as a  
Torres Strait Islander  
person. Yes/No tick box. 
Patient reasons for the 
encounterT  
 The patient’s view of the 
reasons he/she is consult-
ing the GP. Free text. 
TDefinition of term available in glossary  
Enables deter-
mination of age-
sex distribution 
of patients at 
general practice 
encounters. 
Enables some 
assessment of 
continuity of 
care. 
Enables 
assessment 
of access to 
care. Enables 
measurement 
of socio-
economic   
disadvantage. 
Enables 
assessment 
of cultural 
diversity 
and the  
demand for 
care from 
different 
cultural 
back-
grounds. 
Enables  
assessment  
of demand  
for care. 
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Problems managed at the encounter 
Data elements relating to the problems managed at the encounter, also 
collected on the patient encounter form (Appendix 3), included those 
displayed in Figure 3.3. 
 
 
Figure 3.3 Data elements collected about the problems managed at the encounter 
Element  Definition and format 
Diagnosis / problemT  
(up to 4 per patient) 
 A statement of the provider’s 
understanding of a health prob-
lem presented by a patient. 
GPs are instructed to record at 
the highest ’diagnostic’ level 
possible from the information 
available at the time. This may 
be described as a disease, a 
symptom or a process of care. 
Free text. 
Problem status (for 
each problem) ‘New’T  
Vs ‘Old’T  
 New = the problem is new to 
the patient; a new episode of a 
recurrent problem (eg URTI) 
Old = previous treatment by 
any doctor for this chronic prob-
lem or this episode of an acute 
problem. Tick box for ‘new’ or 
‘old’ 
Work-relatedT  Whether the symptom or  
problem resulted (in the GP’s 
option) from a work-related ac-
tivity (irrespective of the source 
of payment for the  
encounter). Tick box. 
T Definition of term available in glossary  
Enables col-
lection of 
information 
about multi-
ple problems 
and co-
morbidity 
managed. Identifies 
whether the 
problem  
has been 
managed 
previously by 
a medical  
practitioner. 
Enables  
estimation of 
work -related 
injuries man-
aged by GPs. 
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Management for each problem 
Data elements relating to the management of each problem at the encounter, 
also collected on the encounter form (Appendix 3), were those displayed in 
Figure 3.4. 
Figure 3.4: Data elements collected about the management of each problem at the encounter 
Element  Definition and format 
Medication/s -  
• Prescribed 
• Advised for over-the- 
  counter (OTC) purchase 
• Supplied by the GP 
• Brand nameT  
• FormT  
• StrengthT  
• RegimenT  
• Medication statusT  
• Number of repeats 
 Medications that were pre-
scribed / advised / supplied 
at this encounter only—not 
those previously prescribed 
by this or another practitio-
ner. Up to 4 medications per 
problem can be recorded. 
 
Tick box for OTC, GP  
supply, and medication 
status. 
Free text for all other ele-
ments   
Other treatments 
• Procedures 
• Counselling, advice,   
   education 
 Non-pharmacological treat-
ments provided at this en-
counter only. Up to 2 proce-
dures per problem can be 
recorded. Free Text. 
Referrals 
• Specialists 
• Hospitals 
• Allied health                    
   professionalsT  
 Type of specialist(s) or al-
lied health professionals to 
whom referral has been 
made; referrals for clinical 
measurements such as  
spiromet ry .  
Free text, and circle number 
for problem(s) to which each 
referral relates. 
Imaging / other tests 
• Diagnostic radiology 
• Ultrasound 
• Comput’ed tomography 
• Nuclear medicine imaging 
• Magnetic resonance  
   imaging 
 Name of the imaging test 
(e.g. X-ray) and body site. 
Up to 2 imaging tests per 
encounter. 
Free text, and circle number 
for problem(s) to which each 
imaging test relates. 
Pathology 
• Single tests (e.g. 
HbA1CT ) 
• Sets of tests (e.g. Full 
Blood Count) 
 Details of up to 5 tests or 
batteries of tests undertaken 
or ordered at the encounter. 
Free text, and circle number 
for problem(s) to which each 
pathology test relates. 
 T Definition of term available in glossary  
Enables  
determination of  
pharmacological 
treatments and  
calculation of pre-
scribed daily dose 
for all medications 
prescribed at the 
encounter, and 
provides a  
measure of ad-
vice for non-
prescription  
medications. 
Enables  
measurement of 
proportion of 
problem manage-
ment that is non-
pharmacological 
and determina-
tion of types of 
managements 
being provided. 
Enables 
assessment 
of GP intent 
regarding 
utilisation of 
diagnostic 
services in 
the care of 
the patient. 
Enables 
assessment 
of GP intent 
regarding 
utilisation of 
these  
services. Enables 
assessment 
of GP intent 
regarding 
utilisation of 
imaging 
services in 
the care of 
the patient.  
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Patient risk factors and health states 
Supplementary Analysis of Nominated Data (SAND) 
A section at the bottom of each patient encounter form is called the 
Supplementary Analysis of Nominated Data (SANDŦ) and investigates 
aspects of patient health or health care delivery in general practice that are 
not covered by the encounter-based information (see Appendix 3). The SAND 
section and methodology are described in detail elsewhere46 but were not 
utilised in this study, with one exception. Forty of the forms in each GP 
research pad were used to record the starting time and the finishing time for 
the encounter, to determine its length in minutes.  
The BEACH relational database 
The BEACH relational database is described diagrammatically in Figure 3.5. 
Note that all variables can be directly related to GP and patient characteristics 
and to the encounter. Reasons for encounterŦ have only an indirect 
relationship with problems managed. All types of management are directly 
related to the problem being treated.47 
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Figure 3.5: The BEACH relational database 
Management of each problem 
The encounter 
• date 
• direct (face to face) 
⎯ Medicare item number(s) 
claimable 
⎯ workers compensation 
⎯ other paid 
⎯ no charge 
• indirect (e.g. telephone) 
• start time – finish time
The patient 
• age and sex 
• practice status (new/old) 
• health care card status 
• Veterans’ Affairs card status 
• postcode of residence 
• NESB/Indigenous status 
• reasons for encounter 
Patient risk factors 
• body mass 
• smoking status 
• alcohol consumption  
Problems managed 
• diagnosis/problem label 
• problem status (new/old) 
• work-related problem status 
Medications (up to four per problem) 
• prescribed 
• over-the-counter advised 
• provided by GP 
⎯ drug class 
⎯ drug group 
⎯ generic 
⎯ brand name 
⎯ strength 
⎯ regimen 
⎯ number of repeats  
⎯ drug status (new/continued) 
Other treatments (up to two per 
problem) 
• therapeutic procedures 
• counselling 
Other management 
• referrals (up to two) 
⎯ to specialists 
⎯ to allied health professionals 
⎯ hospital admissions 
• pathology tests ordered (up to five) 
• imaging ordered (up to three) 
GP characteristics 
• age and sex 
• years in general practice 
• country of graduation 
• postgraduate GP 
qualifications 
• size of practice 
Practice characteristics 
• practice size 
• practice location 
• practice accreditation status 
• practice nurse available 
• after-hours arrangements 
• bulk billing policy 
• computer availability 
• teaching practice 
 
GP profile data 
The one page GP profile questionnaire (Appendix 4) collected information 
about both the GP and the practice. Characteristics included are highlighted in 
Figure 3.6. As GPs may work at multiple practices, they were instructed to 
record the characteristics or their major practice address. 
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 Figure 3.6 Data elements collected about the characteristics of each GP and their practice. 
Element  Definition and format 
Age  GP’s age in years. Number only. Free text. 
Sex  GP’s gender. Circled option for ‘male’ or ‘female’ 
Years in practice  
The number of years spent in general practice. Number only. 
Free text. 
Year of graduation  
Year of graduation for primary medical degree. Number only. 
Free text. 
Consultations in language 
other than English  
Proportion of consultations conducted in a language other than 
English.  Circled options numbered 1 to 4. 
GP registrar/training 
status  
Status of the GP as currently undertaking a postgraduate general 
practice training program.  Circled option Yes/No. 
Dept of Veterans’ Affairs 
registration status  
GP’s status as currently registered with the DVA to provide care to 
DVA health concession card holders. Circled option Yes/No. 
FRACGP status  
Status of the GP as a Fellow of the Royal Australian College of 
General Practitioners.  Circled option Yes/No. 
Number of general prac-
tice sessions usually 
worked per week.  
Number of sessions worked by the GP where a session is  
defined as approx. 4 hrs e.g. a morning session.  Number only. 
Free text. 
Hours worked per week 
in direct patient care  
Number of hours worked by the GP per week including direct pa-
tient care, and other services.  Number only. Free text. 
Work undertaken by GPs 
in another clinical setting  
Other clinical settings where the GP has provided patient care in 
the previous four weeks.  Circled options numbered 1 to 4. 
Size of practice  Number of GPs working in the practice.  Number only. Free text. 
Location of practice  Postcode of major practice address.  Number only. Free text. 
Accreditation status  
Whether the practice has undertaken an accreditation process 
against the RACGP Standards.  Circled option Yes/No. 
Practice nurse   
Whether there is a practice nurse at the major practice address. 
Circled option Yes/No 
After hours care arrange-
ments  
Normal after-hours care arrangements of the practice.  Circled  
options numbered 1 to 6. 
Bulk-billing status  
Proportion of patients for whom the consultation is bulk-billed to 
Medicare 
Status as a teaching 
practice  
Whether the practice is a teaching practice for undergraduates or 
registrars.  Circled options Numbered 1 to 3. 
Work undertaken in an 
ACCHS  
Proportion of BEACH consultations undertaken in an Aboriginal 
Community Controlled Health Service.  Circled options numbered 
1 to 3. 
Computer availability  
Availability of computers at the practice and the functions available 
on these computers.  Circled options numbered 1 to 6. 
Computer use by  
individual GPs  
Purposes (clinical or other) for which computers are actually 
used by individual GPs at the practice.  Circled options  
numbered 1 to 3. 
Prescribing/health re-
cord software used  
Prescribing / health record software available / used at the  
practice.  Free text. 
Place of graduation  
Country the GP graduated from the primary medical degree. 
Free text. 
GP character-
istics  
collected in 
BEACH and 
utilised in this 
study. 
Practice 
character-
istics  
collected in 
BEACH and 
utilised in 
this study. 
Character-
istics intro-
duced to 
the GP  
Profile 
question-
naire  
specifically 
for this 
study. 
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3.2.7 Data entry and classification 
Data were directly entered into a Microsoft® Access 9748 database designed 
specifically for BEACH, by trained clinical coding staff. The database was 
designed with keyword activated pull-down pick lists and automated 
classification as described below. 
Classification of data 
Patient reasons for encounter, the problems managed at the encounter, 
therapeutic procedures, other non-pharmacological treatments, referrals, 
pathology and imaging ordered were coded using ICPC-2 PLUSŦ.49 This is an 
interface terminology classified according to the International Classification of 
Primary Care (Version 2) (ICPC-2Ŧ),50 a product of the World Organization of 
Family Doctors (WoncaŦ). The ICPCŦ is regarded as the Australian standard 
for data classification in primary care51 and is included in the World Health 
Organization Family of Classifications.52  
The International Classification of Primary Care 
ICPC has a bi-axial structure with 17 chaptersŦ on one axis (each with an 
alphabetic code) and seven componentsŦ on the other (numeric codes). 
Chapters are based on body systems, with additional chapters for 
psychological and social problems. Components including symptoms and 
complaintsŦ and diagnoses are independent in each chapter and can be used 
for patient RFEsŦ or for problems managed. Other components cover 
processes of care and diagnostic screening and prevention.45 The structure of 
ICPC-2 is shown in Figure 3.7 below. 
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Chapters 
Components A B D F H K L N P R S T U W X Y Z 
1. Symptoms, complaints                   
2. Diagnostic, screening, prevention                  
3. Treatment, procedures, medication                  
4. Test results                  
5. Administrative                  
6. Other                  
7. Diagnoses, disease                  
A General L Musculoskeletal U Urinary 
B Blood, blood-forming N Neurological W Pregnancy, family planning 
D Digestive P Psychological X Female genital 
F Eye R Respiratory Y Male genital 
H Ear S Skin Z Social 
K Circulatory T Metabolic, endocrine, nutritional  
  
Figure 3.7: The structure of the International Classification of Primary Care—Version 2  
 (ICPC–2) 
 
ICPC-2 PLUS 
In 1995, recognising the need for a coding and classification system for 
general practice electronic health records, the Family Medicine Research 
Centre (then Unit) developed an interface terminology classified according to 
the ICPC. These terms were derived from those recorded on more than half a 
million encounter forms by GPs participating in the AMTS45 and in later quality 
assurance options based on it. Each term has its own extended code to allow 
greater specificity in data entry and ensure higher inter-reliability between 
secondary coding staff. It also facilitates analyses of information about more 
specific problems when required through the ICPC-2 Classification.49 
Classification of pharmaceuticals 
Pharmaceuticals prescribed or provided and those advised by the GP for 
over-the-counter purchase were coded and classified according to an in-
house designed classification called the Coding Atlas for Pharmaceutical 
Substances (CAPSŦ). This classification has a hierarchical structure that 
facilitates analysis of data at a variety of levels including medication class, 
medication group, generic composition and brandŦ and product name. CAPS 
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is mapped to the Anatomical Therapeutic Chemical (ATCŦ) classification53 
which is the WHOŦ and Australian standard for classifying medications at the 
generic level. Each generic code in CAPS is mapped to the corresponding 
ATC fifth level code, and all brand names from the one generic are mapped to 
the same ATC code. This allows data to be analysed using the ATC 
classification or the CAPS classification, or both.54 StrengthŦ and regimenŦ are 
independent fields which, when combined with the CAPS code, give an 
opportunity to derive prescribed daily dose for any medication or group of 
medications.45  
3.2.8 Quality Assurance 
For all BEACH data including that collected during this study period, data 
entry staff enter keywords or word fragments and select the required term or 
label to best match the information recorded by the GP, from a pick-list. This 
allows all morbidityŦ and therapeutic data elements to be automatically coded 
and classified by the computer. A quality assurance program has been 
implemented to ensure reliability of data entry. The program includes ongoing 
development of computer aided error checks or ‘locks’ at the data entry stage 
and a series of physical checks of data entered compared with the original 
recording form. For new data entry staff in training, every form is checked by 
senior research staff for the first five pads of 100 recording forms, and then 
one in five forms are checked. As the staff become more experienced one 
form in every ten is checked.45 This process, including the data checking 
procedure, was undertaken for all data provided by the GPs in this study.  
3.2.9 Validity and reliability 
In the development of a database such as BEACH, data gathering moves 
through specific stages: GP sample selection, cluster sampling around each 
GP, GP data recording, and secondary coding and data entry. At each stage, 
the data can be invalidated by the application of inappropriate methods. The 
methods adopted to ensure maximum reliability of coding and data entry have 
been described above. The statistical techniques implemented to ensure valid 
reporting of recorded data are described below. 
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Driver et al demonstrated the extent to which a random sample of GPs 
recording information about a cluster of patients represents all GPs and all 
patients attending GPs.55 Other studies have reported the degree to which 
GP-reported patient RFEs and problems managed accurately reflect those 
recalled by the patient56 and the reliability of secondary coding of RFEs57 and 
problems managed.42 The validity of ICPC as a tool with which to classify the 
data has also been investigated in earlier work.58 These techniques were all 
incorporated in the data collection, data entry and secondary coding to ensure 
validity and reliability in this study. 
3.3 Representativeness  
The extent to which results can be generalised from a sample depends on 
how well the sample represents the population from which it is drawn. 
Random sampling improves the likelihood that a study will be representative, 
because each GP has an equal probability of being selected into the study 
sample. Random sampling error and GP response rates, however, may result 
in some under-representation or over-representation in the sample of certain 
population groups in the final sample.59 
Where a population can be enumerated, inferences about population 
characteristics from a sample can be improved by calculating weights that 
adjust for any under-sampling or over-sampling of particular groups of GPs. 
Weights are assigned by comparing the distribution of those characteristics 
that may influence the final results (e.g. age-group or sex) against the 
distribution in the benchmark population (the sample distribution). Distribution 
weights are calculated as the proportion of each sub-group in the population 
divided by the proportion in the sample. Over-representation in the sample 
results in a weight less than one, under-representation in a weight greater 
than one.59 
When each observation is multiplied by its weight the weighted sample 
distribution will conform to the population distribution. The weights are then 
used to adjust the sample statistic to give a better estimate of the true 
population value. 
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3.3.1 Comparison of BEACH GPs with the GP population 
Each year the characteristics of BEACH participants and the source GP 
population are compared in terms of age, sex, place of graduation (of basic 
qualification), state (where their practice is located), and location in terms of 
the Rural, Remote and Metropolitan Area (RRMAŦ) classification.60 These are 
the only GP characteristics available from the Medicare database regarding 
the source population. 
Statistical comparisons, using the chi-square statistic, are then made between 
BEACH participants and the source population (all recognised GPs in 
Australia who claimed 375 or more general practice Medicare item numbers in 
the previous quarter). DoHA provides information from Medicare Australia 
data for all GPs in the sample frame, for the purpose of this comparison.14 
The GP and practice characteristic data for BEACH participants are drawn 
from their GP profile questionnaire (Appendix 4) and are used to ensure the 
highest reliability, as these data have proved to be more accurate than those 
provided about the GP by DoHA, which are not as recent.  
GP weights 
When the participants are compared with national GP data for the same time 
period (provided by Medicare Australia) the weights are calculated for the 
participants to match the age-sex distribution of all GPs in the source 
population. GP weights are calculated on GP age and sex. As described 
above, where under-representation or over-representation has occurred, 
weights are applied such that the sample more closely reflects the reality of 
the national sampling frame. For example, if male GPs represented 50% of 
the GP population, but only 25% of the BEACH sample, then male GPs in the 
sample would receive a weight of 2 (0.5/0.25) and females would receive a 
weight of 0.67 (0.5/0.75). Weightings for age were stratified by sex, age 
weights being calculated separately for male and female GPs.  
3.3.2 Representativeness of the final encounter sample 
Based on previous findings that 100 encounters provide a reliable sample of 
the GP’s patients and practice style43 the BEACH process requires that each 
GP provide details of 100 consecutive encounters. However, there is 
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considerable variation in the number of services individual GPs provide in a 
given year and this may impact on the reliability of any estimate due to the 
differences in the sampling fraction for each GP. To illustrate, a GP who 
provides 6,000 services in a given year should make a greater contribution to 
any national estimate about encounter activity than a GP who provides 3,000 
services. For this reason, when estimating national activity in general practice, 
post-stratification weights are calculated which reflect the different sampling 
fractions, and encounter details from a BEACH GP who has claimed 6,000 
Medicare services in the previous 12 months are given greater weighting that 
encounters from a GP who claimed 3,000 services. This enables calculation 
of sample weighting that reflects the contribution made by each GP to the 
total number of services for the sample.61 
Encounter weights 
The GP sample weights are used to weight the encounters, based on the 
assumption that the characteristics of the patient encounter are related to the 
characteristics of the GP. It is therefore important to compare the distribution 
of the final weighted sample of patient encounters to the population of general 
practice encounters in Australia, to assess the representativeness of the 
sample encounters. The final encounter weights used in estimating population 
values are calculated by multiplying raw rates by the GP age-sex weight and 
the GP sampling fraction of services in the previous12 months corresponding 
to each annual BEACH data collection period.  
Each year, the DoHA provides the age-sex distribution of patients at all A1Ŧ 
Medicare general practice items claimed during the year, against which the 
age-sex distribution of patients at the final weighted BEACH encounter 
sample is compared.45 
Note – The section above describes how and why weighting is applied each 
year for the sample of BEACH GPs who have recorded data during that year. 
The Medicare Australia data supplied for comparison with BEACH data are 
only provided for the specific BEACH 12 month data period. As participants 
and data combining two separate BEACH data collection periods were used 
in this thesis (participants from the latter third of 2003–04 and all participants 
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from 2004–05), it is not methodologically sound to apply weighting to these 
GPs and data. An unweighted comparison of the study participants with all 
active recognised GPs in Australia is presented in Chapter 4 (Table 4.1). An 
unweighted comparison of the age-sex distribution of (BEACH) patients 
attending encounters in this study with that of patients for whom MBS A1 
services were claimed during 2004 is also presented in Chapter 4 (Table 4.2).  
3.4 Statistical methods used in BEACH 
The analysis of the BEACH database is conducted with SAS versions 6.1262 
and 8.263 and the primary unit of analysis is the encounter. Proportions (%) 
are used only when describing the distribution of an event that can arise only 
once at a consultation (e.g. patient age, patient sex or item number) or to 
describe the distribution of events within a class of events (e.g. problem A as 
a percentage of total problems). Rates per 100 encounters are used when an 
event can occur more than once at the consultation (e.g. RFEs, problems 
managed or medications).59  
Rates per 100 problems are also used when the analysis is problem-based 
because a management event can occur more than once per problem 
managed (e.g. when prescriptions, referrals, tests etc are provided). In 
general, however, the results present the number of observations (n), the rate 
per 100 encounters and the 95% confidence intervals (CIs).59 Non-
overlapping CIs indicate a statistically significant difference (at the <5% 
confidence level) between the results being compared. 
The collection of information about patients is often easier, more appropriate 
and more cost effective if the support of a number of GPs is enlisted. These 
GPs provide access to a number of patients. This type of sampling is called 
‘cluster sampling’ as clusters or groups of patients around a GP are used for 
the investigation.64 However, patients around a GP tend to have a degree of 
similarity in some characteristics so it is important that sample size estimates 
consider the differential clustering effect for the different variables under 
investigation. The BEACH study is essentially a random sample of GPs, each 
providing data about a cluster of encounters. Cluster sampling study designs 
violate the simple random sample (SRS) assumption because the probability 
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of an encounter being included is a function of the probability of the GP being 
selected.64 
There is also a secondary probability function of particular types of encounters 
being included in the GP’s cluster (associated with the characteristics of the 
GP or the type and place of the practice). In addition, there will be inherent 
relationships between encounters from the same cluster. Together these 
design effects of a cluster sample usually result in decreased precision of 
national estimates.59 
Therefore, when a study design other than SRS is used, analytical techniques 
should be employed that consider the study design, and reflect the increased 
uncertainty around the estimates. The BEACH study has demonstrated 
appreciable design effects that need to be adjusted for in reporting the 
precision around any estimates.65 In standard BEACH reporting, and in this 
thesis, the standard error calculations used in the 95% confidence intervals 
accommodate both the single-stage clustered study design and sample 
weighting according to Kish’s66 description of the formulae. In this thesis, SAS 
V6.1262 was used where programs previously written could be used for some 
of these analyses. Because of limitations in its capacity to calculate the 
standard error for the current study design, additional programming was 
required (and already built) to incorporate the formulae.59 SAS V8.263 now 
includes procedures that calculate the robust standard error to adjust for the 
intra-cluster correlation of the cluster sample,14 and was therefore used for all 
analytical programs written specifically for this thesis. 
3.5 Additional methodology of this study 
The BEACH method described above formed the basis of this thesis, with 
some additional techniques which are described below. All GPs from the 
BEACH data collection period 28/10/03–28/03/05 were included in the 
research for this thesis. 
3.5.1 GP profile questionnaire 
Preceding this investigation, the computer questions in the GP Profile 
questionnaire focused on the availability of computers in practices, with the 
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question ‘to what extent are computers used at your major practice address?’. 
Options were ‘not at all’; ‘billing’; ‘prescribing’; ‘medical recordsŦ’; ‘other admin’ 
and ‘internet/email’. The doctors were instructed to circle as many options as 
were applicable. On planning this study I realised that the question in this 
format was not sufficiently specific to determine the level to which individual 
GPs used the computers in the practice where they were available. In October 
2003 I redesigned the computer useŦ question to collect these data (Figure 
3.8). 
 
    “To what extent are computers used - 
(i) at your major practice?         (ii) by you (at work)?  
Not at all ............... 1  Not at all ......................... 1  
Billing.................... 2  Test ordering .................. 2 
Prescribing ........... 3  Prescribing ......................3 
Medical Records .. 4  Medical Records ............ 4 
Other Admin......... 5  Internet ........................... 5 
Internet/Email ....... 6  Email ...............................6 
(iii) Prescribing/Health record software used is   –  
_________________________________________” 
 
 
The AGPSCC Management Committee was consulted about this change and 
accepted it, subject to approval from the AIHW Ethics Committee, which has 
responsibility for changes to the BEACH questionnaires on behalf of itself and 
the Ethics Committee of the University of Sydney. Following Ethics approval, 
the newly formatted GP profile (Appendix 4) was distributed to GPs with their 
recording kits. 
3.5.2 BEACH follow-up questionnaire - computerised medical record use  
From various literature accounts, it became obvious that GPs may use 
computers for storing patient information at a variety of levels – some GPs 
use electronic records only, some use a hybrid system of electronic and paper 
records for the same patients, and some store the majority of their patient 
information on paper and only keep some information (e.g. prescriptions, 
referrals, pathology orders etc) in the computer. When designing the initial 
analyses I realised that the new question about computerised medical record 
Shaded area 
indicates changes 
to GP Profile 
questionnaire 
designed for this 
thesis. 
Figure 3.8 Additional questions on GP profile 
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use on the GP profile questionnaire was still not specific enough to determine 
the type or amount of patient information being stored electronically by GPs 
who reported personal use of computers for medical recordsŦ. Consequently, I 
designed a follow-up questionnaire (Appendix 11) intended for all GPs who 
had indicated on their GP profile that they personally used the computer for 
medical records. The questions asked are presented in Figure 3.9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tick box options were offered indicating differing levels of use, ranging from 
all clinical patient information including all test results and correspondence, to 
individual components such as prescriptions, test orders, referrals or 
immunisations. A free text section was also included to allow the GPs to make 
any comments they chose (see Figure 3.9). As with all new data gathering 
processes and tools used in BEACH, or any changes to those existing, the 
follow-up questionnaire was first submitted to the AGPSCC Management 
Committee for comments and approval. It was then submitted to the AIHW 
Ethics Committee which has the responsibility for approving intermittent 
Page 1 of 1. 
- are held on computer (through software); all 
other clinical patient information is recorded 
on paper. Tick as many as apply. We will 
assume that any item not ticked is held on 
paper. 
 (Please tick) 
To what extent did you use a computerised medical record for your patients at the time you 
participated in BEACH? 
 
1. All clinical patient information (eg. patient history, diagnoses/problems, treatments, 
referrals, requests etc) generated by you is held on computer, i.e., no paper records 
generated. All test results and other external correspondence are imported or scanned 
into the computer record.  
 
2. All clinical patient information (eg. patient history, diagnoses/problems, treatments, 
referrals, requests etc) generated by you is held on computer, i.e., no paper records 
generated. All test results and other external correspondence are kept on paper. 
   
 
3. Patient history 
Current problems being managed 
Prescriptions 
    - problem for which script was given  
Tests ordered 
    - problem for which test was ordered             
 Referrals           
Immunisations 
Comments  
_______________________________________________________________________ 
 
 
OR 
OR 
Figure 3.9: Follow-up questionnaire about computerised medical record use 
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changes on behalf of both the University of Sydney and the Institute. 
Following approval, the follow-up questionnaire was posted to all GPs who 
had nominated individual computer use of ‘Medical Records’ on the GP 
profile. 
GPs who returned the questionnaire were divided into those who kept all 
patient information in the computerised medical record made available 
through their clinical software (Option 1 in Figure 3.9) and those who did not 
keep all patient information in the computerised format but kept some in a 
paper record (Options 2 and 3). A detailed analysis of which components of 
their clinical software GPs are using (from the GP profile data) and the type 
and amount of patient information stored in the medical record component of 
their software (from the follow-up questionnaire) is presented in Chapter 4. 
3.5.3 Selection of Quality Indicators 
A previous analysis of BEACH data to compare GPs who hold Fellowship of 
the RACGP with those who do not, was undertaken in 200267. During this 
process a set of quality indicators were developed that were applicable to the 
BEACH data and could be used to assess quality of care by GPs or primary 
care physicians. I have adopted these quality indicators for this study, and 
undertook a literature search to identify other indicators of quality, appropriate 
for a primary care setting. All quality indicators chosen were applied to the 
total sample in Chapter 6. A more detailed description of the methods used to 
select quality indicators, including a hypothesis for each indicator, is 
presented in Chapter 6. 
3.5.4 Pharmaceutical advertisements embedded in clinical software  
Clinical software programs enable GPs to perform a range of clinical functions 
through their computer. While there are a number of software products 
available, the majority of GPs in Australia use one particular clinical software 
package, Medical Director©,68 because its functionality is similar to its peers 
and the cost of the program is heavily subsidised through embedded 
advertising. It is the only clinical software package in Australia which has 
embedded advertising. A licence for this software was purchased to allow the 
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investigation of the effect of software embedded advertising on GP 
prescribing behaviour in Chapter 7.  
The majority of advertisements were sponsored by the pharmaceutical 
industry, but advertising ‘space’ had also been purchased by medical 
indemnity insurers, private health insurers, pathology providersŦ, divisions of 
general practice, other non-profit organisations (e.g., the Heart Foundation, 
the National Prescribing Service, Medecins Sans Frontieres), employment 
networks and the Australian Government Department of Health and Ageing. 
During this study period, the types of advertisement included full-screen 
images, displayed when any document was printed by the GP, and strip 
messages, with or without animation. The strip messages cycled through the 
screens during the course of each day at the opening of each patient record 
or the addition of any new item to the patient’s record within the software 
package. Messages were also displayed when accessing each of the tools 
available in the program, such as the cardiovascular monitor, or the product 
information leaflets.  
The software program developers provided a version update quarterly and 
advertisements often changed between versions. The advertisements cycled 
for a month within each version of the software, allowing for three different 
‘sets’ of advertisements to be shown within the quarter.  
While I could ascertain an expected date of a new version’s delivery, and had 
actual recording dates for the patient encounter data from the GPs in this 
study, I could not be certain that the GPs who recorded BEACH within the few 
weeks following the release of the update, actually had an updated version of 
the advertising embedded software installed and in use on the days they 
recorded patient data for BEACH. I could not therefore be certain which set of 
advertisements the GP was exposed to during the data collection periods 
which coincided with quarterly updates of the software. This introduced the 
possibility of misclassification error of the exposure variable. 
However, there were several pharmaceutical products that were continuously 
advertised throughout all months of all versions of the advertisement 
embedded software during this study period. I decided to investigate the 
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incidences of prescribing for seven medications that were continually 
advertised throughout all versions of advertisement embedded software for 
the 18 months of the study period. I then compared prescribing ratesŦ, for 
those seven medications, of GPs who were continually exposed to the 
advertisements through the use of their Medical Director© software, and the 
GPs who were not exposed to this form of advertising. More detailed methods 
are presented in Chapter 7. 
3.5.5 Additional statistical methods used in this study 
In this thesis, results are reported in terms of the number of observations (n), 
proportions (%), rates per 100 encounters, rates per 100 problems managed, 
and the 95% confidence intervals. Chi-square statistics were applied to the 
measurement of differences in GP characteristics. Where new programming 
was required, the descriptive analyses performed in this study were 
conducted with SAS version 8.2.63 STATA 8.269 was used for both univariateŦ 
and multivariate analysesŦ. Queries run in Microsoft® Access 9748 were used 
for some analyses in Chapter 4. 
I used general linear modelling to compare the two groups of GPs described 
in each Chapter on a range of outcomes. Potential confounding variables 
were identified and adjusted for, using a series of models built on a 
hierarchical basis, with the ‘families’ of predictors (e.g. the ‘family’ of GP 
characteristics or the ‘family’ of patient characteristics) fitted depending on the 
outcome of interest. The outcomes specific to each topic of interest are 
detailed in each of the associated Chapters, as are the final set of models 
applied for the topic investigated within each Chapter. While the final models 
varied slightly for each topic, the general process for building the models was 
similar and is described below. 
Univariate analysis 
I compared the two groups within each Chapter on variables of interest using 
univariate analyses to identify any relationship between the groups and the 
individual outcome variable. For these analyses, outcome variables were 
collapsed into dichotomous variables (e.g. for the country where GPs attained 
their primary medical degree, there was a multitude of locations which, for 
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ease of analysis, were collapsed into ‘Australia’ versus ‘overseas’). I used 
logistic regression to analyse categorical outcomes and simple linear 
regression to analyse continuous and ordinal variables (e.g. length of 
consultation or patient age distribution). 
In logistic regression the results are expressed as odds ratios where one 
group (e.g. GPs not using a computer for clinical purposes), was used as the 
reference group. If the 95% confidence intervals for the odds ratio do not 
include 1.0, the difference between the groups is statistically significant. An 
odds ratio of 1 implies that the event is equally likely in both groups. For 
example, in Chapter 5, an odds ratio of greater than 1 implies that the event is 
more likely in the group of GPs who use a computer for clinical purposes, 
while an odds ratio of less than 1 implies that the event is less likely in the 
group of GPs who use a computer for clinical purposes. An odds ratio of 1.3 
(OR=1.3) is interpreted as: this event in 1.3 times more likely for GPs who use 
a computer for clinical purposes than for GPs who do not. An odds ratio of 0.7 
(OR=0.7) is interpreted as: this event is 0.7 times less likely to occur for GPs 
who use a computer for clinical purposes than for GPs who do not. 
For the multiple regression used to analyse continuous variables, the results 
are reported in terms of the regression coefficient and P values. A p value of 
<0.05 indicates a significant effect of that predictor on the outcome. 
Multivariate analysis and models used 
The multiple variables collected in BEACH necessitated adjustment for 
multiple potential confounding variables. For example, there is a need to 
determine what characteristics of the GPs or their practices should be 
considered or adjusted for in order to determine whether differences in 
patients/problems/managements found in the descriptive analyses can be 
explained by the significant differences in the GPs or their practices, or are 
independent of these. Differences were identified using the chi-square test 
and simple logistic regression. To select the best regression model for each 
group of characteristics, the model was reduced using stepwiseŦ elimination - 
a procedure whereby all predictor variables are fitted into the model, and the 
non-significant variables are eliminated in turn, starting with the least 
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significant variable, and the model refitted. The process stops when all the 
retained regression coefficients are in some sense, significant.70 As previously 
mentioned, the outcomes investigated and the variables included in the final 
models are detailed within each Chapter. However, development of the 
models followed the same process, which is described below and presented 
graphically in Figure 3.10.  
Model Type A – adjustment for GP and practice characteristics 
For patient outcomes, GP and practice characteristics were compared for the 
two GP groups being evaluated in each thesis chapter. In accordance with the 
stepwise elimination process, I built a series of models on a hierarchical basis 
with predictors fitted and reduced in ‘families’. The families of predictors 
entered into the model depended on the outcome of interest. Predictor 
variables highly correlated with other predictors already in the model or on the 
causal pathway to the outcome were excluded from each model. The 
covariates showing some association (p<0.10) with the dependent variable 
were included in the model reduction procedure. The final model included 
covariates that showed an association at p<0.05. Characteristics retained in 
the final model applied to the comparison of patient outcomes are referred to 
in each thesis chapter as Model Type A. The variables retained in the Type A 
model for each Chapter are specified in the chapter specific Methods section. 
As the characteristics retained in the model may vary for each thesis Chapter, 
the final models will be labelled according to the Chapter. For example, the 
characteristics retained in the Type A model for Chapter 5 will be referred to in 
Chapter 5 as Model 5A.  
Model Type B – adjustment for GP and practice characteristics (as per 
Model A) and patient characteristics 
For morbidity outcomes, i.e. the problems managed at the encounter (at ICPC 
Chapter level), a number of patient characteristics were compared for the two 
GP groups being evaluated for each thesis chapter. The denominator was the 
patients attending the sample of GP–patient encounters. The GP and practice 
characteristics (i.e. those covariates ultimately included in Model A) were 
incorporated as covariates in this stage of the modelling. The covariates 
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retained in the final model applied to the comparison of morbidity outcomes 
are referred to in each thesis chapter as Model B.  
An epidemiological approach was taken in the design of Model B, as the 
following elements collected in BEACH about the patient have already been 
found to be associated with clinical care in other studies: patient sex71,72; 
patient age73; Commonwealth Health Care Benefits CardŦ holder status74; 
Veterans’ Affairs Card holderŦ status75; non-English speaking background 
status76; AboriginalŦ or Torres Strait IslanderŦ status77; ‘new patientŦ’ to the 
practice status78. 
The variables retained in the Type B model for each Chapter will be re-stated 
for the convenience of the reader in the Methods section of each Chapter, and 
because the covariates of the Model A component may vary, the model will be 
labelled according to the Chapter. For example, the characteristics retained in 
the Type B model for Chapter 5 will be referred to as Model 5B. 
Model Type C – adjustment for GP, practice and patient characteristics 
(as per Model B) and morbidity 
Management actions are highly associated with the morbidity being managed 
and so the presence of morbidity in any ICPC Chapter was adjusted for in the 
Type C model. Where the outcome was problem management, i.e. the 
managements provided at the encounter, the denominator was the sample of 
GP-patient encounters. The GP, practice and patient characteristics (i.e. 
those covariates ultimately included in Model B) were incorporated as 
covariates in this stage of the modelling. The covariates retained in the final 
model applied to the comparison of patient morbidity outcomes are referred to 
in each Chapter as Model C. The variables retained in the Type C model for 
each Chapter (where used) will be re-stated for the convenience of the reader 
in the Methods section of each Chapter, and the model will be labelled 
according to the Chapter. For example, the characteristics retained in the 
Type C model for Chapter 5 will be referred to in Chapter 5 as Model 5C. 
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I have described the modelling process using examples where the GP–patient 
encounter was used as the denominator, e.g. the rate of prescriptions per 100 
encounters. However, in some instances the denominator used was the 
number of problems managed e.g. the rate of prescriptions per 100 problems. 
This changes depending on the outcome being investigated e.g. in the quality 
indicator section (Chapter 6) some investigations required the encounter base 
(lifestyle counselling per 100 encounters) and others required the problem 
base (counselling per 100 contacts with diabetes problems). 
Modelling for quality indicators 
I used a series of models structured along the above lines to analyse results 
for the quality indicators investigated in this thesis. Based on the GP-patient 
encounters, the analyses were performed on sub-samples (of encounters or 
problems) that differed according to the criteria for each quality indicator. The 
outcomes were continuous variables expressed as rates per 100 sub-sample 
encounters or per 100 sub-sample problems, e.g. rates of antibiotics 
prescribed per 100 contacts with upper respiratory tract infection; rates of 
Figure 3.10 Data elements adjusted for at various levels of modelling 
Model  Confounding variables 
adjusted for 
Model A — adjusting to 
determine i f descriptive 
differenc es found in pa-
tients can be explained 
by GP/practice charac-
teristics 
 GP characteristics and 
practice characteristics 
(affect patients, morbidity 
and managements  
provided). 
Model B — adjusting to 
determine i f descriptive 
differenc es found in pa-
tient morbidity can be 
explained by GP/
practice or patient char-
acteristics 
 GP characteristics,  
practice characteristics 
and patient characteris-
tics (affect morbidity and 
managements provided). 
Model C — adjusting to 
determine i f descriptive 
differenc es found in 
managements provided 
can be explained by GP/
practice, patient or mor-
bidity characteristics. 
 GP characteristics,  
practice characteristics, 
patient characteristics, 
and morbidity (affect 
managements provided). 
Model A is 
used when 
patients are 
the outcome. 
Model B is 
used when 
morbidity is 
the outcome. 
Model C is 
used when 
management 
is the out-
come. 
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HbA1cŦ tests ordered per 100 diabetes problems managed. More detailed 
methods for the modelling of quality indicators are presented in Chapter 6. 
A second analysis was performed in Chapter 6 to examine whether the use of 
a computer specifically for test ordering had any effect on outcomes involving 
test ordering. A more detailed methodology is provided in Chapter 6 for this 
extra investigation. 
Power calculations 
Despite the use of random samples and adjustments for cluster effects, there 
is always a chance that samples will appear to confirm or disprove a 
hypothesis when in reality the opposite is true. The chances of incurring either 
a Type I or Type II errorŦ are lessened when sample sizes are appropriate. If 
too few subjects or cases are used, a hypothesis test will have too little 
statistical power to reliably detect a significant effect. In order to determine the 
extent to which any conclusions formulated from the results emerging from 
these analyses are reliable, statistical power calculations were performed. I 
decided that a power value of 0.8 would be adequate as a standard for 
hypothesis testing in this thesis.  
I undertook power calculations using Stata 8.0 (comparison of proportions) to 
determine the reliability of results between the two GP groups at α=0.5 level. 
Power calculations were performed whenever the assignment of GPs to 
groups changed. For example: in Chapter 5 GPs were assigned to groups on 
the basis of their use of a computer for clinical activity; in Chapter 6 they 
remained in their Chapter 5 groupings for the majority of the indicators 
analysed, and then were reallocated to groups on the basis of their use of the 
test ordering function of their software; in Chapter 7 their group assignment 
was determined by their use of Medical Director© software.  
A priori calculations were undertaken on the major samples prior to specific 
investigations. At the outset I had no published research on which to base the 
estimates of how many GPs in each of these groups would prescribe a 
branded medication, so in Chapter 7, post hoc calculations were also 
undertaken on the sub-groups of GPs who prescribed medications from the 
ATC classes or groups for each of the selected medications for which 
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advertised brand prescribing was being compared. Some of the resulting 
samples appeared small and consequently introduced caution regarding their 
statistical power. The use of post hoc power calculations is controversial – 
some statisticians believe they are inappropriate, while others feel the 
greatest reliability comes from calculations involving actual numbers rather 
than estimates. Jacob Cohen supported their use and provided tables for 
each of the major statistical tests that indicate a study’s power given the type 
of test, the significance criterion, the study’s actual sample size, and an 
estimate of the effect size being investigated.79 His seminal work reviewing 
articles in the 1960 issue of the Journal of Abnormal and Social Psychology 
was undertaken using post hoc power calculations of the articles reviewed.80 
The results of all power calculations are reported in individual Chapters.  
Group variables of interest 
As previously explained, several topics of interest were examined through the 
sample of GPs in this study. The GPs were reorganised into different sub-
samples in each Chapter according to the topic under investigation and their 
status according to that topic. Similarly, the group variables of interest also 
changed according to the topic under investigation. 
In Chapters 5 and 6 the group variable for all models was clinical computer 
use status. GPs not using computers for clinical purposes made up the 
reference group against which the group who use their computer for clinical 
activity (the experimental group) was compared. In the second part of Chapter 
6 the group variable was the use of a computer for ordering tests. GPs not 
using computers for test ordering was the reference group against which the 
group who did order tests through their computer was compared. 
In Chapter 7 the group variable for all models was the use of software 
containing embedded advertising. GPs not using advertising embedded 
software made up the reference group against which the group who use 
advertising embedded software (the experimental group) was compared. 
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Concession to size of this thesis 
The results section of Chapter 5 includes a full set of tables showing all the 
descriptive analyses for the two GP groups. As there are 33 tables involved in 
reporting the results of both univariate and multivariate comparisons, I have 
included the full set of these tables in this Chapter only, in order to show the 
process undertaken for other Chapters. In subsequent Chapters these 
descriptive analyses were performed but only those characteristics retained in 
the final model and adjusted for in the regression analysis are reported, as are 
the results of univariate and multivariate analyses. To report the full 
descriptive analyses of the GP groups in all Chapters would result in this 
being a thesis in volumes. 
3.6 Ethics approval 
All of the research processes used in this thesis were approved by the Human 
Ethics Committee of the University of Sydney and the Ethics Committee of the 
Australian Institute of Health and Welfare. 
In summary 
This description of the methods should be born in mind throughout this thesis. 
In each Chapter I will present additional, more specific methodology applied 
for that section, determined by the variables being examined and the 
categorisation of the participants. For example, the investigation of differences 
in pathology ordering (as a quality indicator in Chapter 6) occurs between 
GPs who use their computer for test ordering and those who do not; the 
investigation of the influence of embedded advertising on prescribing 
behaviour (Chapter 7) occurs between GPs who use Medical Director© 
Software and those who do not. Each Chapter also carries a description of the 
type of statistical modelling used to carry out the investigation of interest 
therein. 
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CHAPTER 4 
 
COMPUTERS IN GENERAL PRACTICE – WHO’S 
USING THEM AND HOW? 
4.1 Background 
As previously described, computers were initially used in general practice for 
administrative purposes, but over the past decade they have provided GPsŦ 
with alternate methods by which to prescribe, refer, order investigations, 
receive test results, record and store clinical data and access assistance with 
clinical decisions.  
Having a computer available at the workplace does not necessarily assure its 
use. There are many functions available to the GP through their practice 
software, and GPs are free to use all, some or none of these functions in their 
clinical activity. Historically, GPs have had mixed feelings about the 
introduction of a computer into the consulting room which is one reason why 
uptake was slow prior to the use of government incentives in the late 1990’s. 
The reasons for GP reticence vary but some persistent themes have emerged 
from the literature. Cost versus benefit is one issue – some clinicians question 
whether the high initial cost of implementing computers coupled with the 
ongoing expenses of updating hardware and software will result in long term 
benefits.81-84 This is particularly a burden for solo GPs or small practices, 
where the total cost has to be born by one, or a few, individuals.85 A 2005 
study by Miller et al. found that while some practices absorbed the costs over 
a relatively short time period, other practices experienced considerable 
financial risks.86  
The time cost of practice disruption is also a concern, particularly in initial 
stages, as both clinicians and staff learn their way around often complex 
applications and programs.81-83 The initial learning stage can take some 
months as the technology can be difficult to use because of ‘multiplicity of 
screens, options, and navigational aids’.85 Clinicians have reported spending 
more time with patients in this learning stage, and more time with patients 
means longer working days, fewer patients seen, or both.85 Another area of 
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initial time cost is computer installation. The hardware and software are not 
usable ‘straight from the box’.85 A lot of time-consuming activity is required to 
install these products, which again is particularly burdensome for solo GPs or 
those in small practices.  
Cultures and beliefs affect the success of technology adoption. Introducing a 
system that is very different from the way things have always been done can 
be a challenge for both doctors and their staff. Two-thirds of GPs (64.6%) in 
Australia are aged 45 years or over14 and their medical training would not 
have included IT instruction. Anderson and Balas (2006) et al. recently 
surveyed primary care physicians in the US and over 50% cited lack of 
sufficient personal IT knowledge as a barrier to implementation.87 Apart from 
their lack of IT knowledge, many of these clinicians may consider data entry to 
be ‘someone else’s job’.81 Convincing staff that the new system will fit well into 
their working environment presents a challenge to clinicians who may not be 
convinced themselves.81,82 Even when there is agreement in the adoption of 
IT as a concept, perspectives differ where clinicians are more clinically 
motivated and managers are more concerned with fiscal or organisational 
issues, initiating potential for conflict over system design.88 Gibson et al. 
(2005) agree that technology is often rejected by the user community, not 
because of inadequacies in the functional capacity of the technology, but 
because successful implementation requires a ‘fit’ between the technology 
and the users’ working patterns.82  
The use of a computer has brought changes to the consultationŦ and to the 
doctor-patient relationship, and this has been a cause of reluctance for IT 
uptake among GPs.89,90 Pringle et al. (1986) found that on average, 
consultations took longer when computers were used91 and Bui et al. (2005) 
reported that the distribution of time interaction between patient and computer 
will be determined by the complexity of the consultation – the clinical functions 
take different amounts of time, and the number of functions used will affect 
the time left to directly interact with the patient.89 Gibson et al. (2005) refer to 
this as the ‘multi-tasking’ a GP now performs within the consultation.82 Booth 
et al. (2004) argue that increasingly sophisticated tasks are being introduced 
via the computer, requiring more of the GP’s attention, and that the quality of 
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the consultation is directly related to the individual GPs ability to multitask at 
this level.92  
From the patient’s perspective, the time spent by the GP with the computer 
limits the patient’s opportunities to both listen and be heard. Patients prefer 
doctors who listen and encourage them to discuss their problems.93 Further, 
while there is evidence that patients are mainly supportive of the introduction 
of computers into their general practice consultations,94 they remain 
concerned about such issues as privacy, security and accuracy.95,96 Patients’ 
acceptance is also dependent on their own cognisance of information 
technology – Als (1997) found that a positive attitude to the GP’s use of a 
desktop computer was mainly governed by the patient’s own understanding of 
the computer’s functions and potentials.97  
Security and confidentiality are areas which also concern GPs. Reasons for 
the failure of the National Innovations Funding Pool Project to develop a GP 
based state-wide data collection network in Queensland (2002) included GPs’ 
concerns about access, electronic transfer of data through internet or email, 
the destination of patient data, how it would be used, and the reliability of the 
‘de-identification’ process.98 Legal issues arising from breach of 
confidentiality, loss of data or malpractice also rate highly on the list of GP 
concerns.81,83 
Individual components of clinical computer use may attract some users more 
than others. The Productivity Commission Report highlighted the high number 
of PIPŦ registered practices with computerised prescribing and electronic 
transfer capacity available.99 The computer also provides alternate avenues 
for GPs to access guidelines, search for evidence to support clinical 
decisions, to prepare and send referralsŦ and order tests. Electronic 
reminders to test patients periodically for preventive or monitoring care, and 
flags to check for contraindications when prescribing are all potentially 
beneficial to the quality of patient care. The potential of such functions (if used 
to their capacity) have allowed the concept of full computerisation within 
practices, and between practices and other health care providersŦ, to grow 
into the possibility of a fully computerised health system. The 
54 
HealthCONNECT and MediCONNECT trials highlighted the issues previously 
raised by Richards et al21 (see Chapter 2, p.11). For an electronically 
connected health system in Australia to be achieved, success will first be 
required in the development of unique patient identifiers, adequate safeguards 
for privacy, consent and access control, and agreed standards in the areas of: 
data elements; terminologies and vocabularies; communication and data 
exchange; storage architecture; documentation and message format; imaging; 
security; and entity identification for providers, facilities, devices etc.5 All of 
these challenges need to be met if NEHTA’sŦ objectives (as described in 
Chapter 2) are to be realised, but even if they are, an interconnected health 
sector cannot exist unless all areas of the health sector are computerised.  
The decision of the Australian Government Department of Health and Ageing 
to cease funding support for the General Practice Computing Group (GPCGŦ) 
in August 2005 suggests an assumption that the goal of computerising 
general practice had been reached, and there is some evidence for this 
assumption. The AC Nielsen report23 found that in 1997, 31% of practices had 
computers. More recent government incentives such as the inclusion of 
computerisation as a component of the PIP* payment18 have increased the 
uptake of computer technology. The Productivity Commission report did not 
state how many practices in Australia were registered with PIP, but did state 
that PIP practices in 2004 covered about 80% of Australian general practice 
patients.99 The report further claimed that 93.2% of these practices were 
prescribing electronically and 92.0% were using computers to send and/or 
receive data. In March 2003, data from the national BEACHŦ program showed 
that the proportion of GPs with a computer available at the practice had risen 
to 93.7%77 and that 98% of participants from accredited practices had 
computers available (unpublished data). By July 2003, 87% of the estimated 
6,000 practices in Australia had undertaken accreditationŦ against the 
standards of the RACGPŦ.12 This, coupled with the proportion of PIP practices 
reported by the Productivity Commission to be prescribing and transferring 
data electronically, may have produced a view of a ‘computerised’ general 
practice workforce. However there is little evidence of how computers are 
actually being used in the more than 90% of practices where they are 
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reported to be available, of what clinical functions they are using, and to what 
extent GPs are taking full advantage of the computer as a clinical tool. 
4.1.1 Aim 
The aim of this Chapter is to investigate the availability of computers to GPs 
at their major practice address, to determine the purposes for which these 
computers are used, and the proportions of individual GPs who use their 
computer for any, or all, of a range of clinical activities.  
4.2 Methods 
The methods utilised for this chapter are those of the BEACH methods 
described in Chapter 3, and the following.  
4.2.1 The GP Profile questionnaire 
As previously described, in October 2003 I designed additional questions for 
the GP Profile questionnaireŦ (Appendix 4) to investigate the clinical computer 
use of individual BEACH GPs. Preceding this investigation, the GP Profile 
questionnaire focused on the availability of computers at the major practice 
address. Figure 3.8 is shown again here for convenience. 
 
“To what extent are computers used - 
(i) at your major practice?         (ii) by you (at work)?  
Not at all ............ 1  Not at all ......................... 1  
Billing ................. 2  Test ordering .................. 2 
Prescribing......... 3  Prescribing ......................3 
Medical Records 4  Medical Records ............ 4 
Other Admin ...... 5  Internet ........................... 5 
Internet/Email .... 6  Email ...............................6 
(iii) Prescribing/Health record software used is   –  
_________________________________________” 
Figure 3.8: Additional questions on GP profile 
 
Shaded area 
indicates changes 
to GP Profile 
questionnaire 
designed for this 
thesis. 
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4.2.2 The follow-up questionnaire 
As earlier reported, I realised that the new question about computerised 
medical record useŦ on the GP profile questionnaire was still not sufficiently 
specific to determine the type or amount of patient information being stored 
electronically by GPs who reported personal use of computers for medical 
records. Consequently, I designed a follow-up questionnaire intended for all 
GPs who had indicated they personally used the computer for medical 
records (Appendix 11). Figure 3.9 lists these additional questions and is re-
presented here to assist the reader. The definitions used in the follow-up 
questionnaire were decided upon after consulting the literature, discussion 
with supervisors, and drawing on what could be identified as the capabilities 
of the various components of clinical software products used by GPs (e.g., the 
ability of a prescribing tool within clinical software to keep a list or ‘record’ of 
what medications have been prescribed for the patient, what tests have been 
ordered for the patient through the pathology ordering tool, etc). 
Page 1 of 1. 
- are held on computer (through software); all 
other clinical patient information is recorded 
on paper. Tick as many as apply. We will 
assume that any item not ticked is held on 
paper. 
 (Please tick) 
To what extent did you use a computerised medical record for your patients at the time you 
participated in BEACH? 
 
1. All clinical patient information (eg. patient history, diagnoses/problems, treatments, 
referrals, requests etc) generated by you is held on computer, i.e., no paper records 
generated. All test results and other external correspondence are imported or scanned 
into the computer record.  
 
2. All clinical patient information (eg. patient history, diagnoses/problems, treatments, 
referrals, requests etc) generated by you is held on computer, i.e., no paper records 
generated. All test results and other external correspondence are kept on paper. 
   
 
3. Patient history 
Current problems being managed 
Prescriptions 
    - problem for which script was given  
Tests ordered 
    - problem for which test was ordered             
 Referrals           
Immunisations 
Comments  
_______________________________________________________________________ 
 
 
OR 
OR 
Figure 3.9: Follow-up questionnaire about computerised medical record use 
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4.2.3 The participants 
The 1,336 GPs who participated in BEACH between 28/10/03–28/03/05 have 
been included in the analyses for this Chapter.  
Definitions 
Computer availabilityŦ was defined as: a computer is available (whether used 
or not) at the major practice address. 
Computer useŦ was defined as: a computer is used by the responding GP for 
any function. 
Clinical computer useŦ was defined as: the GP’s use of a computer for some 
or all clinical function(s), i.e., prescribing, test ordering, medical records. 
Non-clinical computer useŦ was defined as: the GP’s use of a computer for 
administrative functions, internet and/or email only; without use of clinical 
components. 
Medical record useŦ was defined as: the GP’s use of the clinical records 
component of medical software for storage of some or all patient data. 
Fully computerisedŦ was defined as: the GP uses the medical records 
component of clinical software for all patient data including externally 
generated correspondence. 
Partially computerisedŦ was defined as: the GP uses the medical records 
component of clinical software to store some but not all patient information. 
4.2.4 Statistical methods used in this Chapter 
The analyses for this Chapter were conducted with Microsoft® Access 9748 
and SAS version 8.2.63 
The following results are reported in terms of the number of observations (n) 
and proportions (%). Where GPs did not provide responses, they were 
removed from the total sample before calculations. Denominators vary 
according to the component being analysed (e.g., all GPs, GPs with 
computers, GPs with clinical software). 
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4.3 Results 
4.3.1 Representativeness of GPs and encounters in this study 
In Chapter 3, Sections 3.3.1 and 3.3.2, the importance of a representative 
sample, and the weighting process to ensure the representativeness of the 
GPs and encountersŦ in BEACH were described. As the weighting is applied 
annually to ensure that each annual BEACH GP sample reflects the national 
sample frame, and the sample of GPs used in this study crossed over two 
different BEACH recording years, I have not used weighted data for these 
analyses.  
However, in order to ascertain how well the GPs and encounters in this study 
represent the national situation, I have compared the total group of GPs (from 
the latter part of 2003–04 and the entire group from 2004–05) with the 
national sample frame for the year from which the greater proportion of GPs 
was taken, and compared the patient encounters with MedicareŦ data from 
the same period.  
Table 4.1 shows the comparison of the 1,336 GPs who formed this study 
sample, compared with the national sampling frame for 2005.  
In the 2003–04 BEACH year, GP participants were significantly less likely to 
be under 35 years when compared with the national sample (χ2=29.5, 
p<0.001).59 This under-representation of younger GPs has occurred in 
preceding years of BEACH and was hypothesised to result from the lack of 
requirement for GPs undertaking a general practice vocational training 
program to participate in quality assurance (QAŦ) activities either during 
training, or in the QA triennium in which they completed training. The offer of 
QA points is less likely to attract them, and most of these GPs are less than 
35 years old. 
This hypothesis gained support in the 2004–05 BEACH year (participants 
included in this study). It was the start of a new triennium* and coincided with 
a change in the QA requirements for new graduates to now complete a 
clinical audit activity in the triennium of the completion of their training (QA 
requirements per triennium were described in Chapter 3, Section 3.2.4). It 
was also the first year since BEACH recording began, where the GPs in this 
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age-group were not under-represented. However, when the portion of GPs 
from the 2003–04 year was added to the 2004–05 sample (i.e. the 
participants in this study) there was again an under-representation of younger 
GPs (<35 years). This was the only significant difference between GPs in this 
study sample and those in the national sample frame (Table 4.1).  
To assess the representativeness of the sample of patients at encounters with 
the 1,336 GPs in this study, the age-sex distribution of the patients at A1Ŧ 
Medicare claimable encounters recorded in this study was compared with that 
of all encounters claimed in 2004 as Medicare A1 items of service (data 
provided by the DoHAŦ). Table 4.2 shows this comparison. Overall, there is a 
good fit of the age and sex distribution without weighting, between the MBS 
data and the patients at encounters with the GPs in this study. No age-sex 
category varied by more than 20% from the population distribution. The raw 
precision ratiosŦ for all categories (0.9–1.2) show that the study sample of 
encounters is a good representation of general practice patient encounters in 
Australia.  
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Table 4.1: Comparison of study participants and all active recognised GPs in Australia 
Study (BEACH) participants(a) (b) Australia(a) (c) 
GP characteristic Number(a)
Per cent of GPs(a) 
(n=1,336)  Number(a) 
Per cent of GPs(a) 
(n=18,112)
Sex (Missing) 
(χ2=1.448, p=0.228) 
(0) 
  
(0) 
 
Male 904 67.7  11,963 66.0 
Female 432 32.3  6,149 34.0 
Age (Missing) 
(χ2=11.007, p<0.01168) 
(5) 
  
(0) 
 
<35 years 109 8.2  1,859 10.3 
35-44 years 331 24.8  4,564 25.2 
45-54 years 432 32.3  6,071 33.5 
55+ years 459 34.6  5,638 31.1 
Country of graduation 
(Missing) 
(χ2=0.095, p=0.758) 
(1) 
  
(0) 
 
Australia 949 71.1  12,961 71.5 
Overseas 386 28.9  5,171 28.5 
State (Missing) 
(χ2=10.7, p=0.157) 
(3) 
  
(0) 
 
New South Wales 462 34.7  6,103 33.7 
Victoria 315 23.6  4,489 24.8 
Queensland 252 18.9  3,416 18.8 
South Australia 116 8.7  1,523 8.4 
Western Australia 115 8.6  1,629 9.3 
Tasmania 36 2.7  505 2.8 
Aust Capital Territory 17 1.3  269 1.5 
Northern Territory 20 1.5  135 0.7 
RRMA (Missing) 
(χ2=7.598, p=0.269) 
(0) 
  
(0) 
 
Capital 877 65.6  11,802 65.1 
Other metropolitan 88 6.6  1,358 7.5 
Large rural 71 5.3  1,088 6.0 
Small rural 91 6.8  1,272 7.0 
Other rural 169 12.6  2,245 12.4 
 Remote centre 16 1.2  164 0.9 
Other remote 23 1.7 
 
 203 1.1 
 
(a) Missing data removed. 
(b) Data drawn from the BEACH GP Profile completed by each participating GP. 
(c) All GPs who claimed at least 375 A1 Medicare items during the most recent 3-month Medicare Australia data period. Data 
provided by the Primary Care Division of the Australian Government Department of Health and Ageing. 
Note: RRMA–Rural, Remote and Metropolitan Area classification 
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Table 4.2: Age-sex distribution of patients in study sample (from BEACH) and MBS A1 
services for 2004 
Study (BEACH) participants(a) Australia(b) Precision ratio 
Variable Number Per cent  Per cent unweighted 
Male      
 < 1 year 1,256 1.2  1.2 1.0 
 1– 4 years 2,623 2.5  2.8 1.1 
 5–14 years 3,139 3.0  3.5 1.2 
 15–24 years 3,429 3.2  3.4 1.1 
 25–44 years 9,521 8.9  9.1 1.0 
 45–64 years 12,386 11.6  11.7 1.0 
 65–74 years 6,120 5.7  5.7 1.0 
 75+ years 4,691 4.4  4.6 1.1 
      
Females      
 < 1 year 1,030 1.0  1.0 1.0 
 1– 4 years 2,328 2.2  2.5 1.1 
 5–14 years 3,109 2.9  3.3 1.1 
 15–24 years 6,594 6.2  5.9 1.0 
 25–44 years 16,850 15.8  14.9 0.9 
 45–64 years 17,435 16.4  15.4 0.9 
 65–74 years 7,600 7.1  6.7 0.9 
 75+ years 8,427 7.9  8.2 1.0 
(a) Unweighted data, A1 items only, excluding encounters with patients who hold a DVA Repatriation health card. 
(b) Data provided by the Primary Care Division of the Australian Government Department of Health and Ageing. 
 
4.3.2 Computer availability at the major practice address 
Between October 2003 and March 2004, 1,336 GPs participated in the 
BEACH program and all completed and returned a GP profile questionnaire. 
Of the 1,336 participants, 17 did not respond to questions about computer 
availability and were removed from this analysis. The remaining 1,319 
respondents represented 1,190 individual practices, as the sampling process 
for BEACH involves individual GPs, not practices, and some practices had 
more than one GP participate during the study period. Of the 1,319 
respondents, 79 (6.0%) did not have a computer available in their practice 
(Table 4.3). Counting each practice once, the proportion of practices without a 
computer available was 6.3% (results not tabulated). 
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Table 4.3 Computer availability at major practice address 
 Number of 
GPs 
Per cent of all GPs 
(n=1,319) (a) 
Per cent of GPs with practice 
computers (n=1,240) 
No computer 79 6.0 — 
Computer available for: 
Billing 1,050 79.6 84.6 
Prescribing 1,101 83.5 88.8 
Medical records 934 70.8 75.3 
Other administrative 974 73.8 78.5 
Internet/Email 888 67.3 71.6 
(a) 1,319 GPs from 1,190 practices. Some practices had more than one GP participate during the study period. Excludes 17 GPs who 
did not provide responses about computer availability. 
 
4.3.3 Computer use and clinical software use by individual GPs 
Of the 1,319 GPs who responded to the question about the availability of 
computers in their practice, 79 did not provide responses about their individual 
computer use. Of the 1,240 who did respond, 64 (5.2%) reported not using a 
computer, even though one was available at the practice (Table 4.4). This 
figure, combined with the 6.0% of GPs having no computer at their practice, 
meant that 11.5% of the 1,240 responding GPs were not using a computer in 
their practice for any purpose. 
The majority of GPs used a work computer for electronic prescribing (83.8%), 
ordering tests (72.7%) and keeping some or all patient data in medical 
records (70.3%). Just over half used email and slightly more used the Internet 
(Table 4.4). Six per cent of doctors with clinical software available at the 
practice reported not using the software. Most of these were internet and/or 
email users only.  
4.3.4 Computer functions used by GPs at work 
Just over one-third of GPs (37.1%) used the computer and clinical software 
for all five nominated functions. A further 16.1% used the computer for test 
ordering, prescribing and medical records, but did not use internet or email 
(Table 4.4). 
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Table 4.4 Computer and software use by individual GPs at work* 
 Number of GPs 
using computers and 
software for specific 
functions 
Proportion (%) of all 
GPs with computers 
and software available 
(n=1,240)(a) 
Proportion (%) of GPs 
who use computers 
and software (n=1,097) 
(b) 
Computer use 
Computer not used at all 64 5.2 — 
Computer used for: 
Test ordering 902 72.7 82.2 
Prescribing 1,039 83.8 94.7 
Medical records 872 70.3 79.5 
Internet 732 59.0 66.7 
Email 652 52.6 59.4 
Clinical software: 
Available and used 1,040 83.9 93.4 
Available but not used 74 6.0 6.6 
Use of computer functions 
Clinical functions not used at all(c) 143 11.5 — 
All functions used 460 37.1 41.9 
Test ordering + prescribing + medical 
records 200 16.1 18.2 
Test ordering + prescribing + medical 
records + Internet 83 6.7 7.6 
Test ordering + prescribing 57 4.6 5.2 
Test ordering + prescribing + Internet 
+ email 45 3.6 4.1 
Prescribing + medical records + 
Internet + email 44 3.5 4.0 
Prescribing only 42 3.4 3.8 
Internet + email 26 2.1 2.4 
Prescribing + medical records 20 1.6 1.8 
(a) Excludes missing data from 79 GPs who did not provide responses on individual computer use. 
(b) Excludes data from 79 GPs with no computer available and from 64 GPs who chose not to use available computers. 
(c) Computer used for accounts, administration, Internet and/or email only. 
 
Medical record follow-up questionnaire 
Of the 872 GPs who had ticked the ‘medical record’ option on their GP profile 
(and were therefore subsequently posted the follow-up questionnaire, 
Appendix 11, described in Figure 4.9), 687 (78.8%) returned completed forms. 
Four GPs responded that they were not computerised at all in their practice, 
even though the ‘medical record’ and/or other components had clearly been 
ticked on the GP profile. Because of this inconsistency these four were 
removed from the analyses, leaving 683 usable questionnaires.  
64 
As shown in Table 4.5, of the 683 respondents, just over half (52.1%) 
nominated the ‘fully computerised’ medical record option (Option 1). The 
‘mostly computerised’ option (Option 2) was reported by 73 GPs (10.7%), and 
37.2% reported being ‘partially computerised’ (Option 3). 
Table 4.5: Computerised medical record use 
 
Number of 
GPs 
Per cent of GPs with 
computerised 
medical records 
(n=872) 
Per cent of GPs with 
computerised medical 
records who returned 
follow-up questionnaires 
(n=683) (a)
Questionnaires sent 872 100.0 — 
Questionnaires returned 683 78.3 100.0 
Fully computerised (Option 1) 356 40.8 52.1 
Mostly computerised (Option 2) 73 8.4 10.7 
Partially computerised (Option 3) 254 29.1 37.2 
(a) 687 follow-up questionnaires returned, 4 removed because of inconsistency = 683 
 
Partial use of computerised medical record software function 
Of the 254 GPs who indicated that they keep only some aspects of the 
patient’s information in the computerised medical record available through 
their clinical software (Option 3), the vast majority kept prescribing information 
(97.2%) although more than half (56.3%) kept a record of the problem for 
which the script had been provided. Similarly, while 85.8% reported noting 
tests ordered in the computerised medical record, less than half of these 
(42.5%) recorded the problem for which the investigation was ordered. Fewer 
than half of the 254 partially computerised GPs (48.5%) kept the patient’s 
history in electronic form, and 61.4% kept a record of the current problems. 
Over two-thirds (69.3%) recorded referrals, and a high proportion (84.3%) 
kept details of immunisations in the medical record provided in their software 
(Table 4.6). 
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Table 4.6: Partial computerised medical record use (Option 3) 
Components used: 
Number of 
GPs 
Per cent of GPs with 
partial record use 
(n=254) 
Per cent of GPs with 
computerised medical 
records who returned 
follow-up questionnaires 
(n=683) (a) 
Patient history 123 48.5 80.8 
Current problems managed 156 61.4 85.2 
Prescriptions 247 97.2 99.0 
Problem for script 143 56.3 83.7 
Tests ordered 218 85.8 94.7 
Problem for test 108 42.5 78.6 
Referrals 176 69.3 88.6 
Immunisations 214 84.3 94.1 
(a) Proportions in this column calculated by adding GPs with the nominated component from Option 3 to those using this component 
in the fully computerised (Option 1) and mostly computerised (Option 2) groups. 
 
 
Table 4.7: Most common software function combinations used by GPs with fully 
computerised medical records 
Software function 
Number of 
GPs 
Proportion (%) of 
GPs with fully 
computerised 
medical record 
(n=356) 
Proportion (%)  
of all GPs with 
computers and 
software 
available 
(n=1,240)(a) 
Proportion (%) of 
GPs who use 
computers and 
software 
(n=1,097) (b) 
All 4 other functions used 
with fully computerised 
record 234 65.7 (22.3)   18.9 (25.3) 21.3 
3 other functions used with 
fully computerised record 58 16.3 (5.5) 4.7 (6.4) 5.3 
Test ordering + 
prescribing + Internet 35 9.8 (3.3) 2.8 (3.3) 3.2 
Test order + prescribing 
+ email 14 3.9 (1.3) 1.1 (1.5) 1.3 
Prescribing + Internet + 
email 9 2.5 (0.9) 0.7 (1.0) 0.8 
2 other functions used with 
fully computerised record 62 17.4 (5.9) 5.0 (6.8) 5.7 
Test ordering + 
prescribing 61 17.1 (5.8) 4.9 (6.7) 5.6 
Prescribing + email 1 0.3 (0.1) 0.1 (0.1) 0.1 
1 other function used with 
fully computerised record 2 0.6 (0.2)   0.2 (0.2)   0.2 
(a)  Excludes missing data from 79 GPs who did not provide responses on individual computer use. 
(b) Excludes data from 79 GPs with no computer available and from 64 GPs who chose not to use available computers.  
  Excludes missing data from 189 GPs who did not return usable follow-up questionnaires about medical record use   
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Combinations of software functions used 
Table 4.7 shows the other software functions used by the GPs who reported 
being fully computerised in terms of patient medical records (i.e., Option 1). Of 
the 356 GPs who recorded this option, 234 (65.7%) reported that they also 
used all other clinical functions of their computer (test ordering, prescribing, 
internet and email). This proportion equates to:  
o 18.9% of the 1,240 GPs with computers and software available (22.3% 
of the remaining 1,051 after removing the 189 GPs who did not return 
their follow-up questionnaire – noted with the symbol () in the table)  
o and 21.3% of the 1,097 GPs who actually use their computer and the 
available clinical software (25.3% of the remaining 908 following 
removal of 189 non-respondents – noted with symbol () in the table). 
4.3.5 GPs comments 
Comments were received from 215 GPs (31.5% of those who returned the 
questionnaire). There was an assortment of comments about cost and 
availability, or personal competence, for example: 
• ‘the system is too expensive to maintain’ 
• ‘we aim for full computerisation but are limited by suppliers’ 
• ‘recalls, health assessments & pathology are on computer but we still 
keep paper records due to not being able to be typist as well as doctor’ 
But comments were by and large associated with 3 themes. Examples are 
provided below: 
Quality 
• ‘some information is on computer but we still keep paper records due 
to not being able to be the typist as well as the doctor’ 
• ‘computer records make very poor clinical notes’ 
• ‘this has revolutionised my life as a GP with good quality and quickly 
retrievable accurate information’ 
• ‘fully computerised – that’s why doing your survey was a hassle’ 
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• ‘in practice this is a very difficult system, much harder than paper’ 
• ‘computers were down for one day during BEACH so some information 
(records of consultation) was written into the old patient history (paper 
files) in those cases’ 
Reliability 
• ‘fully computerised – great when system works – panic with down times 
but few and far between’ 
• ‘double records - ie paper records of patient history, treatment, referrals 
are noted on a card as well as kept on computer for back up in case of 
crashes’ 
• ‘a paper record is kept as well for all items listed’  
• ‘we maintain hard copies of all information as the networked computers 
are inclined to still crash periodically’ 
• ‘we double keep records (unfortunately seems to be necessary)’. 
Practice policy vs individual choice 
The most recurring comment highlighted the absence of any structured 
practice policy, resulting in a situation where practices are keeping patient 
information in two formats – some information being stored on computer and 
some on paper – for the same patients in the same practice, depending on 
the decision of the individual doctors in the practice. 
•  ‘the only paper record I keep is for wound dressings and very 
occasional visitors – this only applies to me, not my partners’ 
• ‘some of the doctors in our practice only use computer – some only use 
paper notes. I use both’ 
• ‘my software can cope with prescriptions and referrals on its system 
but I prefer to do these with pen and paper’ 
• ‘all items are in both computer and paper record’ 
• ‘many patients have a mix of paper and computer records’ 
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• ‘computer system has more potential but is not being used as practice 
policy has not changed’ 
• ‘basically I am old fashioned and use written clinical notes 90% of the 
time’ 
• ‘we are regarded as a paper record practice. Several doctors including 
myself keep a computer record & print out the record & add it to the 
paper file. Our computer system often fails making a true computer 
'paperless' record impossible’  
• ‘summary of patient history is kept on computer but not every visit’ 
• ‘not all doctors in our practice are paperless yet’ 
• ‘some doctors in the practice only use the computer for some of these 
functions’ 
• ‘one of the four doctors in our practice still writes his notes – the rest of 
us write an entry with date and diagnosis in the progress notes with 
reference to computer notes for the patient’ 
• ‘complex histories are still put on paper and other doctors in the 
practice use paper more than me’ 
• ‘mixed record keeping as different doctors at the clinic have different 
usage patterns’. 
4.4 Discussion 
These results show that although computers have been rapidly adopted in 
general practice over the past decade, there is still a good deal of reluctance 
among GPs to fully embrace the technology for clinical purposes. 
A limitation of this section of the study was the possibility of recall bias being 
introduced through the follow-up questionnaire. Four GPs were removed from 
the analyses because, while they had reported using the medical record 
function of their computer on the original GP Profile questionnaire, and were 
therefore sent the follow-up questionnaire, they indicated on the latter that 
they did not use the computer for this purpose or were not computerised at all. 
69 
While a relatively small proportion (one in five) used the computer to its full 
functional capacity there is greater acceptance of individual clinical functions. 
The high proportion of GPs in this study who prescribed electronically is 
similar to the proportion of PIP practices reported by the Productivity 
Commission99 to be prescribing electronically, but it seems that many GPs still 
prefer to undertake other clinical functions using a more traditional approach. 
The Commission also reported that 92% of PIP practices “had the capacity to 
send and/or receive clinical information via use of computer technology”.99 
However, only 66.7% of the GPs in this study were using the Internet and 
59.4% using email – even though 71.6% reported having these computer 
services available to them at their major practice. These results would indicate 
that having the capacity to transfer clinical information satisfies PIP 
requirements for the practice but does not guarantee that the facility is being 
used by individual GPs. A study by McInnes et al. (2006) found similar high 
computer use by GPs in general, but again the proportions differed between 
functions, with computerised prescribing and test ordering being the most 
common functions used, and accessing information during the consultation 
being used the least.100 The proportion of GPs in McInnes’ study who used a 
computer for clinical purposes (89.5%) was very similar to the 88.5% (from 
Table 4.4) who reported doing so in this study.100 
GPs may well hold different opinions of their benefit or otherwise of the 
individual functions of their clinical software. As summarised by Wyatt (1995), 
computerised prescribing reduces errors associated with illegibility, saves 
time when printing repeat prescriptions, and results in fewer phone enquiries 
from pharmacists; decision support alerts remind clinicians to check 
appropriateness of medication given the patient’s age, co-morbidity, or other 
medications, or can even calculate the appropriate dose of a suggested 
preparation.35 These functions reduce the likelihood of adverse medication 
events, but the completeness of patient information required for these 
decision support tools to work reliably is subject to the capabilities and 
diligence of a time-poor GP.35,101 This study supports these concerns – for the 
48% of clinicians not using the medical record component of their software to 
its capacity, many of the data elements required for these support tools to be 
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effective will not be present. There is also evidence emerging that while 
computer use may solve problems in some areas, it can also create problems 
in others. Technology is still designed and used by humans and as such, is 
vulnerable to human error.81,102,103 
Clinical software offers an easy mode for GPs to access guidelines. The 
internet also allows access to current, evidence based, scientific literature 
through academic databases. Online evidence is effective in supporting 
clinical decision making but searches may be outside the time constraints of 
real clinical practice.104,105 
In Section 4.3.4 I reported that 37% of GPs used the computer and clinical 
software for all five nominated functions – on closer investigation, it was 
revealed that almost half of these were not fully utilising the medical record 
component of their software (Table 4.5). Even where all patient data are 
stored electronically, there are still other clinical functions of the computer that 
are not being taken advantage of by the GP, e.g. all patient data are stored 
electronically, but the GP does not use the computer for test ordering. The 
perception that general practice is computerised because such a high 
proportion of practices have access to a computer would seem a 
misconception – these results have shown that only 1 in 5 GPs with both a 
computer and clinical software available, and only 1 in 4 of those who actually 
use both of these tools, use them to their full potential. These GPs are the 
only participants in this study who would currently be able to conduct 
comprehensive data exchange with other primary health providers and with 
other areas of the health sector. The paper-based or hybrid nature of practice 
records for the remaining 75–80% would prohibit the extraction of all pertinent 
information into an event summary that could be considered complete.  
Some of the reasons for the GPs’ reticence to fully adopt computerisation 
were offered anecdotally through the ‘comments’ section of their follow-up 
questionnaire (Section 4.3.5). There is a sense that GPs have limited faith in 
the reliability of their computer systems, as evident in comments about ‘down 
times’ and ‘crashes’ and in the claims by many GPs that data stored on 
computer are being backed up with a paper copy. This double-handling for 
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already time-constrained GPs highlights their lack of confidence in their 
computer systems. Many of the impediments offered by the GPs in this study 
were the same as those tendered for the failure of the previously mentioned 
Queensland trial of the National Innovations Funding Pool Project (2002),98 
and in a US study by Linder et al. (2006).106 Linder’s cross-sectional survey of 
primary care clinicians using ambulatory care data reported the same 
concerns regarding time constraints, lack of faith in the performance ability of 
the technology, loss of data – even their own ‘inability to type quickly enough’ 
as was offered by some GPs in my study.106 
An interesting difference between the BEACH GPs in this study and the 
primary care clinicians in the study by Linder et al. (2006) was the issue of 
‘intrusion’ by the computer. While hardly mentioned by the GPs in this study, 
Linder’s clinicians reported ‘loss of eye contact with patient’ (62%), or feeling it 
was ‘rude’ to use the computer in front of the patient (31%) among the most 
commonly selected reasons for not using EHRs during a patient visit.106 
Substantial upkeep costs, lack of confidence in their computer systems, and 
lack of knowledge of their software are some reasons for the lack of 
commitment to electronic systems that were offered by the GPs in this study. 
These are difficult problems to overcome when programs initiated to assist 
with cost or GP education are superseded so quickly. Technology is 
advancing rapidly and many options are becoming outdated before they are 
fully paid for. It is a costly exercise in both time and money for busy practices 
to keep updating hardware and software. Walker (1997) described the myriad 
of application programs, operating system platforms, database computing 
languages and record systems, each with its own unique structure and set of 
data elements available for use in primary care, some with free text entry, 
some with coding systems, and yet others with a mixture of both.107 A decade 
later, while some of the names have changed and capacities improved, this 
variety still exists at every level. Some of these issues will be addressed by 
the standards programs being undertaken by NEHTA, but a real solution is 
still some time away.  
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With regard to the quality of patient records, it seems that in some practices, 
patient information is being stored on paper by some GPs and in a computer 
by others, for the same patients. In some situations this appears to be 
happening only at times when their computer system is down, but for others, 
the inconsistency seems to stem from a lack of agreement between 
practitioners. A reasonable assumption is that neither version of the patient 
record is complete – certainly, neither is likely to be as comprehensive as 
could be assumed if all patient information was kept in one format. This may 
well be an area where, at least in the short term transition period, the 
introduction of computers is potentially impacting negatively on quality of care.  
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CHAPTER 5  
 
PRACTICE BEHAVIOUR OF GPS USING A 
COMPUTER FOR CLINICAL ACTIVITY AND 
THOSE WHO DO NOT 
In Chapter 4 I examined the availability of computers at the major practice 
address for the GPsŦ in this study sample, and how the clinical functions of 
the computer are used by individual GPs in their workplace. In this Chapter I 
will compare the practice behaviour of individual GPs who use their computer 
in the performance of their clinical activities with the practice behaviour of GPs 
who do not use a computer as a clinical tool. The hypothesis has been 
proposed strongly in the literature that the use of a computer will improve 
patient care and efficiencies, for example “information technologies (IT) such 
as electronic health records, e-prescribing, decision support systems, 
electronic management of chronic disease, and bar coding of drugs and 
biological products have been shown to reduce health care costs and medical 
errors”.83 
5.1 Aim 
The aim of this Chapter is to determine whether individual GPs who use a 
computer for clinical functions differ in their practice behaviour from GPs who 
do not use a computer for clinical activity. 
Hypothesis: GPs who use a computer for clinical purposes will differ in their 
practice behaviour compared with GPs who do not use a computer for clinical 
purposes.  
Rationale: The use of a computer in the consultationŦ has been shown to 
affect aspects of GP practice behaviour e.g. the managements they provide35, 
and the time they spend with patients.91 Other aspects of practice behaviour 
may also differ when a computer is used as a tool for referring, prescribing, 
test ordering, or storing clinical data, instead of traditional pen and paper.  
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5.2 Methods 
The methods utilised for this chapter are based on the BEACHŦ methodology 
described in Chapter 3.  
5.2.1 The GP Profile questionnaire 
As described in Chapter 3, the additional questions designed for the GP 
Profile questionnaireŦ (Appendix 3) were used to investigate the clinical 
computer use of individual BEACH GPs (Figure 3.8). Seventeen GPs had not 
provided details of computer availabilityŦ at their major practice address, but 
had clearly responded to their individual use of a computer for clinical activity. 
In consultation with my supervisors and analyst, it was decided that the 
information from these GPs was valid to include in the remaining analyses.  
5.2.2 The participants 
Of the 1,336 GPs who participated in BEACH between 28/10/03–28/03/05 
1,257 provided details of their individual use of a computer for clinical activity 
and were included in analyses for this Chapter. The GPs were assigned to 
two groups according to their self-reported use of a computer for clinical 
activity.  
The GPs who reported clinical computer use (see definition below) will be 
referred to in this Chapter as ‘clinical computerised GPs’ or ‘clinical computer 
usersŦ’ abbreviated to ‘CC users’. There were 1,069 GPs in this group. The 
GPs who reported non-clinical computer use, or did not use a computer at all 
(see definition below), will be referred to in this Chapter as ‘non-clinical/non-
computerised GPs’ or ‘non clinical computer users’ abbreviated to ‘non CC 
users’. There were 188 GPs in this group. 
Definitions 
Clinical computer useŦ was defined as the use of a computer for clinical 
functions i.e. prescribing and/or test ordering and/or medical recordsŦ, with or 
without internet and/or email. 
Non-clinical computer useŦ was defined as the use of a computer for 
administrative functions, internet and/or email only. Clinical components of the 
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medical software application such as prescribing, test ordering, medical 
records, while available, are not utilised by the GP in his clinical practice. 
5.2.3 Statistical methods used in this Chapter 
Unweighted data (see Chapter 3, Section 3.3) from GPs who participated 
during the study period for this thesis were included. While SAS generates 
results to two decimal places, the raw figures in this thesis have been rounded 
to one decimal place for simplicity and consequently, the individual raw 
figures will not always sum exactly to the total. 
The following results are reported in terms of the number of observations (n), 
proportions (%), rates per 100 encountersŦ, rates per 100 problems managed, 
and the 95% confidence intervals. Chi-square statistics were applied to the 
measurement of differences in GP characteristics. 
Power 
As described in Chapter 3 (Section 3.5.5) a priori power estimations for two-
sample comparison of proportions were performed using Stata 8.0.69 Data 
from BEACH and other sources indicated that between 80% and 90% of 
practices had a computer at the end of 2002. I had estimated that 
approximately 1,000 GPs would be included in this analysis, and ran power 
estimates assuming approximately 800 GPs in the computer using group and 
200 GPs in the non-computer using group. The power calculated to find a 
significant difference between 10% and 20% (Type II errorŦ – 1 – power) with 
sample sizes of 800 and 200 was 0.9382. The power calculated to find a 
significant difference between 40% and 60% of GPs (Type II error – 1 – 
power) with sample sizes of 800 and 200 was 0.9990. 
When final participant data were available it was possible to calculate the 
intracluster correlation (ICC) for more specific power calculations on actual 
sample sizes. Because of the numerous variables compared in the analyses, I 
chose the proportion of encounters with at least one medication prescribed as 
an appropriate sample variable to examine. The intracluster correlation was 
calculated as 0.079 with a variance inflation factor of 8.821. When the sample 
sizes of 106,900 and 18,800 encounters were factored down (each was 
multiplied by 1/8.821) the sample ‘n’s used in the power calculation were 
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n1(12122) and n2(2132). The result for a two-sample comparison of 
proportions was a power of 0.8002 (80%) to detect a 3.3% difference between 
estimates, and of 0.8987 (90%) to detect a 3.8% difference between 
estimates.  
Descriptive analysis 
I have used the 95% confidence limits to report the results of univariateŦ 
descriptive comparisons of GP characteristics other than individual computer 
useŦ, their practice characteristics, patient characteristics, patient reasons for 
the encounter (RFEsŦ), the problems managed at the encounter, and their 
management activities. Where confidence intervals do not overlap, the 
difference between the two measures is regarded as statistically significant. 
Chi-square statistics were also applied to further measure the differences in 
GP and practice characteristics, as the Chi-square test allows the 
measurement of differences within and between groups (e.g. GP age can be 
compared between computerised and non-computerised GPs over four 
different age ranges within each group). The descriptive analyses were 
performed using SAS version 8.263 and results from these descriptive 
comparisons are presented in Tables 5.1 to 5.21. 
Univariate analysis 
For a range of outcomes, univariate analyses were performed to determine 
significant associations between the individual outcome variable and the 
status of the GP regarding their use of a computer for clinical purposes. For 
these analyses, outcome variables with multiple categories have been 
collapsed into dichotomous variables. For categorical outcome variables the 
results are reported as odds ratios with 95% CIŦ and P values under the 
unadjusted column in Tables 5.22–5.27. GPs not using a computer for clinical 
purposes are the reference group, with an Odds Ratio of 1 for the outcome of 
interest in the comparisons with GPs using a computer for clinical purposes. 
Where the outcome variable is continuous, the regression coefficient is 
reported (Table 5.22). 
STATA 8.269 was used for both univariateŦ and multivariate analysesŦ as 
reported in Tables 5.22–5.33. 
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Multivariate analysis and models used 
As described in Chapter 3 (Section 3.5.5, Figure 3.10) the step-wise 
elimination process was used to obtain the final models for GP and practice 
characteristics for patient outcomes (Model 5A). For patient morbidityŦ 
outcomes (Model 5B), and management outcomes (Model 5C) an 
epidemiological approach was taken including variables shown in other 
studies to have influenced the outcome variable (described below). 
Model 5A 
This model was applied for patient outcomes. As the base for this model was 
the sample of GPs, a simple random sample design and conventional 
modelling, without correcting for the cluster, was used to analyse these data. 
Figure 5.1 shows all GP and practice characteristics examined in the simple 
logistic regression which were then tested for association in the step-wise 
elimination process. Variables highly correlated with other predictors already 
in the model or on the causal pathway to the outcome were excluded from the 
model. Variables showing some association (P<0.10) with the dependent 
variable (GP computer use for clinical purposes) in the simple logistic 
regression were included in the stepwiseŦ procedure for elimination and 
refitting of the model. 
Covariates in model 5A 
To improve precision, variables were tested at the 95% association level in 
the final model. The variables showing significant association (P<0.05) and 
included as covariates in the final model were:  
• GP age  
• GP status as a Fellow of the RACGPŦ  
• Work in a deputising service in the preceding 4 weeks  
• Bulk-billingŦ for all patients 
• Practice accreditationŦ status 
• Presence of a practice nurse at the major practice address. 
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• GP sex was not significant at the 0.05 level in the final model, but 
previous research has found that medical conditions are managed 
differently by male and female GPs.108 Considering the possible effect 
on the problem management rate I decided to retain GP sex in the final 
model. 
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GP characteristics Practice characteristics 
• Age (45, 45–54, 55+ years)* 
• Sex* 
• Place of graduation* (Australia/other) 
• FRACGP status* (yes/no) 
• Years in general practice (<10, 10–19, 20+)† 
• Years since graduation (<20,20–29, 30+)†  
• Sessions per week (<6, 6–10, 11+) 
• Direct patient care hours per week 
      (<31, 31-40, 41-50, 51+) 
• Work in past 4 weeks— 
• in residential aged care facility* (yes/no) 
• as a locum (yes/no) 
• as salaried/session hospital medical officer *(yes/no) 
• in a deputising service* (yes/no) 
• Whether all patients are bulk-billed* (yes/no) 
• Any consultations in language other than English* (yes/no) 
• Registered with Department of Veterans’ Affairs (yes/no) 
• Registrar status (Registrar/not registrar) 
• Size of practice* (solo, 2-4, 5-
10,11+ GPs) 
• Practice location by RRMA1 
(metropolitan/rural) 
• Practice location by ASGC2* 
(major city/not major city) 
• Practice location by State 
• Socio economic status by 
SEIFA3 (Disadvantaged <4 
SEIFA/less disadvantaged 
SEIFA 4-11) 
• Practice accreditation status* 
(Yes/no) 
• Practice nurse at major 
practice address* (yes/no) 
• After-hours patient care 
arrangements (own or co-
operative/deputising service) 
• Status as a teaching practice 
for undergraduates of 
registrars 
Figure 5.1: GP and practice characteristics compared in simple logistic regression analysis 
and then used in step-wise logistic regression analysis 
† Variables that were found to be highly correlated with other variables and were therefore not retained in the modelling process. 
* Variables that showed some association (p<0.10) with use of a computer for clinical purposes, and were therefore included in the 
logistic regression analysis. 
Note:  FRACGP = Fellowship of the Royal Australian College of General Practitioners. 
1.  Australian Government Department of Health and Ageing. Rural, Remote and Metropolitan Areas (RRMA) classification. 
http://www.health.gov.au/internet/wcms/publishing.nsf/content/work-bmp-where-rrma.  
2.  Australian Bureau of Statistics (ABS). Australian Standard Geographical Classification (ASGCŦ). Canberra: Australian Bureau of 
Statistics, 2004. 
  3.  Australian Bureau of Statistics. Census of population and housing: Socio-Economic Indexes for Areas (SEIFA), Australia. 
Canberra: Australian Bureau of Statistics, 2001. 
 
Model 5B 
This model was used for morbidity outcomes i.e. the problems managed at 
the encounter (at ICPCŦ Chapter level). The base for this model was the 
sample of GP-patient encounters which is a cluster sample, so modelling 
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correcting for the design effect of the cluster sample was used to produce 
Model 5B.  
Covariates in Model 5B 
As described in Chapter 3 (Section 3.5.5), the patient characteristics collected 
in BEACH have been found to affect clinical care in other studies.71-78 
The variables included as covariates and adjusted for in the final model were 
the GP and practice characteristics included in Model 5A, plus: 
• Patient sex 
• Patient age 
• Health care card holder status 
• Veterans’ Affairs card holder statusŦ 
• Non-English speaking background status 
• AboriginalŦ or Torres Straight IslanderŦ status 
Status of patient to the practice (i.e. newŦ or seen previously) 
Model 5C  
This model was applied where the outcome was problem management, i.e. 
the managements provided at the encounter. As described in Chapter 3 
(Section 3.5.5) clinical management is highly associated with the morbidity 
being managed and so the presence of morbidity in each ICPC Chapter was 
adjusted for in the Type C model. As in Model 5B, the base for the model was 
the sample of GP-patient encounters, so the analysis was again based on a 
cluster sample design utilising modelling to correct for the cluster effect. 
Covariates in model 5C 
• The GP, practice characteristics and patient characteristics included in 
Model 5B 
• The presence or absence of each ICPC-2 Chapter at the encounter. 
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Group variable of interest 
For all models, the group variable was GP clinical computer use. GPs not 
using a computer for clinical purposes were the reference group against which 
the GPs using a computer for clinical purposes were compared. 
5.3 Results 
5.3.1 The GPs and their practices 
Between October 2003 and March 2004, 1,336 GPs participated in the 
BEACH program and all completed and returned a GP profile questionnaire. 
Responses to the questions designed for this thesis about individual computer 
use for clinical activity were provided by 1,257 (94.1%) of these GPs. For the 
remainder of this chapter, the GPs who reported using computers for clinical 
activity will be referred to as ‘clinical computer users’or CC users, and GPs 
not using computers for clinical activity (including in this instance those who 
do not use a computer at all) will be referred to as ‘non clinical computer 
users’, or non CC users. 
The characteristics of GPs who were CC users and those who were non CC 
users are compared in Table 5.1, with the characteristics of their practices 
compared in Table 5.3. Where the statistical comparison of means is 
appropriate (for continuous variables such as GP age, years in practice, size 
of practice etc) these are presented in Table 5.2. 
GP Age 
There were significant differences in the age distribution of CC users and non 
CC users. Clinical computer users were far more likely to be in the younger 
age group while non CC users were predominantly in the group aged 55 
years or older, as demonstrated in Figure 5.2 (tabulated with 95% confidence 
intervals in Table 5.1). 
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The age-sex specific rates of GPs using computers for clinical purposes are 
shown in Figure 5.3. Clinical computer use decreased with age for both male 
and female GPs. Almost all GPs aged less than 35 years used a computer for 
clinical purposes and this reduced to 82% of females and 74% of males in the 
55 years and over age group. 
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Figure 5.2: Age distribution of GP participants by clinical computer use status 
Figure 5.3: Age-sex specific rate of GP participant clinical computer use status 
with 95% confidence intervals 
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GP Sex 
Table 5.1 shows that, overall, a greater proportion of CC users were female 
(34.1%, 95% CI: 31.2-36.9) compared with non CC users (21.8%, 95% CI: 
15.9-27.7). Conversely, a greater proportion of non CC users were male 
(78.2%, 95% CI: 72.3–84.1) compared with those who were CC users (65.9%, 
95% CI: 63.1-68.8). 
Other GP and practice characteristics 
When compared with non-clinical computer users, GPs who used a computer 
for clinical purposes: 
• were younger, with a mean age of 48.9 years compared with a mean of 
56.9 years (p<0.0001) (Table 5.2) and in line with this difference in age: 
• had significantly fewer years in general practice, with a mean of 
19.4 years compared with a mean of 25.8 years for non CC 
users (p<0.0001) (Table 5.2) 
• were significantly more likely to have graduated more recently 
(i.e. less than 20 years ago), and significantly less likely to have 
graduated 30 or more years ago (p<0.001) (Table 5.1) 
• were more like to have graduated from their primary medical degree in 
Australia, and significantly less likely to have graduated overseas 
(p=0.001) (Table 5.1) 
• were more than twice as likely to be Fellows of the RACGP 
(FRACGPŦ) than non-computer users (p<0.001) although there were 
larger proportions of non-Fellows than Fellows in both groups (Table 
5.1) 
• were only half as likely to bulk-bill for all patients, and far more likely to 
bulk-bill for selected patients only (p<0.001) (Table 5.1) 
• worked in significantly larger practices, with the mean size of practice 
for CC users being 5.9 GPs and the mean for non CC users being 3.4 
(p<0.0001) (Table 5.2). Clinical computer users were more likely to 
work in practices of 5 or more GPs (58.2%, 95% CI: 55.2–61.1) than 
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non CC users (22.3%, 95% CI: 16.4–28.3), while non CC users were 
more likely to be in solo practice: fewer than one in twelve CC users 
were solo practitioners (7.9%, 95% CI: 6.3–9.5) compared with nearly 
one in three non CC users (31.9%, 95% CI: 25.2–38.6) (Table 5.3) 
• were less likely to practice in major cities (by ASGCŦ) (p=0.001), or in 
metropolitan areas (by RRMAŦ) (p=0.0002) than non CC users (Table 
5.3) 
• were more than twice as likely to work in an accredited practice than 
their non CC users (p<0.001) (Table 5.3) 
• were three times as likely to have a practice nurse at their major 
practice address (p<0.001) (Table 5.3). 
Table 5.1: Characteristics of the GPs 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
GP characteristic Number(a)
Per cent of 
GPs(a) 
(n=1,069)
95% 
LCL
95% 
UCL Number(a) 
Per cent of 
GPs(a)  
(n=188) 
95% 
LCL
95% 
UCL
Sex (missing) 
(χ2=11.0, p=0.001) 
(0)    (0)    
Male 705 65.9 63.1 68.8  147 78.2 72.3 84.1 
Female 364 34.1 31.2 36.9  41 21.8 15.9 27.7 
Age (missing) 
(χ2=58.6, p<0.001) 
(0)    (0)    
<45 years 397 37.1 34.2 40.0  26 13.8 8.9 18.8 
45-54 years 350 32.7 29.9 35.6  56 29.8 23.2 36.3 
55+ years 322 30.1 27.4 32.9  106 56.4 49.3 63.5 
Years in general practice 
(missing) 
(χ2=38.0, p<0.001) 
(5) 
    
(1)    
<10 years 206 19.4 17.0 21.7  11 5.9 2.5 9.3 
10-19 year 337 31.7 28.9 34.5  41 21.9 16.0 27.9 
20+ years 521 49.0 46.0 52.0  135 72.2 65.8 78.6 
Country of graduation 
(missing) 
(χ2=11.2, p=0.001) 
(0) 
    
(0) 
   
Australia 792 74.1 71.5 76.7  117 62.2 55.3 69.2 
Overseas 277 25.9 23.3 28.5  71 37.8 30.8 44.7 
(continued) 
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Table 5.1 (continued): Characteristics of the GPs  
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
GP characteristic Number(a)
Per cent of 
GPs(a) 
(n=1,069)
95% 
LCL
95% 
UCL Number(a) 
Per cent of 
GPs(a)  
(n=188) 
95% 
LCL
95% 
UCL
Years since graduation 
(missing) 
(χ2=53.8, p<0.001) 
(4) 
    
(1) 
   
<20 years 365 34.3 31.4 37.1  31 16.6 11.2 21.9 
20-29 years 392 36.8 33.9 39.7  52 27.8 21.4 34.2 
30+ years 308 28.9 26.2 31.6  104 55.6 48.5 62.7 
Any LOTE consultations 
(missing) 
(χ2=4.2, p=0.04) 
(2) 
     
(1) 
   
Yes 261 24.5 21.9 27.0  59 31.6 24.9 38.2 
No 806 75.5 73.0 78.1  128 68.4 61.8 75.1 
GP registrar (missing) 
(χ2=1.4, p=0.23) 
(11)     (3)    
Yes 42 4.0 2.8 5.1  4 2.2 0.1 4.3 
No 1016 96.0 94.9 97.2  181 97.8 95.7 99.9 
DVA registered (missing) 
(χ2=1.8, p=0.18) (24) 
     
(4) 
   
Yes 943 90.2 88.4 92.0  160 87.0 82.1 91.8 
No 102 9.8 8.0 11.6  24 13.0 8.2 17.9 
FRACGP status (missing) 
(χ2=37.4, p<0.001) (10) 
     
(3) 
   
Yes 465 43.9 40.9 46.9  37 20.0 14.2 25.8 
No 594 56.1 53.1 59.1  148 80.0 74.2 85.8 
Sessions per week 
(missing) 
(χ2=1.1, p=0.57) 
(7)
 
(1) 
 
<6 per week 162 15.3 13.1 17.4 33 17.6 12.2 23.1
6-10 per week 772 72.7 70.0 75.4 129 69.0 62.3 75.6
11+ per week 128 12.1 10.1 14.0 25 13.4 8.5 18.3
Direct patient care hours 
per week (missing) 
(χ2=2.2, p=0.54) 
(31)
 
(4) 
 
0-30 hours 263 25.3 22.7 28.0 43 23.4 17.2 29.5
31-40 hours 329 31.7 28.9 34.5 64 34.8 27.9 41.7
41-50 hours 287 27.6 24.9 30.4 55 29.9 23.3 36.5
51+ hours 159 15.3 13.1 17.5 22 12.0 7.3 16.7
(continued) 
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Table 5.1 (continued): Characteristics of the GPs  
GPs using a computer for clinical 
purposes  
GPs not using a computer for 
clinical purposes 
GP characteristic Number(a)
Per cent of 
GPs(a) 
(n=1,069)
95% 
LCL
95% 
UCL Number(a) 
Per cent of 
GPs(a)  
(n=188) 
95% 
LCL
95% 
UCL
Bulk-billing status (missing) 
(χ2=66.1, p<0.001) 
(4) (0)  
Bulk-bill for all patients 253 23.8 21.2 26.3 99 52.7 45.5 59.8
Do not bulk-bill for all - 
    selected patients only  76.2 73.7 78.8 89 47.3 40.2 54.5
Work in the past four weeks: 
 As a locum  (missing) 
 (χ2=0.7, p=0.42) 
(2)
 
(0) 
 
   Yes 58 5.4 4.1 6.8 13 6.9 3.3 10.5
   No 1009 94.6 93.2 95.9 175 93.1 89.5 96.7
 In a deputising  service 
(missing) 
 (χ2=5.2, p=0.02) 
(2)
 
(0) 
 
   Yes 25 2.3 1.4 3.3 10 5.3 2.1 8.5
   No 1042 97.7 96.7 98.6 178 94.7 91.5 97.9
 In a residential aged 
 care facility  (missing) 
 (χ2=4.9, p=0.03) 
(0)
 
(0) 
 
   Yes 531 49.7 46.7 52.7 77 41.0 33.9 48.0
   No 538 50.3 47.3 53.3 111 59.0 52.0 66.1
 As a salaried/sessional 
 hospital medical officer 
 (missing) 
 (χ2=4.1, p=0.04) 
(2)
 
 
(0) 
 
   Yes 135 12.7 10.7 14.6 14 7.4 3.7 11.2
   No 932 87.3 85.4 89.3 174 92.6 88.8 96.3
(a) Missing data removed. 
Note: LCL = lower confidence limit; UCL = upper confidence limit. Shading indicates statistically significant differences between two 
groups of GPs. LOTE consultations = any consultations conducted in a language other than English. FRACGP = Fellowship of the 
Royal Australian College of General Practitioners. 
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Table 5.2: Comparison of means for continuous GP/practice variables 
 
GPs using a computer for clinical 
purposes  
GPs not using a computer for 
clinical purposes 
GP/practice 
variable Number(a) Mean
95% 
LCL
95% 
UCL Number(a) Mean 
95% 
LCL 
95% 
UCL P value
Age (year) 1,069 48.9 48.3 49.6 188 56.9 55.3 58.5 <0.0001
Years in practice 1,064 19.4 18.7 20.0 187 25.8 24.3 27.4 <0.0001
Sessions per week 1,062 8.3 8.1 8.4 187 8.4 8.0 8.7 0.63
Size of practice 
(number of GPs in 
the practice) 1,061 5.9 5.7 6.1 188 3.4 2.7 4.0 <0.0001
Direct patient care 
hours 1,038 39.8 39.0 40.6 184 40.2 38.4 42.1 0.67
(a) Missing data removed. 
Note: LCL = lower confidence limit; UCL = upper confidence limit. Shading indicates statistically significant differences between two 
groups of GPs. 
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Table 5.3: Characteristics of GPs' practice 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Practice characteristic Number(a)
Per cent of 
GPs(a) 
(n=1,069)
95% 
LCL
95% 
UCL Number(a) 
Per cent of 
GPs(a)  
(n=188) 
95% 
LCL
95% 
UCL
Size of practice (missing) 
(χ2=124.8, p<0.001) 
(8) (0)  
Solo 84 7.9 6.3 9.5 60 31.9 25.2 38.6
2–4 GPs 360 33.9 31.1 36.8 86 45.7 38.6 52.9
5+ GPs 617 58.2 55.2 61.1 42 22.3 16.4 28.3
Practice location by ASGC 
(missing)   χ2=11.2, p=0.001) (3) (0)  
Major city 689 64.6 61.8 67.5 145 77.1 71.1 83.1
Not in Major city 377 35.4 32.5 38.2 43 22.9 16.9 28.9
Practice location by RRMA 
(missing)  (χ2=14.2, 
p=0.0002) 
(1) (0) 
 
Metropolitan 736 68.9 66.1 71.7 155 82.4 77.0 87.9
Not in metropolitan 332 31.1 28.3 33.9 33 17.6 12.1 23.0
Practice location by SEIFA 
(missing)  
(χ2=4.61, p=0.03) 
(12) (3) 
 
Disadvantage SEIFA (<4) 253 23.9 21.4 26.5 58 31.4 24.7 38.0
Less disadvantage SEIFA 
(4-11) 804 76.1 73.5 78.6 127 68.6 62.0 75.3
Accreditation status (missing) 
(χ2=259.6, p<0.001) (9) (1)  
Yes 949 89.5 87.7 91.4 76 40.6 33.6 47.7
No 111 10.5 8.6 12.3 111 59.4 52.3 66.4
Practice nurse at major 
practice (missing) 
(χ2=122.9, p<0.001) 
(6) (2) 
 
Yes 700 65.9 63.0 68.7 42 22.6 16.6 28.6
No 363 34.1 31.3 37.0 144 77.4 71.4 83.4
(a) Missing data removed. 
Note: LCL = lower confidence limit; UCL = upper confidence limit; ASGC = Australian Standard Geographical Classification; RRMA = 
Rural, Remote and Metropolitan Areas; SEIFA = Socio-Economic Indexes for Areas.  Shading indicates statistically significant 
differences between two groups of GPs. 
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As previously reported, the GPs noted the starting time and finishing time for 
40 of their 100 patient encounters. The average length of direct consultations 
(patient seen at the encounter) was calculated on the basis of the recorded 
start time subtracted from the recorded finish time for these 40 encounters. 
The mean length of consultation for clinical computer users and non-clinical 
computer users is compared in Table 5.4. There was no significant difference 
between the two groups: the mean length of consultation being 15 minutes, 
the median being 13 minutes, and the mode, 10 minutes for both groups. 
Table 5.4: Consultation length by GPs using computer for clinical purpose status 
GPs using computer for 
clinical purpose 
(n=34,633)  
GPs not using computer for 
clinical purpose 
(n=6,084) 
Statistical measures – 
minute Mean 
95% 
LCL for 
mean 
95% 
UCL for 
mean  Mean 
95% 
LCL for 
mean 
95% 
UCL for 
mean 
Mean 15.0 14.8 15.3  15.0 14.2 15.7 
Median 13.0 — —  13.0 — — 
Mode 10.0 — —  10.0 — — 
Note: Missing data removed. The start and finish times were recorded for 40 of the 100 encounters. The length of consultation in 
minutes is finish time minus start time. The encounters marked by the GP as claimable for payment through the Medicare system as a 
General Practitioner Attendance item were included in this analysis. LCL = lower confidence limit; UCL = upper confidence limit. 
 
5.3.2 Characteristics of encounters by GP clinical computer use status 
Table 5.5 shows the distribution of the encounters recorded by clinical 
computer users and non clinical computer users. There were no significant 
differences in the proportions of encounters reported as claimable from 
MedicareŦ, through Workers’ CompensationŦ or from other sources. There 
were also no differences in the proportions of encounters described as 
indirect (where the patient was not seen but a service was provided). 
However, there was a significant difference in the proportion of encounters 
recorded as home visits – CC users provided significantly fewer home visits 
(proportionally less than half) than non CC users (0.9%, 95% CI: 0.7–1.1 cf. 
2.3%, 95% CI: 1.4–3.2).  
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Table 5.5: Distribution of services by GP computer use status 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Variable Number(a)
Per cent of 
encounters(a) 
(n=106,900)
95% 
LCL
95% 
UCL Number(a)
Per cent of 
encounters(a) 
(n=18,800) 
95% 
LCL
95% 
UCL
Direct consultations 96,084 96.9 96.6 97.2 16,999 97.3 96.5 98.1
No charge  544 0.5 0.5 0.6 124 0.7 0.3 1.1
Medicare paid 92,431 93.2 92.8 93.7 16,424 94.0 92.9 95.1
 Short surgery 
 consultations  974 1.0 0.8 1.2 177 1.0 0.5 1.5
 Standard 
 surgery consults 73,579 74.2 73.2 75.2 12,625 72.2 68.8 75.7
 Long surgery 
 consults 12,063 12.2 11.5 12.8 1,864 10.7 8.8 12.6
 Prolonged 
 surgery consults  968 1.0 0.8 1.2 194 1.1 0.5 1.7
 Home visits  897 0.9 0.7 1.1 400 2.3 1.4 3.2
 Hospitals  299 0.3 0.2 0.4 70 0.4 0.0 0.8
 Residential aged 
 care facility  1,139 1.1 0.9 1.4 272 1.6 0.6 2.5
 Other items  2,512 2.5 2.2 2.9 822 4.7 2.5 6.9
Worker's 
compensation  2,275 2.3 2.1 2.5 343 2.0 1.5 2.4
Other paid 
 (hospital, state etc)  834 0.8 0.7 1.0 108 0.6 0.3 0.9
Indirect consults  3,069 3.1 2.8 3.4 479 2.7 1.9 3.5
Missing 7,747 1,322 . . .
(a) Missing data removed. 
Note: Shading indicates statistically significant differences between groups. UCL–upper confidence limit; LC– lower confidence limit; 
No charge = the GP service is provided free with no payment from any source. 
 
5.3.3 The content of encounters by GP clinical computer use status 
Table 5.6 shows that compared with encounters with non-clinical/non-
computerised GPs, those with clinical computer users involved: 
• a significantly higher rate of problems managed per 100 encounters 
(150.5 cf. 144.1) 
• a significantly lower prescribed medication rateŦ per 100 encounters 
(81.9 cf. 89.8) 
• a significantly higher rate of pathology tests ordered per 100 
encounters (41.6 cf. 32.6). 
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Table 5.6: Summary of morbidity and management 
 
GPs using computer for clinical purpose 
 
GPs not using computer for clinical purpose 
Variables Number 
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL
Rate per 100 
problems
(n=160,905)
95% 
LCL
95% 
UCL 
 
Number
Rate per 100 
encounters
(n=18,800)
95% 
LCL
95% 
UCL
Rate per 100 
problems
(n=27,091)
95% 
LCL 
95% 
UCL 
General practitioners 1,069 _ _ _ _ _ _  188 _ _ _ _ _ _ 
Encounters 106,900 _ _ _ _ _ _  18,800 _ _ _ _ _ _ 
Reasons for encounter 161,059  150.7 149.2 152.1 _ _ _  28,224 150.1 146.0 154.3 _ _ _ 
Problems managed 160,905  150.5 148.8 152.2 _ _ _  27,091 144.1 140.1 148.1 _ _ _ 
 New problem  59,561  55.7 54.6 56.9 _ _ _  9,952 52.9 50.0 55.9 _ _ _ 
 Old problem 101,344  94.8 93.0 96.6 _ _ _  17,139 91.2 86.7 95.7 _ _ _ 
 Chronic problem 55,172  51.6 50.2 53.0 _ _ _  10,238 54.5 50.7 58.2 _ _ _ 
Medications 107,639  100.7 98.8 102.6 66.9 65.8 68.0  20,515 109.1 102.6 115.6 75.7 71.6 79.8 
 Prescribed 87,529  81.9 80.1 83.7 54.4 53.3 55.5  16,889 89.8 83.9 95.7 62.3 58.6 66.1 
 Advised OTC 10,081  9.43 8.9 10.0 6.3 5.9 6.6  1,958 10.4 8.1 12.8 7.2 5.6 8.8 
 GP-supplied 10,029  9.38 8.6 10.2 6.2 5.7 6.8  1,668 8.9 5.8 11.9 6.2 4.0 8.3 
Non pharmacological 
treatments 61,316 57.3 55.3 59.5 38.1 36.8 39.4  1,012 58.6 52.6 64.5 40.7 36.7 44.6 
 Clinical 42,485  39.7 37.9 41.5 26.4 25.3 27.5  7,547 40.1 35.4 44.9 27.9 24.8 30.9 
 Procedural 18,831  17.6 16.9 18.3 11.7 11.2 12.2  3,465 18.4 15.7 21.2 12.8 10.8 14.7 
Referrals 13,360  12.5 12.1 12.9 8.3 8.0 8.6  2,198 11.7 10.5 12.8 8.1 7.4 8.9 
 Allied health services 3,184  3.0 2.8 3.1 2.0 1.9 2.1  507 2.7 2.2 3.2 1.9 1.5 2.2 
 Specialist 8,886  8.3 8.0 8.6 5.5 5.3 5.7  1,406 7.5 6.7 8.3 5.2 4.7 5.7 
 Emergency dept 161  0.2 0.1 0.2 0.1 0.1 0.1  38 0.2 0.1 0.3 0.1 0.1 0.2 
(continued) 
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Table 5.6 (continued): Summary of morbidity and management 
 
GPs using computer for clinical purpose 
 
GPs not using computer for clinical purpose 
Variables Number 
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL
Rate per 100 
problems
(n=160,905)
95% 
LCL
95% 
UCL 
 
Number
Rate per 100 
encounters
(n=18,800)
95% 
LCL
95% 
UCL
Rate per 100 
problems
(n=27,091)
95% 
LCL 
95% 
UCL 
 Hospital 597  0.6 0.5 0.7 0.4 0.3 0.4  137 0.7 0.5 1.0 0.5 0.3 0.7 
 Referral NOS 532  0.5 0.4 0.6 0.3 0.3 0.4  110 0.6 0.3 0.9 0.4 0.2 0.6 
Pathology 44,439  41.6 40.2 43.0 27.6 26.8 28.5  6,131 32.6 28.7 36.5 22.6 20.1 25.2 
Imaging 9,214  8.6 8.3 8.9 5.7 5.5 5.9  1,537 8.2 7.2 9.1 5.7 5.0 6.3 
Other investigation 1,201  1.1 1.0 1.2 0.8 0.7 0.8  169 0.9 50.0 1.1 0.6 0.5 0.8 
Note: UCL–upper confidence limit; LCL– lower confidence limit. Shading indicates statistically significant differences between groups.
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5.3.4 Patient characteristics by GP clinical computer use status 
The patients at encounters with CC users differed markedly in several areas 
to those encountered by non CC users. 
Patient age  
Clinical computer users saw proportionally more patients in the younger age 
groups up to 24 years (other than the 5–14 years group) and proportionally 
fewer patients aged 45–64 years. There were no significant differences 
between the two groups for patients aged 5–14 years, 25–44 years, those 
aged 65–74 years, or 75 years and older. The age distribution of patients in 
the two groups is presented graphically in Figure 5.4.  
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Patient sex 
A significantly larger proportion of the patients seen by CC users were female 
(59.0%, 95% CI: 58.2–59.8) compared with those seen by non CC users 
(54.8%, 95% CI: 53.0–56.7) (Table 5.7). 
Figure 5.4 Age distribution of patients by GP clinical computer use status 
with 95% confidence limits 
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Other patient characteristics 
A significantly smaller proportion of patients seen by clinical computer users 
were Commonwealth Health Care concession card holders (41.7%, 95% CI: 
40.5–42.9 cf. 47.9%, 95% CI: 44.5–51.2) and fewer were from a non-English 
speaking background (7.0%, 95% CI: 6.0–8.0 cf. 12.8%, 95% CI: 9.4–13.3). 
Figure 5.5 shows a graphic summary of the significant differences described 
above. 
Table 5.7: Characteristics of patients at encounters 
 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Patient variable Number
Percent of 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Percent of 
encounters 
(n=18,800) 
95% 
LCL
95% 
UCL
Sex  
Males 43,429 41.0 40.2 41.8 8,398 45.2 43.3 47.0
Females 62,501 59.0 58.2 59.8 10,189 54.8 53.0 56.7
Missing sex 970 213  
Age  
<1 year 2,138 2.0 1.9 2.2 259 1.4 1.1 1.7
1-4 years 4,602 4.4 4.1 4.6 609 3.3 2.6 4.0
5-14 years 5,849 5.5 5.3 5.8 896 4.8 4.2 5.4
15-24 years 9,829 9.3 8.9 9.7 1,476 7.9 7.2 8.7
25-44 years 25,873 24.4 23.8 25.1 4,584 24.7 22.9 26.4
45-64 years 28,746 27.2 26.7 27.6 5,631 30.3 28.8 31.7
65-74 years 13,159 12.4 12.0 12.8 2,414 13.0 11.9 14.1
75+ years 15,663 14.8 14.1 15.5 2,726 14.7 12.9 16.4
Missing age 1,041 205  
Other characteristics  
C’wealth conc. card  44,599 41.7 40.5 42.9 8,996 47.9 44.5 51.2
VA card holder  3,874 3.6 3.4 3.9 599 3.2 2.6 3.8
NESB 7,500 7.0 6.0 8.0 2,409 12.8 9.4 16.3
Aboriginal 2,013 1.9 1.3 2.5 373 2.0 0.5 3.5
Torres Strait Islander 160 0.1 0.1 0.2 112 0.6 0.0 1.5
Aboriginal & Torres Strait 
Islander  56 0.1 0.0 0.1 14 0.1 0.0 0.1
Aboriginal and/or Torres 
Strait Islander 2,229 2.1 1.5 2.7 499 2.7 0.9 4.4
New to practice 9,776 9.1 8.5 9.7 2,177 11.6 9.4 13.8
(a) Missing data removed. 
Note: Shading indicates statistically significant differences between groups. UCL–upper confidence limit; LCL– lower confidence limit. 
C’wealth conc. card = Health care/benefits card (see glossary). NESB = Non English Speaking Background 
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5.3.5 Patient reasons for encounter by GP clinical computer use status 
The patient’s reasons for the encounter (RFE) are those problems or 
concerns presented by the patient as the reason they’ve consulted the GP. 
GPs were asked to record up to three reasons given by the patient for the 
visit, as closely as possible to the words used by the patient. Each reason 
could be expressed as a symptom (e.g. ‘sore ankle’), in diagnostic terms (e.g. 
‘about my asthma’), as a request for a service (e.g. ‘I need another script’ or ‘I 
need a medical certificate’), an expressed fear or concern (e.g. ‘worried about 
cancer), or the need for a check-up. 
The patient’s reasons for the encounter can have a one-to-many, many-to-
one, or many-to-many relationship with the problem or problems managed, in 
that they may describe several symptoms that relate to the same problem, or 
may offer only one reason that may relate to several problems. Patient RFEs 
reflect the patient’s demand for care and can provide information about 
service utilisation patterns. 
Figure 5.5 Summary of significant differences in patient characteristics by GP 
clinical computer use status with 95% confidence interval 
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There were no significant differences between CC users and non CC users in 
terms of the distribution of number of patient RFEs recorded. In each group, 
approximately 61% reported one RFE, 27% reported two RFEs and 12% 
reported three RFEs (Table 5.8). 
Table 5.8: Number of patient reasons for encounter (RFEs) 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Number of 
reasons  
for encounter 
(n=161,059)  Number 
Per cent of 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Per cent of 
encounters 
(n=18,800) 
95% 
LCL
95% 
UCL
One RFE 65,005 60.8 60.5 61.1  11,556 61.5 60.8 62.2
Two RFEs 29,631 27.7 27.5 28.0  5,064 26.9 26.3 27.6
Three RFEs 12,264 11.5 11.3 11.7  2,180 11.6 11.1 12.1
Total 106,900 100.0 — — 18,800 100.0 — —
Note: Shading indicates statistically significant differences between groups. UCL–upper confidence limit; LCL– lower confidence limit. 
 
Distribution of RFEs by ICPC-2 chapter by GP clinical computer use 
status 
The distribution of RFEs as classified by ICPC-2 chapter (see Methods, 
Chapter 3) showed some significant differences between the two GP groups 
(Table 5.9).  
Patients at encounters with CC users expressed significantly more reasons 
for the encounter that were of a general or unspecified nature (38.5 per 100 
encounters, 95% CI: 37.6–39.4 cf. 33.7, 95% CI: 31.2–36.2) or were 
associated with the female genital system (6.1 per 100 encounters, 95% CI: 
5.7–6.6 cf. 4.6, 95% CI: 3.5–5.6), and significantly fewer problems associated 
with the circulatory system (10.0 per 100 encounters, 95% CI: 9.6–10.4 cf. 
12.6, 95% CI: 11.0–13.7). For pregnancy and family planning, there was a 
marginal but not significant difference (confidence intervals touch but do not 
overlap) with the trend showing fewer of these for non CC users. 
There were no significant differences in the rates of reasons for encounter 
associated with the respiratory, skin, musculoskeletal, digestive, 
psychological, endocrine and metabolic, neurological, ear, eye, urological, 
blood, or male genital systems, or problems of a social nature. 
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Table 5.9: Distribution of patient reasons for encounter by ICPC-2 chapter 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Reasons for 
encounter  Number 
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Rate per 100 
encounters 
(n=18,800) 
95% 
LCL 
95% 
UCL
General & 
unspecified  41,171  38.5 37.6 39.4 6,336 33.7 31.2 36.2
Respiratory  20,148  18.9 18.2 19.5 3,525 18.8 17.1 20.4
Skin  17,257  16.1 15.5 16.8 3,087 16.4 13.9 19.0
Musculoskeletal  16,882 15.8 15.3 16.2 3,294 17.5 15.8 19.3
Circulatory  10,719  10.0 9.6 10.4 2,322 12.4 11.0 13.7
Digestive  10,406  9.7 9.4 10.0 1,966 10.5 9.5 11.4
Psychological  8,391  7.9 7.5 8.2 1,583 8.4 7.3 9.5
Female genital 
system  6,557  6.1 5.7 6.6 855 4.6 3.5 5.6
Endocrine & 
metabolic  6,518  6.1 5.8 6.4 1,257 6.7 5.7 7.7
Neurological  5,211  4.9 4.7 5.1 1,064 5.7 5.0 6.4
Ear  4,268  4.0 3.8 4.2 733 3.9 2.9 4.9
Pregnancy & family 
planning  4,263  4.0 3.7 4.2 543 2.9 2.0 3.7
Eye 2,810 2.6 2.5 2.8 499 2.7 2.3 3.0
Urology 2,723 2.6 2.4 2.7 462 2.5 2.1 2.8
Blood 1,402 1.3 1.2 1.5 244 1.3 1.0 1.6
Male genital system 1,178 1.1 1.0 1.2 261 1.4 0.8 2.0
Social 1,155 1.1 1.0 1.2 193 1.0 0.8 1.3
Total RFEs 161,059 150.7 149.2 152.1 28,224 150.1 146.0 154.3
Note: Shading indicates statistically significant differences between groups. LCL–lower confidence limit; UCL– upper confidence limit 
 
The most frequent individual patient RFEs by GP clinical computer use 
status  
Table 5.10 shows the most commonly reported patient RFEs at a more 
specific level. Patients attending a clinical computer user were more likely to 
attend for test results (7.0 per 100 encounters, 95% CI: 6.7–7.4 cf. 5.4, 95% 
CI: 4.6–6.2), or for preventive immunisations/vaccinations (5.0 per 100 
encounters, 95% CI: 4.6–5.4 cf. 3.3, 95% CI: 2.4–4.2), and less likely to 
attend for hypertension management (1.6 per 100 encounters, 95% CI: 1.4–
1.8 cf. 2.5, 95% CI: 1.9–3.1). Requests for general check-up, and for female 
genital check-up were marginally more common at encounters with CC users, 
and presentations of headache marginally less common (the confidence 
intervals just meeting), that at encounters with non CC users.  
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Table 5.10: Most frequent individual patient reasons for encounter 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Reasons for encounter  Number
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Rate per 100 
encounters 
(n=18,800) 
95% 
LCL
95% 
UCL
Prescription all* 13,363 12.5 12.0 13.0 2,549 13.6 11.7 15.4
Test results* 7,515 7.0 6.7 7.4 1,010 5.4 4.6 6.2
Cough 5,370 5.0 4.8 5.3 958 5.1 4.5 5.7
Immunisation all* 5,326 5.0 4.6 5.4 625 3.3 2.4 4.2
Cardiac check-up* 4,976 4.7 4.4 4.9 973 5.2 4.4 6.0
General check-up* 4,193 3.9 3.7 4.1 594 3.2 2.6 3.7
Back complaint* 3,362 3.1 3.0 3.3 708 3.8 3.2 4.3
Throat complaint 3,150 3.0 2.8 3.1 632 3.4 2.8 3.9
Rash* 3,039 2.8 2.7 3.0 531 2.8 2.4 3.3
Female genital check-up* 2,636 2.5 2.2 2.7 297 1.6 1.0 2.2
Depression* 2,129 2.0 1.9 2.1 362 1.9 1.6 2.3
Abdominal pain* 1,938 1.8 1.7 1.9 347 1.9 1.6 2.1
Administrative procedure 
NOS 1,774 1.7 1.5 1.8 246 1.3 1.0 1.6
Weakness/tiredness 1,770 1.7 1.5 1.8 296 1.6 1.2 1.9
Upper respiratory tract 
infection 1,742 1.6 1.5 1.8 283 1.5 1.2 1.8
Hypertension/high blood 
pressure* 1,699 1.6 1.4 1.8 465 2.5 1.9 3.1
Ear Pain 1,661 1.6 1.5 1.6 273 1.5 1.2 1.7
Fever 1,653 1.6 1.4 1.7 325 1.7 1.2 2.2
Skin complaint 1,624 1.5 1.4 1.6 324 1.7 1.1 2.3
Headache 1,584 1.5 1.4 1.6 363 1.9 1.6 2.3
Total RFEs 161,059 150.7 149.2 152.1 28,224 150.1 146.0 154.3
Note: Shading indicates statistically significant differences between groups. LCL–lower confidence limit; UCL– upper confidence limit. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see ICPC code groupsŦ in Glossary)
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5.3.6 Problems managed at the encounter by GP clinical computer use 
status 
The diagnosis or problem managed at the encounter is the formal label or 
statement of the health issue presented to the GP by the patient. Sometimes 
a clear diagnosis can be reached, but often one cannot be determined without 
follow-up, further investigation or time (i.e. a wait-and-see approach). GPs 
were instructed to record each problem at the most specific level (i.e. highest 
diagnostic level) possible from the information available accepting that at 
times this will be limited to the signs or symptoms presented. 
For each patient, the GP could record up to four problems managed at the 
encounter, with a minimum of one being compulsory. The status of each 
problem (new or old) to the patient was also specified. Unlike the hospital 
system, the concept of a ‘principal diagnosis’ is not relevant in general 
practice as the patient may present with problems from different body 
systems, some of which may be symptoms of a common problem, but others 
may not be related in any way. Some may be of a chronic nature and others 
acute, some may be physical, while others may be social or psychological, but 
all require management at the same encounter. As none of these problems 
may necessarily be of more significance than others, the order in which the 
problems are recorded by the GP is not important. 
Number of problems managed at the encounter by GP clinical computer 
use status 
In Section 5.3.3 (Table 5.6) the average number of problems managed per 
100 encounters was shown to be significantly higher for clinical computer 
users than for non-clinical/non-computerised GPs (150.5 per 100 encounters, 
95% CI: 148.8–152.2 cf. 144.1, 95% CI: 140.1–148.1). The relative 
distribution of problems across encounters is compared in Table 5.11. There 
are significant differences in the rate of problems managed at each level. 
Compared with non CC users, those using a computer for clinical activity were 
significantly less likely to manage a single problem at the encounter (63.6% of 
encounters, 95% CI: 63.3–63.9 cf. 67.3%, 95% CI: 66.6–68.0), but more likely 
to manage two (24.9% of encounters, 95% CI: 24.7–25.2 cf. 23.3%, 95% CI: 
22.7–23.9), three (8.7% of encounters, 95% CI: 8.5–8.9 cf. 7.3%, 95% CI: 
100 
7.0–7.7), or four (2.7% of encounters, 95% CI: 2.6–2.8 cf. 2.0%, 95% CI: 1.8–
2.2) problems per encounter. 
Table 5.11: Number of problems managed at the encounter 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Number of 
problems 
managed Number 
Per cent of 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Per cent of 
encounters 
(n=18,800) 
95% 
LCL 
95% 
UCL
One 68,029  63.6 63.3 63.9 12,653 67.3 66.6 68.0
Two 26,644  24.9 24.7 25.2 4,385 23.3 22.7 23.9
Three 9,320  8.7 8.5 8.9 1,380 7.3 7.0 7.7
Four 2,907  2.7 2.6 2.8 382 2.0 1.8 2.2
Total 106,900 100.0 — —  18,800 100.0 — —
Note: Shading indicates statistically significant differences between groups. LCL–lower confidence limit; UCL– upper confidence limit. 
 
Distribution of problems managed by ICPC-2* Chapter by GP clinical 
computer use status 
As with the patient reasons for encounter, the problems managed were also 
classified according to the ICPC-2, and are reported as a management rate 
per 100 encounters in Table 5.12. Some significant differences were noted. 
Apart from the significantly higher rate of problems managed, compared with 
non CC users, encounters with CC users involved significantly more problems 
that were: 
• of a general or unspecified nature (16.5 per 100 encounters, 95% CI: 
15.9–17.0 cf. 12.9, 95% CI: 11.2–14.5) 
• related to the female genital system (7.2 per 100 encounters, 95% CI: 
6.7–7.6 cf. 5.3, 95% CI: 4.1–6.5) 
• related to pregnancy or family planning (4.5 per 100 encounters, 95% 
CI: 4.2–4.7 cf. 3.2, 95% CI: 2.4–4.0). 
There were no significant differences in the relative rates of management of 
problems associated with the respiratory system; the skin; the 
musculoskeletal system; the circulatory system; the endocrine & metabolic 
system; the digestive system; the ear; the neurological system, the blood or 
blood-forming organs; the male genital system; social problems; or those of a 
of a psychological nature. 
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Table 5.12: Problems managed by ICPC-2 chaptersŦ 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Problems managed Number 
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Rate per 100 
encounters 
(n=18,800) 
95% 
LCL
95% 
UCL
Respiratory 19,740 18.5 17.9 19.0 3,276 17.4 16.0 18.8
Skin 19,050 17.8 17.2 18.5 3,484 18.5 15.4 21.7
Musculoskeletal 18,578 17.4 16.9 17.8 3,234 17.2 15.8 18.6
General & unspecified 17,621 16.5 15.9 17.0 2,418 12.9 11.2 14.5
Circulatory 17,574 16.4 15.8 17.0 3,368 17.9 16.2 19.6
Psychological 12,953 12.1 11.5 12.7 2,325 12.4 10.8 13.9
Endocrine & metabolic 12,855 12.0 11.6 12.5 2,315 12.3 11.0 13.6
Digestive 10,705 10.0 9.8 10.3 1,896 10.1 9.4 10.8
Female genital system 7,665 7.2 6.7 7.6 997 5.3 4.1 6.5
Pregnancy & family 
planning 4,796 4.5 4.2 4.7 603 3.2 2.4 4.0
Ear 4,391 4.1 4.0 4.3 729 3.9 2.8 4.9
Neurological 4,035 3.8 3.6 3.9 700 3.7 3.3 4.2
Urology 3,396 3.2 3.0 3.3 508 2.7 2.4 3.0
Eye 2,872 2.7 2.6 2.8 494 2.6 2.3 2.9
Blood 1,908 1.8 1.6 2.0 290 1.5 1.3 1.8
Male genital system 1,779 1.7 1.6 1.8 335 1.8 1.3 2.3
Social 987 0.9 0.8 1.0 119 0.6 0.5 0.8
Total problems 160,905 150.5 148.8 152.2 27,091 144.1 140.1 148.1
Note: Shading indicates statistically significant differences between groups. UCL–upper confidence limit; LCL– lower confidence limit 
 
The most frequent individual problems managed by GP clinical 
computer use status 
The management rates of the most common individual problems managed at 
encounters with both GP groups are shown in Table 5.13. At encounters with 
clinical computer users, hypertension was managed significantly less often 
(8.7 per 100 encounters, 95% CI: 8.3–9.1 cf. 11.0, 95% CI: 9.7–12.2). 
Problems managed significantly more often at encounters with clinical 
computer users included “prescription” (unspecified problem) (2.4 per 100 
encounters, 95% CI: 2.2–2.7 cf. 1.6, 95% CI: 1.2–2.1), female genital check-
ups (2.4 per 100 encounters, 95% CI: 2.2–2.6 cf. 1.6, 95% CI: 1.0–2.1), and 
general health check-ups (2.4 per 100 encounters, 95% CI: 2.2–2.5 cf. 1.5, 
95% CI: 1.1–1.9). 
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Table 5.13: Most frequent individual problems managed at the encounter 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Problems managed Number
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number 
Rate per 100 
encounters 
(n=18,800) 
95% 
LCL
95% 
UCL
Hypertension* 9,339 8.7 8.3 9.1 2,061 11.0 9.7 12.2
Immunisation-all* 5,759 5.4 4.9 5.8 753 4.0 2.7 5.3
Upper respiratory infection, 
acute 5,076 4.8 4.5 5.0 914 4.9 4.2 5.5
Depression* 4,344 4.1 3.8 4.3 716 3.8 3.3 4.3
Lipid disorders* 3,576 3.4 3.2 3.5 665 3.5 3.0 4.1
Diabetes* 3,438 3.2 3.0 3.4 688 3.7 3.1 4.2
Back complaint* 2,970 2.8 2.6 2.9 507 2.7 2.3 3.1
Osteoarthritis* 2,887 2.7 2.5 2.9 475 2.5 2.1 2.9
Prescription all* 2,577 2.4 2.2 2.7 308 1.6 1.2 2.1
Female genital check-up* 2,563 2.4 2.2 2.6 295 1.6 1.0 2.1
Asthma 2,543 2.4 2.3 2.5 376 2.0 1.7 2.3
General check-up* 2,517 2.4 2.2 2.5 286 1.5 1.1 1.9
Oesophagus disease 2,272 2.1 2.0 2.2 377 2.0 1.7 2.4
Acute bronchitis/bronchiolitis 2,252 2.1 2.0 2.3 393 2.1 1.7 2.5
Anxiety* 1,891 1.8 1.6 1.9 380 2.0 1.6 2.4
Dermatitis, contact/allergic 1,888 1.8 1.7 1.9 317 1.7 1.5 1.9
UTI* 1,868 1.8 1.7 1.8 275 1.5 1.2 1.7
Sleep disturbance 1,860 1.7 1.6 1.9 297 1.6 1.3 1.9
Sprain/Strain* 1,569 1.5 1.4 1.6 314 1.7 1.3 2.0
Oral contraception* 1,551 1.5 1.3 1.6 199 1.1 0.8 1.3
Test results* 1,530 1.4 1.3 1.5 219 1.2 0.9 1.4
Solar keratosis/sunburn 1,487 1.4 1.2 1.6 440 2.3 1.1 3.6
Ischaemic Heart Disease* 1,340 1.3 1.2 1.4 196 1.0 0.8 1.3
Malignant neoplasm skin 1,285 1.2 1.0 1.4 370 2.0 1.0 3.0
Total problems 160,905 150.5 148.8 152.2 27,091 144.1 140.1 148.1
Note: Shading indicates statistically significant differences between groups. LCL–lower confidence limit; UCL– upper confidence limit. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see ICPC code groupsŦ in Glossary) 
5.3.7 Management of problems by GP clinical computer use status 
The overall management rates (including prescribing ratesŦ, rates of non 
pharmacological treatments etc.) were compared earlier (Table 5.6) and 
showed that, compared with non CC users, CC users prescribed medications 
at a significantly lower rate and ordered pathology tests at a significantly 
higher rate per 100 encounters. 
These results are reflected in analysis of the number of encounters at which 
at least one form of management was recorded by the GPs (Table 5.14). 
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While there was no difference in the likelihood of providing a treatment, 
referralŦ or investigation of any type compared with non CC users, CC users: 
• were significantly less likely to prescribe at least one medication 
(53.1%, 95% CI: 52.2–53.9 cf. 57.1, 95% CI: 54.3–59.8) 
• significantly more likely to order at least one investigation of any type 
(23.6%, 95% CI: 23.1–24.2 cf. 20.4%, 95% CI: 18.7–22.1), and in 
particular, 
• significantly more likely to order at least one pathology test (17.6%, 
95% CI: 17.1–18.1 cf. 14.9%, 95% CI: 13.3–16.4). 
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Table 5.14: Encounters at which management was recorded 
GPs using a computer for clinical purposes  GPs not using a computer for clinical purposes 
Management type Number 
Percent of 
encounters 
(n=106,900) 95% LCL 95% UCL  Number 
Percent of  
encounters 
(n=18,800) 95% LCL 95% UCL 
At least one treatment, referral or investigation 97,735 91.4 91.0 91.9 17,365 92.4 91.0 93.7
At least one treatment type 87,280 81.6 81.0 82.3 15,773 83.9 82.1 85.7
At least one medication 67,395 63.0 62.3 63.8 12,455 66.3 63.7 68.8
At least one prescription 56,716 53.1 52.2 53.9 10,726 57.1 54.3 59.8
At least one OTC advised 8,934 8.4 7.9 8.8 1,607 8.5 7.3 9.8
At least one  GP supplied 7,635 7.1 6.6 7.7 1,192 6.3 4.9 7.8
At least one non-pharmacological treatment 46,738 43.7 42.5 45.0 8,167 43.4 39.8 47.0
At least one clinical treatment 33,048 30.9 29.7 32.1 5,816 30.9 27.8 34.1
At least one therapeutic procedure 17,737 16.6 16.0 17.2 3,169 16.9 14.5 19.2
At least one referral 12,585 11.8 11.4 12.1 2,088 11.1 10.1 12.1
At least one referral to specialist 8,569 8.0 7.7 8.3 1,363 7.3 6.5 8.0
At least one referral to allied health service 3,066 2.9 2.7 3.0 490 2.6 2.1 3.1
At least one referral to hospital 597 0.6 0.5 0.7 137 0.7 0.5 1.0
At least one referral to emergency dept 161 0.2 0.1 0.2 38 0.2 0.1 0.3
At least one referral NOS 532 0.5 0.4 0.6 110 0.6 0.3 0.9
At least one investigation 25,252 23.6 23.1 24.2 3,838 20.4 18.7 22.1
At least one pathology order 18,819 17.6 17.1 18.1 2,795 14.9 13.3 16.4
At least one imaging order  8,052 7.5 7.3 7.8 1,312 7.0 6.2 7.7
At least one other investigation 1,143 1.1 1.0 1.1 164 0.9 0.7 1.1
Note:  Tests included in ‘other investigations’ are listed in Appendix 12.  Shading indicates statistically significant differences between groups.
105 
Medication management by GP clinical computer use status 
As previously shown in Section 5.3.3 (Table 5.5), the overall medication rate 
per 100 encounters, the rate of GP supplied medications and the rate of over-
the-counter medications did not differ significantly between CC users and non 
CC users. However, the prescribed medication rates were significantly lower 
for clinical computer users (81.9 per 100 encounters, 95% CI: 80.1–83.7 cf. 
89.8, 95% CI: 83.9–95.7).  
Prescribed medications 
From analyses performed using the CAPSŦ classification described in Chapter 
3 (Section 3.2.7) the distribution of medications commonly prescribed by 
group, sub-group and generic name are shown in Table 5.15, in order of 
medication group and sub-group frequency. Compared with non CC users, 
CC users prescribed significantly lower rates of: 
• medications acting on the cardiovascular system, particularly anti-
hypertensives 
• medications acting on the central nervous system, particularly simple 
analgesics (specifically paracetamol) 
• hypoglycaemic agents 
• medications acting on the musculoskeletal system, particularly non-
steroidal anti-inflammatory drugs, 
and prescribed significantly higher rates of: 
• contraceptives, particularly levonorgestrel/ethinyloestradiol. 
There were no other significant differences in the rates of other prescribed 
medication groups, sub-groups or generic medications between the two 
groups. 
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Table 5.15: Common medications prescribed, by group, sub-group and generic 
medication 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Group 
Sub 
group Generic No.
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL No. 
Rate per 100 
encounters
(n=18,800)
95% 
LCL
95% 
UCL
Cardiovascular 14,749 13.8 13.2 14.4 3,140 16.7 14.5 18.9
 Antihypertensives 8,147 7.6 7.3 8.0 1,803 9.6 8.3 10.9
  Irbesartan 905 0.9 0.8 0.9 192 1.0 0.8 1.2
  Perindopril 839 0.8 0.7 0.9 177 0.9 0.7 1.2
  Ramipril 818 0.8 0.7 0.8 185 1.0 0.8 1.2
  
Irbesartan/Hydro-
cholrothiazide 684 0.6 0.6 0.7 156 0.8 0.6 1.1
  Amlodipine 639 0.6 0.5 0.7 151 0.8 0.6 1.0
 Other CVS drugs 3,284 3.1 2.9 3.2 633 3.4 2.9 3.9
  Atorvastatin 1,444 1.4 1.3 1.4 290 1.5 1.2 1.8
  Simvastatin 1,180 1.1 1.0 1.2 214 1.1 0.9 1.4
 Beta-blockers 1,675 1.6 1.5 1.7 379 2.0 1.7 2.4
  Atenolol 966 0.9 0.8 1.0 209 1.1 0.9 1.3
 Anti-angina 787 0.7 0.7 0.8 169 0.9 0.7 1.1
Anti-infections/infestations 14,526 13.6 13.1 14.0 2,589 13.8 12.6 14.9
 Broadspectrumpenicillins 4,860 4.6 4.3 4.8 946 5.0 4.4 5.6
  Amoxycillin 3,192 3.0 2.8 3.2 629 3.4 2.8 3.9
  
Amoxycillin/ 
potass.clavulanate 1,654 1.6 1.4 1.7 316 1.7 1.4 2.0
 Penicillin/Cephalosporins 4,402 4.1 3.9 4.3 731 3.9 3.4 4.4
  Cephalexin 2,378 2.2 2.1 2.4 352 1.9 1.6 2.2
  
Cefaclor 
monohydrate 660 0.6 0.5 0.7 150 0.8 0.6 1.0
 Other antibiotics 2,829 2.7 2.5 2.8 468 2.5 2.1 2.9
  Roxithromycin 1,077 1.0 0.9 1.1 211 1.1 0.9 1.4
 Anti-infectives 981 0.9 0.8 1.1 138 0.7 0.6 0.9
 Tetracyclines 909 0.9 0.8 0.9 200 1.1 0.8 1.3
  Doxycycline 741 0.7 0.6 0.8 155 0.8 0.6 1.0
CNS 10,318 9.7 9.2 10.1 2,260 12.0 10.6 13.4
 Simple analgesics 3,179 3.0 2.8 3.2 796 4.2 3.5 4.9
  Paracetamol 2,463 2.3 2.1 2.5 639 3.4 2.8 4.0
  Aspirin 703 0.7 0.6 0.7 156 0.8 0.6 1.0
 Narcotic analgesics 2,701 2.5 2.3 2.8 519 2.8 2.1 3.4
  Tramadol 1,018 1.0 0.9 1.0 174 0.9 0.7 1.1
(continued) 
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Table 5.15 (continued): Common medications prescribed, by group, sub-group and 
generic medication 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Group 
Sub 
group Generic No.
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL No. 
Rate per 100 
encounters
(n=18,800)
95% 
LCL
95% 
UCL
 Compound analgesic 2,405 2.3 2.1 2.4 502 2.7 2.2 3.1
  
Paracetamol/Cod
eine 2,017 1.9 1.8 2.0 425 2.3 1.8 2.7
 Antiemetic/Antinauseant 1,248 1.2 1.1 1.3 265 1.4 1.2 1.7
Psychological 8,252 7.7 7.4 8.1 1,609 8.6 7.4 9.7
 Antidepressants 3,535 3.3 3.1 3.5 590 3.1 2.7 3.6
 Antianxiety 2,080 2.0 1.8 2.1 512 2.7 2.1 3.4
  Diazepam 1,134 1.1 1.0 1.2 287 1.5 1.2 1.9
  Oxazepam 684 0.6 0.6 0.7 173 0.9 0.6 1.2
 Sedatives/Hypnotics 2,053 1.9 1.8 2.0 340 1.8 1.5 2.1
  Temazepam 1,308 1.2 1.1 1.3 231 1.2 1.0 1.4
 Antipsychotic 584 0.6 0.5 0.6 167 0.9 0.5 1.3
Hormones 5,643 5.3 5.0 5.5 1,131 6.0 5.2 6.9
 Hypoglycaemic 2,022 1.9 1.7 2.0 511 2.7 2.1 3.3
  Metformin 943 0.9 0.8 1.0 211 1.1 0.8 1.4
 Sex hormones/Anabolic 1,550 1.5 1.3 1.6 238 1.3 1.0 1.5
 Corticosteroids 1,245 1.2 1.1 1.3 228 1.2 1.0 1.4
Musculoskeletal 5,218 4.9 4.7 5.1 1,157 6.2 5.5 6.8
 NSAID  4,400 4.1 3.9 4.3 937 5.0 4.4 5.6
  Celecoxib 1,021 1.0 0.9 1.0 193 1.0 0.8 1.2
  
Diclofenac sodium 
systemic 842 0.8 0.7 0.9 195 1.0 0.8 1.2
Respiratory 4,436 4.2 3.9 4.4 762 4.1 3.5 4.6
 
Bronchodilator/Spasm 
relaxant 2,130 2.0 1.9 2.1 376 2.0 1.7 2.3
  Salbutamol 1,475 1.4 1.3 1.5 271 1.4 1.2 1.7
 Asthma preventives 1,844 1.7 1.6 1.8 295 1.6 1.4 1.8
  
Fluticasone/Salme
terol 876 0.8 0.8 0.9 144 0.8 0.6 0.9
Skin 4,161 3.9 3.7 4.1 711 3.8 3.4 4.2
 Topical steroids 2,755 2.6 2.5 2.7 446 2.4 2.1 2.7
  Mometasone 755 0.7 0.6 0.8 107 0.6 0.4 0.7
  
Betamethasone 
topical 747 0.7 0.6 0.8 121 0.6 0.5 0.8
(continued) 
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Table 5.15 (continued): Common medications prescribed, by group, sub-group and 
generic medication 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Group 
Sub 
group Generic No.
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL No. 
Rate per 100 
encounters
(n=18,800)
95% 
LCL
95% 
UCL
Digestive 4,073 3.8 3.6 4.0 819 4.4 3.9 4.9
 Antiulcerants 2,775 2.6 2.5 2.7 526 2.8 2.4 3.2
  Esomeprazole 734 0.7 0.6 0.8 126 0.7 0.5 0.8
  Omeprazole 715 0.7 0.6 0.7 143 0.8 0.6 1.0
Allergy, immune system 4,004 3.8 3.4 4.1 568 3.0 2.4 3.6
 Immunization 3,577 3.4 3.0 3.6 459 2.4 1.8 3.1
  
Influenza virus 
vaccine 1,229 1.2 1.0 1.3 183 1.0 0.5 1.4
Blood 2,249 2.1 2.0 2.2 420 2.2 1.8 2.7
 Other blood drugs 1,387 1.3 1.2 1.4 253 1.4 1.0 1.7
  Warfarin sodium 1,034 1.0 0.9 1.1 189 1.0 0.7 1.3
 Haemopoietics 861 0.8 0.7 0.9 166 0.9 0.7 1.1
Contraceptives 2,047 1.9 1.8 2.0 242 1.3 1.0 1.5
 Contraceptives oral/systemic 2,026 1.9 1.8 2.0 242 1.3 1.0 1.5
  
Levonorgestrel/Ethin
yloestradiol 1,326 1.2 1.2 1.3 168 0.9 0.7 1.1
Urogenital 1,868 1.8 1.6 1.9 357 1.9 1.6 2.2
 Diuretic 1,054 1.0 0.9 1.1 223 1.2 0.9 1.4
Ear, nose topical 1,718 1.6 1.5 1.7 284 1.5 1.2 1.8
 Topical otic 986 0.9 0.8 1.0 174 0.9 0.7 1.1
Eye medications 1,677 1.6 1.5 1.7 321 1.7 1.5 1.9
 Anti-infectives eye 1,045 1.0 0.9 1.0 200 1.1 0.9 1.2
  
Chloramphenicol 
eye 925 0.9 0.8 0.9 178 1.0 0.8 1.1
Nutrition, metabolism 1,656 1.6 1.4 1.7 323 1.7 1.4 2.0
Anti neoplastics 423 0.4 0.3 0.4 86 0.5 0.1 0.8
Miscellaneous 314 0.3 0.3 0.3 69 0.4 0.3 0.5
Surgical preparations 129 0.1 0.1 0.2 24 0.1 0.1 0.2
Diagnostic agents 68 0.1 0.0 0.1 17 0.1 0.0 0.1
Total prescribed medications 87,529 81.9 80.1 83.7 16,889 89.8 83.9 95.7
Note: Shading indicates statistically significant differences between groups. LCL–lower confidence limit; UCL– upper confidence limit; 
CVS–cardiovascular system; CNS–central nervous system; NSAID–non-steroidal anti-inflammatory drug; 
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Non–pharmacological management by GP clinical computer use status 
Earlier in this Chapter (Section 5.3.3, Table 5.6) it was shown that CC users 
and non CC users did not differ in their rates of providing non-
pharmacological clinical treatments such as (counselling). Table 5.16 shows 
the top ten clinical treatments provided by both GP groups (which accounted 
for more than 86% of clinical treatments for each). GPs who used a computer 
for clinical purposes provided counselling/advice for nutrition or weight 
problems significantly less often than their counterparts. While the confidence 
intervals for psychological counselling and for other 
administration/documentation showed a marginal difference, there were no 
significant differences between the two GP groups in the rate per 100 
encounters for any non pharmacological treatments listed.  
Table 5.16: Clinical treatments 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Clinical treatment Number
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Rate per 100 
encounters 
(n=18,800) 
95% 
LCL
95% 
UCL
Advice/education* 7,811 7.3 6.7 7.9  1,416 7.5 5.9 9.2 
Counselling - problem* 5,114 4.8 4.3 5.3  948 5.0 3.2 6.9 
Counselling/advice – 
nutrition/weight* 4,904 4.6 4.2 4.9  1,224 6.5 5.2 7.8 
Advice/education – 
treatment* 4,338 4.1 3.7 4.4  831 4.4 3.6 5.2 
Advice/education – 
medication* 3,848 3.6 3.3 3.9  565 3.0 2.4 3.6 
Counselling – 
psychological* 3,690 3.5 3.2 3.7  516 2.7 2.2 3.3 
Counselling/advice – 
exercise* 1,812 1.7 1.5 1.9  364 1.9 1.3 2.6 
Other 
admin/documentation* 1,811 1.7 1.5 1.8  219 1.2 0.9 1.5 
Reassurance, support 1,741 1.6 1.5 1.8  295 1.6 1.1 2.1 
Sickness certificate 1,587 1.5 1.3 1.6  207 1.1 0.6 1.6 
Subtotal (% of total) 36,656 86.3 – –  6,585 87.3 – – 
Total clinical 
treatments 42,485 39.7 37.9 41.5  7,547 40.1 35.4 44.9 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see ICPC code groupsŦ in Glossary); LCL–lower confidence limit; UCL– upper 
confidence limit; shading indicates statistically significant differences between groups. 
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Procedural treatments by GP clinical computer use status 
Only one significant difference was found between the two GP groups in the 
types of procedural treatments provided per 100 encounters – CC users 
provided preventive procedures significantly more often than non CC users 
(0.5 per 100 encounters cf. 0.2 per 100). The procedural treatments shown in 
Table 5.17 accounted for over 90% of those provided by each group. 
Table 5.17: Procedural treatments 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Procedural treatment Number
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Rate per 100 
encounters 
(n=18,800) 
95% 
LCL
95% 
UCL
Local 
injection/infiltration* 3,914 3.7 3.4 4.0 669 3.6 2.4 4.7
Excision/removal 
tissue/biopsy/destruction
/debridement/cauterisati
on* 3,592 3.4 3.0 3.7 844 4.5 2.5 6.4
Dressing/pressure/comp
ression/tamponade* 2,117 2.0 1.8 2.1 318 1.7 1.3 2.0
Physical 
medicine/rehabilitation* 1,862 1.7 1.6 1.9 398 2.1 1.6 2.7
Pap smear 1,452 1.4 1.2 1.5 181 1.0 0.4 1.5
Other therapeutic 
procedures/surgery 
NEC* 1,229 1.2 1.0 1.3 332 1.8 0.6 2.9
Incision/drainage/flushin
g/aspiration/removal 
body fluid* 1,175 1.1 1.0 1.2 204 1.1 0.9 1.3
Repair/fixation – 
suture/cast/prosthetic 
device (apply/remove)* 966 0.9 0.8 1.0 177 0.9 0.7 1.2
Other preventive 
procedures* 497 0.5 0.4 0.6 33 0.2 0.1 0.3
Physical function test* 457 0.4 0.4 0.5 96 0.5 0.0 1.0
Glucose test 237 0.2 0.2 0.3 50 0.3 0.2 0.4
Subtotal (% of total) 17,261 91.6 – – 3,269 94.3 – –
Total procedural 
treatments 18,831 17.6 16.9 18.3 3,465 18.4 15.7 21.2
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see ICPC code groupsŦ in Glossary); LCL–lower confidence limit; UCL– upper 
confidence limit; shading indicates statistically significant differences between groups. 
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Referrals by GP clinical computer use status 
As shown earlier in Section 5.3.3 (Table 5.6), there were no significant 
differences between the two GP groups in the total referral rates or in rates of 
referrals to medical specialists or to allied health professionalsŦ. Table 5.18 
shows the most common specific referrals per 100 encounters to medical 
specialists, and Table 5.19 the rates of referrals to more specific types of 
allied health professionals. There remained no significant differences between 
clinical computer users and non-clinical computer users at this more specific 
level. 
Table 5.18: Referrals to medical specialists 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Medical specialists Number
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Rate per 100 
encounters 
(n=18,800) 
95% 
LCL
95% 
UCL
Surgeon 919 0.9 0.8 0.9 155 0.8 0.6 1.0
Ophthalmologist 899 0.8 0.8 0.9 135 0.7 0.6 0.9
Dermatologist 816 0.8 0.7 0.8 135 0.7 0.6 0.9
Orthopaedic surgeon 797 0.8 0.7 0.8 133 0.7 0.5 0.9
Gynaecologist 639 0.6 0.5 0.7 95 0.5 0.4 0.6
Ear, nose & throat 589 0.6 0.5 0.6 93 0.5 0.4 0.6
Cardiologist 541 0.5 0.5 0.6 91 0.5 0.3 0.7
Gastroenterologist 444 0.4 0.4 0.5 75 0.4 0.3 0.5
Referral; urologist 313 0.3 0.3 0.3 42 0.2 0.2 0.3
Referral; psychiatrist 287 0.3 0.2 0.3 53 0.3 0.2 0.4
Referral; neurologist 262 0.3 0.2 0.3 43 0.2 0.1 0.3
Subtotal (%of total) 6,244 70.3 – – 1,008 69.0 – –
Total referrals to 
medical specialists 8,886 8.3 8.0 8.6 1,460 7.5 6.7 8.3
Note: LCL–lower confidence limit; UCL– upper confidence limit. 
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Table 5.19: Referrals to allied health professionals 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Allied health 
professionals Number
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Rate per 100 
encounters 
(n=18,800) 
95% 
LCL
95% 
UCL
Physiotherapist 1,146 1.1 1.0 1.2  194 1.0 0.7 1.3 
Psychologist 281 0.3 0.2 0.3  31 0.2 0.1 0.2 
Podiatrist/chiropodist 265 0.3 0.2 0.3  36 0.2 0.1 0.3 
Dietitian/nutritionist 226 0.2 0.2 0.2  27 0.1 0.1 0.2 
Dentist 183 0.2 0.1 0.2  37 0.2 0.1 0.3 
Acoustic testing 115 0.1 0.1 0.1  15 0.1 0.0 0.1 
Diabetes education 89 0.1 0.1 0.1  12 0.1 0.0 0.1 
Counsellor 88 0.1 0.1 0.1  19 0.1 0.0 0.2 
Mental health team 74 0.1 0.1 0.1  17 0.1 0.0 0.1 
Optometrist 62 0.1 0.0 0.1  8 0.0 0.0 0.1 
Drug & alcohol service 58 0.1 0.0 0.1  15 0.1 0.0 0.1 
Rehabilitation 30 0.0 0.0 0.0  13 0.1 0.0 0.1 
Subtotal 2,529 79.4 – –  404 79.7 – – 
Total referrals to allied 
health 3,184 3.0 2.8 3.1  507 2.7 2.2 3.2 
Note: LCL–lower confidence limit; UCL– upper confidence limit. 
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Pathology tests and imaging orders by GP clinical computer use status 
Table 5.6 (Section 5.3.3) showed that CC users recorded significantly more 
pathology test orders per 100 encounters than non CC users (41.6 per 100 
encounters, 95% CI: 40.2–43.0 cf. 32.6 per 100, 95% CI: 28.7-36.5). The 
more common specific pathology test types are shown in Table 5.20. 
Compared with non CC users, CC users ordered significantly more: 
• Chemistry tests generally (22.6 per 100 encounters, 95% CI: 21.7–23.4 
cf. 17.7 per 100, 95% CI: 15.2–20.2), in particular – 
o tests for lipids (3.9 per 100 encounters, 95% CI: 3.7–4.1 cf. 3.1 per 
100, 95% CI: 2.6–3.6) 
o liver function tests (2.7 per 100 encounters, 95% CI: 2.6–2.9 cf. 2.0 
per 100, 95% CI: 1.6–2.4) 
o thyroid function tests (2.4 per 100 encounters, 95% CI: 2.3–2.6 cf. 
1.9 per 100, 95% CI: 1.5–2.2) 
• tests classified as haematology (7.8 per 100 encounters, 95% CI: 7.5–
8.2 cf. 6.3 per 100, 95% CI: 5.3–7.4) 
• tests classified as microbiology (6.4 per 100 encounters, 95% CI: 6.0–
6.8 cf. 3.9 per 100, 95% CI: 3.1–4.6), in particular – 
o urine M,C&S tests (1.9 per 100 encounters, 95% CI: 1.8–2.0 cf. 1.4 
per 100, 95% CI: 1.2–1.7) 
o other microbiology tests (0.9 per 100 encounters, 95% CI: 0.8–1.0 
cf. 0.3 per 100, 95% CI: 0.2–0.4) 
There were no significant differences between the two groups in the ordering 
rates of any other types of pathology tests. 
There were no significant differences between CC users and non CC users in 
the rates of orders for imaging overall (Section 5.3.3, Table 5.6) or in the more 
specific imaging tests shown in Table 5.21. 
114 
Table 5.20: Pathology tests by MBS pathology groups and most frequent tests ordered 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Pathology test ordered Number
Rate per 100 
encs
(n=106,900)
95% 
LCL
95% 
UCL Number
Rate per 100 
encs 
(n=18,800) 
95% 
LCL
95% 
UCL
Chemistry 24,103 22.6 21.7 23.4 3,327 17.7 15.2 20.2
 Lipids 4,133 3.9 3.7 4.1 588 3.1 2.6 3.6
 Electrolyte, urea & 
 creatinine 3,164 3.0 2.7 3.2 423 2.3 1.7 2.8
 Liver function 2,928 2.7 2.6 2.9 370 2.0 1.6 2.4
 Thyroid function 2,597 2.4 2.3 2.6 351 1.9 1.5 2.2
 Glucose tolerance 2,551 2.4 2.2 2.5 398 2.1 1.7 2.5
 Multibiochemical 
 analysis 1,764 1.7 1.4 1.9 239 1.3 0.6 1.9
 Ferritin 1,096 1.0 0.9 1.1 126 0.7 0.4 0.9
 Chemistry; other 1,088 1.0 0.9 1.1 176 0.9 0.7 1.2
 HbA1c 1,044 1.0 0.9 1.1 153 0.8 0.6 1.0
 Hormone assay 918 0.9 0.8 1.0 127 0.7 0.4 0.9
 Prostate specific 
 antigen 629 0.6 0.5 0.6 101 0.5 0.4 0.7
 C-reactive protein 534 0.5 0.4 0.6 50 0.3 0.2 0.4
Haematology 8,356 7.8 7.5 8.2 1,192 6.3 5.3 7.4
 Full blood count 5,819 5.4 5.2 5.7 823 4.4 3.5 5.2
 Erythrocyte 
 sedimentation rate 1,170 1.1 1.0 1.2 157 0.8 0.6 1.1
 Coagulation 955 0.9 0.8 1.0 163 0.9 0.7 1.1
Microbiology 6,837 6.4 6.0 6.8 725 3.9 3.1 4.6
 Urine M,C&S 2,045 1.9 1.8 2.0 267 1.4 1.2 1.7
 Microbiology; other 938 0.9 0.8 1.0 63 0.3 0.2 0.4
 Hepatitis serology 670 0.6 0.6 0.7 77 0.4 0.2 0.6
Cytopathology 2,533 2.4 2.1 2.6 287 1.5 0.9 2.1
 Pap smear 2,502 2.3 2.1 2.6 283 1.5 0.9 2.1
Other NEC 812 0.8 0.7 0.9 187 1.0 0.7 1.3
 Blood test 270 0.3 0.2 0.3 75 0.4 0.2 0.6
Histopathology 779 0.7 0.6 0.8 269 1.4 0.6 2.3
 Histology; skin 723 0.7 0.6 0.8 239 1.3 0.6 1.9
Immunology 609 0.6 0.5 0.6 69 0.4 0.2 0.5
Infertility/pregnancy 
test  296 0.3 0.2 0.3 68 0.4 0.0 0.8
Total pathology orders 44,439 41.6 40.2 43.0 6,131 32.6 28.7 36.5
Encs–encounters; NEC–not elsewhere classified; Shading indicates statistically significant differences between groups. LCL–lower 
confidence limit; UCL– upper confidence limit; HbA1c = Haemoglobin, type A1c; M,C & S = Microscopy, culture and sensitivity. 
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Table 5.21: Imaging tests by MBS group and most frequent tests ordered 
GPs using a computer for clinical 
purposes  
GPs not using a computer for clinical 
purposes 
Imaging test ordered Number
Rate per 100 
encounters
(n=106,900)
95% 
LCL
95% 
UCL Number
Rate per 100 
encounters 
(n=18,800) 
95% 
LCL
95% 
UCL
Diagnostic radiology 4,925 4.6 4.4 4.8 895 4.8 4.1 5.4
 X-ray; chest 1,099 1.0 1.0 1.1 196 1.0 0.8 1.3
 X-ray; knee 463 0.4 0.4 0.5 86 0.5 0.3 0.6
 Mammography; F 433 0.4 0.4 0.5 67 0.4 0.2 0.5
 X-ray; foot/feet 257 0.2 0.2 0.3 41 0.2 0.1 0.3
 X-ray; hip 238 0.2 0.2 0.3 36 0.2 0.1 0.3
 Test; densitometry 228 0.2 0.2 0.2 33 0.2 0.1 0.3
 X-ray; ankle 225 0.2 0.2 0.2 46 0.2 0.1 0.3
 X-ray; shoulder 218 0.2 0.2 0.2 39 0.2 0.1 0.3
 X-ray; wrist 187 0.2 0.1 0.2 31 0.2 0.1 0.2
 X-ray; spine; 
 lumbosacral  182 0.2 0.1 0.2 33 0.2 0.1 0.2
 X-ray; spine; 
 cervical 130 0.1 0.1 0.1 17 0.1 0.0 0.1
 X-ray; hand 129 0.1 0.1 0.1 32 0.2 0.1 0.2
 X-ray; spine; lumbar 103 0.1 0.1 0.1 22 0.1 0.1 0.2
Ultrasound 3,107 2.9 2.8 3.0 454 2.4 2.1 2.8
 Ultrasound; pelvis 601 0.6 0.5 0.6 79 0.4 0.3 0.6
 Ultrasound; 
 abdomen 326 0.3 0.3 0.3 64 0.3 0.2 0.4
 Ultrasound; breast;F 320 0.3 0.3 0.3 39 0.2 0.1 0.3
 Ultrasound; 
 obstetric 289 0.2 0.2 0.3 30 0.2 0.1 0.3
 Ultrasound; 
 shoulder 253 0.2 0.2 0.3 41 0.2 0.1 0.3
 Test; doppler 134 0.1 0.1 0.1 17 0.1 0.0 0.1
Computerised 
tomography 1,028 1.0 0.9 1.0 169 0.9 0.7 1.1
 CT scan; brain 208 0.2 0.2 0.2 27 0.1 0.1 0.2
 CT scan; abdomen 122 0.1 0.1 0.1 20 0.1 0.1 0.2
 CT scan; spine; 
 lumbosacral 100 0.1 0.1 0.1 25 0.1 0.1 0.2
Nuclear medicine 
imaging 112 0.1 0.1 0.1 15 0.1 0.0 0.1
Magnetic resonance 
imaging 42 0.0 0.0 0.1 4 0.0 0.0 0.0
Total imaging orders 9,124 8.6 8.3 8.9 1,537 8.2 7.2 9.1
Note: LCL–lower confidence limit; UCL– upper confidence limit. 
 
The above analyses show realistically the comparison between GPs who use 
computers in their clinical activity and those who do not. Clinical computer 
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users differ in many respects from their non-clinical/non-computerised 
counterparts in terms of their personal and practice characteristics. These 
differences have in turn attracted different types of patients with different 
reasons for seeking an encounter with the GP. Together these differences 
have resulted in different morbidities being managed, and different 
management patterns for the problems seen by clinical computer users and 
non-clinical/non-computerised GPs. 
These differences are likely to exist because of factors other than the GPs’ 
use of computers – their age, the size and geographic location of the practice 
in which they work etc, are just as likely to influence these outcomes. 
Similarly, the mix of patients and the morbidities they bring with them will be 
influenced by characteristics of the GP and the practice, and in turn, the 
morbidity they bring will influence the management techniques employed by 
the GPs. 
The extent to which the differences shown in the above section are 
determined by GP computer use, or can be explained by other characteristics, 
are investigated and presented below. 
Univariate and multivariate analysis 
Results of univariate and multivariate analyses are shown in Tables 5.22–
5.33.  
Note: In the case of all significant differences remaining or emerging after 
adjustment for GP, practice, patient and morbidity characteristics in the 
following results, the differences have been interpreted as being attributable 
to the GPs’ use of a computer for clinical activity, and/or to a variable(s) not 
measured in this study. 
5.3.8 Patient characteristics by GP clinical computer use status after 
adjustment (Model 5A) 
Outcome variables were compared after adjustment for GP and practice 
characteristics as per Model 5A, and only one of the patient characteristics 
remained significantly different. Clinical computer users saw significantly 
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fewer patients who were holders of a Commonwealth Health Care Card 
(OR=0.89, p=0.035) (Table 5.22). 
Table 5.22: Univariate and multivariate analysis of patients' characteristics 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted  Adjusted(a) 
Outcome variable –  
Patient characteristic Odds ratio 95% CI P  Odds ratio  95% CI P 
Male patients 0.84 0.78-0.91 <0.001 0.95 0.88-1.03 0.23
C’wealth conc. card 0.78 0.68-0.90 0.001 0.83 0.70-0.99 0.035
VA card holder 1.14 0.94-1.39 0.19 1.04 0.77-1.40 0.79
NESB 0.51 0.36-0.72 <0.001 1.20 0.82-1.77 0.35
Aboriginal and/or Torres 
strait islander 0.78 0.37-1.66 0.52 0.79 0.30-2.09 0.64
New to practice 0.77 0.61-0.97 0.02 0.81 0.61-1.06 0.12
      
 
Regression 
coefficient 95% CI P  
Regression 
coefficient(a) 95% CI P 
Age -1.80 -3.30 - -0.29 0.019 -0.70 -2.47-1.07 0.44
(a) Model A: Controlling for the following GP/practice characteristics: sex, age, fellowship of RACGP status, working in a deputising 
service over the past four weeks, bulk-billing all patients status, practice accreditation status, practice nurse at major practice.  
Note: CI=confidence intervals; C’wealth conc. card = Health care/benefits card (see glossary); Shading indicates statistically 
significant differences between groups. 
 
5.3.9 Patient reasons for encounter by GP clinical computer use status 
after adjustment (Model 5B) 
The descriptive analysis in Table 5.10 showed that patients attending a CC 
user were more likely to present for test results or for preventive 
immunisations/vaccinations, and less likely to attend for hypertension 
management. A number of other reasons for encounter that were marginal in 
the descriptive analysis were found to be significantly different once p values 
were produced through univariate analyses (Table 5.23). Patients attending a 
CC user were less likely to attend for back complaintŦ and headache, and 
more likely to attend for general check-up, female genital check-up, or for 
administrative procedures. 
After adjustment, however, the only differences remaining between the two 
groups that could be attributed to the use of a computer (or other factors not 
examined in this study) were for patients presenting for test results (OR=1.20, 
p=0.045) and for those with hypertension/high blood pressure (OR=0.67, 
p=0.03). 
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Table 5.23: Univariate and multivariate analysis of most frequent individual RFEs 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted  Adjusted(a) Outcome variable – (rates) 
Presence of individual 
RFE Odds ratio 95% CI P  Odds ratio 95% CI P 
Prescription all* 0.94 0.80-1.10 0.44  0.97 0.81-1.16 0.74 
Test results* 1.33 1.13-1.56 0.001  1.20 1.00-1.43 0.045 
Cough 0.98 0.86-1.13 0.82  1.11 0.95-1.30 0.17 
Immunisation all* 1.52 1.14-2.01 0.004  1.41 0.99-2.00 0.06 
Cardiac check-up* 0.89 0.75-1.06 0.20  0.97 0.80-1.19 0.80 
General check-up* 1.25 1.03-1.52 0.024  1.10 0.88-1.36 0.40 
Back complaint* 0.83 0.71-0.98 0.024  0.94 0.80-1.10 0.41 
Throat complaint 0.88 0.74-1.04 0.12  1.01 0.84-1.22 0.91 
Rash* 1.00 0.84-1.20 0.97  1.09 0.91-1.32 0.35 
Female genital check-up* 1.59 1.10-2.29 0.013  1.00 0.72-1.40 0.98 
Depression* 1.04 0.86-1.25 0.70  0.86 0.70-1.07 0.18 
Abdominal pain* 0.99 0.84-1.16 0.91  1.05 0.86-1.28 0.65 
Administrative procedure 
NOS 1.28 1.02-1.60 0.03  1.10 0.86-1.41 0.44 
Weakness/tiredness 1.05 0.83-1.34 0.67  1.05 0.70-1.56 0.82 
Upper respiratory tract 
infection 1.08 0.85-1.38 0.52  1.03 0.79-1.35 0.82 
Hypertension/high blood 
pressure 0.64 0.48-0.84 0.001  0.67 0.47-0.96 0.03 
Ear pain 1.07 0.90-1.28 0.45  1.00 0.82-1.21 0.98 
Fever 0.89 0.65-1.22 0.47  0.95 0.66-1.36 0.76 
Skin complaint 0.88 0.62-1.24 0.47  0.90 0.63-1.28 0.55 
Headache 0.76 0.63-0.93 0.008  0.88 0.69-1.12 0.29 
(a) Model B: Controlling for the following GP/practice characteristics: sex, age, fellowship of RACGP status, working in a deputising 
service over the past four weeks, bulk-billing all patients status, practice accreditation status, practice nurse at major practice; and 
patient characteristics: sex, age, holding health care card, holding Veterans’ Affairs card, Non English Speaking background, 
Aboriginal and/or Torres Strait Islander, new to practice. 
Note: C’wealth conc. card = Health care/benefits card (see glossary);  LCL–lower confidence limit; UCL– upper confidence limit. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see ICPC code groupsŦ in Glossary)  
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5.3.10 Morbidity managed by GP clinical computer use status after 
adjustment (Model 5B) 
Although CC users were found to manage more problems per 100 encounters 
than non CC users in the descriptive analyses (150.5 per 100, 95% CI:148.8–
152.2 cf. 144.1 per 100, 95% CI: 140.1–148.1), this difference was no longer 
apparent after adjustment (RC=3.44, p=0.12) (results tabulated in Chapter 6, 
Table 6.1(a)).  
As previously reported, the problems managed at the encounter were 
compared for both GPs groups on the basis of the presence or absence of 
each ICPC-2 chapter, after adjustment for both GP and patient characteristics 
(Model B).  
Problems managed by ICPC-2 chapter 
Descriptive results of problems managed by ICPC-2 Chapter were reported in 
Table 5.12), showing a significant difference between the GP groups in the 
proportion of encounters where problems managed were of a general or 
unspecified nature, associated with the female genital system, or associated 
with pregnancy or family planning. Once p values were produced through 
univariate analyses, two other differences became significant. Clinical 
computer users managed significantly more problems: 
• associated with the urological system (OR=1.18, p=0.009), or 
• of a social nature (OR=1.45, p=<0.009). 
All of these differences disappeared after adjustment, indicating that the 
differences were explained by characteristics of the two GP groups and their 
patients, rather than being a result of computer use (Table 5.24). 
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Table 5.24: Univariate and multivariate analysis of problems managed by ICPC-2 
chapter 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted  Adjusted(a) Outcome variable – 
(rates) 
Presence of problem 
managed (ICPC-2 
chapter) Odds ratio 95% CI P  Odds ratio 95% CI P 
Respiratory 1.07 0.97-1.18 0.20  1.09 0.97-1.22 0.15 
Skin 0.99 0.82-1.18 0.89  1.02 0.84-1.24 0.85 
Musculoskeletal 1.00 0.91-1.11 0.98  1.02 0.92-1.13 0.68 
General & unspecified 1.33 1.16-1.53 <0.001  1.16 0.99-1.35 0.06 
Circulatory 0.90 0.80-1.01 0.067  0.96 0.85-1.08 0.52 
Psychological 0.98 0.85-1.12 0.73  0.94 0.82-1.08 0.38 
Endocrine & metabolic 0.98 0.87-1.11 0.80  1.01 0.90-1.15 0.83 
Digestive 0.99 0.91-1.07 0.79  0.99 0.91-1.09 0.86 
Female genital system 1.37 1.10-1.71 0.005  1.06 0.86-1.24 0.75 
Pregnancy & family 
planning 1.40 1.07-1.84 0.014  1.00 0.79-1.26 1.00 
Ear 1.08 0.85-1.39 0.53  0.97 0.80-1.19 0.80 
Neurological 1.02 0.91-1.15 0.76  1.03 0.91-1.17 0.62 
Urology 1.18 1.04-1.34 0.009  1.13 0.98-1.30 0.09 
Eye 1.02 0.90-1.16 0.71  1.11 0.96-1.29 0.16 
Blood/blood-forming 
organs 1.16 0.95-1.42 0.15  1.31 0.89-1.93 0.17 
Male genital system 0.94 0.69-1.27 0.68  0.90 0.69-1.17 0.44 
Social 1.45 1.10-1.91 0.009  1.09 0.79-1.51 0.60 
(a) Model B: Controlling for the following GP/practice characteristics: sex, age, fellowship of RACGP status, working in a deputising 
service over the past four weeks, bulk-billing all patients status, practice accreditation status, practice nurse at major practice; and 
patient characteristics: sex, age, holding health care card, holding Veterans’ Affairs card, Non English Speaking background, 
Aboriginal and/or Torres Strait Islander, new to practice. 
Note: LCL–lower confidence limit; UCL– upper confidence limit. 
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Individual problems managed  
The results of descriptive analyses for the relative frequencies of the most 
common individual problems managed were reported in Table 5.13. In Table 
5.25, some new differences were observed which became significant once p 
values were produced through univariate analyses. In addition to the 
differences in management rates for hypertension, recording of a prescription, 
female genital check-up, and general check-up, compared with non CC users, 
CC users managed significantly more:  
• asthma (OR=1.19, p=0.02) 
• urinary tract infections (OR=1.20, p=0.041), and 
• oral contraception problems (OR=1.37, p=0.004) 
• cardiac check-ups (OR=1.56, p=0.004). 
After adjustment (Model B) the significant difference in the relative rate of 
management of hypertension was the only difference to remain (OR=0.86, 
p=0.044). However, a new difference emerged – CC users managed 
significantly more ischaemic heart disease at the encounter than non CC 
users (OR=1.36, p=0.017). No other new significant differences emerged 
between the two GP groups (Table 5.25).  
Table 5.25: Univariate and multivariate analysis of the most frequent individual 
problems managed at the encounter 
GPs not using computer for clinical purposes : GPs using computer for clinical purposes 
Unadjusted  Adjusted(a) Outcome variable – 
presence of problem 
managed (rates) Odds ratio 95% CI P  Odds ratio 95% CI P 
Hypertension* 
  
0.78 0.70-0.89 <0.001  0.86 0.75-1.00 0.04 
Immunisation-all* 1.37 0.96-1.94 0.08  1.26 0.85-1.88 0.25 
Acute upper respiratory 
infection (URTI) 0.98 0.84-1.14 0.76  1.02 0.86-1.20 0.82 
Depression* 1.07 0.92-1.24 0.37  0.89 0.76-1.04 0.15 
Lipid disorders* 0.95 0.80-1.12 0.53  1.05 0.87-1.28 0.59 
Diabetes* 0.87 0.74-1.03 0.11  1.01 0.85-1.20 0.92 
Back complaint* 1.04 0.87-1.24 0.68  0.99 0.83-1.17 0.89 
Osteoarthritis* 1.07 0.90-1.27 0.44  1.14 0.95-1.37 0.15 
(continued) 
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Table 5.25 (continued): Univariate and multivariate analysis of the problems managed 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted  Adjusted(a) Outcome variable -  
presence of problem 
managed (rates) Odds ratio 95% CI P  Odds ratio 95% CI P 
Prescription all* 1.44 1.08-1.93 0.012  1.24 0.80-1.90 0.33 
Female genital check-up* 1.52   1.04-2.21 0.03  0.97 0.69-1.37 0.87 
Asthma 1.19 1.03-1.38 0.02  1.15 0.97-1.37 0.11 
General check-up* 1.57 1.20-2.05 0.001  1.24 0.90-1.70 0.18 
Oesophageal disease 1.06 0.88-1.28 0.55  1.08 0.88-1.32 0.47 
Acute bronchitis/bronchiolitis 1.01 0.82-1.23 0.94  0.96 0.75-1.24 0.75 
Anxiety* 0.87 0.71-1.07 0.20  0.91 0.72-1.14 0.40 
Contact dermatitis 1.05 0.91-1.22 0.51  1.13 0.95-1.35 0.16 
Urinary tract infection* 1.20 1.01-1.42 0.041  1.07 0.89-1.30 0.47 
Sleep disturbance 1.10 0.90-1.36 0.36  1.17 0.94-1.46 0.17 
Sprain/strain 0.87 0.70-1.08 0.20  1.03 0.82-1.30 0.78 
Oral contraception* 1.37 1.10-1.70 0.004  1.05 0.83-1.31 0.70 
Test results* 1.25 0.98-1.58 0.07  1.11 0.87-1.41 0.39 
Solar keratosis/sunburn 0.59 0.33-1.04 0.07  0.74 0.42-1.32 0.31 
Ischaemic heart disease* 1.20 0.96-1.50 0.11  1.36 1.06-1.75 0.017 
Malignant neoplasm skin 0.62 0.37-1.04 0.07  0.77 0.43-1.35 0.36 
Other viral disease NOS 1.24 0.94-1.65 0.13  1.23 0.90-1.68 0.19 
Acute/chronic sinusitis 1.06 0.86-1.30 0.58  0.98 0.76-1.26 0.88 
menopausal 
complaint/symptom 1.30 1.00-1.68 0.050  1.14 0.85-1.53 0.37 
Acute otitis media/myringitis 1.14 0.91-1.42 0.25  0.88 0.68-1.14 0.34 
Cardiac check-up* 1.56 1.16-2.09 0.004  1.16 0.81-1.67 0.42 
Fracture* 0.91 0.47-1.75 0.77  1.15 0.53-2.49 0.72 
Tonsillitis* 1.11 0.87-1.40 0.41  0.98 0.73-1.31 0.90 
Presumed gastroenteritis, 
infection 0.83 0.66-1.05 0.12  0.88 0.68-1.14 0.32 
Skin disease, other 0.90 0.63-1.29 0.58  1.02 0.70-1.48 0.93 
Injury musculoskeletal NOS 0.82 0.60-1.11 0.19  0.88 0.66-1.17 0.38 
(a) Model B: Controlling for the following GP/practice characteristics: sex, age, fellowship of RACGP status, working in a deputising 
service over the past four weeks, bulk-billing all patients status, practice accreditation status, practice nurse at major practice; and 
patient characteristics: sex, age, holding health care card, holding Veterans’ Affairs card, Non English Speaking background, 
Aboriginal and/or Torres Strait Islander, new to practice. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see ICPC code groupsŦ in Glossary);  
Note: LCL–lower confidence limit; UCL– upper confidence limit; Shading indicates statistically significant differences between groups. 
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5.3.11 Management of problems by GP clinical computer use status after 
adjustment (Model 5C) 
The proportion of encounters at which at least one of a range of management 
events could occur were compared between CC users and non CC users, and 
the descriptive results shown in Table 5.14. Again, at the univariate level, 
once p values were produced some other marginal difference became 
significant (Table 5.26). In addition to the previously reported differences in 
rates of prescribed medications, overall investigations, and pathology orders, 
clinical computer users significantly less often recorded: 
• at least one treatment of any type (OR=0.85, p=0.019) and 
• at least one medication (OR=0.87, p=0.021) 
However, after adjustment for the characteristics of the GP, the practice, the 
patient, and the morbidity managed (Model C), all the differences apparent in 
the univariate analysis disappeared, and one new difference emerged. 
Compared with non CC users, those using computers for clinical activity 
recorded significantly fewer referrals to allied health professionals at the 
encounter (OR=0.81, p=0.03). 
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Table 5.26: Univariate and multivariate analysis of management activities at the 
encounter 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted  Adjusted(a) Outcome variable -  
at least one management 
type Odds ratio 95% CI P Odds ratio 95% CI P
treatment, referral or 
investigation 0.87 0.71-1.06 0.18 0.86 0.68-1.08 0.20
  1 + treatment type 0.85 0.74-0.97 0.019 0.89 0.76-1.04 0.14
  1 + medication 0.87 0.77-0.98 0.021 0.90 0.79-1.01 0.08
  1 + prescription 0.85 0.76-0.96 0.007 0.91 0.81-1.03 0.12
  1 + OTC advised 0.98 0.82-1.16 0.78 0.85 0.70-1.03 0.09
  1 + GP supplied 1.14 0.88-1.47 0.33 1.02 0.76-1.35 0.92
 1 + non-
 pharmacological 
 treatment 1.01 0.87-1.18 0.89 0.92 0.77-1.09 0.34
  1 + clinical   
 treatment 1.00 0.85-1.17 0.99 0.90 0.75-1.08 0.26
  1 + therapeutic     
 procedure 0.98 0.83-1.17 0.83 0.94 0.79-1.10 0.44
 1 + referral 1.07 0.96-1.19 0.24 0.90 0.80-1.01 0.06
  1 + referral to  
  specialist 1.11 0.99-1.25 0.07 1.00 0.88-1.13 0.99
  1 + referral to allied  
 health service 1.10 0.91-1.34 0.32 0.81 0.67-0.98 0.03
  1 + referral to  
  hospital 0.77 0.51-1.14 0.19 0.81 0.46-1.40 0.45
  1 + referral to  
  emergency dept 0.74 0.43-1.30 0.30 0.66 0.37-1.18 0.16
 1 + investigation 1.21 1.08-1.34 0.001 0.98 0.87-1.11 0.78
  1 + pathology  
  order 1.22 1.07-1.39 0.002 0.97 0.84-1.12 0.68
  1 + imaging order  1.09 0.96-1.23 0.19 0.97 0.84-1.11 0.64
  1 + other   
 investigation 1.23 0.96-1.57 0.10 1.04 0.78-1.38 0.80
(a): Model C: Controlling for the following GP/practice characteristics other than GPs using computer for clinical purpose status: sex, 
age, fellowship of RACGP status, working in a deputising service over the past four weeks, bulk-billing all patients status, practice 
accreditation status, practice nurse at major practice; and patient characteristics: sex, age, holding health care card, holding Veterans’ 
Affairs card, Non English Speaking background, Aboriginal and/or Torres Strait Islander, new to practice, and presence of problems 
managed by ICPC-2 chapter at the encounter. 
Note: LCL–lower confidence limit; UCL– upper confidence limit; Shading indicates statistically significant differences between groups. 
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Management with prescribed medication by GP clinical computer use 
status after adjustment (Model 5C) 
In Section 5.3.7 (Table 5.15) the distribution of prescribed medications across 
groups and sub-groups was compared for the two GP groups. The unadjusted 
odds ratios in Table 5.27 compare the proportion of encounters at which at 
least one of the specific medication groups, sub-groups, or generics, were 
prescribed by the two GP groups. At this level of analysis, CC users were 
found to prescribe significantly fewer: 
• cardiovascular drugs (OR=0.84, p=0.015), particularly … 
• antihypertensives (OR=0.79, p=0.002), specifically … 
 ramipril (OR=0.78, p=0.049) 
• beta blockers (OR=0.77, p=0.008) 
• tetracyclines (OR=0.80, p=0.047) 
• medications acting on the central nervous system (OR=0.78, p<0.001), 
particularly … 
o simple analgesic (OR=0.69, p<0.001), specifically … 
 paracetamol (OR=0.67, p<0.001) 
• antiemetics/antinauseants (OR=0.82, p=0.046) 
• anxiolitics (OR=0.72, p=0.006), specifically … 
o diazepam (OR=0.69, p=0.006) 
• hypoglycaemic agents (OR=0.71, p=0.001) 
• musculoskeletal agents (OR=0.80, p<0.001), particularly … 
o non-steroidal anti-inflammatory drugs (OR=0.82, p=0.003), 
specifically … 
 diclofenac sodium systemic (OR=0.76, p=0.01) 
• medications acting on the digestive system (OR=0.87, p=0.032). 
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In contrast, CC users prescribed significantly more: 
• contraceptives (OR=1.49, p<0.001), particularly … 
o oral, systemic (OR=1.48, p=0.001), specifically … 
 levonorgestrel/ethinyloestradiol (OR=1.39, p=0.004). 
After adjusting for GP and practice characteristics, patient characteristics, and 
morbidity managed at the encounter (Model C) fewer significant differences 
remained. GPs using computers for clinical purposes prescribed fewer: 
• antihypertensives (OR=0.82, p=0.033), specifically … 
o ramipril (OR=0.73, p=0.037) 
• beta blockers (OR=0.79, p=0.022) 
• simple analgesics (OR=0.77, p=0.017), specifically … 
• paracetamol (OR=0.75, p=0.022) 
• hormones (OR=0.86, p=0.036), particularly …  
• hypoglycaemic agents (OR=0.78, p=0.039) 
• musculoskeletal agents (OR=0.80, p=0.005, particularly … 
• non-steroidal anti-inflammatory drugs (OR=0.82, p=0.022) 
One new difference emerged, that being a significantly lower prescribing rate 
of hormones by CC users (OR=0.86, p=0.036), as included above. All other 
differences between the two groups were no longer apparent. 
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Table 5.27: Univariate and multivariate analysis of the most common medications 
prescribed, by group, sub-group and generic medication 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Outcome variable – at least one 
medication prescribed Unadjusted  Adjusted(a) 
Group 
Sub 
group Generic 
Odds 
ratio 95% CI P  
Odds 
ratio 95% CI P 
Cardiovascular 0.84 0.73-0.97 0.015 0.90 0.76-1.07 0.23
 Antihypertensives  0.79 0.68-0.92 0.002 0.82 0.68-0.98 0.033
  Irbesartan  0.82 0.66-1.03 0.09 0.96 0.76-1.22 0.76
  Perindopril 0.83 0.65-1.06 0.13 0.91 0.69-1.21 0.53
  Ramipril 0.78 0.60-1.00 0.049 0.73 0.55-0.98 0.037
 Other CVS drugs 0.91 0.77-1.07 0.24 1.00 0.83-1.20 0.96
  Atorvastatin 0.87 0.71-1.08 0.21 0.93 0.74-1.17 0.53
  Simvastatin 0.97 0.79-1.20 0.79 1.10 0.86-1.41 0.43
 Beta-blockers 0.77 0.64-0.93 0.008 0.79 0.65-0.97 0.022
  Atenolol 0.81 0.65-1.01 0.058 0.79 0.63-1.01 0.06
Anti-infections/infestations 0.97 0.88-1.08 0.60 0.93 0.82-1.06 0.29
 Broad spectrum penicillins 0.90 0.78-1.03 0.13 0.89 0.75-1.06 0.20
  Amoxycillin 0.89 0.75-1.05 0.17 0.94 0.75-1.18 0.60
  
Amoxycillin/potass
ium clavulanate 0.92 0.75-1.12 0.40 0.83 0.66-1.05 0.12
 Penicillin/Cephalosporins 1.06 0.93-1.21 0.37 1.05 0.89-1.24 0.56
  Cephalexin 1.19 1.00-1.42 0.046 1.15 0.92-1.44 0.23
 Other antibiotics 1.06 0.89-1.27 0.48 0.96 0.78-1.18 0.69
  Roxithromycin 0.90 0.70-1.15 0.39 0.91 0.68-1.20 0.50
 Anti-infectives 1.14 0.89-1.45 0.31 1.19 0.87-1.63 0.27
 Tetracyclines 0.80 0.64-1.00 0.047 0.78 0.60-1.02 0.07
  Doxycycline 0.84 0.65-1.08 0.17 0.83 0.62-1.12 0.22
CNS 0.78 0.68-0.89 <0.001 0.86 0.73-1.01 0.06
 Simple analgesics 0.69 0.57-0.83 <0.001 0.77 0.62-0.95 0.017
  Paracetamol 0.67 0.55-0.82 <0.001 0.75 0.59-0.96 0.022
  Aspirin 0.79 0.60-1.04 0.10 0.83 0.60-1.14 0.25
 Narcotic analgesics 0.92 0.71-1.20 0.55 1.12 0.83-1.52 0.46
  Tramadol 1.04 0.83-1.32 0.72 1.11 0.84-1.48 0.47
 Compound analgesic 0.84 0.70-1.00 0.052 0.81 0.65-1.01 0.064
  
Paracetamol/Code
ine 0.83 0.68-1.02 0.069 0.78 0.61-1.00 0.052
 Antiemetic/Antinauseant 0.82 0.68-1.00 0.046 0.88 0.69-1.12 0.28
(continuted) 
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Table 5.27 (continued): Univariate and multivariate analysis of the most common 
medications prescribed, by group, sub-group and generic medication 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Outcome variable – at least one 
medication prescribed Unadjusted  Adjusted(a) 
Group 
Sub 
group Generic 
Odds 
ratio 95% CI P  
Odds 
ratio 95% CI P 
Psychological 0.92 0.80-1.06 0.24 0.88 0.73-1.06 0.17
 Antidepressants 1.04 0.89-1.21 0.63 0.84 0.69-1.02 0.08
 Antianxiety 0.72 0.57-0.91 0.006 0.88 0.68-1.14 0.33
  Diazepam 0.69 0.53-0.90 0.006 0.90 0.68-1.19 0.46
 Sedatives/Hypnotics 1.06 0.89-1.26 0.51 1.12 0.90-1.40 0.32
  Temazepam 1.00 0.82-1.21 0.97 1.02 0.79-1.31 0.89
Hormones 0.91 0.80-1.04 0.17 0.86 0.74-0.99 0.036
 Hypoglycaemic 0.71 0.57-0.87 0.001 0.78 0.61-0.99 0.039
  Metformin 0.78 0.60-1.02 0.067 0.79 0.59-1.06 0.12
 Sex hormones/Anabolic 1.18 0.99-1.40 0.066 0.97 0.79-1.18 0.75
 Corticosteroids 0.97 0.79-1.18 0.74 0.83 0.64-1.07 0.15
Musculoskeletal 0.80 0.71-0.91 <0.001 0.80 0.68-0.93 0.005
 NSAID  0.82 0.72-0.93 0.003 0.82 0.69-0.97 0.022
  Celecoxib 0.93 0.74-1.16 0.52 0.79 0.63-1.00 0.051
  
Diclofenac sodium 
systemic 0.76 0.61-0.94 0.01 0.86 0.66-1.13 0.29
Respiratory 1.02 0.89-1.18 0.77 1.03 0.87-1.23 0.71
 
Bronchodilator/Spasm 
relaxant 1.00 0.85-1.18 0.96 0.90 0.74-1.10 0.30
  Salbutamol 0.97 0.82-1.16 0.75 0.91 0.74-1.12 0.37
 Asthma preventives 1.09 0.94-1.26 0.28 0.96 0.79-1.17 0.69
  
Fluticasone/Salme
terol 1.07 0.86-1.34 0.55 0.98 0.75-1.29 0.89
Skin 1.04 0.92-1.17 0.57 1.16 0.96-1.40 0.13
 Topical steroids 1.07 0.93-1.23 0.37 1.19 0.97-1.47 0.10
  Mometasone 1.24 0.96-1.58 0.094 1.32 0.96-1.82 0.09
  
Betamethasone 
topical 1.09 0.86-1.37 0.48 1.21 0.90-1.63 0.21
Digestive 0.87 0.77-0.99 0.032 0.88 0.75-1.03 0.11
 Antiulcerants 0.92 0.80-1.07 0.29 0.90 0.75-1.08 0.27
  Esomeprazole 1.02 0.79-1.32 0.87 0.85 0.62-1.17 0.32
  Omeprazole 0.87 0.66-1.16 0.36 0.88 0.65-1.18 0.39
Allergy, immune system 1.16 0.91-1.47 0.22 1.00 0.76-1.32 0.99
 Immunization 1.31 0.97-1.77 0.08 1.10 0.79-1.54 0.58
  
Influenza virus 
vaccine 1.18 0.71-1.98 0.52 1.06 0.61-1.82 0.85
(continuted) 
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Table 5.27 (continued): Univariate and multivariate analysis of the most common 
medications prescribed, by group, sub-group and generic medication 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Outcome variable – at least one 
medication prescribed Unadjusted  Adjusted(a) 
Group 
Sub 
group Generic 
Odds 
ratio 95% CI P  
Odds 
ratio 95% CI P 
Blood 0.95 0.78-1.14 0.56 0.95 0.78-1.16 0.64
 Other blood drugs 0.96 0.76-1.20 0.72 1.02 0.79-1.30 0.90
  Warfarin sodium 0.94 0.72-1.22 0.64 1.06 0.79-1.43 0.70
 Haemopoietics 0.92 0.71-1.20 0.55 0.82 0.61-1.10 0.19
Contraceptives 1.49 1.22-1.82 <0.001 1.00 0.76-1.32 0.99
 
Contraceptives 
oral/systemic 1.48 1.21-1.81 <0.001 1.00 0.76-1.32 0.99
  
Levonorgestrel/Ethi
nyloestradiol 1.39 1.11-1.74 0.004 0.94 0.69-1.29 0.72
Urogenital 0.92 0.79-1.08 0.32 0.88 0.73-1.07 0.20
 Diuretic 0.84 0.68-1.04 0.11 0.80 0.65-1.01 0.060
Ear, nose topical 1.07 0.88-1.29 0.52 1.17 0.94-1.45 0.15
 Topical otic 1.00 0.79-1.26 0.99 1.11 0.86-1.44 0.41
Eye medications 0.93 0.80-1.09 0.38 0.97 0.77-1.22 0.80
 Anti-infectives eye 0.92 0.77-1.11 0.40 0.81 0.63-1.005 0.11
  
Chloramphenicol 
eye 0.93 0.76-1.13 0.45 0.92 0.70-1.20 0.52
Nutrition, metabolism 0.92 0.76-1.10 0.34 0.94 0.75-1.17 0.58
Anti neoplastics 0.85 0.37-1.95 0.70 1.09 0.51-2.33 0.82
Miscellaneous 0.82 0.59-1.14 0.23 0.82 0.53-1.25 0.35
Surgical preparations 0.89 0.54-1.48 0.66 1.01 0.49-2.09 0.98
Diagnostic agents 0.75 0.40-1.39 0.36 1.05 0.58-1.89 0.87
(a) Model C: Controlling for the following GP/practice characteristics: sex, age, fellowship of RACGP status, working in a deputising 
service over the past four weeks, bulk-billing all patients status, practice accreditation status, practice nurse at major practice; and 
patient characteristics: sex, age, holding health care card, holding Veterans’ Affairs card, Non English Speaking background, 
Aboriginal and/or Torres Strait Islander, new to practice, and presence of problems managed by ICPC-2 chapter at the encounter. 
Note: Shading indicates statistically significant differences between groups. LCL–lower confidence limit; UCL– upper confidence limit; 
CVS–cardiovascular system; CNS–central nervous system; NSAID–non-steroidal anti-inflammatory drug; 
 
Non-pharmacological management by GP clinical computer use status 
after adjustment (Model 5C) 
The descriptive analysis in Table 5.16 showed that CC users provided 
counselling/advice for nutrition or weight problems significantly less often than 
their counterparts. Two other clinical treatments showing a marginal 
difference in the descriptive analysis were found to be significantly different 
once p values were produced through univariate analyses (Table 5.28). 
Clinical computer users provided counselling for psychological problems more 
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often (OR=1.26, p=0.032), and undertook administrative/documentation work 
associated with the problem under management (OR=1.46, p=0.007) more 
frequently. 
After adjustment only one significant difference remained that could be 
ascribed to clinical computer use, or to some other variable not measured in 
this thesis. Clinical computer users provided counselling/advice for nutrition or 
weight problems significantly less often (OR=0.71, p=0.002).  
Table 5.28: Univariate and multivariate analysis of most frequent clinical treatments 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted  Adjusted(a) 
Clinical treatment Odds ratio 95% CI P Odds ratio 95% CI P
Advice/education* 0.97 0.75-1.24 0.78  0.86 0.64-1.15 0.32 
Counselling - problem* 0.96 0.67-1.39 0.84  0.88 0.56-1.40 0.60 
Counselling/advice – 
nutrition/weight* 0.71 0.57-0.88 0.002  0.71 0.57-0.89 0.002 
Advice/education – 
treatment* 0.92 0.74-1.13 0.42  0.98 0.77-1.24 0.84 
Advice/education – 
medication* 1.19 0.95-1.49 0.13  1.11 0.86-1.44 0.42 
Counselling – psychological* 1.26 1.02-1.55 0.032  1.20 0.92-1.57 0.18 
Counselling/advice – 
exercise* 0.87 0.61-1.25 0.46  0.84 0.61-1.17 0.31 
Other admin/documentation* 1.46 1.11-1.93 0.007  1.22 0.89-1.68 0.22 
Reassurance, support 1.04 0.74-1.45 0.83  1.18 0.79-1.75 0.41 
Sickness certificate 1.35 0.88-2.07 0.17  1.06 0.73-1.54 0.75 
(a) Model C: Controlling for the following GP/practice characteristics: sex, age, fellowship of RACGP status, working in a deputising 
service over the past four weeks, bulk-billing all patients status, practice accreditation status, practice nurse at major practice; and 
patient characteristics: sex, age, holding health care card, holding Veterans’ Affairs card, Non English Speaking background, 
aboriginal and/or Torres Strait Islander, new to practice, and presence of problems managed by ICPC-2 chapter at the encounter.  
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see ICPC code groupsŦ in Glossary). 
Note: LCL–lower confidence limit; UCL– upper confidence limit; Shading indicates statistically significant differences between groups. 
 
Procedural treatments by GP clinical computer use status after 
adjustment (Model 5C) 
In Table 5.17 the descriptive analysis showed that CC users provided 
significantly more preventive procedures. No other significant differences 
were observed from the univariate analysis (Table 5.29). However one new 
difference emerged after adjustment. Clinical computer users provided 
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significantly fewer procedural treatments that involved physical 
medicine/rehabilitation (OR=0.76, p=0.043).  
Table 5.29: Univariate and multivariate analysis of most frequent procedural treatments 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted Adjusted(a) 
Procedural treatment 
Odds 
ratio 95% CI P 
 
Odds 
ratio 95% CI P 
Local injection/infiltration* 1.03 0.74-1.44 0.86  1.01 0.70-1.46 0.96 
Excision/removal 
tissue/biopsy/destruction/de
bridement/cauterisation* 0.77 0.50-1.19 0.24  0.86 0.63-1.18 0.36 
Dressing/pressure/compress
ion/tamponade* 1.17 0.94-1.45 0.16  1.16 0.86-1.56 0.33 
Physical 
medicine/rehabilitation* 0.81 0.60-1.08 0.15  0.76 0.58-0.99 0.043 
Pap smear 1.41 0.80-2.46 0.23  0.90 0.57-1.40 0.64 
Other therapeutic 
procedures/surgery NEC* 0.65 0.33-1.30 0.22  0.81 0.45-1.46 0.48 
Incision/drainage/flushing/as
piration/removal body fluid* 1.01 0.82-1.24 0.91  0.83 0.64-1.07 0.15 
Repair/fixation – 
suture/cast/prosthetic device 
(apply/remove)* 0.94 0.71-1.23 0.65  0.75 0.55-1.04 0.09 
Other preventive 
procedures* 2.66 1.61-4.39 <0.001  1.61 0.98-2.65 0.063 
Physical function test* 0.82 0.33-2.04 0.66  0.63 0.32-1.26 0.19 
Glucose test 0.83 0.52-1.32 0.44  1.04 0.59-1.86 0.88 
(a) Model C: Controlling for the following GP/practice characteristics other than GPs using computer for clinical purpose status: sex, 
age, fellowship of RACGP status, working in a deputising service over the past four weeks, bulk-billing all patients status, practice 
accreditation status, practice nurse at major practice; and patient characteristics: sex, age, holding health care card, holding Veterans’ 
Affairs card, Non English Speaking background, Aboriginal and/or Torres Strait Islander, new to practice, and presence of problems 
managed by ICPC-2 chapter at the encounter. 
* Includes multiple ICPC-2 or ICPC-2 PLUS codes (see ICPC code groupsŦ in Glossary). 
Note: LCL–lower confidence limit; UCL– upper confidence limit; Shading indicates statistically significant differences between groups. 
 
Referrals by GP clinical computer use status after adjustment (Model 
5C) 
No significant differences between the two groups were observed from the 
descriptive analyses in the total referral rates (Table 5.6), in the rates of 
referrals to medical specialists (Table 5.18) or to allied health professionals 
(5.19). No differences emerged in univariate or multivariate analyses for 
referrals to medical specialists (Table 5.30). 
Univariate analysis also showed no differences in the rates of referrals to 
allied health professionals (Table 5.31). However, following adjustment 
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(Model C) two new differences emerged – CC users provided significantly 
fewer referrals for counselling (OR=0.28, p=0.027), and for rehabilitation 
(OR=0.28, p=0.001). These individual differences largely account for the 
significant difference noted following adjustment in the rate of referrals to 
allied health professionals (Table 5.26), where GPs using computers for 
clinical activity recorded significantly fewer referrals of this type (OR=0.81, 
p=0.03). 
Table 5.30: Univariate and multivariate analysis of most frequent referrals to medical 
specialists 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted  Adjusted(a) 
Medical specialists 
Odds 
ratio 95% CI P 
 Odds 
ratio 95% CI P 
Surgeon 1.04 0.83-1.31 0.72  0.98 0.74-1.31 0.89 
Ophthalmologist 1.17 0.93-1.48 0.18  1.06 0.81-1.38 0.69 
Dermatologist 1.06 0.84-1.34 0.60  0.92 0.69-1.24 0.60 
Orthopaedic surgeon 1.05 0.81-1.37 0.69  0.90 0.69-1.19 0.48 
Gynaecologist 1.18 0.91-1.54 0.21  0.99 0.75-1.31 0.94 
ENT specialist 1.11 0.85-1.46 0.43  1.00 0.74-1.36 0.99 
Cardiologist 1.05 0.72-1.53 0.82  1.13 0.79-1.62 0.50 
Gastroenterologist 1.04 0.79-1.37 0.77  0.84 0.62-1.14 0.27 
Urologist 1.31 0.95-1.80 0.09  1.16 0.74-1.82 0.53 
Psychiatrist 0.95 0.64-1.42 0.81  0.93 0.60-1.45 0.75 
Neurologist 1.07 0.72-1.60 0.73  0.97 0.62-1.52 0.89 
(a) Model C: Controlling for the following GP/practice characteristics other than GPs using computer for clinical purpose status: sex, 
age, fellowship of RACGP status, working in a deputising service over the past four weeks, bulk-billing all patients status, practice 
accreditation status, practice nurse at major practice; and patient characteristics: sex, age, holding health care card, holding Veterans’ 
Affairs card, Non English Speaking background, Aboriginal and/or Torres Strait Islander, new to practice, and presence of problems 
managed by ICPC-2 chapter at the encounter. 
Note: LCL–lower confidence limit; UCL– upper confidence limit; Shading indicates statistically significant differences between groups. 
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Table 5.31: Univariate and multivariate analysis of most frequent referrals to allied 
health professionals 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted  Adjusted(a) 
Allied health professionals 
Odds 
ratio 95% CI P  
Odds 
ratio 95% CI P 
Physiotherapist 1.04 0.78-1.38 0.79  0.83 0.63-1.09 0.17 
Psychologist 1.60 0.96-2.64 0.07  0.81 0.44-1.47 0.49 
Podiatrist/chiropodist 1.30 0.89-1.88 0.18  0.90 0.61-1.32 0.59 
Dietitian/nutritionist 1.47 0.82-2.65 0.20  1.09 0.56-2.13 0.80 
Dentist 0.87 0.59-1.29 0.49  1.13 0.72-1.78 0.58 
Acoustic testing 1.35 0.80-2.28 0.26  0.86 0.46-1.59 0.62 
Diabetes education 1.96 0.64-5.95 0.24  2.63 0.69-10.04 0.16 
Counsellor 0.81 0.34-1.97 0.65  0.28 0.09-0.86 0.027 
Mental health team 0.77 0.39-1.49 0.43  0.70 0.34-1.42 0.32 
Optometrist 0.91 0.49-1.69 0.76  0.77 0.38-1.58 0.48 
Drug & alcohol service 0.68 0.29-1.57 0.37  0.82 0.26-2.60 0.73 
Rehabilitation 0.41 0.15-1.10 0.08  0.28 0.13-0.57 0.001 
(a) Model C: Controlling for the following GP/practice characteristics other than GPs using computer for clinical purpose status: sex, 
age, fellowship of RACGP status, working in a deputising service over the past four weeks, bulk-billing all patients status, practice 
accreditation status, practice nurse at major practice; and patient characteristics: sex, age, holding health care card, holding veterans’ 
Affairs card, Non English Speaking background, Aboriginal and/or Torres Strait Islander, new to practice, and presence of problems 
managed by ICPC-2 chapter at the encounter. 
Note: LCL–lower confidence limit; UCL– upper confidence limit; shading indicates statistically significant differences between groups. 
 
Pathology tests and imaging orders by GP clinical computer use status 
after adjustment (Model 5C) 
As shown in the descriptive analysis (Table 5.20) clinical computer users 
ordered significantly more pathology tests overall, and chemistry tests 
(specifically tests for lipids, liver function tests, thyroid function tests), 
haematology tests, and microbiology tests (specifically urine microscopy, 
culture and sensitivity (MC&S) tests, and other microbiology tests). As well as 
these differences, a number of other marginal observations in the descriptive 
analysis were found to be significantly different once p values were produced 
through univariate analyses (Table 5.32) – CC users ordered significantly 
more: 
• electrolyte, urea & creatinine tests (OR=1.33, p=0.035) 
• ferritin tests (OR=1.52, p=0.016) 
• C-reactive protein tests (OR=1.88, p=0.001) 
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• full blood count tests (OR=1.26, p=0.027) 
• tests classified as Immunology (OR=1.47, p=0.03) 
and significantly fewer: 
• tests classified as Histopathology (OR=0.51, p=0.036), and 
• histology tests of the skin (OR=0.48, p=0.028). 
Following adjustment however, only one significant difference remained, that 
being the higher rate of ‘other’ microbiology tests ordered by CC users 
(OR=1.81, p=0.002). Also, the previously observed significant difference in 
the overall rate of pathology ordering between the two groups did not remain 
after adjustment (RC -0.11, p=0.96) (tabulated in Chapter 6, Table 6.1(a)). 
In Table 5.21, there were no significant differences found between the two 
groups in the rate of imaging orders. At the univariate analysis, one difference 
became significant–CC users ordered more ultrasounds than their 
counterparts (OR=1.21, p=0.017) (Table 5.33). Following adjustment this 
difference was no longer apparent, but a new difference emerged. Clinical 
computer users ordered significantly fewer X-rays of the lumbar spine 
(OR=0.58, p=0.038). 
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Table 5.32: Univariate and multivariate analysis of most frequent pathology orders by 
MBS pathology groups 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted  Adjusted(a) 
Pathology test ordered 
Odds 
ratio 95% CI P 
 Odds 
ratio 95% CI P 
Chemistry 1.26 1.09-1.45 0.002  1.01 0.82-1.20 0.89 
 Lipids 1.29 1.08-1.53 0.004  1.08 0.89-1.32 0.43 
 Electrolyte, urea & 
 creatinine 1.33 1.02-1.72 0.035  1.03 0.76-1.39 0.85 
 Liver function 1.40 1.13-1.74 0.002  1.17 0.90-1.15 0.24 
 Thyroid function 1.38 1.15-1.66 <0.001  1.03 0.85-1.26 0.74 
 Glucose tolerance 1.13 0.92-1.39 0.23  0.91 0.72-1.15 0.43 
 Multibiochemical  analysis 1.30 0.75-2.25 0.34  0.98 0.50-1.91 0.95 
 Ferritin 1.52 1.08-2.14 0.016  0.94 0.62-1.44 0.79 
 Chemistry; other 1.07 0.79-1.45 0.65  0.98 0.71-1.35 0.88 
 HbA1c 1.23 0.92-1.65 0.16  1.06 0.80-1.40 0.68 
 Hormone assay 1.23 0.86-1.77 0.26  0.96 0.60-1.53 0.85 
 Prostate specific  antigen 1.10 0.84-1.43 0.50  0.76 0.54-1.07 0.12 
 C-reactive protein 1.88 1.28-2.76 0.001  1.37 0.87-2.17 0.18 
Haematology 1.22 1.02-1.46 0.029  0.99 0.80-1.23 0.94 
 Full blood count 1.26 1.03-1.54 0.027  1.00 0.78-1.29 0.98 
 Erythrocyte 
 Sedimentation Rate 1.31 0.96-1.81 0.09  1.06 0.70-1.60 0.78 
 Coagulation 1.02 0.78-1.33 0.89  0.97 0.72-1.31 0.85 
Microbiology 1.59 1.34-1.87 <0.001  1.19 0.97-1.45 0.10 
 Urine M,C&S 1.35 1.11-1.65 0.002  1.01 0.79-1.30 0.93 
 Microbiology; other 2.50 1.78-3.53 <0.001  1.81 1.24-2.65 0.002 
 Hepatitis serology 1.47 0.93-2.32 0.10  1.19 0.68-2.08 0.53 
Cytopathology 1.49 1.00-2.24 0.051  0.86 0.64-1.18 0.36 
 Pap smear 1.50 0.99-2.25 0.053  0.87 0.64-1.19 0.39 
Other NEC 0.74 0.55-1.00 0.052  0.82 0.57-1.17 0.27 
 Blood test 0.63 0.35-1.13 0.12  0.89 0.44-1.83 0.76 
Histopathology 0.51 0.27-0.96 0.036  0.68 0.39-1.16 0.16 
 Histology; skin 0.48 0.25-0.92 0.028  0.67 0.39-1.17 0.16 
Immunology 1.47 1.04-2.09 0.03  1.02 0.69-1.52 0.93 
Infertility/pregnancy test  0.75 0.24-2.33 0.62  1.22 0.54-2.76 0.63 
(a) Model C: Controlling for the following GP/practice characteristics: sex, age, fellowship of RACGP status, working in a deputising 
service over the past four weeks, bulk-billing all patients status, practice accreditation status, practice nurse at major practice; and 
patient characteristics: sex, age, holding health care card, holding Veterans’ Affairs card, Non English Speaking background, 
Aboriginal and/or Torres Strait Islander, new to practice, and presence of problems managed by ICPC-2 chapter at the encounter. 
Encs–encounters; NEC–not elsewhere classified; MS&C–Microscopy, culture & sensitivity. 
Note: LCL–lower confidence limit; UCL– upper confidence limit; shading indicates statistically significant differences between groups. 
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Table 5.33: Univariate and multivariate analysis of most frequent imaging tests by MBS 
group and most frequent tests ordered 
GPs using a computer for clinical purposes : GPs not using a computer for clinical purposes 
Unadjusted  Adjusted(a) 
Imaging test ordered 
Odds 
ratio 95% CI P 
 Odds 
ratio 95% CI P 
Diagnostic radiology 0.97 0.84-1.14 0.74  0.87 0.72-1.04 0.13 
 X-ray; chest 0.99 0.79-1.23 0.90  0.92 0.69-1.23 0.59 
 X-ray; knee 0.95 0.69-1.30 0.73  0.88 0.64-1.22 0.44 
 Mammography; F 1.14 0.70-1.84 0.60  0.75 0.49-1.17 0.20 
 X-ray; foot/feet 1.10 0.78-1.56 0.58  1.04 0.72-1.49 0.84 
 X-ray; hip 1.16 0.80-1.69 0.43  1.05 0.69-1.61 0.82 
 Test; densitometry 1.22 0.77-1.92 0.40  0.96 0.56-1.64 0.88 
 X-ray; ankle 0.86 0.56-1.32 0.49  0.84 0.51-1.40 0.51 
 X-ray; shoulder 0.98 0.67-1.45 0.93  0.88 0.55-1.39 0.58 
 X-ray; wrist 1.06 0.68-1.66 0.80  0.85 0.49-1.50 0.58 
 X-ray; spine; 
 lumbosacral  0.97 0.67-1.40 0.87  0.80 0.50-1.29 0.36 
 X-ray; spine;  cervical 1.35 0.82-2.20 0.24  1.10 0.61-1.97 0.75 
 X-ray; hand 0.71 0.47-1.07 0.10  0.74 0.47-1.18 0.21 
 X-ray; spine; lumbar 0.82 0.49-1.37 0.46  0.58 0.34-0.97 0.038 
Ultrasound 1.21 1.03-1.42 0.017  1.04 0.89-1.23 0.62 
 Ultrasound; pelvis 1.34 0.94-1.92 0.11  1.20 0.90-1.60 0.21 
 Ultrasound; 
 abdomen 0.90 0.66-1.22 0.48  0.89 0.60-1.31 0.55 
 Ultrasound; breast;F 1.44 0.91-2.29 0.12  1.00 0.63-1.58 0.99 
 Ultrasound;  obstetric 1.70 0.94-3.07 0.08  1.05 0.66-1.68 0.83 
 Ultrasound; 
 shoulder 1.09 0.75-1.57 0.67  1.02 0.66-1.59 0.92 
 Test; doppler 1.39 0.77-2.50 0.28  1.38 0.70-2.73 0.35 
Computerised tomography 1.07 0.87-1.32 0.52  1.02 0.79-1.31 0.91 
 CT scan; brain 1.36 0.86-2.15 0.20  1.42 0.79-2.57 0.24 
 CT scan; abdomen 1.07 0.63-1.83 0.80  1.07 0.63-1.83 0.80 
 CT scan; spine; 
 lumbosacral 0.70 0.43-1.14 0.16  0.74 0.42-1.33 0.32 
Nuclear medicine imaging 1.31 0.75-2.30 0.34  0.80 0.40-1.57 0.51 
Magnetic resonance 
imaging 1.85 0.66-5.19 0.24  1.70 0.62-4.68 0.31 
(a) Model C: Controlling for the following GP/practice characteristics other than GPs using computer for clinical purpose status: sex, 
age, fellowship of RACGP status, working in a deputising service over the past four weeks, bulk-billing all patients status, practice 
accreditation status, practice nurse at major practice; and patient characteristics: sex, age, holding health care card, holding Veterans’ 
Affairs card, Non English Speaking background, aboriginal and/or Torres Strait Islander, new to practice, and presence of problems 
managed by ICPC-2 chapter at the encounter. 
Note: LCL–lower confidence limit; UCL– upper confidence limit; shading indicates statistically significant differences between groups. 
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5.4 Discussion 
These results show the demographic and activity profile of the GPs in this 
study who use a computer for clinical activity. Clinical computer use was more 
common among female than male GPs. Users were more likely to be in the 
under 45 years age group, and in parallel with their younger age, had spent 
fewer years in practice and were more likely to have graduated from their 
primary medical degree less than 20 years ago. They were more likely to 
have undertaken their primary medical degree in Australia (than overseas), 
and to hold FRACGP. 
Clinical computer users were less likely to bulk-bill for all patients, and more 
likely to be selective of the patients for whom they bulk-bill. They were more 
likely to work in larger practices (of more than 5 GPs), while non CC users 
were more likely to be in solo practice. Clinical computer users were more 
likely to practice in areas other than major cities or metropolitan areas, were 
more likely to work in accredited practices and to have a practice nurse at the 
major practice address. 
The sex and age distribution of GPs who are using computers in clinical 
practice suggests that adoption will increase with natural attrition. Computer 
use was more common among female GPs and the general practice 
workforce is becoming proportionally more feminised over time.109 Usually, in 
publications of general practice activity through BEACH, GP age is reported in 
<35 years and 35–44 years categories. In this study, these age groups were 
combined because, of the 109 GPs in the <35 group, only two GPs were non 
CC users–one GP did not use a computer at all, and one used a computer for 
internet and email only (a further two were removed because these data were 
missing). Computer use has become an integral part of the school education 
system and eventually general practice will be populated by clinicians for 
whom the use of a computer is the norm. It is the older age groups, and 
interestingly, males more than females who seem reluctant to adopt 
technology in practice. 
An increasing number of clinicians working in general practice were trained 
overseas, and they currently account for 25% of the Australian medical 
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workforce.110,111 Recent work by Bayram et al (2007)112 has shown that these 
GPs practice differently to Australian trained doctors, and this thesis 
demonstrates that these GPs are less likely to use a computer for clinical 
activity. Training in computer use for these doctors may be an area of 
consideration for GP educators. 
Size of practice may affect computer use for a variety of reasons. GPs were 
more likely to use a computer if they worked in practises of 5 or more GPs, 
and this may be influenced by the greater number of partners or colleagues to 
share the cost burden of purchasing and maintaining computers and 
upgrades in privately owned practices, or by the provision by owners in 
corporate practices. The time cost in training and familiarising clinicians and 
other staff with new systems may also be more easily managed in practices 
where the time to work and train can be shared. A larger practice is more 
likely to be able to support an on-site IT staff member. User support is also 
facilitated if there is a colleague with sufficient IT knowledge to solve a 
problem rather than having to call up an external consultant. 
GPs who work in locations other than major cities or metropolitan areas were 
more likely to use a computer and they may find the computer more 
necessary to their clinical practice. Depending on their degree of isolation, the 
computer may provide a more vital conduit for accessing information than it 
does to clinicians who, because of close proximity, have access to resources 
in large teaching hospitals, university or clinical libraries, or a greater number 
of colleagues.  
The mean length of time the CC users and non CC users spent in a 
consultation with a patient was identical–15.0 minutes. The only difference 
between the two groups in the type of services they provided was the 
provision of significantly fewer home visits by clinical computer users 
compared with their non-computerised counterparts. It seems unlikely that CC 
users would be less inclined to provide home visits simply because they 
cannot take their computer with them, or because they have to download 
information to a central patient file from a laptop or other electronic device on 
their return to the practice. Charles et al (2006)113 found that younger GPs 
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(<35 years of age) provided significantly fewer home visits, had lower 
prescribing rates and saw younger patients. These differences were also 
observed for GPs in this study who used a computer in their clinical activity 
and, because computer use is highest among younger GPs, it might be 
assumed that these differences are associated with GP age. However, these 
differences remained after adjustment for GP age (as well as other GP, 
practice, patient and morbidity characteristics) and so the differences cannot 
be attributed to that variable.  
In the descriptive analysis of patient, morbidity and management outcomes 
there were more than forty-five observable differences between the two GP 
groups. The majority of these were explained by other characteristics of the 
GP, practice, patients, or morbidity managed which were adjusted for in the 
regression analyses. Less than half retained a significant association with the 
use of a computer for clinical activity (or some other factor not examined in 
this thesis). 
Clinical computer users see fewer patients who are holders of a 
Commonwealth Health Care Benefits cardŦ, which one might think may be 
related to their lower rate of bulk-billing for all patients, but this difference 
remained after adjusting for GP characteristics including their bulk-billing 
status. Similarly, the fewer encounters with Health Care card holders may at 
first appear to provide some explanation for their lower prescribing rate for 
simple analgesics (particularly paracetamol) as these patients are the group 
for whom a GP is most likely to prescribe such products, given the cost on 
prescription may be less than the over-the-counter price. However, this 
difference also remained after adjustment for GP, practice and patient 
characteristics including the patients’ Health Care card holder status. These 
differences must therefore be due to clinical computer use, or to some other 
factor not measured in this study. 
As mentioned above, the age of patients differs between the two GPs groups, 
with clinical computer users seeing more patients in the younger age groups 
and fewer patients in the 45 to 64 year age group. Again this may appear to 
explain the lower prescribing rate for medications associated with illnesses 
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more likely to be found in older patients – anti-hypertensives, beta blockers, 
hypoglycaemic agents, musculoskeletal agents (particularly NSAIDsŦ). 
However, this difference remained after adjustment for GP, practice and 
patient characteristics (including patient age) and the morbidity managed. 
Clinical computer use or some other unmeasured factor must be contributing 
to this difference.  
Clinical computer users managed hypertension less often but ischaemic heart 
disease more often so this does not explain the lower rates of cardiovascular 
medications prescribed. There was also no difference in the management 
rates of diabetes or musculoskeletal conditions to correspond with the lower 
prescribing rates of hypoglycaemic or NSAID medications. One possible 
explanation is that some clinical software has been found to default to the 
maximum number of repeats allowed under PBSŦ rules when a prescription is 
‘written’.38 If this is the case, and patients at encounters with CC users are 
leaving the consultation with the maximum number of medication repeats 
allowable, they will not need to return for prescriptions as frequently as those 
given fewer repeats. If they do return for management of other problems in 
the interim, they will not need to have these prescriptions renewed until a later 
date. This would result in a lower prescribing rate per 100 encounters overall. 
Clinical computer users had a lower rate of referrals to allied health 
professionals, and provided fewer procedural treatments involving physical 
medicine/rehabilitation. They also provided fewer referrals to rehabilitation 
services so it would seem that their patients did not receive rehabilitation 
treatments provided either by the GPs themselves or by other health 
professionals. These differences persisted after adjustment for patient age 
and morbidity managed, and remain unexplained, as does the lower provision 
of counselling/advice for nutrition/weight, and fewer referrals to counsellors 
generally. There also does not appear to be a clear explanation for the higher 
rates of microbiology (other) tests or lower rates of lumbar spinal X-rays 
ordered by GPs who use a computer for clinical activity. These differences 
remain after adjustment for characteristics of GPs, practice, patient and 
morbidity, and so are associated with the clinicians’ use of a computer for 
clinical activity (or another variable not measured in this study). Whether or 
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not these differences affect the quality of patient care is as yet, unknown. In 
Chapter 6 I will employ a set of quality indicators to explore the positive or 
negative effects of differences in practice behaviour between the two GP 
groups. 
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CHAPTER 6 
 
QUALITY INDICATORS 
6.1 Background - What is ‘quality’? 
Having investigated GPŦ computer useŦ in clinical activity and whether the use 
of a computer as a clinical tool is associated with any differences in practice 
behaviour between GPs who use a computer and those who do not, I will now 
focus on how those differences affect the quality of care GPs provide to their 
patients. 
The first part of this process is to define what is meant by ‘quality’. The Oxford 
Dictionary defines ‘quality’ as ‘a degree or level of excellence’.114 It is a term 
often used in contrast to ‘quantity’ – for example, in science, the work of 
Aristotle focused on the measurement of ‘quality’, whereas the work of Galileo 
resulted in the study of ‘quantity’.115 But ‘quality’ is a subjective term that is 
defined by its context. Within each context it is defined by measuring one 
value against another, with one value being designated as a ‘standard’ e.g. an 
‘Environmental Quality Standard is a value, generally defined by regulation, 
which specifies the maximum permissible concentration of a potentially 
hazardous chemical in an environmental sample, generally of air or water’.116 
In a health-related context ‘Quality of Life’ is defined from a personal 
perspective, as the overall enjoyment of life. Many clinical trials measure 
aspects of an individual’s sense of well-being and their ability to perform daily 
functions, to assess the effects of an illness and its treatment on their ‘quality 
of life’.117 
Definitions of ‘quality’ in the context of health care also vary but they have a 
common theme. For example, the US Agency for Healthcare Research and 
Quality uses a simple definition for consumers and patients on their website – 
‘quality health care means doing the right thing, at the right time, in the right 
way, for the right person – and having the best possible results.’118 In its 
report Crossing the Quality Chasm: A New Health System of the 21st Century, 
the Institute of Medicine defined quality as ‘the degree to which health 
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services for individuals and populations increase the likelihood of desired 
health outcomes and are consistent with current professional knowledge.’119 
In Australia, the Australian Council on Healthcare Standards (ACHS), defines 
‘quality’ as ‘the extent to which the properties of a service or product produces 
a desired outcome’.120 
The definition and assessment of quality have been long recognised as 
complex issues. Avedis Donabedian framed most of his life’s work around the 
simple question: ‘How can you tell if you have good-quality health care?’.121 
He believed that before assessment can begin we must decide how quality is 
to be defined, and that agreement is needed on what the elements are that 
constitute quality.122 Donabedian proposed seven attributes of health care to 
define its quality:  
‘efficacy – the ability of care, at its best, to improve health; effectiveness 
– the degree to which attainable health improvements are realised; 
efficiency – the ability to obtain the greatest health improvement at the 
lowest cost; optimality – the most advantageous balancing of costs and 
benefits; acceptability – conformity to patient preferences regarding 
accessibility, the patient-practitioner relation, the amenities, the effects of 
care, and the cost of care; legitimacy – conformity to social preferences 
concerning all of the above; and equity – fairness in the distribution of 
care and its effects on health.’123  
He and other authors have offered input on how to measure quality so that it 
may be assessed.122,124,125 
In recent years there has been increasing demand by health economists, 
policy makers, health professionals and consumers for the assessment and 
improvement of quality, and the demand for information on health care 
quality.126 While this is an international trend, the approach to quality 
measurement, and the capacity to validly assess quality varies widely 
between countries.127,128 The demand for quality assessment and 
improvement has given rise to the development of ‘indicators’. Indicators are 
‘explicitly defined and measurable items referring to the structures, processes, 
or outcomes of care’.129 Indicators are made operational by using standards, 
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guidelines or review criteria but they differ from these entities in that they are 
the mechanism by which care may be measured against such standards.130 
There are various types of indicators: activity indicators measure the 
frequency of an event e.g. the rate of vaccinations for influenza; performance 
indicators monitor performance (e.g. the use of resources) without any 
inference about quality; quality indicators infer a judgement about the quality 
of care provided. They do not give definitive answers but indicate potential 
problems or good quality of care.131  
In primary care, as in other areas of the health system, the use of quality 
indicators has become accepted as a reasonable approach for assessing 
quality, although for some time the focus has been on process measures 
which tell what was done. More recently the focus has shifted to outcome 
measures, which show the effect of what was done.132 Quality indicators are a 
useful tool if applied appropriately, to assessing the change in quality resulting 
from a change in other system processes–for example, the introduction of a 
computer as a tool to assist with clinical practice. A quality indicator has been 
defined by the European Working Party on Quality in Primary Care (EQuiP) 
as: ‘A measurable element of practice performance for which there is 
evidence or consensus that it can be used to assess quality, and hence 
change in the quality, of care provided’.133 
Quality indicators have been developed which are applicable to everything 
from prescribing, to monitoring programs, assessing interventions, to 
identifying poor performers.126 Not all indicators are applicable in every 
situation, and the application of a quality indicator inappropriate to the 
situation in which it is used will invalidate the result. Creating meaningful 
indicators from accurate data is a challenging exercise,124 and Pont et al 
argue that ‘face and content validity, on which validation has centred to date, 
are not adequate substitutes for concurrent validity, checking if an indicator 
adequately describes what can be observed in actual clinical practice.126 They 
use the example of creating prescribing indicators from computerised data 
such as sales records, claims data or pharmacy records to emphasis this 
point. If no indication is available to correspond to the prescribing data, this 
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can result in misclassification and undermine the possibility of validly 
assessing the prescribing quality for a specific disease.126  
As described in Chapter 2, there is a general theme among the literature that 
using a computer will ‘improve’ the management of health information by 
facilitating the provision of information needed to assess performance of 
individual practitioners, to evaluate programs, to monitor patient disease and 
risk management, and to provide data for research. A considerable amount of 
literature supports the notion that computerisation will improve quality of care 
for patients. On closer reading, however, it is apparent that, to date, there is 
not a great deal of actual evidence about the benefits or otherwise, of using a 
computer in a health care setting. Many authors begin their writing with a 
claim that computerisation has improved some aspect of health delivery, and 
reference previous work in support of this claim. But more often than not, the 
paper trail leads back to a supposition someone made 15 or 20 years 
previously, that others have subsequently built on, until - like a Chinese 
whisper - it appears in recent works as fact. For example, Garrido et al, in a 
2005 publication, include in their introduction the statement that ‘Electronic 
health records reduce uncertainty by providing greater accessibility, accuracy 
and completeness of clinical information than their paper counterparts’. They 
reference a 1991 report by the General Accounting Office in Washington. But 
what the General Accounting Office actually said was ‘automated systems 
show promise’ … ‘speed with which records are updated and transferred and 
the accuracy of the information should improve greatly’ … ‘better 
management of information should improve the quality of care’ …. and 
added that ‘no fully automated medical record system exists, so the strengths 
and weaknesses of such a system have not been documented, and are not 
clearly understood.’ As stated in Chapter 2, other authors have also failed to 
find real evidence in support of many of the claims.21,32,33 Himmelstein and 
Woolhandler borrowed an expression of Woody Allen’s to describe this 
phenomenon, which I agree has summed it up rather well: ‘At the moment it’s 
just a notion, but with a bit of backing I think I could turn in into a concept, and 
then an idea.’134 
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In considering how computer use may affect the quality of care in general 
practice, evidence is needed to assess whether there are differences in the 
behaviour of GPs who use a computer for clinical purposes compared with 
those who do not. In the absence of a model based on evidence rather than 
conjecture for determining how computers would alter behaviour and affect 
quality, I have decided to approach the problem from the perspective of best 
quality and compare clinical computers and non-clinical computer users to 
see which group performs ‘best’. To make this assessment, I have measured 
their behaviour against a set of quality indicators applicable in a primary care 
setting. The BEACHŦ database on which this study is based, has been shown 
to be valid and reliable as a data source of GP behaviour and activity.14 
6.2 Aim 
The aim of this Chapter is to determine, via a set of quality indicators 
applicable to general practice, whether GPs who use a computer for clinical 
activity differ from GPs who do not use a computer for clinical activity in the 
quality of care they provide to their patients. 
Hypothesis: GPs who use a computer in their clinical activity will perform 
‘better’ on a range of primary care quality indicators than those who do not. 
Rationale: The theme in recent literature is that computer use will ‘improve’ 
aspects of management and care. 
6.3 Method 
The methods utilised for this chapter are based on the BEACH methodology 
described in Chapter 3. As also described in Chapter 3, the additional 
questions designed for the GP Profile questionnaireŦ were used to investigate 
the clinical computer use of individual BEACH GPs.  
A set of 36 quality indicators covering 13 domains of care were selected and 
used to compare the practice behaviour of GPs assigned to two groups 
according to their use of a computer for clinical purposes. The process of 
selecting the quality indicators is described below. The average length of 
consultationŦ in minutes was investigated for a sub-sample of GPs in each 
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group, in which the clinician had recorded the start time and finish time for a 
random sample of 40 consultations per GP. 
Definitions 
Clinical computer use was defined as the use of a computer for clinical 
functions e.g. prescribing and/or test ordering and/or medical recordsŦ, with or 
without internet and/or email. As in Chapters 4 and 5, the GPs who reported 
clinical computer use will be referred to in this Chapter as ‘clinical computer 
users’Ŧ or ‘CC users’. 
Non-clinical computer use was defined as the use of a computer for 
administrative functions, internet and/or email only. Clinical components of the 
medical software application such as prescribing, test ordering, medical 
records, while available, were not utilised by the GP in his clinical practice. 
GPs who did not use a computer at all were included in this group. As in 
Chapters 4 and 5, the GPs who reported not using a computer for clinical 
activity, or did not use a computer at all, will be referred to in this Chapter as 
‘non clinical computer users’ or ‘non CC users’. 
6.3.1 The participants 
The participants for this section were the 1,257 GPs for whom I was able to 
determine individual computer use status as described in Chapter 3. There 
were 1,069 GPs in the group of clinical computer users and 188 GPs in the 
group who did not use a computer for clinical purposes. The sub-sets of 
consultationsŦ with start and finish time recorded included 34,633 
consultations with CC users and 6,084 consultations with non CC users. The 
denominators for each of the quality indicators vary. For example, the 
denominator for PSAŦ tests is the 1,888 encountersŦ with male patients aged 
50 years or older. The denominators for each of the quality indicators are 
specified in Table 6.1(a). 
Test ordering – because the denominator for CC users included GPs who used 
a computer for any clinical purpose, there were a number of GPs in the 
computer use group who do not use the test ordering function of their clinical 
software. For this reason, I have examined the test ordering behaviour for the 
total set of clinical computer users and their counterparts in the first instance, 
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and then repeated the investigation for eight of the quality indicators (those 
specific to test ordering), with the GPs grouped according to their use of the 
test ordering function of their software. For these additional analyses, there 
were 901 GPs in the group who nominated test ordering as a clinical task for 
which they use a computer, and 356 in the group of GPs who did not use the 
computer for test ordering. 
6.3.2 Selection and development of quality indicators  
A previous analysis of BEACH data to compare GPs who hold Fellowship of 
the Royal Australian College of General Practitioners (FRACGPŦ) with those 
who do not, was undertaken in 2002.67,135 For that study (referred to hereafter 
as the FRACGP study/report) a set of quality indicators were developed that 
were applicable to the BEACH data and could be used to assess quality of 
care by GPs or primary care physicians.  
At the start of that project, the authors found that there had been little work 
done on primary care quality indicator development, and where indicators had 
been developed, they were patient based indicators from very limited data 
sets or relied on administrative databases. The authors found a small number 
of studies using the US National Ambulatory Medical Care Survey database, 
a national data set not dissimilar to BEACH,136-155 and a French study of 
prescribing indicators using IMS prescribing survey data.156 They reviewed 
databases of indicators such as the Conquest database of the US Agency for 
Health Care Research and Quality,157 the Health Plan Employer Data and 
Information Set (HEDIS) of the US National Committee for Quality Assurance 
(NCQA)158 and the UK National Performance Assessment Framework.159 
Australian and international guidelines for preventive activities were also 
reviewed, including the RACGPŦ ‘Red Book’,160 the Canadian guide to clinical 
preventive healthcare,161 and guidelines for the management of National 
Health Priority problems such as the Heart Foundations CVD guidelines.162 
Indicators that could be applied to BEACH data were identified and/or 
adapted from indicators used with administrative or patient-based data.67  
Advice on sources of quality indicators was sought from representatives of the 
National Prescribing Service (Dr Lynn Weeks), the Quality Use of Medicines 
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Research Centre (Dr Libby Roughead), the Priorities and Quality Branch of 
the (then) Commonwealth Department of Health and Ageing, and from Dr 
Barbara Booth, previous Director of Quality Assurance at the RACGP.67  
Final selection of indicators, and the rationale for each, was undertaken in 
consultation with Dr Grant Russell, RACGP National Manager of Quality Care 
and Research, and the RACGP National Standing Committee on 
Research.67,135 The resulting quality indicators have been adopted for this 
study. The original search of literature, databases, Australian and international 
guidelines undertaken to develop the quality indicators for the FRACGP study 
was thorough, and was performed only two years prior to the commencement 
of this study.67,135 As well as citing the FRACGP report, I have included the 
citations used by Miller et al67 within each of the rationale descriptions for 
each indicator for the convenience of the examiners, but these should be 
considered as ‘secondary’ references to this work. For example, where Miller 
et al67 referred to a search of the CONQUEST 2.0 database, I have included a 
reference for this database, but have not personally been involved in a review 
of it. In the case of the research papers used by Miller et al67 in this process, I 
have undertaken a PubMed search to ensure that each is still accessible, and 
where necessary have updated URL addresses in cases where organisations 
such as Beyondblue163 and the National Heart Foundation162 have changed, 
and the original used by Miller et al67 are no longer available. While I have 
personally reviewed some of the journal articles I in no way wish to infer that I 
have reviewed all of the work undertaken by Miller et al67 in the quality 
indicator development process. I have simply attempted to provide the fullest 
description possible of the process undertaken in the development of the 
indicators adopted for this study. 
I undertook a further literature search to determine if there were any other 
indicators of quality published in the interim which may have been applicable 
for this analysis. PubMed, Medline and EMBASE were searched using terms 
such as ‘quality indicator’; ‘family practice’; ‘primary care’; ‘general practice’; 
‘ambulatory care’; ‘standards’; ‘quality of health care’; ‘quality assurance 
health care’; ‘quality health outcomes’ in a variety of combinations. For the 
time frame determined, 67 papers resulted. Some articles were disease 
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specific, specific to areas other than primary care, applicable only to specific 
systems that don’t exist in Australia, or ‘think pieces’, but any with indicators 
that may have been applicable to primary care were considered.126-128,164-170 
Ultimately, there were no new indicators offered by these works that were 
suitable for use with the BEACH data set, that had not previously been 
selected for the FRACGP study.  
The individual rationale for each of the domains of care was based on what is 
considered ‘best practice’ for each domain, and followed the overall 
hypothesis for this Chapter, i.e. the assumption in each case that computer 
users would perform ‘better’. The rationale for many of the indicators 
remained the same as that applicable in the FRACGP report, although some 
were updated. Where I could not make a decision independently about best 
quality, further advice was sought from my supervisors. 
A list of inclusions for each of the specific quality indicators, with ICPC-2Ŧ 
rubrics, ICPC-2 PLUSŦ codes and labels, is available in Appendix 13. 
6.3.3 Statistical methods 
The denominator for each of the quality indicators for each of the GP groups 
is provided in Table 6.1(a), together with the rate of occurrence of the event 
expressed as a percentage of the denominator. The unadjusted linear 
regression coefficient (RC) is presented for comparison of the rates of the 
event in the two groups to show the raw difference between the rates. The 
Model used in the adjusted linear regression for each indicator is then 
presented, followed by the adjusted linear regression coefficient resulting after 
adjusting for the characteristics included in the named Models for each 
indicator. The results for each indicator are described in full in the body of this 
chapter, including results from earlier chapters where necessary. The results 
of univariateŦ and multivariate analysesŦ are shown in Table 6.1(a), and a 
summary of all indicators, showing acceptance or rejection of each hypothesis 
is provided in Table 6.2(a).  
Power  
The power estimations performed for, and reported in, Chapter 5 (Section 
5.2.3) are also applicable to this Chapter. 
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6.3.4 Multivariate analyses and Models used 
As the GPs being compared in this Chapter were assigned to the same 
groups as they had for Chapter 5, the Models and covariates used in Chapter 
5 were also used in this Chapter.  
As the GPs we reallocated to groups according to their use of a computer for 
test ordering, the modelling process was again undertaken to determine what 
characteristics would require adjustment for in the logistic regression analysis. 
NOTE: I have applied two different sets of models to the analyses for this 
Chapter. Models 5A – 5C are the models designed in Chapter 5 for clinical 
computer users versus non-clinical computer users and applied to the same 
GP groups in this Chapter. The GP and practice characteristics shown in 
Figure 5.1 (Chapter 5, Section 5.2.3), and those listed in that section as being 
included in the final models (5A, 5B and 5C) are all used identically for these 
analysis. Models 6A – 6C were designed using the same process but a 
different set of characteristics were found to be associated with the dependent 
variable (GP computer use for test ordering). Figure 6.1 shows all GP and 
practice characteristics examined in the simple logistic regression which were 
then tested for association in the step-wise elimination process. Variables 
highly correlated with other predictors already in the model or on the causal 
pathway to the outcome were excluded from the model. The variables 
showing some association (P<0.10) with the dependent variable in the simple 
logistic regression were included in the stepwiseŦ procedure for elimination 
and refitting of the model. 
Covariates in model 6A 
The variables showing significant association (P<0.05) and included as 
covariates in the final model were:  
• GP age  
• GP sex 
• Place of graduation 
• GP status as a Fellow of the RACGP (FRACGP) 
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• Size of practice 
• Practice location by ASGCŦ  
• Bulk-billingŦ for all patients 
• Practice accreditationŦ status 
• Presence of a practice nurse at the major practice address. 
 
GP characteristics Practice characteristics 
• Age (45, 45–54, 55+ years)* 
• Sex* 
• Place of graduation* (Australia/other) 
• FRACGP status* (yes/no) 
• Years in general practice (<10, 10–19, 20+)† 
• Years since graduation (<20,20–29, 30+)†  
• Sessions per week (<6, 6–10, 11+)* 
• Direct patient care hours per week 
     (<31, 31-40, 41-50, 51+) 
• Work in past 4 weeks— 
• in residential aged care facility* (yes/no) 
• as a locum (yes/no) 
• as salaried/session hospital medical officer (yes/no) 
• in a deputising service (yes/no) 
• Whether bulk-bill all patients* (yes/no) 
• Any consultations in language other than English* (yes/no) 
• Registered with Department of Veterans Affairs* (yes/no) 
• Registrar status (Registrar/not registrar) 
• Size of practice* (solo, 2-4, 5-
10,11+ GPs) 
• Practice location by RRMA1 
(metropolitan/rural) 
• Practice location by ASGC2* 
(major city/not major city) 
• Practice location by State* 
• Socio economic status by 
SEIFA3 (Disadvantages <4 
SEIFA/less disadvantages 
SEIFA 4-11)* 
• Practice accreditation status* 
(Yes/no) 
• Practice nurse at major 
practice address* (yes/no) 
• After-hours patient are 
arrangements (own or co-
operative/deputising service) 
• Status as a teaching practice 
for undergraduates of 
registrars 
Figure 6.1 GP and practice characteristics compared in simple logistic regression analysis 
and then considered in step-wise logistic regression analysis 
† Variables that were found to be highly correlated with other variables and were therefore not retained in the modelling process. 
* Variables that showed some association (p<0.10) with use of a computer for test ordering purposes, and were therefore included in 
the logistic regression analysis. 
1.  Australian Government Department of Health and Ageing. Rural, Remote and Metropolitan Areas (RRMA) classification. 
http://www.health.gov.au/internet/wcms/publishing.nsf/content/work-bmp-where-rrma.  
2.  Australian Bureau of Statistics (ABS). Australian Standard Geographical Classification (ASGCŦ). Canberra: Australian Bureau of 
Statistics, 2004. 
3.  Australian Bureau of Statistics. Census of population and housing: Socio-Economic Indexes for Areas (SEIFA), Australia. 
Canberra: Australian Bureau of Statistics, 2001. 
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Covariates in model 6B 
The variables showing significant association (P<0.05) and included as 
covariates in the final model were the GP and practice characteristics 
included in Model 6A, plus:  
• Patient sex 
• Patient age 
• Commonwealth health care benefits cardŦ holder status 
• Veterans’ Affairs card holder statusŦ 
• Non-English speaking background status (NESBŦ ) 
• AboriginalŦ or Torres Straight IslanderŦ status 
• Status of patient to the practice (i.e. newŦ or seen previously) 
Covariates in model 6C 
• The GP, practice characteristics and patient characteristics included in 
Model 6B 
• The presence or absence of problems managed by ICPC-2 Chapter at 
the encounter. 
Group variable of interest 
For Models 5A – 5C the group variable was GP clinical computer use. GPs 
not using a computer for clinical purposes were the reference group against 
which the GPs using a computer for clinical purposes were compared. 
For Models 6A – 6C the group variable was GP computer use for test 
ordering. GPs not using a computer for test ordering were the reference group 
against which the GPs using a computer for test ordering were compared. 
6.4 Results 
6.4.1 Clinical computer users versus non clinical computer users 
The results for the comparison of CC users vs non CC users are shown in 
Table 6.1(a). The quality indicator for consultation time measured differences 
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in the mean consultation length in minutes before and after adjustment, and 
other indicators measured the difference between rates of occurrence per 100 
encounters or per 100 contacts as applicable. The Model used in the 
multivariate analysis is tabulated beside each indicator. The characteristics of 
the GP, practice, patient or morbidityŦ included in each of the Models are 
listed in the footnotes.  
Consultation patterns 
Distribution of MBS items and mean length of consultation 
Hypothesis: Clinical computer users will spend more time with patients and 
this will be reflected in a greater proportion of long and prolonged 
consultations and in a longer mean consultation time.67 
Rationale: Length of consultation has been identified as an important predictor 
or proxy for the quality of general practice care,149,171-174 particularly in relation 
to psychosocial problems, and leads to greater levels of patient satisfaction.67 
Distribution of Medicare item number 
Results: The univariate descriptive analysis demonstrated no significant 
difference between CC users and non CC users in the proportion of 
MedicareŦ encounters designated as long consultations or prolonged 
consultations (Chapter 5: Table 5.5). This result remained unchanged after 
adjustment for GP, practice, patient and morbidity characteristics (Model 5C) 
(p=0.70; p=0.76 respectively) as shown in Table 6.1(a). 
Conclusion: The hypothesis was rejected. 
Length of consultation in minutes 
Results: The univariate descriptive analysis demonstrated no significant 
difference between CC users and non CC users in the mean length of 
consultation, both being 15 minutes (Chapter 5: Table 5.4). This result 
remained unchanged after adjustment for GP, practice, patient and morbidity 
characteristics (Model 5C) (p=0.40) as shown in Table 6.1(a). 
Conclusion: The hypothesis was rejected. 
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Reasons for encounter and problems managed per 100 encounters 
Hypothesis: Clinical computer users will elicit more patient reasons for 
encounter, and therefore manage more problems at the encounter than non 
CC users.  
Rationale: As reported by Miller et al,67 the importance of patient-centred care 
in improving patient outcomes has been the subject of studies in the United 
States,175 Canada176 and the United Kingdom.177,178 It has been demonstrated 
that primary care physicians frequently fail to elicit all the patient’s concerns 
and may thus leave problems unaddressed.67,175,179 Patient-centred care will 
result in the GP eliciting more patient reasons for encounter, and detecting a 
larger number of patient problems. This will be reflected in a greater number 
of patient reasons for encounter and a greater number of problems managed 
at the encounter.67 
Reasons for encounter 
Results: The univariate descriptive analysis demonstrated no significant 
difference between CC users and non CC users in the number of patient 
reasons for encounter recorded (Chapter 5: Table 5.6). This result remained 
unchanged after adjustment for GP, practice and patient characteristics 
(Model 5B) (p=0.82) as shown in Table 6.1(a).  
Conclusion: The hypothesis was rejected. 
Problems managed 
Results: The univariate descriptive analysis demonstrated that CC users 
managed significantly more problems at the encounter (150.5 problems per 
100 encounters, 95% CI: 148.8–152.2) than non CC users (144.1 per 100, 
95% CI: 140.1–148.1 (Chapter 5: Table 5.6) (p=0.003; Table 6.1(a)). 
Following adjustment for GP, practice and patient characteristics (Model 5B) 
there was no longer a significant difference between the two groups (p=0.12) 
(Table 6.1(a)) 
Conclusion: The hypothesis was rejected. Clinical computer users were 
shown to manage more problems per 100 encounters, but this difference was 
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due to the influence of characteristics of the GPs and/or their patients, other 
than use of a computer for clinical activity. 
Non-pharmacological management 
Clinical treatment rates 
Hypothesis: Clinical computer users will provide counselling and advice about 
lifestyle, medication and problem management more often than non CC 
users.  
Rationale: A characteristic of patient-centred care and good preventive care is 
the provision of higher levels of counselling and advice regarding lifestyle and 
problem management.67 The provision of preventive care in the form of 
lifestyle counselling (about diet, weight, exercise, smoking, alcohol intake etc) 
is an important part of general practice care and is supported by the 
guidelines issued by the RACGP.160,180 Advice about medications prescribed 
and treatments given are also beneficial to the patient. The value of 
counselling for patients with depression and other psychological problems is 
also well supported in the literature and by initiatives such as 
Beyondblue.67,163 
Results: There was no significant difference between CC users and non CC 
users in the rate of provision of clinical treatments overall, either in the 
univariate descriptive analysis (p=0.88) or after adjustment for GP, practice, 
patient and morbidity characteristics (Model 5C) (p=0.32), as demonstrated in 
Table 6.1(a). 
Conclusion: The hypothesis was rejected. 
Therapeutic procedure rates 
Hypothesis: In addition to counselling and pharmacological managements, 
CC users will provide more therapeutic procedures for their patients than non 
CC users.  
Rationale: Comprehensiveness of care is one of the hallmarks of good 
general practice and this is reflected in the RACGP curriculum181 for general 
practice vocational training and in the provision of continuing professional 
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development programs by the RACGP and the Australian College of Rural 
and Remote Medicine (ACRRMŦ).67 
Results: As shown in Table 6.1(a), there was no significant difference 
between CC users and non CC users in the relative rate of provision of 
procedural treatments, either in the univariate descriptive analysis (p=0.57) or 
in the multivariate analysis (p=0.31) following adjustment for GP, practice, 
patient and morbidity characteristics (Model 5C). 
Conclusion: The hypothesis was rejected. 
Prescribing rates 
Hypothesis: GPs who use a computer for clinical purposes will prescribe 
fewer medications per 100 encounters than GPs who do not use a computer 
for clinical activity. 
Rationale: While there is good evidence for the belief that prescribing in 
certain conditions does not reflect best practice (for example, antibiotic 
prescribing for URTI), there is less evidence for the overall proposition that 
‘less prescribing is better’. However, such a view is often expressed in media 
and administrative comment. Pharmaceutical resource use is an undoubted 
financial problem in most parts of the world. It may therefore be argued that 
the opportunity cost of current levels of prescribing is not in the public 
interest.67 
Results: As demonstrated earlier (Chapter 5: Table 5.6) the rate of prescribed 
medications provided per 100 encounters was significantly less at encounters 
among CC users (81.9, 95% CI: 80.1–83.7) than their counterparts (89.8, 
95% CI: 83.9–95.7) (p=0.01). Following adjustment for GP, practice, patient 
and morbidity characteristics (Model 5C), this result remained significantly 
different (p=0.02) as shown in Table 6.1(a). 
Conclusion: The hypothesis was accepted and the lower prescribing rateŦ can 
be said to be the result of computer use, or some other GP, practice or patient 
variable(s) not measured in this study. 
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Referrals 
Hypothesis: GPs who use a computer for clinical purposes will refer less often 
to hospitals and specialists but more frequently to allied health professionalsŦ 
than GPs who do not use a computer for clinical activity.67 
Rationale: Better GPs should exhibit more comprehensive clinical and 
procedural skills, in line with those tested in the FRACGP examination,182 than 
non-clinical computer users, and should therefore need to call on the support 
services of specialists and hospitals less frequently. The countervailing effects 
of medical indemnity problems may however limit the ability of GPs to 
undertake procedures even if they possess the required skills. 
Conversely, the CC users should be attuned to multi-disciplinary team care of 
their patients and thus use allied health professionals more frequently.67 
Results: The univariate descriptive analysis demonstrated no significant 
difference between the GP groups in the overall rate of referralsŦ (Chapter 5: 
Table 5.6). No significant differences emerged from either the univariate or 
multivariate analyses in the rate of referrals to specialists or hospitals. There 
was also no significant difference between the GP groups in the univariate 
descriptive comparison for the rate of referrals to allied health professionals. 
However, after adjusting for GP, practice, patient and morbidity characteristics 
(Model 5C), CC users referred patients to allied health professionals at a 
significantly lower rate than non CC users (p=0.03) (Table 6.1(a)). 
Conclusion: The hypotheses regarding referral rates to hospitals and 
specialists were rejected at all levels of analysis. For referral rates to allied 
health professionals, a negative difference emerged following adjustment for 
other characteristics of the GP, practice and patients, and this difference was 
concluded to be associated with the GPs’ use of a computer for clinical 
activity, or some other GP/practice/patient variable not measured in this study. 
The hypothesis was rejected and reversed. 
Tests and investigations 
Hypothesis: GPs who use a computer for clinical purposes will order less 
pathology, less imaging, and fewer investigations overall than GPs who do not 
use a computer for clinical activity.67 
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Rationale: Research into pathology ordering183 and imaging ordering184 by 
GPs in Australia demonstrates some areas of excess utilization of these 
resources. Clinical computer users could be expected to be more judicious in 
their use of pathology and imaging with a resulting lower overall rate of 
ordering.67 
Total Investigations 
Results: In the univariate descriptive comparisons GPs who use a computer 
for clinical purposes ordered investigations in the management of a problem 
at a significantly higher rate than non CC users (p<0.001) (Table 6.1(a)). 
However, after adjustment for GP, practice, patient and morbidity 
characteristics (Model 5C) this difference was no longer observed (p=0.82) 
(Table 6.1(a)). 
Conclusion: Clinical computer users order investigations at a higher rate but 
this difference is explained by characteristics of the GP, practice, patient or 
morbidity, other than the GPs status as a clinical computer user. The 
hypothesis was therefore rejected. 
Pathology orders 
Results: In the univariate descriptive analysis GPs who use a computer for 
clinical purposes ordered pathology tests for management of a problem at a 
significantly higher rate than non CC users (p<0.001) (Table 6.1(a)). However, 
after adjustment for GP, practice, patient and morbidity characteristics (Model 
5C) this difference was no longer apparent (p=0.96) (Table 6.1(a)). 
Conclusion: GPs using a computer for clinical purposes are more likely to 
order pathology but this difference is explained by characteristics of the GP, 
practice, patient or morbidity, other than the GPs status as a clinical computer 
user. The hypothesis was therefore rejected.  
Imaging orders and other investigations 
Results: In the univariate descriptive analysis there was no significant 
difference in the proportion of problems for which imaging investigations were 
ordered (Chapter 5: Table 5.14) and no difference in the rate of imaging tests 
ordered per 100 encounters (8.6 per 100 for CC users cf. 8.2 for non CC 
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users) (Table 5.6), nor was any difference observed in this indicator after 
adjustment for GP, practice, patient and morbidity characteristics (Model 5C) 
in the multivariate analysis (p=0.35) (Table 6.1(a)). Similar results were 
observed for other investigations ordered, with no significant differences 
emerging at either the univariate (p=0.05) or multivariate analyses (p=0.78) 
(Table 6.1(a)).  
Conclusion: There being no differences between the two groups, the 
hypothesis was rejected.  
Social disadvantage services 
Hypothesis: GPs who use a computer for clinical purposes will have 
encounters with more patients of Aboriginal and Torres Strait Islander origin, 
and with more patients who are holders of a Commonwealth Health Care 
Benefits card, than GPs who do not use a computer for clinical activity.67 
Rationale: Patients of Aboriginal and Torres Strait Islander origin are highly 
disadvantaged both in terms of health status and access to health care. 
Similar disadvantage may exist among patients who hold a Commonwealth 
Health Care Benefits card.74 The principles of primary health care suggest 
that good primary care practitioners should endeavour to meet the needs of 
disadvantaged groups.67 
Encounters with patients Aboriginal and Torres Strait Islander origin 
Results: There was no significant difference between the two GP groups in 
the proportion of encounters at which the patient identified themselves as an 
Aboriginal person, or a person of Torres Strait Islander origin (Chapter 5: 
Table 5.7) either before or after adjustment for GP and practice characteristics 
(Model 5A) (Table 5.22) 
Conclusion: There being no differences between the two groups, the 
hypothesis was rejected.  
Encounters with Commonwealth Health Care Benefits card holders 
Results: In the univariate descriptive comparisons, the proportion of 
encounters at which the patient was a Commonwealth Health Care Benefits 
card holder was significantly smaller with GPs who use a computer for clinical 
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purposes (41.7 per 100 encounters, 95% CI: 40.5–42.9), than the proportion 
attending non CC users (47.9 per 100, 95% CI: 44.5–51.2) (Chapter 5: Table 
5.7). After adjustment for GP and practice characteristics (Model 5A) this 
difference remained (p=0.035) (Table 5.22). 
Conclusion: Clinical computer users see fewer patients who are 
Commonwealth Health Care Benefits card holders, which is the opposite to 
the hypothesised result. The difference between the two GPs groups in the 
proportion of encounters with Commonwealth Health Care Benefits card 
holders remained after adjustment for other GP and practice characteristics 
and is therefore assumed to be directly associated with the GPs status as a 
clinical computer user, or other variables not measured in this study. The 
hypothesis was therefore rejected and reversed. 
Preventive care 
Hypothesis: Clinical computer users will provide higher levels of preventive 
care than non CC users.  
Rationale: Prevention of disease is an important public and personal health 
service provided by GPs, and therefore ‘good’ GPs will provide higher levels 
of preventive care to their patients. The RACGP promotes the role of the GP 
in activities such as screening for cervical cancer and immunization through 
the ‘Red’ and ‘Green’ books.67,160,180 
Rates of Pap Smears at encounters with females aged 15–70 years 
Results: In the univariate descriptive analysis, the rate of pap smears per 100 
encounters with women aged 15–70 years was slightly higher for CC users 
(5.7 per 100) than for non CC users (4.1 per 100). However, after adjustment 
for GP and practice characteristics and patient age (Model 5A plus patient 
age, because of the age range most likely to be sexually active) this 
difference was no longer observed (p=0.82) (Table 6.1(a)). 
Conclusion: Pap smear rates per 100 encounters with women aged 15–70 
years were higher for GPs who use a computer for clinical activity than for non 
clinical computer users, however the slightly higher rate was explained by 
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variables other than the GPs status as a clinical computer user. The 
hypothesis was therefore rejected. 
Rates of immunisation given at encounters with children aged less than 5 years 
Results:  In the univariate descriptive analysis, the rate of immunisations per 
100 encounters with children aged less than 5 years was significantly higher 
for GPs who use a computer for clinical purposes (20.5 per 100) than for non 
CC users (15.2 per 100). However, after adjustment for GP and practice 
characteristics (Model 5A) this difference was no longer observed (p=0.34) 
(Table 6.1(a)). 
Conclusion: Clinical computer users do have a higher immunisation rate per 
100 encounters with children aged less than 5 years, than non CC users, but 
this was explained by GP or practice characteristics other than the GPs status 
as a clinical computer user. As the difference could not be attributed to clinical 
computer use, the hypothesis was therefore rejected.  
Rates of lifestyle counselling provided to patients 
Hypothesis: Clinical computer users will provide higher levels of counselling of 
patients about high-risk life-style behaviours than non CC users. 
Rationale: The frequency of high-risk behaviours such as smoking, high 
alcohol intake and poor diet by patients of GPs has been demonstrated in the 
BEACH reports on GP activity in Australia.185 The RACGP Guidelines for 
prevention activities stress the importance of monitoring and intervening in 
detrimental lifestyle factors.160 ‘High quality’ is associated with higher levels of 
GP counselling of patients regarding high-risk lifestyle behaviours.67 
Results: In the univariate descriptive analysis, the rate for provision of lifestyle 
counselling was significantly lower for GPs who use a computer for clinical 
purposes than for GPs who do not (p=0.03). After adjustment for GP, practice 
and patient characteristics (Model 5B) this difference remained (p=0.03) 
(Table 6.1(a)). 
Conclusion: The relative rate of provision of lifestyle counselling to patients is 
lower for GPs who use a computer for clinical activity compared with non CC 
users. As the difference remained after adjustment for GP, practice and 
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patient characteristics, the difference is associated with clinical computer use 
by the GP, or another variable(s) not measured in this study. The hypothesis 
was therefore rejected and reversed. 
Inappropriate preventive care 
Rates of Prostate Specific Antigen (PSA) screening tests for males aged over 50 years 
Hypothesis: GPs who use a computer for clinical purposes will order fewer 
prostate specific antigen tests for the screening of prostate cancer in 
asymptomatic male patients aged over 50 years.67 
Rationale: PSA testing is not recommended as a preventive activity by the 
RACGP and numerous other authorities.67,160 ‘High quality’ GPs will therefore 
not use prostate specific antigen for the screening of prostate cancer in 
asymptomatic patients.67 
Results: There was no significant difference in the relative rate of orders for 
PSA testing for males aged 50 years and over between the two GP groups 
either before (p=0.19) or following adjustment for GP and practice 
characteristics (Model 5A) (p=0.08) (Table 6.1(a)). 
Conclusion: As there was no difference between the two groups the 
hypothesis was rejected. 
Diabetes 
Hypothesis: Clinical computer users will order more HbA1cŦ tests for patients 
with diabetes and will refer these patients to allied health professionals at a 
higher rate than GPs who do not use a computer for clinical activity.  
Rationale: High quality care of patients with diabetes includes monitoring 
HbA1c levels and appropriate referrals to ophthalmologists, dieticians and 
podiatrists.67 National Guidelines for diabetes management highlight the 
importance of glycaemic control and monitoring neurological and vascular 
complications of diabetes.67,186 
HbA1c orders in the management of diabetes 
Results: In the univariate analysis the CC users ordered HbA1c tests for 
patients with diabetes at a significantly higher rate than non CC users (25.1 
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per 100 diabetes contacts cf. 17.6 per 100) (p=0.001) Following adjustment 
for GP and practice characteristics (Model 5A) however, this difference was 
no longer apparent (p=0.24) (Table 6.1(a)). 
Conclusion: Clinical computer users order HbA1c tests per 100 encounters 
with diabetic patients, at a higher rate than non CC users, but the higher rate 
is explained by characteristics of the GP or practice other than the GP’s status 
as a clinical computer user. The hypothesis was therefore rejected. 
Referral of patients with diabetes to ophthalmologists or allied health 
Results: Clinical computer users referred patients with diabetes to 
ophthalmologists or allied health professionals at a significantly higher rate 
than GPs not using a computer for clinical activity (7.1 per 100 diabetes 
contacts cf. 3.6 per 100) (p<0.001). Following adjustment for GP and practice 
characteristics (Model 5A) this difference remained (p=0.002) (Table 6.1(a)). 
Conclusion: Clinical computer users refer patients with diabetes to 
ophthalmologists or allied health professionals at a significantly higher rate 
per 100 encounters than non CC users, both before and after adjustment. The 
difference is associated with clinical computer use by the GP, or another 
variable(s) not measured in this study, and the hypothesis was therefore 
accepted. 
Cardiovascular 
Prescribing of ACE inhibitors in the management of heart failure, ischaemic heart 
disease, diabetes and cerebrovascular disease 
Hypothesis: Clinical computer users will prescribe ACE inhibitors for the 
management of heart failure, ischaemic heart disease, diabetes and 
cerebrovascular disease at a higher rate than non CC users.67 
Rationale: There is increasing evidence that the use of ACE inhibitors will 
reduce morbidity and mortality in patients with cardiovascular disease and/or 
diabetes.67,187,188 
Results: There was no significant difference in the prescribing rate of ACE 
inhibitors for these morbidities either in the univariate analysis (p=0.07) or 
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following adjustment for GP and practice characteristics (Model 5A) (p=0.86) 
(Table 6.1(a)). 
Conclusion: The hypothesis was rejected. 
Prescribing/advising of aspirin or clopidogrel in the management of heart failure, 
ischaemic heart disease, diabetes and cerebrovascular disease 
Hypothesis: Clinical computer users will prescribe/advise aspirin or 
clopidogrel for the management of heart failure, ischaemic heart disease, 
diabetes and cerebrovascular disease at a higher rate than non CC users.67 
Rationale: There is increasing evidence that aspirin decreases mortality and 
reinfarction when given to patients with unstable angina, and when given as 
long-term secondary preventive therapy in a wide range of patients with 
established cardiovascular disease.67,189,190 
Results: There was no significant difference in the rate of prescribing or 
advising for aspirin or clopidogrel for these morbidities either in the univariate 
analysis (p=0.16) or following adjustment for GP and practice characteristics 
(Model 5A) (p=0.077) (Table 6.1(a)). 
Conclusion: The hypothesis was rejected. 
Prescribing of warfarin for patients with atrial fibrillation 
Hypothesis: Clinical computer users will prescribe warfarin for patients with 
atrial fibrillation at a higher rate than GPs who do not use a computer for 
clinical activity.67 
Rationale: Warfarin reduces the risk of stroke in patients with atrial fibrillation 
and over 60 years of age by two-thirds.67,191 
Results: There was no significant difference between the GP groups in the 
prescribing rate of warfarin for patients with atrial fibrillation aged over 60 
years, either in the univariate analysis (p=0.42) or following adjustment for GP 
and practice characteristics (Model 5A) (p=0.42) (Table 6.1(a)). 
Conclusion: The hypothesis was rejected. 
166 
Musculoskeletal 
Imaging orders for low back pain or strain/sprain (any site) 
Hypothesis: Clinical computer users will order significantly fewer imaging tests 
for patients with low back pain or strains and sprains of the musculoskeletal 
system.67 
Rationale: Research into imaging ordering by GPs in Australia184 
demonstrated that imaging orders for low back pain and sprains/strains were 
in excess of what might be expected if GPs were all complying with US and 
Australian guidelines.192-194 These guidelines are based on evidence that 
imaging has low productivity in these conditions.67,184 
Results: There was no significant difference between the GP groups in the 
rate of imaging orders made for patients with low back pain and 
sprains/strains of the musculoskeletal system either in the univariate analysis 
(p=0.37) or following adjustment for GP and practice characteristics (Model 
5A) (p=0.15) (Table 6.1(a)). 
Conclusion: The hypothesis was rejected. 
Prescribing patterns in the management of arthritis 
Hypothesis 1: Clinical computer users will prescribe fewer non-steroidal anti-
inflammatory agents (NSAIDSŦ) for arthritis in patients aged 65 years and 
over.67 
Hypothesis 2: Clinical computer users will prescribe more simple and 
compound analgesics that are not NSAIDS for arthritis in patients aged 65 
years and over.67 
Rationale: The adverse effects (such as GI bleeding) of long term NSAID use 
is well documented in older patients,195,196 despite the long term pain control 
these medications provide.197 In reducing the prescribing of NSAIDS, clinical 
computer users may prescribe alternative analgesics more often for these 
patients.67 
NSAIDS 
Results: There was no significant difference between the GP groups in the 
rate of prescribing of NSAIDS for patients aged 65 years and older with 
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arthritis either in the univariate analysis (p=0.66) or following adjustment for 
GP and practice characteristics (Model 5A) (p=0.77) (Table 6.1(a)). 
Conclusion: Hypothesis 1 was rejected. 
Simple and compound analgesics other than NSAIDS 
Results: There was no significant difference between the GP groups in the 
rate of prescribing of simple and compound analgesics other than NSAIDS for 
patients aged 65 years and over with arthritis either in the univariate analysis 
(p=0.41) or following adjustment for GP and practice characteristics (Model 
5A) (p=0.38) (Table 6.1(a)). 
Conclusion: Hypothesis 2 was rejected. 
Infections 
Prescribing of antibiotics for upper respiratory tract infection (URTI) 
Hypothesis: Clinical computer users will prescribe antibiotics for URTI less 
frequently than non CC users67 
Rationale: The ineffectiveness of antibiotics in URTI, and the risk of 
antimicrobial resistance promoted by inappropriate prescribing, has been well 
documented in the literature.67,198,199 
Results: There was no significant difference between the GP groups, either 
before or after adjustment for GP and practice characteristics (Model 5A), in 
the prescribing rates of: 
• antibiotics per 100 contacts with URTI (univariate p=0.08; multivariate 
p=0.54) 
• antibiotics per 100 new presentations of URTI (univariate p=0.24; 
multivariate p=0.44) 
• antibiotics per 100 contacts with URTI at encounters with children aged 
less than five years (univariate p=0.42; multivariate p=0.92) (Table 6.1(a)). 
Conclusion: The hypothesis was rejected. 
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Psychological problems 
Depression and insomnia 
Hypothesis 1: Clinical computer users will detect and treat more patients with 
depression than non CC users.67 
Hypothesis 2: Clinical computer users will provide psychological counselling 
more often in their management of patients with depression than non CC 
users.67 
Hypothesis 3: Clinical computer users will prescribe antidepressants less 
frequently in their management of patients with depression than non CC 
users.67 
Hypothesis 4: Clinical computer users will prescribe benzodiazepines less 
frequently for insomnia than non CC users.67 
Rationale: Reviews of management of depression reported in Clinical 
Evidence suggest that both antidepressant medication and psychological 
counselling are effective in mild depression and a combination of the two 
modalities is more effective in moderate to severe depression.67,200  
The use of benzodiazepines in insomnia has caused concern in Australia for 
some years. The RACGP has introduced educational programs for GPs to 
reduce benzodiazepine use in insomnia.67,201 
Detection of new cases of depression 
Results: In the univariate descriptive analysis there was no significant 
difference between the GP groups in the management rate of new cases of 
depression (p=0.39). Following adjustment for GP, practice and patient 
characteristics (Model 5B) however, a difference emerged which was opposite 
to that hypothesised. GPs not using a computer for clinical purposes 
managed new cases of depression at a significantly higher rate than clinical 
computer users (p=0.043) (Table 6.1(a)). 
Conclusion: Non-clinical computer users managed new cases of depression 
at a higher rate than clinical computer uses after adjustment for other 
characteristics of the GP, practice and patient, and this difference is therefore 
assumed to be directly associated with the GPs status as a clinical computer 
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user, or with another variable(s) not measured in this study. Hypothesis 1 was 
therefore rejected and reversed. 
Psychological counselling 
Results: There was no significant difference between the GP groups, either in 
the univariate descriptive analysis (p=0.41) or following adjustment for GP and 
practice characteristics (Model 5A) (p=0.39), in the rates of psychological 
counselling provided to patients with depression (Table 6.1(a)). 
Conclusion: Hypothesis 2 was rejected 
Antidepressants 
Results: In the univariate analysis, there was no significant difference 
between the two GP groups in the rates of prescribing antidepressants to 
patients with depression (p= 0.07). However, following adjustment for GP and 
practice characteristics (Model 5A) CC users prescribed antidepressants for 
depression at a significantly lower rate (p=0.02) (Table 6.1(a)). 
Conclusion: A significant difference was observed between the GP groups, 
with clinical computer users prescribing of antidepressants for patients with 
depression at a lower rate than their counterparts. This difference was 
concluded to be associated with the GPs’ use of a computer for clinical 
activity, or for a GP or practice variable(s) not measured in this study. 
Although the power calculated from this sample size was only 0.6, the p value 
of 0.02 shows that the difference is large enough to be detected even with 
mid-range power. Hypothesis 3 was accepted. 
Benzodiazepines 
Results: There was no significant difference between the GP groups, either in 
the univariate analysis (p=0.53) or in the multivariate analysis after adjustment 
for GP and practice characteristics (Model 5A) (p=0.97) in the prescribing 
rates of benzodiazepines for insomnia (Table 6.1(a)). 
Conclusion: Hypothesis 4 was rejected.  
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6.4.2 Quality indicators for GPs with computerised vs non-computerised 
test ordering 
For the analyses of the 8 quality indicators examined comparing GPs who 
order tests through their computer compared with those who do not, the 
results are reported below and presented in Table 6.1(b). Again, the Model 
used in the multivariate analysis is tabulated beside each indicator, and the 
characteristics of the GP, practice, patient or morbidity included in each of the 
Models are listed in the footnotes.  
Tests and investigations 
Hypothesis:  GPs who use the test ordering function of their clinical software 
will order less pathology, less imaging, and fewer investigations overall than 
GPs who do not use a computer for test ordering.  
Rationale: The use of the test ordering function in clinical software will 
encourage GPs to be more judicious in their use of pathology and imaging, 
therefore reducing their ordering rates for tests and investigations. 
Total Investigations 
Results: In the univariate analysis, GPs who use a computer for test ordering 
ordered investigations at a higher rate than GPs not using a computer for test 
ordering (p<0.001), which was the reverse of the hypothesised result. 
However, after adjustment for GP, practice, patient and morbidity 
characteristics (Model 6C) this difference was no longer observed (p=0.68) 
(Table 6.1(b)). 
Conclusion: Clinical computer users who use the computer to order tests had 
a significantly higher ordering rate but this difference is explained by 
characteristics of the GP, practice, patient or morbidity, other than the GPs 
use of the test ordering function of their clinical software. The hypothesis was 
therefore rejected. 
Pathology orders 
Results: In the univariate analysis GPs who use a computer for test ordering 
ordered pathology tests for management of a problem at a significantly higher 
rate than GPs not using a computer for test ordering (p<0.001), which was the 
reverse of the result hypothesised. However, after adjustment for GP, 
171 
practice, patient and morbidity characteristics (Model 6C) this difference was 
no longer apparent (p=0.41) (Table 6.1(b)). 
Conclusion: GPs who use a computer to order tests ordered pathology tests 
at a higher rate but this difference is explained by characteristics of the GP, 
practice, patient or morbidity, other than the GP’s use of a computer to order 
tests. The hypothesis was therefore rejected.  
Imaging orders  
Results: In the univariate analysis there was no significant difference in the 
rate of imaging tests ordered per 100 encounters between GPs who order 
tests via their computer and those who do not (p=0.64), nor was any 
difference observed in this indicator after adjustment for GP, practice, patient 
and morbidity characteristics (Model 6C) (p=0.34) (Table 6.1(b)).  
Conclusion: There being no differences between the two groups, the 
hypothesis was rejected.  
Other investigations 
Results: In the univariate analysis GPs who use a computer for test ordering 
were more likely to order at least one test labelled as ‘other’ investigations for 
management of a problem (1.1 per 100 encounters) than GPs not using a 
computer for test ordering (1.0 per 100 encounters) (p=0.046), which was the 
reverse of the result hypothesised. However, after adjustment for GP, 
practice, patient and morbidity characteristics (Model 6C) this difference was 
no longer apparent (p=0.69) (Table 6.1(b)). 
Conclusion: GPs who use a computer to order tests are more likely to order 
other investigations (the reverse of the hypothesis) but this difference is 
explained by characteristics of the GP, practice, patient or morbidity, other 
than the GPs use of a computer to order tests. The hypothesis was therefore 
rejected.  
Preventive care 
Hypothesis:  GPs who use the test ordering function of their clinical software 
will provide higher levels of preventive care than GPs who do not use a 
computer for test ordering.  
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Rationale: Prevention of disease is an important public and personal health 
service provided by GPs, and therefore ‘good’ GPs will provide higher levels 
of service.67 
Rates of Pap Smears at encounters with females aged 15–70 years 
Results: In the univariate analysis, the rate of pap smears per 100 encounters 
with women aged 15–70 years was slightly higher for GPs who use a 
computer for test ordering (5.9 per 100) than for GPs who do not order tests 
through their clinical software (4.3 per 100) (p=0.006). However, after 
adjustment for GP and practice characteristics and patient age (Model 6A plus 
patient age, because of the age range most likely to be sexually active) this 
difference was no longer observed (p=0.85) (Table 6.1(b)). 
Conclusion: Pap smear rates per 100 encounters with women aged 15–70 
years were higher for GPs who order tests through a computer than for GPs 
who do not, however the slightly higher rate was explained by variables other 
than the GPs use of a computer to order tests. The hypothesis was therefore 
rejected. 
Inappropriate preventive care 
Rates of Prostate Specific Antigen (PSA) screening tests for males aged over 50 years 
Hypothesis:  GPs who use the test ordering function of their clinical software 
will order fewer prostate specific antigen tests for the screening of prostate 
cancer in asymptomatic male patients aged over 50 years.67 
Rationale: PSA testing is not recommended as a preventive activity by the 
RACGP and numerous other authorities.67,180 ‘High quality’ GPs will therefore 
not use prostate specific antigen for the screening of prostate cancer in 
asymptomatic patients.67 
Results: There was no significant difference in the rate of orders for PSA 
testing for males aged 50 years and over between the two GP groups either 
before (p=0.34) or following adjustment for GP and practice characteristics 
(Model 6A) (p=0.27) (Table 6.1(b)). 
Conclusion: As there was no difference between the two groups the 
hypothesis was rejected. 
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Diabetes 
Hypothesis:  GPs who order tests through their computer will order more 
HbA1c tests for patients with diabetes than GPs who do not order tests 
through their computer. 
Rationale:  High quality care of patients with diabetes includes monitoring 
HbA1c levels. National Guidelines for diabetes management highlight the 
importance of glycaemic control.67,186 
HbA1c orders in the management of diabetes 
Results: In the univariate analysis GPs who ordered tests through their 
computers ordered HbA1c tests for patients being managed for diabetes at a 
significantly higher rate than their non-computerised counterparts (26.3 per 
100 diabetes contacts cf. 18.6 per 100) (p<0.001). Following adjustment for 
GP and practice characteristics (Model 6A), this difference remained 
(p=0.015).  
Conclusion: GPs who order tests through their computer ordered HbA1c tests 
per 100 contacts with patients with diabetes, at a higher rate than GPs who 
did not order tests through their computer, and this difference can therefore 
be attributed to the GPs use of clinical software for test ordering or for a GP or 
practice variable(s) not measured in this study (Table 6.1(b)). The hypothesis 
was accepted 
Musculoskeletal 
Imaging orders for low back pain or strain/sprain (any site) 
Hypothesis:  GPs who order tests through their computer will order 
significantly fewer imaging tests for patients with low back pain or strains and 
sprains of the musculoskeletal system.67 
Rationale:  Research into imaging ordering by GPs in Australia demonstrated 
that imaging orders for low back pain and sprains/strains were excessive 
compared with that expected if GPs were working in compliance with US and 
Australian guidelines. The guidelines are based on evidence that imaging had 
low productivity in these conditions.67,184 
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Results: There was no significant difference between the GP groups in the 
rate of imaging orders made for patients with low back pain and 
sprains/strains of the musculoskeletal system either in the univariate analysis 
(p=0.64) or following adjustment for GP and practice characteristics (Model 
6A) (p=0.34) (Table 6.1(b)). 
Conclusion: The hypothesis was rejected. 
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Table 6.1(a): Univariate and multivariate analysis of quality indicators (using linear regression) (ordinal and continuous variables) 
 
GPs using a computer for 
clinical purposes  
GPs not using a computer 
for clinical purposes Unadjusted Adjusted (a) 
Quality indicator Denominator (n) Mean  Denominator (n) Mean 
Regression 
coefficient p value  Model used 
Regression 
coefficient p value 
Consultation length (in minutes) 34,633 15.0  6,084 15.0 0.05 0.90  C -0.38 0.40 
 Denominator (n)
Rate per 
100 of (n)  Denominator (n) 
Rate per 
100 of (n)
Regression 
coefficient p value  
Model used 
(b)
Regression 
coefficient p value 
Long consultations per 100 encounters 99,153 12.2  17,478 10.7 1.50 0.14  C -0.41 0.70 
Prolonged consultations per 100 encounters 99,153 1.0  17,478 1.1 1.37 0.24  C -0.37 0.76 
Reasons for encounter per 100 encounters 106,900 150.7  18,800 150.1 0.54 0.81  B 0.59 0.82 
Problems managed per 100 encounters 106,900 150.5  18,800 144.1 6.42 0.003  B 3.44 0.12 
Clinical treatments per 100 encounters 106,900 39.7  18,800 40.1 -0.40 0.88  C -2.72 0.32 
Procedural treatments per 100 encounters 106,900 17.6  18,800 18.4 -0.82 0.57  C -1.26 0.31 
Prescribed medications per 100 encounters 106,900 81.9  18,800 89.8 -7.96 0.01  C -6.54 0.02 
Allied health referrals per 100 encounters 106,900 3.0  18,800 2.7 0.28 0.29  C -0.55 0.03 
Hospital referrals per 100 encounters 106,900 0.6  18,800 0.7 -0.17 0.23  C -0.14 0.47 
Specialist referrals per 100 encounters 106,900 8.3  18,800 7.5 0.83 0.06  C -0.01 0.98 
Total investigations per 100 encounters 106,900 51.3  18,800 41.7 9.6 <0.001  C -0.60 0.82 
Pathology test orders per 100 encounters 106,900 41.6  18,800 32.6 8.96 <0.001  C -0.11 0.96 
(continued) 
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Table 6.1(a) (continued): Univariate and multivariate analysis of quality indicators (using linear regression) (ordinal and continuous variables) 
 
GPs using computer for 
clinical purpose  
GPs not using computer for 
clinical purpose  Unadjusted Adjusted (a) 
Quality indicator Denominator (n)
Rate per 
100 of (n) Denominator (n) 
Rate per 
100 of (n)
Regression 
coefficient p value Model used
Regression 
coefficient p value 
Imaging test orders per 100 encounters 106,900 8.6  18,800 8.2 0.44 0.38  C -0.53 0.35 
Other investigations per 100 encounters 106,900 1.1  18,800 0.9 0.22 0.05  C 0.04 0.78 
Pap smear per 100 encounters with females 
aged 15-70 yrs 43,090 5.7  7,095 4.1 1.58 0.045  
A + patient 
age -0.16 0.82 
All immunisation per 100 encounters with 
patients < 5 years old  6,740 20.5  868 15.2 5.24 0.036  A 3.50 0.34 
Lifestyle counselling per 100 encounters 106,900 7.2  18,800 8.9 -1.70 0.03  B -1.72 0.03 
PSA tests per 100 screening contacts with 
males > 50 years old 1,674 9.8  214 13.1 -3.29 0.19  A -4.85 0.08 
HbA1c per 100 contacts with diabetes 3,432 25.1  688 17.6 7.53 0.001  A 3.10 0.24 
Referrals to ophthalmologist or allied health per 
100 contacts with diabetes 3,432 7.1  688 3.6 3.50 <0.001  A 2.94 0.002 
ACE inhibitors per 100 contacts with LVF, IHD, 
diabetes or cerebrovascular disease 5,838 5.9  1,075 4.5 1.48 0.07  A 0.16 0.86 
Aspirin or clopidogrel per 100 contacts with LVF, 
IHD, diabetes or cerebrovascular disease 5,838 8.7  1,075 9.6 -0.90 0.46  A -1.93 0.14 
Warfarin per 100 contacts with atrial fibrillation 906 35.4  145 40.0 -4.57 0.42  A -5.23 0.42 
(continued) 
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Table 6.1(a) (continued): Univariate and multivariate analysis of quality indicators (using linear regression) 
 
GPs using computer for 
clinical purpose  
GPs not using computer for 
clinical purpose  Unadjusted Adjusted (a) 
Quality indicator Denominator (n)
Rate per 
100 of (n) Denominator (n) 
Rate per 
100 of (n)
Regression 
coefficient p value Model used
Regression 
coefficient p value 
Imaging per 100 contacts with lower back pain or 
strain/sprain 5,036 14.8  917 16.3 -1.48 0.37  A -2.73 0.15 
NSAIDs per 100 contacts with arthritis (all types) 
and >65  2,347 38.0 394 39.6 -1.59 0.66  A -1.18 0.77 
Analgesics (non NSAID) per 100 contacts with 
arthritis and >65 2,347 27.2 394 29.7 -2.51 0.41  A -3.51 0.38 
Antibiotics prescriptions per 100 contacts with 
URTI 5,072 34.7 912 41.2 -6.49 0.08  A 2.66 0.54 
Antibiotics prescriptions per 100 contacts with 
new URTI 3,841 36.9 714 41.7 -4.82 0.24  A 3.65 0.44 
Antibiotics prescriptions per 100 contacts with 
URTI in children aged <5 1,122 20.4 154 24.7 -4.27 0.42  A 0.60 0.92 
New diagnosis of depression per 100 encounters 106,900 0.7 18,800 0.8 -0.07 0.39  B -0.21 0.043 
Counselling per 100 contacts with depression 4,342 13.5 716 12.0 1.53 0.41  A 1.87 0.39 
Antidepressants per 100 contacts with 
depression 4,342 61.3 716 66.6 -5.31 0.07  A -7.57 0.02 
Benzodiazepine per 100 contacts with insomnia 1,719 57.6 284 60.6 -2.97 0.53  A -0.16 0.97 
(a) Adjusted using one of the following models:  
Model A - controlling for GP age; GP sex; FRACGP status; work in deputising service in preceding 4 weeks; bulk-billing for all patients; practice accreditation status; presence of a practice nurse at the major practice address.      
Model B - controlling for patient age; patient sex; Commonwealth Health Care Benefits Cardholder status; Veterans’ Affairs card holder status; NESB status; Aboriginal or Torres Strait Islander status; ‘new patient’ status; GP and 
practice characteristics included in Model A.  
Model C - controlling for the presence or absence of problems managed by ICPC-2 Chapter at the encounter; the GP, practice and patient characteristics included in Model B. 
Note: Shading = statistically significant difference; PSA = Prostate Specific Antigen; LVF = left ventricular failure; IHD = Ischaemic heart disease; HbA1c = Haemoglobin, type A1c; ACE = angiotensin converting enzyme; URTI = 
upper respiratory tract infection; NSAID = non-steroidal anti-inflammatory drug. 
 
 
178 
Table 6.1(b): Univariate and multivariate analysis of quality indicators (using linear regression) (ordinal and continuous variables) 
 
GPs using a computer for 
test ordering  
GPs not a using computer 
for test ordering  Unadjusted (a) Adjusted (b) 
Quality indicator Denominator (n)
Rate per 
100 of (n) Denominator (n) 
Rate per 
100 of (n)
Regression 
coefficient (a) p value Model used (b)
Regression 
coefficient (b) p value 
Pathology test orders per 100 encounters 90,100 42.6  35,600 34.3 8.25 <0.001  C 1.28 0.41 
Imaging test orders per 100 encounters 90,100 8.6  35,600 8.4 0.19 0.62  C -0.59 0.15 
Other investigations per 100 encounters 90,100 1.1  35,600 1.0 0.18 0.046  C 0.04 0.69 
Total investigations per 100 encounters 90,100 52.3  35,600 43.7 8.62 <0.001  C 0.73 0.68 
Pap smear per 100 encounters with females 
aged 15-70 yrs 36,751 5.9  13,434 4.3 1.57 0.006  A + patient age -0.09 0.85 
PSA tests per 100 screening contacts with males 
> 50 years old 1,408 9.7  480 11.5 -1.73 0.34  A -2.22 0.27 
HbA1c per 100 contacts with diabetes 2,838 26.3  1,282 18.6 7.69 <0.001  A 4.72 0.015 
Imaging per 100 contacts with lower back pain or 
strain/sprain 4,182 14.8  1,771 15.4 -0.59 0.64  A -1.32 0.34 
(a):  Missing data removed.  
(b):  Adjusted using one of the following models:  
Model A - controlling for GP age; GP sex; FRACGP status; work in deputising service in preceding 4 weeks; bulk-billing for all patients; practice accreditation status; presence of a practice nurse at the major practice address.         
Model B - controlling for patient age; patient sex; Commonwealth Health Care Benefits Cardholder status; Veterans’ Affairs card holder status; NESB status; Aboriginal or Torres Strait Islander status; ‘new patient’ status; GP and 
practice characteristics included in Model A.  
Model C - controlling for the presence or absence of problems managed by ICPC-2 Chapter at the encounter; the GP, practice and patient characteristics included in Model B. 
Note: Shading = statistically significant difference. 
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6.4.3 Overview of results for quality indicators 
Table 6.2(a) provides an overview of all the quality indicators examined either 
in earlier sections or in the current chapter. It shows the indicators that did not 
discriminate at either univariate descriptive or multivariate levels of analysis, 
or both (marked with a single X). For other indicators, the use of a tick (9) 
shows where differentiation occurred between clinical computer users and 
GPs who did not use a computer in their clinical activity, by showing that the 
indicator discriminated and the hypothesis was accepted in either the 
unadjusted results, after statistical adjustments were made, or both. For some 
indicators, the hypothesis was accepted at the univariate level (as indicated 
with a tick (9), but ultimately rejected following adjustment (marked with a 
single X). Where the hypothesis was rejected, and the outcome was a 
reversal of the hypothesis, the result is marked with XX. 
From the 36 quality indicators tested, a significant difference was detected 
between the two groups for only seven indicators. These are reported below. 
Consultation patterns 
Of the quality indicators associated with consultation patterns, the only 
difference to emerge was in the number of problems managed at the 
encounter. GPs who use a computer for clinical activity managed more 
problems per encounter than non CC users. However, the higher number of 
problems managed per encounter was explained by characteristics other than 
their use of a computer. 
Pharmacological management 
In pharmacological management, the quality indicator demonstrated that (as 
hypothesised) CC users overall prescribed significantly fewer medications 
than non CC users. 
Referrals 
The quality indicators measuring referrals showed no differences between the 
two groups in rates of referral to hospitals or to specialists at any level of 
analysis. However, the rate of referral to allied health professionals was 
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significantly lower for CC users after adjustment, although the difference was 
small and not apparent in the descriptive analysis.  
Appropriate preventive care 
In the domain of appropriate preventive care, CC users performed ‘better’ 
than their counterparts for both the rate of pap smears for women of 15–70 
years, and in the rate of immunisations with patients aged less than 5 years. 
However, in both cases, the differences were explained by characteristics 
other than computer use for clinical activity. 
Management of diabetes 
In the management of diabetes, CC users ordered significantly more HbA1c 
tests for patients with diabetes, but the difference was associated with 
characteristics other than their use of a computer. As hypothesised, clinical 
computer users referred patients with diabetes to ophthalmologists and other 
allied health professional at a higher rate than non CC users, and this was 
due to clinical computer use (or other variables not measured in this study). 
Management of psychological problems 
In the management of psychological problems, non CC users prescribed 
antidepressants to patients with depression at a lower rate than CC users, but 
the difference was small and not discernable in the descriptive analysis. The 
detection rate of ‘new’ cases of depression did not differ between the groups 
in the univariate comparison, but following adjustment for GP, practice and 
patient characteristics, it emerged that CC users recorded fewer new cases of 
depression than non CC users. The hypothesis that CC users would detect 
new cases of depression at a higher rate was rejected and reversed. There 
were no other differences between the two GP groups for the other quality 
indicators measured in this domain. 
Quality indicators for GPs with computerised vs non-computerised test 
ordering  
Table 6.2(b) provides a similar overview for those indicators compared 
between the GPs who specifically used the test ordering function of their 
computer, to determine whether the use of this specific function elicits a 
different result to the use of a computer itself as a clinical tool. 
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The results of the eight additional analyses to investigate any differences 
specifically associated with test ordering through the computer (as opposed to 
using the computer as a clinical tool in practice activity) produced only one 
significant difference that remained after adjustment for other variables in the 
modelling process. 
At the univariate level, GPs who ordered tests through their computer had 
significantly higher ordering rates for pathology tests, total tests, other 
investigations, and pap smears for females aged 15–20 years. After 
adjustment for other GP, practice, patient and morbidity characteristics these 
differences were no longer observable, and must therefore be associated with 
factors other than the GP’s use of the computer for test ordering. There were 
no differences at either level of analysis in the ordering rate for imaging tests, 
PSA tests per 100 contacts with males aged 50 years or older, or for imaging 
for patients with lower back pain or strain/sprain. 
Management of diabetes 
In the management of diabetes, GPs who ordered tests through their 
computer ordered significantly more HbA1c tests for patients with diabetes, 
and this difference remained after adjustment for other GP and practice 
characteristics. There is a real association between use of clinical software for 
ordering these tests and an increase in the rate of tests ordered. 
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Table 6.2(a): Summary of results for all quality indicators 
Domain Quality indicator 
Descriptive 
analysis 
After 
adjustment 
Consultation patterns Proportion of long consultations  
(hypothesis = computerised GPs more) X X 
 
Proportion of prolonged consultations 
(hypothesis = computerised GPs more) X X 
 
Length of consultation (minutes and seconds)
hypothesis = computerised GPs longer) X X 
 
Number of patient reasons for encounter 
(hypothesis = computerised GPs more) X X 
 
Number of problems managed at encounter 
(hypothesis = computerised GPs more) 9 X 
Non-pharmacological 
management 
Clinical treatment rate 
(hypothesis = computerised GPs more) X X 
 
Procedural treatment rate 
(hypothesis = computerised GPs more) X X 
Pharmacological 
management 
Overall prescribing rate 
(hypothesis = computerised GPs lower) 9 9 
Referrals Referrals to allied health professionals 
(hypothesis = computerised GPs more) X X X 
 
Referrals to hospitals 
(hypothesis = computerised GPs less) X X 
 
Referrals to specialists 
(hypothesis = computerised GPs less) X X 
Tests and investigations Investigations (total) 
(hypothesis = computerised GPs less) X X X 
 
Pathology test order rate 
(hypothesis = computerised GPs less) X X X 
 
Imaging test order rate 
(hypothesis = computerised GPs less) X X 
 
Other investigation order rate 
(hypothesis = computerised GPs less) X X 
Social disadvantage 
services 
Encounters with Aboriginal or Torres Strait 
Islander people 
(hypothesis = computerised GPs more) X X 
 
Encounters with patients holding a 
Commonwealth Health Care Benefits card 
(hypothesis = computerised GPs more) X X X X 
Appropriate preventive 
care 
Pap smears per 100 encounters with females 
ages 15-75 years 
(hypothesis = computerised GPs more) 9 X 
 
All immunisations per 100 encounters with 
patients aged <5 years 
(hypothesis = computerised GPs more) 9 X 
 
Lifestyle counselling per 100 encounters 
(hypothesis = computerised GPs more) X X X X 
(continued) 
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Table 6.2(a) (continued): Summary of results for all quality indicators 
Domain Quality indicator 
Descriptive 
analysis 
After 
adjustment 
Inappropriate preventive 
care 
PSA tests/100 screening encounters with males 
aged 50+ years 
(hypothesis = computerised GPs less) X X 
Diabetes management HbA1cs ordered per 100 contacts with patients with 
diabetes  
(hypothesis = computerised GPs more) 9 X 
 
Referrals to ophthalmologists per 100 contacts with 
patients with diabetes 
(hypothesis = computerised GPs more) 9 9 
Cardiovascular disease 
management 
ACE inhibitors per 100 encounters with patients with 
heart failure, ischaemic heart disease, diabetes or 
cerebrovascular disease 
(hypothesis = computerised GPs more) X X 
 
Aspirin or clopidogrel per 100 encounters with 
patients with heart failure, ischaemic heart disease, 
diabetes or cerebrovascular disease 
(hypothesis = computerised GPs more) X X 
 
Warfarin per 100 contacts with patients with atrial 
fibrillation 
(hypothesis = computerised GPs more) X X 
Musculoskeletal disease 
management 
Imaging orders per 100 patients with low back pain 
or strain/sprain (any site) 
(hypothesis = computerised GPs less) X X 
 
Prescribing of non-steroidal anti-inflammatory 
agents in the management of arthritis for patients 
65+ years 
(hypothesis = computerised GPs less) X X 
 
Prescribing of simple analgesics for the 
management of arthritis for patients 65+ years 
(hypothesis = computerised GPs more) X X 
Infection management Antibiotics for upper respiratory tract infection (total) 
(hypothesis = computerised GPs less) X X 
 
Antibiotics for new presentations of upper 
respiratory tract infection 
(hypothesis = computerised GPs less) X X 
 
Antibiotics for upper respiratory tract infection in 
patients <5 years 
(hypothesis = computerised GPs less) X X 
Psychological problem 
management 
Detection of depressed patients 
(hypothesis = computerised GPs more frequent 
management) X X X 
 
Rates of counselling in management of depression 
hypothesis = computerised GPs more) X X 
 
Prescription rate of anti-depressants for depression 
hypothesis = computerised GPs less) X 9 
 
Prescription of benzodiazepines for insomnia 
(hypothesis = computerised GPs less) X X 
Note:  9 – Hypothesis accepted; X – Hypothesis rejected, there being no significant differences between the groups; XX – Hypothesis 
rejected, result reversed from that hypothesised. 
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Table 6.2(b): Summary of results for all quality indicators – computerised test ordering 
vs non-computerised test ordering 
Domain Quality indicator 
Descriptive 
analysis 
After 
adjustment 
Tests and investigations Pathology test order rate 
(hypothesis = computerised GPs less) X X X 
 
Imaging test order rate 
(hypothesis = computerised GPs less) X X 
 
Other investigations order rate 
(hypothesis = computerised GPs less) X X X 
 
Investigations (total) order rate 
(hypothesis = computerised GPs less) X X X 
Appropriate preventive 
care 
Pap smears per 100 encounters with females 
ages 15-75 years 
(hypothesis = computerised GPs more) 9 X 
Inappropriate preventive 
care 
PSA tests/100 screening encounters with 
males aged 50+ years 
(hypothesis = computerised GPs less) X X 
Diabetes management HbA1cs ordered per 100 contacts with 
patients with diabetes 
(hypothesis = computerised GPs more) 9 9 
Musculoskeletal disease 
management 
Imaging orders per 100 patients with low back 
pain or strain/sprain (any site) 
(hypothesis = computerised GPs less) X X 
Note:  9 – Hypothesis accepted; X – Hypothesis rejected, there being no significant differences between the groups; XX – Hypothesis 
rejected, result reversed from that hypothesised. 
 
6.4.4 Summary of results for quality indicators 
The results are presented more concisely in Table 6.3, with the indicators 
being grouped according to whether the hypotheses were proven or not. 
Table 6.3(a): Indicators in which CC users differ from non CC users in reality 
and for which their use of a computer for clinical activity remains the only 
explanation (from measured factors) for the difference in behaviour between 
the groups. 
Table 6.3(b): Indicators in which CC users perform ‘better’ than non CC users, 
but the difference is explained by other measured factors rather than their use 
of a computer for clinical activity. 
Table 6.3(c): Indicators which showed no significant difference between the 
two GP groups in either the descriptive analysis or following adjustment for 
other factors. 
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Table 6.3(d): Indicators in which CC users demonstrated in either the 
univariate and/or multivariate analyses the reverse behaviour to that 
hypothesised.  
Table 6.3(a): Indicators for which clinical computer use remains the only explanation 
(from measured factors) for differences 
Quality indicator Descriptive analysis After adjustment 
Overall prescribing rate 
(hypothesis = computerised GPs lower) 9 9 
Referrals to ophthalmologists per 100 contacts with 
patients with diabetes 
(hypothesis = computerised GPs more) 9 9 
Prescription rate of anti-depressants for depression 
(hypothesis = computerised GPs less) X 9 
Computer vs non-computer - test ordering   
HbA1cs ordered per 100 contacts with patients with 
diabetes 
(hypothesis = computerised GPs more) 9 9 
Note:  9 – Hypothesis accepted; X – Hypothesis rejected, there being no significant differences between the groups. 
 
Table 6.3(b): Indicators for which clinical computer users perform ‘better’ but the 
difference is due to other measured factors rather than their status as clinical 
computer users 
Quality indicator Descriptive analysis After adjustment 
Number of problems managed at encounter 
(hypothesis = computerised GPs more) 9 X 
Pap smears per 100 encounters with females ages 
15-75 years 
(hypothesis = computerised GPs more) 9 X 
All immunisations per 100 encounters with patients 
aged <5 years 
(hypothesis = computerised GPs more) 9 X 
HbA1cs ordered per 100 contacts with patients with 
diabetes 
(hypothesis = computerised GPs more) 9 X 
Computer vs non-computer - test ordering   
Pap smears per 100 encounters with females ages 
15-75 years 
(hypothesis = computerised GPs more) 9 X 
Note:  9 – Hypothesis accepted; X – Hypothesis rejected, there being no significant differences between the groups. 
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Table 6.3(c): Indicators which showed no significant difference between clinical 
computer users and non-clinical computer users both in descriptive analyses and after 
adjustment for other factors 
Quality indicator Descriptive analysis After adjustment 
Proportion of long consultations  
(hypothesis = computerised GPs more) X X 
Proportion of long + prolonged consultations  
(hypothesis = computerised GPs more) X X 
Length of consultation (minutes and seconds) 
(hypothesis = computerised GPs longer) X X 
Number of patient reasons for encounter  
(hypothesis = computerised GPs more) X X 
Clinical treatment rate  
(hypothesis = computerised GPs more) X X 
Procedural treatment rate  
(hypothesis = computerised GPs more) X X 
Referrals to hospitals  
(hypothesis = computerised GPs less) X X 
Referrals to specialists  
(hypothesis = computerised GPs less) X X 
Imaging test order rate  
(hypothesis = computerised GPs less) X X 
Other investigations order rate  
(hypothesis = computerised GPs less) X X 
Encounters with Aboriginal or Torres Strait Islander 
people  
(hypothesis = computerised GPs more) X X 
PSA tests/100 screening encounters with males aged 
50+ years  
(hypothesis = computerised GPs less) X X 
ACE inhibitors per 100 encounters with patients with 
heart failure, ischaemic heart disease, diabetes or 
cerebrovascular disease  
(hypothesis = computerised GPs more) X X 
Aspirin or clopidogrel per 100 encounters with patients 
with heart failure, ischaemic heart disease, diabetes or 
cerebrovascular disease  
(hypothesis = computerised GPs more) X X 
Warfarin per 100 contacts with patients with atrial 
fibrillation 
(hypothesis = computerised GPs more) X X 
Imaging orders per 100 patients with low back pain or 
strain/sprain (any site)  
(hypothesis = computerised GPs less) X X 
Prescribing of non-steroidal anti-inflammatory agents in 
the management of arthritis for patients 65+ years 
(hypothesis = computerised GPs less) X X 
Prescribing of simple analgesics for the management of 
arthritis for patients 65+ years  
(hypothesis = computerised GPs less) X X 
Antibiotics for upper respiratory tract infection (total) 
(hypothesis = computerised GPs less) X X 
(continued) 
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Table 6.3(c)(continued): Indicators which showed no significant difference between 
clinical computer users and non-clinical computer users both in descriptive analyses 
and after adjustment for other factors 
Quality indicator Descriptive analysis After adjustment 
Antibiotics for new presentations of upper respiratory 
tract infection  
(hypothesis = computerised GPs less) 
X X 
Antibiotics for upper respiratory tract infection in patients 
<5 years 
(hypothesis = computerised GPs less) X X 
Rates of counselling in management of depression 
(hypothesis = computerised GPs more) X X 
Prescription of benzodiazepines for insomnia 
(hypothesis = computerised GPs less) X X 
Computer vs non-computer - test ordering   
Pathology test order rate  
(hypothesis = computerised GPs less) X X 
Other investigations order rate 
(hypothesis = computerised GPs less) X X 
Investigations (total) order rate  
(hypothesis = computerised GPs less) X X 
Note:  X – Hypothesis rejected, there being no significant differences between the groups. 
 
 
Table 6.3(d): Indicators for which clinical computer users demonstrated the reverse 
behaviour to that hypothesised in the univariate and/or multivariate analyses 
Quality indicator Descriptive analysis After adjustment 
Referrals to allied health professionals 
(hypothesis = computerised GPs more) X X X 
Investigations (total) 
(hypothesis = computerised GPs less) X X X 
Pathology test order rate  
(hypothesis = computerised GPs less) X X X 
Encounters with patients holding a Commonwealth 
Health Care Benefits card  
(hypothesis = computerised GPs more) X X X X 
Detection of depressed patients  
(hypothesis = computerised GPs more frequent 
management) X  X X 
Lifestyle counselling per 100 encounters 
(hypothesis = computerised GPs more) X X X X 
Computer vs non-computer - test ordering   
Pathology test order rate  
(hypothesis = computerised GPs less) X X X 
Other investigations order rate 
(hypothesis = computerised GPs less) X X X 
Investigations (total) order rate 
(hypothesis = computerised GPs less) X X X 
Note:  X – Hypothesis rejected, there being no significant differences between the groups;  XX – Hypothesis rejected, result reversed 
from that hypothesized.
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6.5 Discussion 
These results show that the use of a computer as a clinical tool has not 
brought about many measurable changes in the quality of care GPs provide to 
their patients. Clinical computer users performed ‘better’ on only three of 36 
quality indicators, where the use of a computer remained the only explanation 
for the differences after adjusting for other variables. Two of these were 
prescribing indicators, one for overall prescribing rates, and the other for the 
prescribing rate of anti-depressant medications for patients with depression. 
The third indicator was for referrals to ophthalmologists for patients with 
diabetes. 
On four indicators, the clinical computer users performed ‘worse’ – they 
provided fewer referrals to allied health professionals; saw fewer patients who 
were holders of a health care card; managed fewer new cases of depression 
at the encounter; and provided lifestyle counselling less often. In these 
instances, the use of a computer remained the only explanation for the 
reversal of the hypothesis that they would perform ‘better’ than their non-
clinically computerised counterparts. 
Of the eight quality indicators investigated in regard to the specific use of the 
test ordering computer function, there was no difference between the two 
groups for seven, and GPs ordering tests through their software performed 
‘better’ on only one. While using a computer as a tool for some clinical 
practice activities did not result in behavioural differences for GPs in terms of 
their ordering of HbA1c tests for diabetic patients, specifically using the 
computer for test ordering did affect their practice behaviour in this area. After 
adjustment for other influences, clinicians who used their computers for this 
function ordered significantly more HbA1c tests for diabetic patients than 
those who did not, directly relating this result to their use of the test ordering 
software component. Perhaps there is a familiarity with the function of 
ordering tests through the computer that makes this method more time 
efficient and therefore one more readily undertaken by GPs who use this 
function, but if so, there would be a similar result apparent for other tests 
ordered using this method. Similarly, all GPs using a computer for clinical 
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activity would presumably be exposed to the alerts which appear in the clinical 
software to remind GPs of HbA1c testing for diabetic patients – this is not a 
support tool that would only be shown to GPs who order tests through their 
software, and so is unlikely to be associated with the difference in test 
ordering behaviour for these tests.  
In some cases I have reported no difference between the GP groups for some 
of the variables measured but acknowledge that where differences are very 
small, there may have been too few cases to make a reliable acceptance of a 
null hypothesis. For example, the rate of other investigations (Chapter 5, 
Table 5.6 and Chapter 6, Table 6.1(a)) compared 1,201 cases in the clinical 
computer user group to 169 cases in the group of GPs not using a computer 
for clinical purposes. These occurred in each group at a comparatively low 
rate, of only 11 in every 1,000, and 9 in every 1,000 patient encounters. 
A limitation that became obvious when planning the analyses for this chapter 
was that I had not been specific enough in questioning the GPs about their 
test ordering behaviour. It was not possible to differentiate between those who 
ordered all tests, those who mostly ordered pathology but not imaging, or 
whether only selected tests for each were made via a computer. It may be 
that some of these GPs were ordering only pathology tests, and so a 
comparison of their imaging ordering behaviour has limited validity. Similar 
limitations may apply to referring behaviour – that some GPs use their clinical 
software for prescribing, medical records or test ordering, did not allow me to 
differentiate between those who refer with letters produced using their 
software functions and those who prefer the old fashioned pen-and-paper 
approach. However, this would not explain why clinical computer users 
provided more referrals to ophthalmologists for their diabetic patients but 
fewer overall referrals to allied health professionals for their patients generally. 
Added to the result for their increased test ordering of HbA1c’s, it is tempting 
to infer that the clinical use of a computer results in a GP providing better care 
for diabetic patients. Electronic reminders are effective in modifying physician 
behaviour202 and it might follow that GPs who are exposed to electronic 
reminders for diabetic patients in their software respond and therefore act 
differently, however GPs who do not use the test ordering function of their 
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software would still be exposed to these reminders, so electronic flags alone 
are unlikely to cause the difference in this test ordering behaviour. 
Length of consultation has been widely discussed in the literature as it affects 
quality, and it might be natural to assume that proficient keyboard use 
compared with long-hand writing may result is shorter consultations. However, 
the use of a computer has been shown to result in longer rather than shorter 
primary care consultations.91,203 My study has shown no difference in the 
mean consultation length between the two groups. This finding supports the 
work of Britt et al (2005), who found many factors associated with the length 
of a consultation, but computer use was not one of them.78 This may mean 
that GPs who use a computer are spending less time interacting face-to-face 
with their patients. 
As previously mentioned, quality is difficult to measure, and the incorrect 
application of inappropriate quality indicators will not produce a valid or 
reliable result. Campbell et al state that wherever possible, indicators should 
be based solely on scientific evidence, but that some areas of health care 
have a limited or methodologically weak evidence base, including primary 
care. In such cases, quality indicators should be developed using other 
evidence in conjunction with expert opinion.130 The RACGP is responsible for 
setting and maintaining standards in Australian general practice, as well as for 
quality assurance and continual professional development (described in 
Chapter 3). The set of indicators used in this study was designed originally in 
consultation with the RACGP National Manager, Quality Care and Research 
and the RACGP National Standing Committee: Research, and drawing from 
Australian and international guidelines for preventive activities, as described 
earlier in this Chapter.67 The quality indicators were validated in the previous 
work done for the RACGP67,135 and are suitable for use with the data source 
used in this study, from a sample of practitioners shown to be representative 
of the practising GP population in Australia. 
A similar cross-sectional analysis was performed by Linder et al in the US, on 
data from the 2003 and 2004 Ambulatory Medical Care Survey, examining the 
association of EHR use with 17 ambulatory care quality indicators, with similar 
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results.204 For 14 of the 17 indicators, there was no difference in performance 
between visits with and without the use of an EHR. On two indicators, the 
clinicians using EHRs performed ‘better’ and on one indicator they performed 
‘worse’. The US study is supporting evidence for the findings of this Chapter, 
that the use of a computer in clinical practice has not affected the quality of 
care insofar as it can be measured via this method. 
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CHAPTER 7 
 
EMBEDDED ADVERTISING IN CLINICAL 
SOFTWARE 
7.1 Background 
Medications in Australia are strictly controlled. Each drug is subjected to a 
series of checks and evaluations prior to its approval for release on the 
market, and further restrictions apply once marketing has been approved.205 A 
series of schedules have been devised called the Standard for the Uniform 
Scheduling of Drugs and Poisons,206 and each medication is accessible only 
under the restrictions determined by its schedule e.g, Schedule 2 medications 
are available from pharmacies and other retailers licensed to sell Schedule 2 
poisons; Schedule 3 medications can only be purchased from a pharmacy 
with pharmacist’s advice and are stored in restricted areas of the pharmacy; 
and Schedule 4 medications and above are only available via prescription, 
with yet tighter restrictions requiring other government approvals for those in 
Schedule 5 and above. Since the introduction of the PBSŦ the Federal 
Government is the major purchaser of pharmaceutical products in Australia 
with individual patients providing co-payments. Australian Federal 
Government expenditure on non-hospital prescriptions for the fiscal year 
ending June 30, 2005, was US $3,848 million.207 Over 85% of prescriptions, 
either privately purchased or subsidised by the PBSŦ, are provided by general 
practitioners.208 
The prescribing behaviour of GPsŦ is considered an indicator of quality in 
regard to patient care. Prescribing behaviour is also of interest for public 
health and social welfare reasons–one of the contributing factors to the widely 
reported increasing anti-microbial resistance to currently available antibiotics 
is believed to be inappropriate prescribing over several decades.209,210 The 
prescribing of a new, expensive medication where a cheaper, equally 
efficacious alternative exists is a long term threat to the sustainability of the 
PBS in Australia, or the access to medication itself in countries where patients 
pay full price from their own pockets. Thus, as stated by Greco & Eisenberg, 
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‘the ability to change physicians’ practices could improve the quality of health 
care while controlling expenditures’.211 
The process of prescribing a medication for a patient involves two main 
decisions for the GP – firstly, whether or not to prescribe a medication at all 
for the problem under management, and secondly, once the decision to 
prescribe has been made, to select a medication from the pharmacopoeia 
available. A number of factors have been shown to influence the prescribing 
behaviour of general practitioners at both levels of this decision making 
process. Interested stakeholders are keen to know what ‘works best’ in order 
to either use that method of promotion, or to curtail it where possible, 
depending on their perspective.  
General practice educational bodies advocating best practice, groups 
promoting Quality Use of Medicines (QUM) and government departments 
interested in judicious prescribing both for QUM and for reasons of economy, 
are motivated to align prescribing behaviour with clinical practice guidelines, 
ideally based on current clinical evidence. Multiple authors have discussed 
the various effectiveness of educational interventions such as guidelines & 
reminders,211-214 academic detailingŦ,211,214 feedback to prescribers,211-213 
active participation by physicians to effect change,211,213,214 and other 
educational interventions, although several authors agree that a combination 
of more than one method tends to be more effective.211-213 Evidence in the 
scientific literature is also influential in affecting behavioural change of family 
physicians, both in clinical decisions about diagnoses, and in the treatments 
they choose.215-218 
Other well documented influences on prescribing behaviour include detailing 
visits from pharmaceutical company representatives which may include 
distribution of promotional materials and product samples;219-221 attitudes of 
peers and ‘opinion leaders’ or authority figures;222,223 prescribing behaviour of 
specialists or hospital physicians;224,225 the expectation of a patient, or their 
desire to receive a prescription;226-228 advertising in medical journals and 
periodicals;225,229-231 and industry sponsored education and gifts ranging from 
meals to conference travel to research funding.219,232,233 While a great deal of 
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literature describes the effects of advertising and other methods of promotion, 
including the psychological aspects and subliminal inducements of many of 
the current methods,220,222,234-237 doctors generally feel that they are immune 
to the effects of these influences.215,219,222,235  
The promotion of products to clinicians by the pharmaceutical industry has a 
simple motivation – they are looking to recoup the vast capital outlay invested 
in developing and producing the medications doctors prescribe and to make a 
profit through securing and maintaining a market share.238 Current legislation 
does not allow for direct-to-consumer advertising in Australia, so the major 
focus for product promotion is the clinician. Promotion is viewed both 
positively, because it is a source of information about new products which 
may be beneficial to patients, and negatively, because it lowers the price 
sensitivity of doctors who may prescribe these products even where there are 
cheaper, equally efficacious medications available.239 Critics are concerned 
that promotion increases expenditure on medications that do not provide more 
effective or efficient care.240 
Comparatively, the pharmaceutical industry spends more on product 
promotion than any other area of the economy. Firms generally spend around 
2% of their revenues on promotion, but pharmaceutical companies spend an 
estimated amount of 15–25%.239 More than 80% of resources for promoting 
prescription medications by the pharmaceutical industry is spent on direct 
promotion to health care professionals.240 In the US 70–80% of promotional 
spending is allocated to detailing visits by sales representatives to clinicians, 
with a much smaller proportion spent (around 10%) on advertising in print or 
other media.240 A proportionally similar division exists for promotional 
spending in Australia (personal communication from Mary Graham, Janssen-
Cilag Pty. Ltd., (from Cegedim data); personal communication from Philip 
Spiers, AstraZeneca Pty. Ltd.).  
Pharmaceutical representatives visit medical practitioners in their surgeries to 
promote and sell their products. They disseminate information about new 
drugs and serve as a major source of medication information to clinicians. 
They have a considerable influence on prescribing practices, and greater 
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potential to influence prescribing behaviour than other types of 
promotion.205,227,241,242 The reasons for their high level of influence vary. The 
practical enticements of gifts234,235 and the occasional ‘free lunch’241 are 
discussed in the literature, but the main influence is the relationship of trust 
that forms between the representative and the GP, leading to the doctor being 
more receptive to information provided through this personal contact.220,221,227 
The influence of the pharmaceutical industry on clinician behaviour has led to 
the creation in many countries of national bodies to monitor the interactions 
between the industry and doctors. Codes of conduct such as those of the 
Association of the British Pharmaceutical Industry, the Pharmaceutical 
Research and Manufacturers of America, and Medicines Australia, 
concentrate mainly on marketing activities.243 
The influence of pharmaceutical advertising on GP prescribing behaviour has 
also attracted scrutiny. Avorn et al reported that while clinicians believed they 
were more influenced by scientific literature in journals than by the drug 
advertisements also contained therein, when tested about the medications 
advertised, their knowledge favoured views promoted in the advertisements 
rather than in the literature. The authors believe this is problematic given that 
the benefits of new products are likely to be espoused in the advertising 
campaigns accompanying their launch, but any problems or risks associated 
with the drug in the long run are more likely to be reported in the scientific 
literature.215 Other concerns lie with the accuracy of claims made in 
pharmaceutical advertisements, with some authors reporting advertisements 
which are misleading because they are not supported by evidence,244,245 that 
the evidence used in support of the claims is often biased,233 or that 
inappropriate comparators have been selected which makes a particular drug 
look much better than it might when compared with a different one.233,241,246 
Techniques employed in drug advertisements and the subliminal effects of 
these techniques are also widely reported with exhortations that doctors 
should be aware of these.223,237,247-250 
The perception that advertising ‘works’ is supported by the placement of 
advertisements in scientific journals.225,229-231 Glassman et al used the 
example of advertisements in the New England Journal of Medicine (NEJM) 
 196
and Journal of the American Medical Association (JAMA). The publishers 
produce multiple editions of the same journal that have the same text but 
different pharmaceutical advertisements depending on the geographic region 
and physician specialty intended for that issue. Primary care physicians 
receive editions with the most advertisements and libraries receive those with 
the fewest.230  
Medical journals have contained pharmaceutical advertisements for many 
years, but the introduction of information technology has provided a new 
avenue for promoters to deliver their message. In the early 1990s, Medical 
Director,68 the first (and currently only) clinical software system with 
embedded advertising was released to medical practitioners in Australia. The 
vendors employed an advertising revenue strategy to offset the cost of the 
product, similar to that employed by journals, and sent a full working copy out 
to all GPs.251 It quickly became the market leader because its business model 
of reliance on pharmaceutical promotion heavily subsidised the cost of 
purchasing and updating the software for GPs.208 
At the time this study commenced (November 2003) the types of 
advertisements embedded in the software included full screen images and 
strip messages, with or without animation. The ‘pop-up’ full-screen 
advertisements appeared when any document was printed (this function has 
since been removed). The strip messages cycled through the program’s 
screens during the course of each work session, at the opening of each 
patient record, when new data were added to a record, or when prescriptions 
or pathology orders were prepared. The strip advertisements were also 
displayed when the software’s clinical support tools were accessed. The 
software developers provided quarterly updates, and advertisements could 
change with each new version. The advertisements cycled for a month within 
each version, allowing for three different sets of advertisements to be shown 
within the quarter. An advertisement could be repeated in all three sets, and in 
multiple cycles. 
Promotional information from the software developers (in 2003) quoted the 
price of primary full screen advertisements as $7,380 for one month ($19,557 
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for 3 months) and the minor strip advertisements at $4,768 for one month 
($12,675 for three months).252 While the majority of advertisements were for 
pharmaceutical products, advertising ‘space’ had also been purchased by 
medical indemnity insurers, private health insurers, pathology providersŦ, 
divisions of general practice, employment networks, the Australian 
Government Department of Health and Ageing (DoHAŦ), and other non-profit 
organisations such as the National Heart Foundation, the National Prescribing 
Service, and Medicines San Frontieres.  
In 2005, Harvey et al253 reviewed Medical Director software and reported that 
95% of pharmaceutical advertisements appeared to be noncompliant with the 
Medicines Australia Code of Conduct254 through one or more of the following: 
missing information; illegibility of generic names; claims that were 
unsubstantiated; lack of PBS listing information, or were in breach of the 
Therapeutic Goods Act 1989255 regarding direct to consumer advertising of 
pharmaceutical products.  
As previously described, there have been many studies undertaken 
describing the influence of advertising in print media. To date, no research 
has been performed to examine the effect of the continuous, repetitive 
exposure of advertising in clinical software on the GPs who use Medical 
Director in the performance of their clinical activity. 
7.2 Aim 
The aim of this Chapter is to determine whether advertising embedded in 
clinical software influences the prescribing behaviour of GPs exposed to 
advertising via this medium. 
Hypothesis: GPs who are exposed to advertising in their clinical software will 
choose to prescribe the products advertised over other products in the same 
therapeutic class or group 
Rationale: The continual exposure to advertised products through clinical 
software possibly has a more lasting effect on a GP than other forms of 
advertising because of its recurring nature. Mildred Cho, associate director of 
the Stanford Centre for Biomedical Ethics at Stanford University, claims that 
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the repetitive exposure to the name of a drug can be ‘pernicious. The more 
times someone is exposed to a name, the more likely they are to use that 
product’.223 This may influence the GP, having made the decision to prescribe 
a medication to a patient, to choose the product most easily recalled because 
of the repetitious exposure, rather than another product from the same 
therapeutic class or group. This may influence the quality of the prescribing, 
as another product may be equally efficacious yet may be more suitable to the 
patient – because of side-effects, or cost where the two products differ in the 
patient co-payment required.  
7.3 Method 
The methods utilised for this chapter are based on the BEACHŦ methodology 
described in Chapter 3. As also described in Chapter 3, the additional 
questions designed for the GP Profile questionnaireŦ were used to investigate 
the clinical computer use of individual BEACH GPs, and in particular the 
brandŦ of clinical software they use.  
7.3.1 The participants 
As described in previous Chapters, 79 GPs from the original group of 1,336 
included in this study were removed because they had not responded to the 
question about computer useŦ. A further 35 GPs had not indicated the type of 
software used at their practice and were also removed from this section of the 
analysis, reducing the sample to 1,222 GPs. These were divided into two 
groups according to their responses nominating their use of clinical software.  
The GPs who had reported using the Medical Director brand of software and 
who indicated that they use the clinical functions of their software program 
were included into the ‘exposed’ group on the basis that they would be 
exposed to advertisements through their software. There were 773 GPs in this 
group. GPs who did not use Medical Director software, did not use the 
computer for clinical activity, or who did not use a computer at all, were 
included in the second, ‘non-exposed’ group. The second group also included 
20 GPs who reported having the advertising embedded software available at 
their practice, but 15 of these did not use a computer at all, 4 used their 
computer for internet access only, and 1 for internet and email only. These 
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were included in the non-exposure group on the basis that they would not 
have been exposed to the advertising. There were 484 GPs in the ‘non-
exposed’ group. 
Definitions 
The exposed group was defined as the users of Medical Director software 
(the advertising software) for clinical functions as previously defined in earlier 
Chapters i.e. prescribing and/or test ordering and/or medical recordsŦ, with or 
without internet and/or email. 
The non-exposed group was defined as the GPs who used other software, did 
not use a computer for clinical purposes, or did not use a computer at all (i.e. 
those not exposed to advertising through software). 
7.3.2 Pharmaceutical product advertisements 
As previously mentioned in Chapter 3 (3.5.4), although I had specific 
recording dates for the patient encounterŦ data for each GP in BEACH, and 
therefore can reasonably match those dates with the advertisements shown in 
the software, I could not ascertain which version of the software was being 
used by GPs who recorded around the time of the release of software 
updates. Consequently, I cannot be certain which advertisements they were 
exposed to in their software during their BEACH recording time. For this 
reason I chose to investigate the prescribing for those products that were 
shown continuously throughout the study period in every version of the 
software.  
There were seven products shown continuously i.e. in the cycle of 
advertisements through every month of each quarterly updated version of the 
advertising embedded software. These products were: 
• Lipitor  (atorvastatin – a HMC CoA reductase inhibitor) 
• Micardis (telmisartan – an angiotensin II receptor antagonist) 
• Mobic  (meloxicam – a non-steroidal anti-inflammatory agent) 
• Nexium (esomeprazole – a proton pump inhibitor) 
• Norvasc (amlodipine besylate – a calcium channel blocker) 
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• Natrilix (indapamide hemihydrate – a low-ceiling diuretic)  
• Zanidip (lercanidipine hydrochloride – a calcium channel blocker) 
None of the medications were new to the market–Nexium had been available 
for 13 months, and all other brands for a minimum or 18 months, prior to the 
commencement of this study.  
Incorporating the final GP and practice characteristic model, the two GP 
groups were compared on their prescribing behaviour for each of the above 
medications.  
7.3.3 Statistical methods 
The problems which resulted in at least one prescription for each of the seven 
medications under investigation were identified using SAS procedures. The ‘at 
least one’ identifier applies because there are problems for which different 
strengthsŦ of the same medication are co-prescribed in order to obtain the 
required dosage for the patient. For example, a GP advising a patient to take 
60mg of Lipitor would provide a prescription for a 40mg tablet and one for a 
20mg tablet, as a 60mg tablet is not available. If more than one medication in 
the same therapeutic class or group was prescribed for the same problem, so 
that the medications were not mutually exclusive and could be categorised 
into both the brand under investigation and another brand or generic 
substance from the same class or group. These cases were removed from the 
analysis. 
For each of the seven advertised medications selected, prescriptions for the 
advertised product as a proportion of all prescriptions for all products in its 
ATCŦ class were compared between the two GP groups e.g. the proportion of 
HMG CoA (3–hydroxy–3–methylglutaryl coenzyme A) reductase inhibitor 
(ATC Code: C10AA) prescriptions that were for Lipitor using logistic 
regression. After the seven nominated products were examined individually, 
they were grouped together and the total number of prescriptions for the 
advertised medications was compared as a proportion of all medications 
prescribed in the combined ATC classes.  
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The results are expressed as odds ratios where GPs not using Medical 
Director software are the reference group held constant as ‘1’.  
Power calculations 
As described in Chapter 3 (Section 3.5.5) a priori power estimations for two-
sample comparison of proportions were performed using STATA 8.069 
software. Sales information from the HCN indicated that between 70% and 
80% of GPs were using Medical Director software. I performed power 
estimates assuming approximately 700 GPs in the Medical Director using 
group and 300 GPs in group using other software or none. The power 
calculated to find a significant difference between 10% and 20% (Type II 
errorŦ – 1 – power) with sample sizes of 700 and 300 was 0.9786. The power 
calculated to find a significant difference between 40% of GPs and 60% of 
GPs (Type II error – 1 – power) with sample sizes of 700 and 300 was 0.9999. 
The post hoc calculations performed on actual sample sizes of GPs who 
prescribed a medication from an ATC class of group including the advertised 
brands are reported in Section 7.4.2. 
7.3.4 Multivariate analyses and Models used 
The modelling process as described in Chapter 3 was again adopted for this 
analysis. Between the two GPs groups, univariateŦ comparisons were made 
of the characteristics of the GPs and their practices. The sample of GPs was 
a simple random sample, but the sample of encounters was cluster based (as 
described in Chapter 3) so the p values and 95% confidence intervals are 
reported after adjusting for the cluster effect. Procedures in SAS 8.2 were 
used for this adjustment.63  
All GP and practice characteristics described in Chapter 3 were included. 
Those characteristics considered to be highly correlated with others were 
eliminated from the modelling process. Simple logistic regression was used to 
identify characteristics associated (α<0.1) with use of Medical Director 
software. The stepwiseŦ procedure described in Chapter 3 (Section 3.5.5) was 
used to obtain the final model of GP and practice characteristics (Model A). 
Figure 7.1 shows all GP and practice characteristics examined in the simple 
logistic regression which were then tested for association in the step-wise 
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elimination process. The variables showing some association (p<0.10) with 
the dependent variable (GP use of Medical Director software) in the simple 
logistic regression were included in the stepwise procedure for elimination and 
refitting of the model. 
 
GP characteristics Practice characteristics 
• Age (45, 45–54, 55+ years)* 
• Sex* 
• Place of graduation* (Australia/other) 
• FRACGP status* (yes/no) 
• Years in general practice (<10, 10–19, 20+)† 
• Years since graduation (<20,20–29, 30+)†  
• Sessions per week (<6, 6–10, 11+) 
• Direct patient care hours per week* 
      (<31, 31-40, 41-50, 51+) 
• Work in past 4 weeks– 
• in residential aged care facility (yes/no) 
• as a locum (yes/no) 
• as salaried/session hospital medical officer *(yes/no) 
• in a deputising service (yes/no) 
• Whether bulk-bill all patients* (yes/no) 
• Any consultations in language other than English (yes/no) 
• Registered with Department of Veterans Affairs (yes/no) 
• Registrar status (Registrar/not registrar) 
• Size of practice* (solo, 2-4, 5-
10,11+ GPs) 
• Practice location by RRMA1 
(metropolitan/rural) 
• Practice location by ASGC2* 
(major city/not major city) 
• Practice location by State 
• Socio economic status by 
SEIFA3 (Disadvantages <4 
SEIFA/less disadvantages 
SEIFA 4-11) 
• Practice accreditationŦ status* 
(Yes/no) 
• Practice nurse at major 
practice address* (yes/no) 
• After-hours patient are 
arrangements (own or co-
operative/deputising service) 
• Status as a teaching practice 
for undergraduates of 
registrars 
Figure 7.1 GP and practice characteristics compared in simple logistic regression analysis 
and then used in step-wise logistic regression analysis 
† Variables that were found to be highly correlated with other variables and were therefore not retained in the modelling process. 
* Variables that showed some association (p<0.10) with use of Medical Director software for clinical purposes, and were therefore 
included in the logistic regression analysis. 
1.  Australian Government Department of Health and Ageing. Rural, Remote and Metropolitan Areas (RRMA) classification. 
 http://www.health.gov.au/internet/wcms/publishing.nsf/content/work-bmp-where-rrma.  
2.  Australian Bureau of Statistics (ABS). Australian Standard Geographical Classification (ASGCŦ). Canberra: Australian Bureau 
of  Statistics., 2004. 
3.  Australian Bureau of Statistics. Census of population and housing: Socio-Economic Indexes for Areas (SEIFA), Australia. 
 Canberra: Australian Bureau of Statistics, 2001. 
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Covariates in model 7A 
The variables showing significant association (P<0.05) and included as 
covariates in the final model were:  
• GP age  
• Direct patient care hours worked per week 
• Bulk-billingŦ for all patients 
• Practice accreditation status 
• Practice location by ASGCŦ  
Factors such as the patient’s age, sex and morbidityŦ will have been 
considered by the GP when forming the decision to prescribe a medication 
from the therapeutic class or group. The patient characteristics and morbidity 
were therefore not included in the modelling for this analysis because the 
decision to prescribe is not the factor being examined – it is the choice of 
medication once the prescribing decision has been made.  
7.4 Results 
7.4.1 Participants and prescribed medications 
The 773 GPs exposed to advertising through Medical Director software 
represented 63.3% of the 1,222 GPs included in this analysis. They 
prescribed 63,335 medications at 77,300 patient encounters, equating to 
62.2% of the 101,230 medications prescribed by the two GP groups. The 449 
GPs (36.7%) in the non-exposure group prescribed 37,896 medications at 
44,900 encounters, representing 37.4% of the total medications prescribed 
(Table 7.1). 
Table 7.1: Proportion of GPs in each group and of the medications each prescribed. 
 
GPs using Medical 
Director (MD) software 
GPs not using Medical 
Director (MD) software Total 
No. of GPs (row %) 773 (63.3%) 449 (36.7%) 1,222 (100.0%) 
No. of medications 
prescribed (row %) 63,335 (62.6%) 37,895 (37.4%) 101,230 (100.0%) 
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7.4.2 GP prescribing behaviour for selected brands 
The prescriptions for each of the seven advertised medications under 
investigation and all other medications in the same ATC class were identified 
and numbers of each are shown in Table 7.2. The final denominator for each 
variable is shown, after removing cases where an advertised product and 
another medication from the same class or group were prescribed for the 
same problem. In total, 29 cases were excluded across the seven medication 
brands, and the numbers excluded for each medication group are listed by 
ATC class in the footnotes to Table 7.2. 
The distribution of prescribing for each of the seven brands of interest and 
other brands or generics in the same medication class or group are also 
shown in Table 7.2. There was no significant difference in the prescribing rate 
of Lipitor (Adj. OR = 0.90; p=0.18); Micardis (Adj. OR = 0.98; p=0.87); Mobic 
(Adj. OR = 1.02; p=0.83); Norvasc (Adj. OR = 1.02; p=0.87); or Natrilix (Adj. 
OR = 0.80; p=0.23) as a proportion of all medications in the ATC classes of 
these products. For Nexium however, a significant difference between the two 
GP groups emerged after adjustment (Adj. OR = 0.78; p=0.02). The GPs who 
were continually exposed to the advertisements for this product through their 
software prescribed significantly less of this brand as a proportion of all 
PPIs/H2RAs, compared with those GPs who were not subjected to 
advertisements embedded in clinical software. 
When the seven advertised products were combined there was no significant 
difference in the prescribing behaviour between the two groups either before 
or after adjustment (Adj. OR = 0.96; p=0.42). 
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Table 7.2: Distribution of prescriptions by advertised medication brands and other 
brands within the same ATC drug groups 
Number  
(Per cent of 
group) 
Number  
(Per cent of 
group) Odds Ratio 
Number of problems managed with at 
least one prescription for… GPs exposed GPs not exposed
Unadjusted 
(95% CI) 
p value 
Adjusted (a)
(95% CI) 
p value 
HMG CoA reductase inhibitors 
(ATC:C10AA)b  2,162 (100.0) 1,348 (100.0) 
 Lipitor  983 (45.5) 646 (47.9) 
 Other 1,179 (54.5) 702 (52.1) 
0.91 
 (0.76–1.07) 
p =0.26 
0.90 
(0.76–1.08) 
p =0.26 
Agents acting on the renin-angiotensin 
system (ATC: C09)c 3,927 (100.0) 2,576 (100.0) 
 Micardis  169 (4.3) 125 (4.9) 
 Other  3,758 (95.7) 2,451 (95.1) 
0.88  
(0.62–1.25) 
p =0.48 
0.98
 (0.66–1.45) 
p =0.91 
Anti-inflammatory and anti-rheumatic 
products, non-steroids (ATC code: 
M01A)d 3,107 (100.0) 2,039 (100.0) 
 Mobic  458 (14.7) 296 (14.5) 
 Other  2,649 (85.3) 1,743 (85.5) 
1.02  
(0.80–1.30) 
p =0.89 
1.02 
(0.78–1.33) 
p =0.89 
Proton pump inhibitors and H2 receptor 
antagonists (ATC code: A02BC & 
A02BA)e  1,955 (100.0) 1,170 (100.0) 
 Nexium  487 (24.9) 330 (28.2) 
 Other 1,468 (75.1) 840 (71.8) 
0.84  
(0.69–1.03) 
p =0.1 
0.78 
(0.63–0.96) 
p =0.02 
Calcium channel blockers (ATC code: 
C08)f  1,491 (100.0) 914 (100.0) 
 Norvasc  465 (31.2) 279 (30.5) 
 Other 1,026 (68.8) 635 (69.5) 
1.03 
(0.85–1.25) 
p =0.76 
1.01
 (0.82–1.25) 
p =0.91 
Total low-ceiling diuretics (C03A & 
C03B)g 424 (100.0) 232 (100.0) 
 Natrilix prescription  257 (60.6) 152 (65.5) 
 Other  167 (39.4) 80 (34.5) 
0.81  
(0.54–1.21) 
p =0.30 
0.80 
(0.51–1.25) 
p =0.32 
Calcium channel blockers (ATC: C08)h 1,492 (100.0) 912 (100.0) 
 Zanidip  148 (9.9) 105 (11.5) 
 Other 1,344 (90.1) 807 (88.5) 
0.85  
(0.62–1.16) 
p =0.30 
0.88 
(0.62–1.25) 
p =0.47 
All medication decisions included above 14,558 (100.0) 9,191 (100.0) 
 Advertised brand medications 2,967 (20.4) 1,933 (21.0) 
 Non advertised brand medications 11,591 (79.6) 7,258 (79.0) 
0.96  
(0.88–1.05) 
p =0.38 
0.96 
(0.87–1.06) 
p=0.42 
(a) Model controlling for the following GP/practice characteristics:, age, practice location, bulk-billing all patients status, practice 
accreditation status. 
(b) Number of encounters excluded due to co-prescription of Lipitor and other brand within this group–1 
(c) Number of encounters excluded due to co-prescription of Micardis and other brand within this group–15 
(d) Number of encounters excluded due to co-prescription of Mobic and other brand within this group–4 
(e) Number of encounters excluded due to co-prescription of Nexium and other brand within this group–5 
(f) Number of encounters excluded due to co-prescription of Norvasc and other brand within this group–1 
(g) Number of encounters excluded due to co-prescription of Natrilix and other brand within this group–0 
(h) Number of encounters excluded due to co-prescription of Zanidip and other brand within this group–3 
Note: AS = advertising software; CI = confidence intervals; ATC = Anatomical Therapeutic Chemical. 
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Power calculations 
The post hoc power calculated from the sample of prescriptions for: 
•  HMG CoA reductase inhibitors (n=3,510) was 0.8139 (for Lipitor) 
• agents acting on the renin-angiotensin system (n=6,503) was 1.000 (for 
Micardis) 
• anti-inflammatory/anti-rheumatic products, non-steroidal (n=5,146) was 
0.9995 (for Mobic) 
• proton pump inhibitors/H2 receptor antagonists (n=3,125) was 0.8500 
(for Nexium) 
• calcium channel blockers (n=2,405) was 0.9570 (for Norvasc) 
• low-ceiling diuretics (n=656) was 0.2144 (for Natrilix) 
• calcium channel blockers (n=2,404) was 0.9568 (for Zanidip) 
and for the total combined sample (n=23,749) the power was estimated at 
1.000. 
7.5 Discussion 
Exposure to advertisements embedded in clinical software had one significant 
and selective effect on the prescribing behaviour of the GPs in this study, and 
this effect was negative. However, this effect was subsumed in the overall 
result when all seven products were grouped. 
As with all observational studies, consideration should be given to the 
influence of confounding factors. I do not know for instance, the exposure of 
the GP to a product’s advertisement at the exact time of prescribing. I could 
not determine what exposure GPs had to advertising through other mediums, 
but assumed that GPs in both groups had an equal chance of exposure to 
advertisements via scientific journals, periodicals, visits from pharmaceutical 
representatives etc. I did not investigate the appropriateness of the chosen 
medication for the condition for which it was prescribed – my purpose was to 
detect any influence of the advertising once the decision to prescribe had 
been made. I also had no way of examining the effect, if any, on patients 
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exposed to the advertisements, and acknowledge that patient request is a 
recognised influence on how GPs prescribe.226-228 I considered it unlikely that 
cost would have a great influence on the prescribing decisions as all the 
branded medications and their alternatives are available on the PBS. It would 
have been interesting to compare brand choice for those medications being 
prescribed for the patient for the first time, rather than all medications, as a 
new choice must be made at that point. However, new prescriptions form a 
very small proportion of all prescriptions, particularly in the area of chronic 
disease management so this would have resulted in too small a sample size 
for meaningful comparison.  
For all but one sample (low ceiling diuretics), the size was sufficient to detect 
a difference of 5% with power at 0.81 or over. Because the differences in 
prescribing between the two GP groups were so small (ranging from 0.2% to 
4.9%) there may be insufficient power in some of the sample sizes to 
conclude the null effects with certainly and there is a possibility that a Type II 
error has occurred, and that some of these results are false negatives. The 
sample size for PPIs/H2RAs (3,125 cases) had power calculated at 0.85 
giving greater reliability to the Nexuim result. I had hypothesised that the 
promotion would produce greater prescribing of the advertised product, and 
think it is clinically significant that the result is the opposite of that 
hypothesised. If I have incurred a Type I errorŦ and reported a difference 
where in fact none exists, this further supports a finding of no difference, and 
that the influence of advertising via this medium has not been demonstrated. 
Although this is the first study to examine the effect of advertising in clinical 
software, other studies have had similar results when examining the 
relationship between prescribing and advertising in journals. Jones et al found 
no relationship between the extent of advertising for a drug and the amount of 
prescribing by GPs.225 Mackowiak & Gagnon reported no correlation between 
changes in expenditure on detailing or journal advertising and size of market 
or market share. They concluded that the most likely cause of their negative 
results was that there is so much spent on promotion that additional 
advertising makes little difference to prescribing under the law of diminishing 
returns.256 As the majority of promotion expenditure is for detailing visits by 
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representatives, and a comparative paucity is spent on media advertising,240 
there may be so much compared with so little that the extra amount spent 
advertising in software makes no difference. The software vendors promote 
their product to potential advertising purchasers by quoting Quadrant research 
figures of 70% recall on full-screen advertisements and 50% recall on strip 
messages.257 My results would suggest that this may possibly be the case, 
but recall of the product does not ensure that it will be prescribed. 
The influence of the pharmaceutical industry must be considered in any 
discussion about prescribing behaviour as it applies to quality of care. Much 
has been written about bias in clinical research sponsored or undertaken by 
the industry, when later evidence shows that original findings were inaccurate 
or incomplete,258,259 or when only favourable findings are published.233,260 If 
unfavourable results are not published, meta analyses can only be performed 
on published (i.e. favourable) data.261 Loke et al (2002) undertook an audit of 
pharmaceutical advertisements in Australian literature and found only 28% of 
claims made were unambiguous, and 45% could not be substantiated.244 If 
research and advertisements containing bias are influencing the prescribing 
behaviour of GPs then there is cause for concern about the quality of the 
prescribing decisions. However, my results would suggest that, at least where 
advertising in software is concerned, the advertisements are having little 
effect on GP prescribing behaviour. 
I have not undertaken to investigate the ‘honesty’ of the advertisements in 
Medical Director, although Harvey et al highlighted areas where many fell 
short of Code of Conduct regulations.253 However, just as advertising in 
journals has come under scrutiny, it is appropriate that the avenue of 
delivering pharmaceutical industry messages in clinical software is also 
assessed. The advertisements in journals, for example, will be placed without 
regard for the other academic or scientific content of the journal. In contrast, 
the software enables advertisements to be displayed in association with 
specific clinical tools or functions. Provision 3.10.11 (of Edition 14, now 3.9.2 
of Edition 15) of Medicines Australia’s Code of Conduct254,262 is arguably 
being breached when advertisements are (in some cases) clearly targeted 
toward a condition or clinical function with which the condition is associated 
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(for example, the only two advertisements in the cardiovascular monitor tool 
were for Micardis or Norvasc; the only two in the product information tool for 
musculoskeletal drugs were for Celebrex and Mobic.) Edition 15 (Provision 
3.9.1) of the Code now precludes a company from placing advertisements 
within clinical tools (e.g. the Cardiovascular Monitor).262 Direct-to-consumer 
advertising is also a contravention of the Code (Provision 9.4)262 and Harvey 
et al found that there were instances where patients were exposed to 
advertisements placed in clinical tools. They voiced concerns about the 
potential public health consequences of promoting prescription 
pharmaceuticals through software used with patients present.253 The 
pharmaceutical industry is held responsible for any breaches of the Code of 
Conduct. To date there are no regulations governing the clinical software 
industry and the pharmaceutical industry is the only party considered legally 
accountable. With effective industry standards and accreditation for clinical 
software perhaps these regulations might be better followed and breaches 
better controlled in the future.  
Incidental exposure of patients to advertisements is one aspect of the ethical 
debate concerning advertisement embedded software, but exposure of GPs is 
the dominant one, and echoes the same issues involving pharmaceutical 
advertising in medical or scientific journals.225,229-231 The assumption that this 
method of advertising influences prescribing behaviour is supported both by 
the amount of advertising pharmaceutical companies commission, and by the 
example (given in the introduction to this Chapter) of some publications 
producing multiple versions of the same issue aligning advertisements with 
intended recipients. 230 This collaboration in promoting pharmaceutical 
products does not correlate with best practice ideals and creates a potential 
conflict of interest for the organisations publishing the journals and for their 
policies. Nonetheless, this advertising offsets the cost of the journals and is a 
significant source of funding for some physician organisations that, in some 
cases, might not exist without it.230  
To some extent the same dilemma is assumed for users of advertising 
software – removing the advertisements would mean removing the subsidy 
made available through advertising revenue, and the software would then 
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become more expensive for its purchasers. Despite the obvious amount of 
revenue contributed by advertisements, and acknowledging that there is 
similar software available at a much higher price, the current price of the 
advertising software does align with at least two similar clinical software 
packages presently available in Australia, which do not have 
advertisements.263  
In this study the advertisements for Nexium had a negative effect on the GPs 
exposed to advertisements. Some GPs providing feedback to Harvey et al 
stated that advertisements were ‘annoying’.253 and perhaps our result is 
associated with an ‘annoyance’ factor – the strip advertisement for Nexium 
appeared in the pathology ordering tool continually throughout the study 
period, as well as in the routine display through the software’s general cycle of 
advertisements. While warnings and reminders can be switched off in the 
software, the advertisements are very difficult to eliminate for the average 
user. In any case, the software has achieved market dominance, so neither 
moral indignation nor the annoyance factor would appear to have the same 
influence as the perceived cost saving. Computerisation is an expensive 
process, requiring continued updates of hardware, software and other 
associated equipment. It has become almost essential and the costs are 
borne by the practice. Given the previous cost saving no longer exists 
practices may begin to reconsider their choice. However, the advertising 
software has first to market advantage and ‘vendor lock in’ arising from a lack 
of standards to facilitate data transfer between systems may deter many from 
considering change. 
While I could measure differences in the prescribing behaviour for the 
products nominated, I could not test the effect of advertisements for the other 
non-pharmaceutical organisations. Given the cost of these advertisements, 
and that this mode of advertising may not effect an increase in prescriptions 
for the advertised product this may not be the best use of advertising 
expenditure. The pharmaceutical industry may afford to absorb the cost for 
this questionably efficient method of promotion (which also exposes it to 
criticism and potential fines for breaches of the MA Code of Conduct), on the 
basis of possible marginal increases in sales (within the confidence intervals 
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demonstrated in this study) but organisations being funded by the public 
purse may not be as able to justify such expenditure. 
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CHAPTER 8  
 
DISCUSSION 
This research has shown that while computers have been widely adopted in 
general practice they do not appear to have been well integrated to date. For 
a variety of reasons, only a minority of GPsŦ are using their computer to its 
maximum capacity as a clinical tool. Those who do use a computer for clinical 
purposes show some differences in practice behaviour, which remain after 
adjustment for the GP, practice, patient and morbidityŦ characteristics 
measured in this study. While these differences appear to be associated with 
clinical computer use, they may also be associated with a factor(s) other than 
those I have measured. On 44 quality indicators designed for primary care 
assessment with these data, the two GP groups differed on only eight. For the 
36 quality indicators designed to compare the groups on their use of a 
computer for any clinical function, the GP groups differed on only seven – 
those using a computer performed ‘better’ on three indicators and ‘worse’ on 
four. For the remaining 29 they exhibited no detectable difference. When the 
sub-set of the same quality indicators was applied to compare GPs who use 
their computer specifically for test ordering with those who do not, the two GP 
groups again performed equivalently on seven indicators, with those ordering 
tests through their computer performing ‘better’ on the remaining one. 
Exposure to pharmaceutical advertising embedded in clinical software does 
not appear to influence the prescribing behaviour of the GPs so exposed. 
Despite the belief espoused by many that computer useŦ will improve the 
quality of care, I have found no evidence to demonstrate that the introduction 
of the computer has affected, either positively or negatively, the quality of care 
GPs provide to their patients. 
As with all observational studies there are limitations in this one. As far as 
possible I have adjusted for variables which have shown an association with 
the measured outcomes, but there may well be other unknown factors 
influencing the practice behaviour of these GPs for which I had no measure, 
for example, their business structure or employment status (solo vs 
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partnership vs corporation). The data are cross-sectional which has its own 
limitations, for example, I have been able to determine management rates for 
specific problems and how they have been managed, but I was unable to 
determine how often a patient may return to their GP for prescriptions or other 
managements. This has particular bearing on some of the results produced in 
the thesis such as the significantly lower overall prescribing rateŦ observed in 
GPs using a computer for clinical activity, particularly for medications such as 
antihypertensives, beta blockers, hypoglycaemic agents, and NSAIDsŦ. These 
medications are all likely to be continually used by the patient and will require 
repeat prescriptions. There is an associated broader limitation to encounterŦ 
data that involves more than just the repeats given when prescribing. I have 
no way of knowing how often the patients in the general practice population 
are managed by the GPs who provide their care. This limitation has a bearing 
on many of the variables measured in BEACHŦ – prescriptions, tests, 
referralsŦ, the number of problems managed, the length of the consultationŦ, 
etc–as the behaviour of the GP in regard to patient management may partially 
reflect the patient’s access to care. The age–sex distribution of patients, their 
distance from care, the number of patients being serviced by the one 
providerŦ (and therefore affecting the patients’ opportunities to be seen by 
busier GPs) will all impact on the number of problems the patient presents, 
the number of repeats given for a prescription, the likelihood of ordering a 
pathology test, the number of tests ordered, the opportunity to perform health 
checks (such as pap smears), or the likelihood of being referred to another 
health professional. In the example of repeat prescriptions referred to above, 
where the age distribution of patients is older, patients may access care more 
often, allowing the GP to prescribe fewer repeats prior to the next opportunity 
to monitor the patient’s health. Alternatively, s/he may prescribe less often for 
the patient’s total encounters in the year, with full repeats on each 
prescription. This scenario changes if the patient lives some distance away, or 
is tended to by a GP servicing a population of 2,500 patients compared with a 
patient of the same age living a short distance from care, provided by a GP 
who is servicing only 1,800 patients. These factors all affect rates of 
management actions per 100 encounters for an individual GP. Ideally the 
comparison between groups would be longitudinal and patient based, and 
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measurement of outcomes. In the future, this may be possible. The potential 
of complete computerised patient information is such that it would allow the 
observation of patients individually, to track the progression of diseases and 
the effectiveness of managements and interventions over the course of time. 
At present this situation does not exist for the majority of GPs and their 
patients. The true benefits of computer use may only become apparent over 
time, from patient-focused, longitudinal studies. 
The BEACH method (and therefore that of this study) employs the clinician as 
the data collector. Limitations concerning the reliability and validity of 
practitioner-recorded morbidity data were discussed in detail by Britt et al 
(1999) in ‘General practice activity in Australia 1998–99’ (pages 10–11).45 
These include clarity of communication between physician and patient, inter-
doctor differences in interpretation of language and signals, regular absence 
of sufficient information to conclude a diagnosis, and the influence of 
therapeutic decisions on diagnostic labels. All have input to the final label 
selected by a clinician to describe the problem under management.45 
However these apply equally to data passively drawn from medical records 
(whether paper-based or electronic) and to active data collection methods 
such as BEACH.264,265 There is as yet no more reliable method of gaining 
detailed data about morbidity and its management in general practice.266 
Morbidity data collected by GPs in active data collection methods have been 
shown to provide a reliable overview of the morbidity managed in general 
practice.267 There is also no reason to assume that, whatever the limitations 
concerning this method of data collection, they would not apply equally to all 
GPs who participated in this study, regardless of their status as a clinical 
computer userŦ. 
All GP profileŦ responses were self reported. I cannot verify that the claims 
made by GPs about their clinical use of the computer are accurate. A further 
limitation was the lack of specificity in the questions designed for the study. 
The original question about computer use lacked sufficient specificity in the 
question about medical record useŦ and this necessitated the follow-up 
questionnaire. Apart from the review by a single GP to assess its clarity, the 
follow-up questionnaire was not piloted for validation. It was not possible to 
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validate that their responses reflected their actual behaviour because that 
observation would need to be performed on site at multiple practices and this 
was not practicable. Unlike other countries (e.g. the US), it is not common 
practice for GPs in Australia to dictate or transcribe notes – they are taken 
during and at the end of the consultation, by hand into paper notes, or directly 
into the computer on the GP’s desk.  I can only accept the honesty of the 
GP’s responses that to the best of their knowledge, they have accurately 
described their use of a computer as a clinical tool. An element of recall bias 
may have influenced the responses about the computerised medical record 
function used during BEACH recording in the follow-up questionnaire. On 
follow-up I omitted to seek further information about the type and extent of test 
ordering through the clinical software. For example, there may have been 
GPs who order pathology through their software but not imaging tests. I also 
did not seek enough information about the use of the various decision support 
functions available in the software, to gauge how well these functions are 
used by GPs in overall patient care. Most evidence of positive outcomes of 
computer use described in the literature are associated with decision support 
tools such as alerts for preventive and monitoring care, and for prescribing 
decision support. 
In some cases I have reported no difference between the GP groups for some 
of the variables measured because of overlapping confidence intervals or 
large p values, but acknowledge that there may have been too few cases, and 
therefore insufficient power, to accept a null hypothesis with certainly (i.e. 
incurring a Type II errorŦ). For example, the rate of referrals to emergency 
departments (Chapter 5, Table 5.6) compared 161 cases in the clinical 
computer user group to 38 cases in the group of GPs not using a computer for 
clinical purposes. These occurred in each group at a rate of only twice in 
every 1,000 patient encounters. Also, the sheer volume of variables collected 
and compared in this thesis provides the potential for reporting a difference 
between groups when in fact, none exists (i.e. incurring a Type I errorŦ). There 
may have been occasions where a difference has been detected by chance 
rather than because it exists in reality. 
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I acknowledge that the act of completing an encounter formŦ for this project 
must have affected the length of consultation to some extent. Anecdotally, 
members of the BEACH research staff are occasionally told by GPs that the 
encounter is extended by approximately 2–3 minutes. I am also aware that 
the length of the encounter is affected by the topic being investigated in the 
supplementary section at the bottom of each encounter form (the SANDŦ 
section). However, the start and finish time for the consultations are always 
recorded on the same topic form (that which investigates patient height and 
weight, alcohol consumption and smoking status) and there is no reason to 
assume that any extension of the consultation caused by participation in 
BEACH would be different for GPs using computers and those who are not. 
In Chapter 7, I could not determine the level of exposure of the GPs to the 
product advertisements at the time of prescribing (i.e. that the advertisement 
for the product was appearing on their screen at that precise moment), nor 
could I establish what exposure GPs had to advertising through other 
mediums. I assumed however, that they would have an equal chance of 
exposure to advertisements in scientific journals, medical newspapers, 
periodicals and detailing visits from pharmaceutical company representatives. 
I also had no way of determining whether patients were exposed to the 
advertisements and what part patient request may have played in the GP’s 
decision to prescribe. 
For better or worse, and regardless of stimuli to expedite the process, 
progression of time will eventually see the full computerisation of general 
practice achieved. As stated in Chapter 5 (Section 5.4) I did not report 
computer use in the under 35 year age group for GPs because there were 
only two GPs (of 109) in this age group who were not using a computer for 
clinical activity. Computer use has become an integral part of the school 
education system and eventually general practice will be populated by 
clinicians for whom the use of a computer is the norm. A recent study of 
computer use by medical students showed that they adopt and use electronic 
information resources much more willingly and frequently than has been 
reported among practicing clinicians.268 It is the older GPs, and interestingly, 
males more than females who seem reluctant to adopt technology in practice. 
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Computer use was more common among older females (55 years and over) 
than older males, and perhaps this is a reflection of them as individuals – 
thirty to fifty years ago medicine was still very much male dominated. That 
they entered the medical workforce as clinicians rather than nurses may 
indicate that they were women ahead of their time and perhaps their attitude 
towards technology reflects their ability to confront change as a challenge 
rather than something to fear or avoid. It may also be associated with the 
work structure for many women, which is often part-time over the years of 
child bearing and raising a family. These women are more likely to be 
employees of others in the profession and therefore the decision to use a 
computer may not be autonomous.  
While in general it is older GPs who are hesitant to fully embrace technology it 
would be simplistic to consider their attitude as one of just not liking change. 
The longer these physicians have been in practice, the more they have 
learned about what can go wrong, and no doubt have developed a degree of 
prescience about actions and decisions. As evidence emerges of the new 
problems computerisation can introduce – of which they have no foresight and 
with which they have no experience – they may well feel that technology is a 
‘can of worms’ well left unopened. At best, they have learned through 
experience, that many conditions resolve faster and with a better outcome if 
the ‘wait and see’ approach is applied rather than intervening with an 
unproven remedy. It is quite likely that they view computerisation in this 
manner, and are prepared to wait until the evidence of all its perceived 
benefits is verified.  
Independent of all the GP, practice, patient and morbidity characteristics 
controlled for in this study there are real differences in the practice behaviour 
of the two groups of GPs. Clinical computer users saw fewer patients who 
hold Health Care Benefits cardsŦ. On a quality indictor basis, these patients 
represent an opportunity for good primary care practitioners to meet the 
needs of disadvantaged groups and so it was assumed that the group who 
saw more of these patients would indicate ‘better’ care on an equity of access 
basis. From the equity of access perspective, the clinical computer users 
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performed ‘worse’ than their counterparts, but there is no reason to question 
the quality of medical care they provide to the patients they see.  
Clinical computer users also saw proportionally fewer older patients (in the 
45–64 year age group), and proportionally more patients in the younger age 
groups. It would be interesting to know whether practice ownership has any 
association with this patient age demographic. I was unable to determine 
whether GPs were self-employed, in partnership, employed by small 
businesses or by corporations, and it may be that the manner of their 
employment influences some of the areas in which these GP groups 
remained significantly different following adjustment for the variables 
considered. As general practice becomes increasingly corporatised, the 
individual clinicians appear to be experiencing less autonomy in some aspects 
of their practice behaviour, including building a long term patient base. 
Anecdotally, GPs have declined to participate in BEACH because they are 
‘not allowed’ to involve themselves in research or any other activity which 
might impact on the consultation length. Some practitioners employed as 
independent contractors or employees in medical centres claim that ‘office 
staff are responsible for itemisation on documents for MedicareŦ benefit’ 
(although this defence is not acceptable to the Professional Service Review 
Committee).269 Their autonomy in regard to computer use itself may be 
restricted by the business model of their employer – for example, Outterson 
(2001)270 cited the following statement from the annual report of a publicly 
traded US physician management corporation:  
‘… the Company utilizes sophisticated information systems to improve the 
operational efficiency of, and reduce the costs associated with, operating 
the Company’s network and the practices of the affiliated physicians …’271 
While I have no data on the business model of the GPs in this study, the 
analyses have shown that clinical computer users are more likely to work in 
larger practices, and larger practices are those most likely to be corporatised. 
As throughput means dollars in the corporate world, and older people may 
take longer in a consultation because of multiple morbidity272, this may be a 
reason why clinical computer users see fewer older patients. If clinical 
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computer users are, as a direct result of corporatisation, charging patients 
directly and at higher than the standard fee, this may also explain the lower 
rate of encounters with Health Care Card holders and of bulk-billingŦ for 
patients. 
There were many other differences for which no explanation is obvious: 
clinical computer users prescribed fewer simple analgesics (particularly 
paracetamol), anti-hypertensives, beta blockers, hypoglycaemic agents, and 
musculoskeletal agents (particularly NSAIDs). They managed hypertension 
less often but ischaemic heart disease more often. As suggested in Chapter 5 
(Section 5.4), a possible explanation for the lower prescribing rates of these 
medications may be that the clinical software defaults to the maximum 
number of repeats allowed, so that patients need to attend less frequently for 
repeats of these medications. While the attendance rate of the population as a 
whole has not changed significantly over the past few years,273 the patients 
may only ask for the repeats when these are necessary, after the maximum 
number previously prescribed have finally been dispensed. The only 
difference between the two GPs groups in the services they provided was the 
provision of fewer home visits by clinical computer users. Hamilton et al 
(2003)274 also found that GPs who used computerised patient records 
recorded fewer home visits. As previously discussed (Chapter 5, Section 5.4) 
it seems unlikely that they would not provide home visits simply because they 
can’t take the computer with them, or because they have to download patient 
information from a laptop into a practice file after the consultation. It may be 
that they provide a similar number but, because they do not usually make 
paper notes, they did not take their BEACH recording pad with them to home 
visits, and so failed to record them. Whatever other possible causes exist, the 
difference remained after adjusting for GP age and other GP, practice, patient 
and morbidity characteristics measured in this study. 
The behaviours in which they differed generally, or as indicators of quality 
(that were associated with their clinical use of a computer), are not, in most 
cases, explainable. Clinical computer users provided fewer referrals to allied 
health professionalsŦ (a quality indicator where the hypothesis was 
inexplicably reversed), and fewer procedural treatments involving physical 
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medicine/rehabilitation. They provided fewer referrals to rehabilitation 
services, fewer referrals to counsellors generally, provided counselling/advice 
for nutrition/weight less often, and ordered more microbiology (other) tests 
and X-rays of the lumbar spine than GPs who did not use a computer for 
clinical activity. While some of these differences may at first appear to be a 
reflection of the age mix of the patients – fewer older patients, therefore fewer 
cases of age-related morbidity and its associated management – this was not 
the case. These differences remained after adjustment for characteristics that 
included patient age, and there appears no clear explanation for these 
disparities.  
The lower overall prescribing rate of clinical computer users may be related to 
their software use if, as suggested above, the majority of software was set on 
a default to prescribe the maximum number of repeats allowable under the 
PBSŦ regulations for all medications. Because these data are cross-sectional, 
I have no way of knowing how often patients at these encounters visit their 
GP. If GPs who prescribe through their software provide the maximum 
number of prescriptions, particularly for chronic conditions, then they will need 
to return less frequently for new prescriptions and therefore have a lesser 
chance of being sampled in BEACH. The decision to prescribe is a clinical 
one, but does having the facility to prescribe electronically affect the clinical 
decision? Printing repeats of prescriptions already listed in the patient’s 
prescription history is a relatively simple process, but depending on keyboard 
skills, entering the details for a new medicationŦ may take longer through the 
computer than in does to write one on paper – does this cause the GP to 
reconsider whether a new prescription is really needed and therefore affect 
the final decision to provide it? In a case of real need this is probably an 
unlikely scenario, but in instances where a GP might provide, for example, a 
prescription for an antibiotic with instructions to only fill it if the patient is not 
improving within 24–48 hours, will the time to prescribe electronically affect 
this decision? 
While I hypothesised that clinical computer users would detect more cases of 
depression, but prescribe fewer antidepressants, the reality was that they 
detected fewer new cases – a reversal of the hypothesis. However, their 
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overall management rate of depression did not differ, and their rates of 
counselling for patients with depression did not differ, (although it was 
hypothesised that they would provide this more often) (Chapter 5, Table 5.13). 
They prescribed fewer antidepressants relative to the number of cases 
managed (accepting the hypothesis). Depression is an illness which is not 
easily detected, particularly in situations where the patient is unwilling to 
disclose the full extent of their symptoms.275 Managing a problem once it has 
been diagnosed is a different scenario to making a new diagnosis and in this 
case, perhaps it is the division of consultation time between the patient and 
the computer, and the diversion of attention from the patient, that is the key to 
missing some of the unspoken signals which GPs often rely on in these 
situations (these issues are discussed further in the latter part of this chapter). 
Clinical computer use was associated with higher rates of referral to 
ophthalmologists for patients with diabetes, and this increased rate may be 
due to the alert function in the computer system reminding GPs to check 
whether such a referral is warranted for the patient. During the time these 
data were collected various diabetes awareness campaigns and programs 
were launched, particularly in the area of general practice – the Australian 
Primary Care Collaboratives Program addressing diabetes276; the National 
Integrated Diabetes Program277; and the Diabetes Australia Government 
Action Plan278 – but while such programs may have heightened the 
awareness of GPs there is no explanation for why computerised GPs would 
be more affected, or why ophthalmologists in particular would be selected 
over other allied health professionals (such as dietitians and podiatrists). 
A similar situation applies to the GPs using their computer specifically for test 
ordering. The only difference in their test ordering behaviour compared with 
their counterparts was an increase in the rate of HbA1cŦ test orders for 
patients with diabetes. Again there is no reason to assume that programs 
such as those listed above would affect the behaviour of one group of GPs 
more so than the other, or why HbA1c test orders would be affected 
specifically. Computerised reminders have been associated with an increase 
in both laboratory and screening tests279 but why only HbA1c tests for these 
GPs is not clear. The GPs did not differ on this indicator when measured on 
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clinical computer use only – it is specifically related to their use of a computer 
for test ordering – so the possibility that the alerts to recommend a test when 
a patient with diabetes attends is not an explanation. These flags would occur 
in the software for such patients regardless of whether the test order is made 
manually or via the computer, so they would not encourage an increase in test 
ordering by GPs who do this through their software to any degree greater than 
should also be seen in the group who receive these reminders just as 
regularly but order their tests via a paper based method. One possibility is that 
where tests were previously ordered for the patient via computer, the software 
may, in some systems, retain a list of these previously ordered tests, therefore 
prompting the repeat ordering of the same tests. 
Determining what these differences mean to quality of care remains complex. 
As discussed in Chapter 6 (Sections 6.1 & 6.5) the use of quality indicators is 
an inexact science at best. The indicators designed for use with these data, 
and selected for this study, were formulated around a frequency of event 
perspective on a group basis–I have not at any point attempted to single out 
individual encounters and assess the appropriateness of a particular referral 
or prescription for a particular patient. In designing and selecting indicators, 
consultation with the most learned and experienced can produce a consensus 
about which result will best indicate good quality. Parameters for many of the 
chosen quality indicators are fluid, hence the term ‘indicator’ rather then a 
noun of conclusion or goal. These tools are at best a directional pointer, and 
while much research, debate and discussion has gone into devising best 
practice guidelines, it may be that neither group has achieved ‘best’ practice, 
or that both have, on some or all of these indicators.  
These tools can give an indication of which performance is ‘better’ quality by 
deciding on a direction for best care, but at what point might the direction 
reverse? When decisions are subjective, when is one measure ‘enough’ and 
another ‘not enough’ or ‘too much’? For example, the prescribing of antibiotics 
for some respiratory conditions is considered poor quality of care because 
they are an unnecessary medication given their action applies only to bacteria 
and many such conditions are viral in origin. Being selective with these 
medications (i.e. prescribing fewer), is agreed to be an indicator of good 
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quality. But at what point does less revert to poor quality again, given that in 
the case of secondary bacterial infection, prescribing none would not be 
considered best practice either? The same question applies to HbA1c tests. 
Better quality is demonstrated by the group who ordered more of these for 
their patients with diabetes – but at what point does the number of tests 
become an unnecessary waste of resources and time for the funder, the 
pathologist and the patient? Fewer antidepressants for patients suffering 
depression is ‘better’ quality – no antidepressants for these patients would 
certainly not be considered so. 
The reality for many GPs looking to improve the quality of care is that they will 
strive to perform what is considered best practice for their patients, but 
predetermined targets can only be met within the confines of the patient’s 
unique circumstances, e.g. ideal blood pressures or cholesterol levels may 
not be achievable for some patients because of the co-morbidities they carry. 
Goals and targets set in guidelines and standards are an ideal but ‘care rarely 
meets absolute standards’.130 Assessing care when there are multiple 
conditions is problematic because it once again moves the boundaries of 
individual targets.169 Some researchers question the use of such indicators of 
performance as a measure of quality because of the variable nature of so 
many scenarios in general practice.132,280 Many seem hesitant about the 
adoption of quality indicators because they reflect only a fragmented view of a 
speciality whose goal is to care for the individual patient in a holistic way. 
Davies & Lampel (1998)132 believe that these indicators reflect end of process 
error detection rather than a measurement of quality, and may be 
counterproductive as this sort of performance measurement may in the long 
term, ‘engender an adversarial and defensive culture detrimental to quality’132 
Exworthy et al (2003)280 believe that as such indicators are used more in the 
health setting, they challenge the clinical autonomy of GPs and may have 
long term implications for the nature of the general practice profession.280 
Regardless of the complexities of quality indicators, they are the most agreed 
upon technique currently available for measuring quality, and the fact remains 
that the two GP groups (clinical computer users vs non-users; computerised 
test ordering vs non-computerised test ordering) examined on the indicators 
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adopted for this study did not differ on 36 of the 44 indicators investigated (in 
total). Of the remaining eight, they performed ‘better’ on four and ‘worse’ on 
four – a result any adjudicator would declare a draw. As mentioned in Chapter 
6 (Section 6.5) these results correlate with those of Linder et al (2006)204 – for 
14 of 17 quality indicators investigated using Ambulatory Medical Care Survey 
data, the physicians using electronic health records and those who did not, 
differed on only three indicators. Those using the electronic record performed 
‘better’ on two indicators and ‘worse’ on one. Neither study has produced any 
evidence that computerisation has had any effect at all on the quality of care – 
certainly none to show that it has improved quality in any way. 
The prescribing behaviour of GPs is considered to be an indicator of quality of 
patient care, and for this reason I attempted to determine whether the GPs 
exposed to pharmaceutical advertisements in their clinical software were 
being influenced to prescribe an advertised brandŦ over other, equally 
efficacious (and perhaps less expensive) alternatives. The GPs did not show 
any bias toward the advertised products examined and these results indicate 
that, at least where clinical software is concerned, the GPs were not 
influenced by the advertising embedded therein. For only one product, 
Nexium, was there a difference in the prescribing behaviour, and surprisingly 
the result showed that the advertising had a ‘negative’ affect from a marketing 
perspective (though the difference was small in clinical terms).  
As reported by Harvey et al (2005)253 GPs find the advertising in their 
software annoying. If annoyance played a role in the ‘negative’ affect of 
prescribing for Nexium, what bearing does this have on the quality of care? 
Just as it is considered inappropriate for clinicians to be influenced to 
prescribe one product over another, what of the patient who would benefit 
from such a product but the GP is too irritated to prescribe it? GPs are often 
unaware of bias or feel that they are not susceptible to the influence of 
promotion235 and anecdotally, GPs have told me that they ‘take no notice’ of 
the advertisements. These results suggest that they may not. Perhaps the 
cacophony of advertising media ‘noise’ that they are currently exposed to has 
nullified the effects of promotion to some degree. But will this become too 
much of a good thing? At what point does a GP become so inured to 
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advertisements that they postpone trying something new which may be 
beneficial to patients? Calfee (2002)281 argues for pharmacological marketing, 
because faster dissemination of information about new pharmaceuticals, or 
new uses for existing ones, improves patient care. Physicians are often slow 
to alter prescribing behaviour even when new evidence-based practice 
guidelines recommend it. They also pay more attention to diagnosing 
conditions when they know there are effective treatments.281  
There is no argument that the pharmaceutical industry is focused on sales of 
product – they can invest years and millions of dollars on medications that 
often don’t work or have side-effects which make them unusable238 – but 
ultimately there is no benefit in developing a product for which there is no 
market. Will it be detrimental to patients if GPs become less interested in new 
treatments because they are bombarded with advertising to the extent that 
they ‘tune out’? Just as in the case of inappropriate antibiotic prescribing, 
where patients are leaving with prescriptions they don’t need, are there 
patients walking out of consultations without prescriptions they do need? 
Dowden (2003)258 argued that GPs are easily influenced by promotional hype 
when new products are released because they want to do the best by their 
patients. Using the example of the introduction of Cox-2 inhibitors, he claimed 
that the prescribing of other NSAIDs did not decrease because the availability 
of coxibs increased the number of people being treated for musculoskeletal 
disorders ‘suggesting the new drugs were being prescribed for conditions 
beyond the restrictions of the PBS’.258 In some instances this may have been 
occurring but it could also have transpired that there were a large number of 
patients with musculoskeletal disorders, in need of pain relief, who could not 
take non-Cox-2 NSAIDs, for which there was now a treatment they could 
tolerate, and that many who could tolerate regular NSAIDs were still taking 
them. What happens to those groups of patients for whom there currently is 
no treatment if GPs become oblivious to information about new medications, 
or are ‘annoyed’ to the point of selective product refusal? 
The spectre of ‘BIG PHARMA’ as a necessary evil will continue because, 
whatever view is held, neither medicine nor the pharmaceutical industry can 
function in isolation from each other, and the patient’s quality of care – or life – 
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is significantly dependent on both. It is a cyclical co-dependence – the 
patients rely on the GPs to manage their ailments, the physicians cannot offer 
managements that have not yet been developed (by the pharmaceutical 
industry), and the pharmaceutical industry cannot market products without the 
GPs prescribing them or the patients involving themselves in clinical trials. For 
researchers, the pharmaceutical industry is often the only provider of funds to 
support such trials, but because of their reputation for not reporting failed or 
inconclusive results233,260, this work is often treated with suspicion, and many 
patients and clinicians are hesitant to participate. Roughead et al (1998)236 
observed that, compared with the amount pharmaceutical companies spend 
on promotion, they spend only one-third on research – but how much 
research would be performed without their backing? Would it not be more 
productive to encourage the transparency, validity and reliability of their 
investigations rather than limit research further by trying to function without 
their financial support? Smith (2005)259 calls for more public funding for 
clinical trials as this would bring with it more transparency. Contract research 
(unlike competitive grants such as through the National Health and Medical 
Research Council) that is totally government funded cannot be considered 
any less susceptible to censorship than private company sponsorship – the 
best balance is surely one where co-contributors keep each other ‘honest’. 
The transparency that allows GPs to confidently prescribe what the 
pharmaceutical industry has produced and that has been declared safe and 
efficacious can only enhance the quality of patient care. Where ‘winning 
markets’ is concerned however, product information and promotion remain the 
only tools for influencing prescribing behaviour. Recently, the Australian 
Competition and Consumer Commission introduced regulations to ensure that 
the ‘carrots’ previously offered by the pharmaceutical industry to physicians 
(lunches, gifts, travel and sponsorship etc) must now be declared twice-yearly 
and posted on the internet,282 and the industry has never had the ‘big stick’ 
capacity of the government to influence physician behaviour. 
As suggested in Chapter 2, the concept of technology managing health 
information and improving health care has arisen from the perceived benefits 
that technology has brought to other areas of the business sector. The 
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Australian Government has embarked on an exercise of reforming the health 
sector to promote and achieve an ideal of full computerisation. It is generally 
assumed that full computerisation of the processes of general practice will 
overcome many of the shortcomings of paper based health records. Sprague 
(2004) summarised the ideal succinctly:  
‘At the spiritual as well as practical center of the IT campaign is a belief 
that health care can be dramatically improved if accurate information is 
collected, arrayed, and communicated. Widespread use of EHRs is 
expected to eliminate many of the problems inherent in a paper-based 
system: information that cannot be retrieved, or deciphered, or checked 
against the notes in another doctor’s office; tests repeated because earlier 
results are not available; transitions where crucial information is left 
behind when a patient moves from one care setting to another. All of 
these can result in care that is not as effective as it could be or even 
harmful to the patient.’81  
There are many obvious benefits to be gained for ongoing patient care if 
every prescription is legible, every test order (and results) documented in a 
timely fashion, and all information relating to a patient’s history and ongoing 
health care are combined in one, easily accessible place.  
There are many benefits for the research community as well, and primary 
care research is growing exponentially – Ward et al (2000) reported an almost 
five-fold increase in Australian general practice research published in 1990–
99 compared with the previous decade.283 The ideal from a research 
perspective is that each patient record is similar in structure, includes a 
standardised comprehensive range of data elements, a minimum data set 
requiring completion, uses standard terminology and classification systems, 
and that every record is thoroughly and accurately completed at every patient 
visit. Access to such a comprehensive source of longitudinal patient health 
data would be welcomed by financial managers, clinicians, epidemiologists, 
policy makers and health educators, across the country. 
However, there are still many barriers to its achievement, and coming from a 
Health Information Management background, it has been somewhat 
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disheartening to discover during the process of this thesis, just how far from 
reality the fully-functioning ideal remains. The GPs in this study who noted 
their reservations about reliance on computers in their practice raised similar 
issues to those expressed by other clinicians reported in the literature, both in 
general practice and in other health settings – cost, reliability, privacy, 
security, interference with the consultation etc – and ultimately, GP 
acceptance is the final barrier to overcome. It is difficult to make a convincing 
argument for change without evidence, and at present the capabilities and 
benefits assumed of a computerised general practice, or indeed health 
system, have not been proven.  
While technology is advancing and improving almost daily, there are still many 
practical hurdles preventing the ‘physical’ interoperability needed for an 
electronically connected health network to function properly. Just in the area 
of general practice these are considerable, but they are similar to those faced 
across the health sector. As discussed in Chapter 4 (Section 4.4) the myriad 
of computer applications listed by Walker et al in 1997107, in a wide variety of 
exclusive formats, is still as prolific a decade later.83,284 How do GPs know 
which product to choose? How do they know which one is the ‘best’ – is it the 
least expensive? … the most ‘user-friendly’? … the one with the most bells 
and whistles? And by what yardstick do they compare one brand with 
another? Be it for initial purchase of systems, or for upgrades which become 
available at an ever increasing pace, clinicians have no criteria (i.e. 
standards) against which to measure the operating systems they are using. 
There is very little evidence of the assessment of any of this technology in a 
primary care setting, to determine whether these new systems are cost 
effective or time efficient in the long term. 
Where technical advances have undergone evaluation attempts in other 
health settings, the rapid pace of change has been identified as an 
impediment to true assessment. In the case of computerised decision support 
systems (CDSSŦ), for example, Garg & Tonelli (2005)285 argue that the 
cumulative knowledge that drives the recommendation for change is itself 
always changing, making it unrealistic to fully evaluate each version of 
software. Hardware, they claim, is constantly improving, such that ‘negative 
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studies taking years to complete may be attributed to outdated technology’.285 
Where assessments of CDSSs are undertaken, these are often performed by 
their creators. Garg & Adhikari (2005)286 summarised 100 trials of CDSSs 
over a 6 year period, two-thirds of which claimed improvements in clinician 
performance. Less than half showed improvement when the number of trials 
was reduced to authors who were not also the system developers.286 Wears & 
Berg (2005)287 observe that, while it has become accepted in software 
engineering that systems cannot be adequately evaluated by their developers, 
this principle seems to be commonly overlooked in health care. 
Apart from the difficulties in evaluating the equipment and systems (and 
probably more important in the move to convince clinicians of the benefits of 
technology), is the lack of evidence that the cost and inconvenience will 
ultimately result in improved quality of care for their patients. Pagliara 
(2007)288 believes that ‘the effectiveness of emerging eHealth technologies in 
improving the processes or outcomes of health care is unproven’. Her claim is 
supported by Garg & Tonelli (2005) who argue that, in the area of CDSSs, for 
example, only a handful of trials have examined cost effectiveness or patient 
outcomes, and as yet no real observed benefits have emerged.285 CDSSs 
have been shown to improve practitioner performance but to date, the effects 
on patient outcomes remain ‘under-investigated, and when studied, 
inconsistent’.286  
Reluctance by clinicians and other health workers to use IT systems has been 
identified as a barrier to the adoption of computerisation, and the lack of user 
involvement in development and design of technology has led to a level of 
dissatisfaction with the end product.288,289 There are some instances where 
clinicians have been engaged in these processes e.g. Frank Pyefinch, 
Andrew Magennis and Peter McIsaac are all GPs and were all involved in the 
creation and development of Medical Director software (A/Prof. Graeme 
Miller, personal communication). However, generally there are only one or two 
token participants in the technology design process, and there is little market 
research into design features. Even where work has involved considerable 
GP input, it has not been applied because Governments have not been willing 
(to date) to set these standards in place. The work undertaken to produce a 
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minimum set of data items for use in GP computer systems is one example of 
this. In a project funded by the GPCGŦ and undertaken by the AGPSCCŦ, 
data items were derived from established data sets currently used in 
Australian general practice. A final reporting minimum data set was developed 
in 2005 but has not yet been applied in practice.290 
In general, however, many software programs are developed by technicians 
who have little knowledge of medical care, and the involvement of end users 
in their design can only improve the long-term acceptance of these 
products.288,289 This is a systemic issue rather than a problem specific to 
general practice. Pagliari (2007) claims that ‘the clinical appropriateness and 
usability of eHealth technologies have been compromised by insufficient end-
user engagement in the design process’.288 The author believes that the lack 
of effective user involvement has been the direct cause of failure for many 
potentially useful systems across the health sector in recent years, because 
the ‘technical, human or organizational issues’ were unanticipated and only 
emerged after rollout.288  
A rather frightening example of this was the scenario emerging following the 
2002 introduction of a computerised physician order entry system into the 
Pittsburgh Children’s Hospital. Two clinicians from this hospital published 
papers in different journals reporting on the outcomes of implementing this 
technology. Upperman et al (2005) reported that since the new system was 
introduced there had been a significant reduction in adverse drug events 
throughout the hospital – and rightly concluded this to be a positive 
outcome.291 However, Han et al (2005)40 found that since the new computer 
system was introduced, the mortality rate in ICU for infants transferred from 
other facilities, had more than doubled because the usual chain of events for 
new admissions through transfer had been altered. Delays involved with 
ordering medications and treatments through the computer system, and other 
changes to routine introduced by the new technology, ultimately cost 
childrens’ lives.  
Yet as Coiera and Westbrook (2006)292 argue, perhaps the fault lay not so 
much with the software in this situation, as in the time taken to implement the 
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new system – less than a week. If anything this scenario highlights the need 
to act with caution in the introduction of these new technologies, and is 
perhaps a good reason for the Australian Government to reconsider the 
hurried approach it has taken to the computerisation of general practice in 
Australia. The ‘demand to rapidly introduce new information systems to 
improve the safety and quality of clinical practice’ is being more frequently 
questioned in light of recently appearing case reports indicating that ‘clinical 
software can sometimes cause harm’.292 
The previously mentioned variety of available software is not only problematic 
for GPs in determining what to choose. In itself it presents many obstructions 
to an IT connected health sector. Anderson et al (2006)83 observed that there 
are still ‘many competing vendors each with their own products’, such that 
interoperability remains a barrier to implementation of electronic record 
systems. Clinical programs have been designed in isolation, in an 
environment of competition for vendors who aim to keep their customers 
locked in to their product. Interoperability allows the ‘freedom’ for customers to 
take their business elsewhere with no disruption to their practice processes, 
so there is little incentive for developers to produce compatible products. To 
date there are no standards or regulations to which developers are required to 
adhere, resulting in products that in some cases have ‘significant gaps in 
functionality’ which may ultimately cause harm.292 Harvey (2005) reported 
incidences of defaults which caused the maximum number of repeats, or a ‘do 
not substitute generic drugs’ message, to be printed on prescriptions.208 On 
testing four popular software packages, the NPS found that some missed 
serious drug-drug interactions, and others produced numerous clinically 
unimportant alerts which ultimately led the GP to turn off all alerts.208 In these 
situations, serious harm could result, and these are clear examples of the 
opportunity for computerisation to adversely affect the quality of patient care 
rather than improve it.  
Presently in Australia, the software embedded in or linked to clinical devices, 
is tightly regulated, but clinical decision-support software such as prescribing 
programs ‘are not considered “therapeutic goods” and are not subject to 
regulation’,292 although some believe it should be.292,293 In arguing for 
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regulation of clinical software, Coiera and Westbrook (2006) promote the 
certification of software users to ensure safety across the system.292  
Training and certifying software users may resolve human error to some 
degree, but no matter how well advanced the technology, while ever systems 
are designed and operated by humans, errors will occur and quality of care 
will be compromised. Koppell et al (2005) reported 22 different types of 
medication errors made possible by the use of a computerised physician 
order entry system. A number of these may have been design flaws, but many 
were also associated with operator error.39 Ash et al (2004) found that user 
errors fell into two main categories – those related to the process of entering 
or retrieving information, e.g. ‘juxtaposition’ error where something is selected 
because it is close in appearance, or immediately next to, the intended item 
on a pick list, and those involving communication and coordination processes, 
e.g. the way that the use of a computer can undermine communication about 
events and activities.103 These human errors were often associated with 
human-computer interaction in a work environment which in reality, is fast 
paced, interactive, reactive and often interrupted by colleagues, patients, 
beepers, telephones etc. Most computer-human interfaces are designed for 
utilisation in an isolated, objective, rationalised, single-task environment which 
allows concentration on one event at a time.103,287 Unintended adverse 
consequences associated with human-computer interaction were also 
identified by Campbell et al (2006).102 These consequences fell into nine 
major categories, and included: more/new work for clinicians; unfavourable 
workflow issues; never ending system demands; problems related to paper 
persistence; untoward changes in communication patterns and practices; 
negative emotions; the generation of new kinds of errors; unexpected 
changes in the power structure; and overdependence on the technology.102 
Many of these problems could be solved by certifying software users as 
Coiera and Westbrook (2006)292 suggest. Training and certification would at 
least ensure that those using the software are familiar with it, and there would 
be consistency in the way data are entered and fields completed, but again 
there is a time and monetary cost involved in training all users to a 
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certification competency level. In the long term, however, the cost may be 
worthwhile if it reduces adverse events and consequent litigation. 
A regulation process for clinical software is a positive objective, but in order to 
introduce such regulation, standardisation will be required. NEHTAŦ has 
embarked on a standardisation path in Australia but progress is slow. It 
seems premature to be even thinking of standards and regulations for clinical 
software which includes patient records, when as yet there is not even a 
consensus in Australia on what is meant by the term ‘electronic health record’ 
(EHR). While perceived improvements in quality and efficiency have driven 
interest and investment in EHR technology, most potential customers for 
these systems have largely depended on vendors to tell them what an EHR is 
and what its capabilities should be. Clinicians with little software design 
knowledge are subject to different vendors referring to the EHR concept by 
different names, with some preferring ‘electronic medical record’ and others, 
‘clinical information management systems’.81 How an EHR is defined and 
what it includes has been the subject of policy debate in many countries. In 
the US, for example, the Institute of Medicine, at the request of the 
Department of Health and Human Services, compiled a list of ‘core 
functionalities’ that should work together to meet five EHR criteria, and 
employed the Health Level 7 organisation to develop a draft functional model 
for an EHR system as a standard against which purchasers can compare the 
capabilities of systems they are considering. Its use was voluntary, and 
because requirements for hospitals are different from those of general 
practitioners, most systems were gradually modified to suit the end users, 
ultimately leading back to diversity.81 Any standardisation or regulation 
process in Australia would need clear definitions that allow for different 
requirements in a variety of health settings across the health sector. Even in 
primary care alone, it cannot be assumed that one size will fit all where the 
design and implementation of an EHR is concerned, given the variety of 
settings in which they can be applied and the impact of different cultures and 
belief systems throughout the patient community.294  
However, given that all the technical problems are one day rectified, will 
expected gains in quality of care from the EHR materialise? Evidence of the 
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perceived benefits of the EHR remains scarce, and supporters are still 
reporting its ‘potential’. James (2005) stated that ‘interoperable electronic 
medical records (EMRs) have the potential to produce better health outcomes 
while improving the efficiency of care delivery and reducing its costs’.295 This 
is another example of the assumption having become the fact, as raised in 
Chapter 6 (Section 6.1). An article by the National Health Service of British 
Columbia296 is yet another example of an author employing this reasoning - 
statistics of adverse events were presented from many sources, as were three 
different studies claiming ‘regular tracking of dosages could cut errors’ … ‘has 
the potential to prevent’ errors … ‘could potentially have prevented’ errors – 
from which the author concluded ‘In short, information technology with 
computer decision support systems can help reduce medication errors’.296 
One of the studies used as evidence by the author was that of Upperman 
from the Pittsburgh Childrens’ Hospital291 (reported above) – Han’s 
experience of the same CPOE system was not mentioned.40 Beside the many 
claims of ‘potential’ benefit stand the reports of real evidence (such as those 
cited earlier39,40,102,103) of what can go wrong given system and computer 
error, the negative effect on quality of care, and the subsequent 
dissatisfaction of staff.  
Staff dissatisfaction with clinical electronic systems will lead to their reluctance 
to use them, and jeopardise their long term successful integration.82 But when 
all technical issues are resolved, and reliable, user-friendly systems are being 
readily employed by contented health workers, where is the evidence that the 
perceived benefits will materialise? Will quality of care be improved? 
Likourezos et al (2004)297 reported that clinicians and staff in an emergency 
department at a large teaching hospital were generally satisfied with the 
computer system, found it easy to use and were positive about its impact on 
their work routines – but they believed the introduction of the electronic 
medical record had no positive impact on patient care. Clinicians and nurses 
felt that the electronic record would ‘not yet improve the quality of care, will 
not reduce costs, will not decrease waiting times, will not lessen the number 
of laboratory tests, will not reduce the number of ED visits, and will not 
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attenuate ED overcrowding’. The authors allow that clinicians in other 
institutions and health settings may feel differently.297  
There was no evidence to support the feelings or beliefs of these health 
workers, but are their feelings and beliefs any more or less valid than those of 
the IT promoters who believe technology will cure all ills? For a decision 
support system to work effectively in identifying errors of omission or 
commission, it needs all the information to be available and current.296 There 
may be many benefits to computerised records but the quality of the data in 
them remains unknown274 and largely under-investigated. The notes entered 
in an electronic record will be more legible, but where is the evidence that 
they will be any more complete than those that have been hand written? 
Where is the evidence that tests won’t be repeated where clinician’s rely on a 
computer system which may or may not have the information entered? Even 
where the GP is fastidious in the completeness and accuracy of his/her own 
patient information that will not guarantee the reliability of a pathologist or 
technician being as timely or consistent in delivering results. Computerised 
prescribing will certainly make prescriptions legible, but what of the 
juxtaposition error referred to by Ash (2004)?103 ‘Prescription generation 
appears to be an activity which makes particular attentional demands upon 
the GP’82 – what measures ensure that the correct prescription is selected 
from a ‘pick-list’ in a busy practice, in a stressful consultation with a distraught 
mother trying to simultaneously calm a screaming infant and keep her toddler 
from emptying the sharps bin? Can the same selection errors result from 
similarly designed pick-lists for pathology or imaging orders? Whether 
delivered by the patient personally, or the GP electronically, will the 
pharmacist question the prescription when it is presented? Will the 
pathologist, or the radiographer? What if downloaded information sought in 
clinical decision support is incorrect? In the event that errors result from a 
design flaw in a software update, who is liable if system problems lead to an 
adverse event – the designer, the vendor or the user? 
The use of technology in general practice has introduced new areas for 
potential litigation.81 Apart from scenarios like those mentioned above, there is 
potential for harm in the use of the ‘hybrid’ patient record, described by 
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Walker (1994) as ‘a cumbersome byproduct of the evolution to the computer-
based patient record’.298 Anderson (2006) observed that ‘fragmented and 
inaccessible clinical information adversely affects both the cost and quality of 
health care as well as compromises patient safety’.83 In the UK, Hamilton et al 
(2003)274 compared computer-only record keeping with paper-only and hybrid 
systems in a primary care setting. They found that computers encourage 
‘minimalist record keeping’ – fewer symptoms were noted in the consultation 
and fewer home visits were recorded in computerised records. Paper records 
included fewer telephone consultations, but contained more symptoms 
reported at the consultation, better recording of absent symptoms and better 
recording of severity of symptoms. Surprisingly, a higher rate of consultations 
were documented in hybrid systems than in either paper-only or computer-
only systems and the authors questioned whether this is simply the result of 
clinicians keeping better records when both options are kept in parallel. They 
concluded that their results had ‘medicolegal implications, as well as 
implications for continuity of care, for researchers and for compilers of 
information about primary care usage’.274 These implications must also apply 
to the records being kept by Australian GPs. My research shows that only half 
of the GPs who claimed to use electronic medical records actually keep all 
their patient data in electronic format, the remainder using a hybrid system 
where some information is kept electronically and some in paper format. This 
equates to 29.8% of the 1,069 GPs who use computers for clinical activity. As 
a consequence, clinical information for these patients is now in two locations 
instead of one, which means that relevant information could be overlooked, 
possibly leading to adverse consequences for both the patient medically, and 
the GP legally. In this instance, the introduction of technology into a health 
setting has potentially a very negative affect on the quality of patient care.  
Further evidence of incomplete recording was reported by McInnes et al 
(2006)100. They found that 98% of the Australian GPs surveyed were 
prescribing electronically, but only 65% were recording a ‘reason’ for the 
prescription (i.e. an indication of the problem being managed). Although the 
authors did not define ‘mostly’, they reported that 64.4% of GPs recorded 
progress notes mostly by computer, 19.6% mostly be paper, and 13.5% both 
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computer and paper, results which also show evidence of hybrid records.100 
Apart from quality of care and medicolegal concerns, the quality of data 
contained in these records must be of questionably value for research 
purposes, considering the comments of Pont et al (2004) previously 
mentioned in Chapter 6 (Section 6.1) – ‘if prescribing information and no 
indication is available, misclassification of patients occurs, undermining the 
possibility of a valid assessment of prescribing quality for a specific 
disease’.126  
Hamilton et al’s findings of computers encouraging ‘minimalist record 
keeping’274 support the findings of the BEACH investigators (who are often 
asked why data cannot be collected via computer rather than the current 
structured paper forms) from a ‘trial’ of ‘computer BEACH’ in 2003. The trial 
involved 40 GPs from Western Sydney who had previously participated in 
BEACH and, while all had completed the paper version, only 27 completed 
the electronic version as they found it far more time consuming and tedious to 
be juggling between computer screens than writing the information on paper. 
They recorded fewer problems managed at the consultation, and fewer 
managements for those problems, than they had when recording information 
on the paper forms.299 
There are also legal ramifications if patient privacy and confidentiality are 
breached. The electronic storage of patient information is only as safe as the 
next generation of ‘hackers’ – the Age newspaper of 25th Aug 07 reported a 
16 year old boy taking only thirty minutes to break an $84 million security filter 
developed by the Australian Government to prevent pornographic sites being 
accessed by children.300 Despite the guarantees, be it for provision of care301 
or for purposes of research,302,303 there is not yet evidence to convince 
clinicians that adequate security infrastructures are in place, particularly for 
the electronic transfer of patient information to another setting. Data 
linkage304,305 offers much potential from an epidemiological perspective but 
privacy is a primary concern to patients95,306 and, while there is a very real 
need for access to patient data for ongoing disease surveillance and benefit to 
public health,307 Australian information security technologies are presently 
inadequate and require improvement for the security of EHRs.308-310 GPs’ lack 
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of certainty in the security of patient information is an impediment to their 
commitment to IT. Will enforcing interoperability among health care providers 
affect the quality of the data GPs enter in their patients’ records? If they fear 
breaches of confidentiality will they censor or restrict what they write? If the 
system becomes truly interoperable who will own the patient’s record? Who 
will ensure the quality of the data? Who will be responsible for its 
completeness – and be accountable if gaps occur? Even when all care 
providers have the capacity to send and receive information electronically, 
where is the evidence that each will fulfil their obligation in a timely manner, or 
at all? Time-poor clinicians may still struggle to meet these demands 
regardless of the data transfer capacity or how secure the communication 
systems become. 
Communication systems such as email and voice-mail are still not 
commonplace in many heath settings.311 As reported in Chapter 4 (Section 
4.4), a significant proportion of GPs in this study with internet and email 
available at the practice did not use them. Email has potential advantages in 
delivering health care: it can be sent and received at anytime from almost 
anywhere; it can offer access to care for patients in remote areas; patient 
information can be written down instead of given orally; it allows patients to 
clarify instructions or report adverse events; clinicians can confer with 
colleagues to give a more considered response.312 Its disadvantages, 
however, are the absence of physical cues that aid interpretation; quality of 
care may be compromised through the potential to respond too slowly to 
messages that might be urgent; and the ‘threat to patient privacy including 
unauthorised interception of unencrypted emails, receipt or retrieval of emails 
by unauthorised people, or inappropriate physical security measures’.312 
While patients are becoming more interested in email communication with 
their GP,313-315 as yet there is little evidence that potential benefits can be 
translated into routine clinical care.312 What many clinicians may fear in an era 
of electronic data exchange, either between health care providers, or between 
doctor and patient, is the potential for privacy and confidentiality to be 
compromised, and the outcome of not receiving information in a timely 
enough manner to act on it where necessary. Sending an email does not 
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ensure that the recipient has time to immediately read it. Who is legally 
accountable if emails are not responded to ‘in time’ with adverse 
consequences, or if sensitive information is inappropriately accessed? Even if 
litigation does not result, the doctor-patient relationship is certainly 
compromised. The relationship may also become strained if the patient 
becomes too demanding. Replying to emails places an extra strain on an 
already heavy workload.313,314 As Delbanco (2004) observes, ‘for doctors, at a 
time of disquiet, fatigue, and bombardment by paper and electronic “noise”, 
even if e-mail improves the quality of communication with patients, it threatens 
to break the camel’s back’.314 The doctor cannot claim payment from 
Medicare for these communications – at what point is it acceptable to expect 
the patient to pay for the GP’s time? 
The relationship with the patient is an area where the introduction of 
technology has inspired much debate and is one of the major barriers to full 
computer uptake by GPs.106 There is evidence that patients are wary97 but 
becoming more accepting of the computer in the consultation,94,95 and as time 
progresses there will be a generation of patients for whom its presence is 
routine and unquestioned. But personal communication is critical to quality of 
care – it is the nuances, the vocal intonations, the body language, the 
momentary hesitations, that often convey the additional information allowing 
the GP the best chance to elicit all of the patient’s concerns.312 Patients in 
turn, prefer a doctor who will listen to their problems93 and are ultimately more 
satisfied with the quality of a consultation where they feel they have been 
heard, regardless of its length.316 The premature interruption of patients 
results in the potential loss of relevant information179 and consultation time 
previously given entirely to the patient is now being shared with the computer, 
which limits patient interaction time.82,92,317 (It is this aspect which may have a 
bearing on the difference in management rates for ‘new’ cases of depression, 
raised earlier in this chapter). Britten et al (2000) argue that lack of exchange 
of relevant information in both directions causes misunderstandings which can 
lead to errors, adverse events, and legal issues at best.93 In this study, the 
mean consultation length for the GPs who employed a computer in their 
clinical activity was identical to that of the GPs who did not use a computer. 
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Does this mean that the patients of clinical computer users received a lesser 
quality consultation because some part of their time was surrendered to the 
GP’s interaction with the computer? To what extent is interpersonal 
communication being compromised? Is it less compromised if the clinician is 
proficient at using the computer? Is it more compromised by the number of 
functions used by the GP in the consultation? Is it further compromised by 
GPs juggling their attention between computer functions, paper notes and the 
patient? Gibson et al (2005)82 reported this ‘multitasking’ observed during the 
consultation, and Booth et al (2004)92 found that generally GPs are not able to 
multitask at this level. Bui (2005) adds that the distribution of work within the 
consultation has changed since the introduction of computers.89 GPs can 
attend to both the patient and the computer screen during the consultation but 
both activities require a level of attention that precludes them from happening 
simultaneously.92 How do we measure whether the trade off – the benefits 
gained from more legible and precise prescriptions and clinical notes, at the 
cost of time interacting with the patient – is an advantage or disadvantage? 
How do we assess its impact on the overall quality of care?  
The ability of technology to affect the communication between clinicians and 
their colleagues can also impact on the quality of patient care. As Coiera 
(2000) described, the computer has become the centre of information 
systems in health settings as ‘computational models of clinical problems allow 
computers to make inferences and create views on data or perhaps prompt, 
critique, or actually make clinical decisions’.318 He argues that in the 
computational paradigm, clinicians turn to computer-based systems for clinical 
decision support, but in reality, people prefer to communicate with each other 
and turn to their colleagues and peers for information and decision support.318 
Many clinical actions result from the variety of input received through 
interactions with other health care providers which incorporate their collective 
knowledge and experience. Computers are an excellent source of answers 
given they are asked a question in the ‘right’ way, and have been 
programmed with the ability to access and present the information in the first 
instance. However, anyone who has ever used a search engine can verify 
that, no matter how much information may have been acquired, said 
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information will never be presented unless the seeker follows a specific logical 
path, which may or may not be obvious. Humans have the ability to converse, 
share and interpret information as an interactive process, through questions, 
answers, explanations and descriptions. A busy clinician may not find the 
opportunity to seek decision support via technology for several days – but the 
answer may well be provided through a conversation with colleagues on the 
short walk to the car park. As Coiera (2000) states: ‘the biggest information 
repository in health care lies in the people working in it, and the biggest 
information system is the web of conversations that link the actions of these 
individuals’.318  
Perhaps even more significant than the benefit of clinicians communicating is 
the potential for harm when this communication is absent. Communication 
failures are a source of significant morbidity and mortality, and contribute 
significantly to adverse clinical events and outcomes.103,318 In an incident-
monitoring study of general practitioners, Bhasale et al (1998) reported that 
over 40% of all detected adverse events were associated with errors in 
communication – between patients and health professionals (23%) and 
between health professionals (with each other, 19%).319 How will greater 
reliance on technology affect these communication processes? Will 
encouraging practitioners to follow the computational paradigm for decision 
support instead of interacting with colleagues improve their decisions? The 
GP now shares the patient’s communication time with a computer. What will 
be the outcome for patient care of sharing colleague communication time in 
the same manner? Will the errors increase because there is less 
communication with peers, or decrease because technology can provide 
better answers? 
There is no denying that technology has improved many aspects of health 
delivery – sophisticated cameras, instruments and computer screens allow 
keyhole surgery,320,321 scans and photographs can be taken of babies in 
utero,322,323 photography software improves accuracy of geometric verification 
in radiotherapy,324 clinical applications of telemedicine are now found in 
virtually every specialty325 and allow city specialists to consult patients 
hundreds of kilometres away.326,327 Technology has also provided avenues for 
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harm – prescription medications can be ordered and imported via the internet 
for patient use without any medical supervision.328,329  
Regardless of the pros and cons, the current political move for primary care in 
Australia is toward full computerisation in the interest of ‘safer, better, more 
convenient and more efficient health care’.330 The Government’s approach is 
likely to be motivated from a business paradigm as much as from concern for 
the best outcomes for patients. Health has become an ‘industry’ over the past 
few decades and as the population ages and health care costs increase 
exponentially, health economists will favour reducing costs wherever 
possible.82  
Those who provide care are often in conflict with those in financial 
governance, because the quality of patient care is of primary importance to 
the provider. Pearce & Trumble (2006)317 described the rise of the patient 
centred approach to primary care and its adoption within general practice. 
GPs think it a worthwhile approach to patient care because of the evidence 
gathered over several decades of the benefit to the patient from being treated 
holistically. Pearce sites evidence of greater identification of psychosocial 
problems, improved patient satisfaction and enablement, and overall 
improvement in the doctor-patient relationship.317 It is the personal 
communication between doctor and patient that ultimately produces a good 
outcome from the consultation for both parties and that is achieved through 
treating the person as an entity rather than as a collection of anatomical parts, 
one or several of which are experiencing a biological symptom. It is this 
relationship that is central to the quality of care, and from the clinician’s 
perspective, what can challenge that relationship can challenge the quality. At 
present, the computer screen may be influencing this relationship, but again 
this is a situation that may improve with time regardless of other 
interventions–the GPs currently making this transition are not as adept or 
comfortable with the use of the computer as their younger counterparts, and 
as the next generation of clinicians commence primary care, their familiarity 
and ease with technology may negate its intrusiveness. 
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The current trend to consider health provision a business, and patient care a 
commodity, is in conflict with the very premise inherent in medicine. In the 
words of the ‘father of quality assurance’, Avedis Donabedian, ‘health care is 
a sacred mission. It is a moral enterprise and a scientific enterprise but not 
fundamentally a commercial one. We are not selling a product’.121 He 
lamented the commercialised road that health care has taken, particularly as 
many of the structural features of current health maintenance organisations 
are those which he strongly advocated – but always with the provision that the 
objective was improving care, not reducing costs.121 In an interview shortly 
before his death, he expressed concern for the fate of the medical profession. 
He felt that doctors are being exploited by corporate enterprise and are 
gradually losing the respect of the public.121 As corporations purchase and 
take over primary care practices they may well be impacting on the autonomy 
of GPs to provide the highest quality care for their patients. If the real 
motivation to computerise general practice is from a commercial perspective it 
is not surprising that clinicians will react with caution. I believe this is one of 
the major reasons for resistance by many GPs in embracing IT – they are not 
convinced of its benefits, are seeing more evidence of its potential to cause 
harm, and no matter how well this technology performs in other areas of 
industry one fact remains – if a computer system fails in the banking industry 
money may be lost; if it fails in a health setting, lives can be lost. 
Recent developments  
The Australian Government’s investment in IT is not insubstantial. Since the 
late 1990s it has provided more than $700 million to support the use of 
information technology in general practice and has committed $69 million to 
providing broadband access for GPs and pharmacists.330 A further $98 million 
will create ‘EasyClaim’, a card swipe service whereby patients can obtain their 
Medicare rebate online from their doctor’s surgery, and yet another $79 
million has been committed towards NEHTA’s development of unique 
identifiers for patients and providers, and developing a ‘common language’ for 
use in patient records, so that terms have the same clinical meaning across 
different record systems.330 The latter is vital for true interoperability – for an 
EHR to be in any way useful it must contain meaningful information, not 
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simply isolated pieces of data. On paper, clinicians have used whatever terms 
they prefer, which can include their own shorthand, jargon, and expressions. 
To communicate effectively with other health care providers, common 
definitions of symptoms, conditions and treatments will be necessary.81 To 
this end, the Government announced that as of July 1st 2006,331 it has 
adopted SNOMED CT (Systematized Nomenclature of Medicine – Clinical 
Terms), a clinical terminology comprising terms for more than 360,000 
medical concepts. Despite its size and inclusiveness, however, SNOMED CT 
does not serve all needs for end users.81 It does not include terms for 
conditions unique to Australia (such as brown snake bite), and will still need to 
be synchronised or ‘mapped’ to classification systems currently in use, such 
as ICPC-2Ŧ (used in primary care) and ICD-10 AM Ŧ (used in hospital 
systems). The annual cost to the Government for the national SNOMED CT 
licence fee is $US244,957.00 ($AU298,292.00).332 
Given the cost of this investment, the Government is using all the ‘carrots and 
sticks’ at its disposal to encourage GPs to computerise. In the past year, there 
have been references by health department representatives as well as the 
Federal Health Minister, to possible repercussions for GPs who do not 
computerise, such as revoking their accreditationŦ and removing their access 
to Medicare payments.330,333 Some theorists promote financial incentives as a 
method of encouraging the adoption of IT.334,335 Most recently, the Federal 
Health Minister announced plans for access to PIPŦ payments or even the 
MBS itself to become ‘subject to best practice in health record-keeping.’330 As 
the Minister observed in his recent address at the Australian Health Summit, 
‘it would be fair to say that policy makers have been impatient to see an 
operational return on these investments rather than a proliferation of trial 
projects and pilot schemes’.330 Yet the Minister also observed that ‘the British 
Government has discovered that it’s much easier to spend money on health 
IT than to produce a functioning e-health system’.330 There are some who 
may advise the Minister to learn from the UK lesson. Gibson et al (2005) state 
that the introduction of new technologies into the NHS has been politically 
driven because ‘policy makers regard the promotion and implementation of 
innovative health technologies as politically attractive, promising both clinical 
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and cost effectiveness’ when ‘relatively few studies have detailed how such 
technologies are actually utilised and their consequent impacts on users’ 
practices.’82 Coiera (2007)336 summarised the pros and cons of the NHS 
National Program for IT and recommended that Australia should learn from 
that experience. He proposes Australia begin its IT modernisation program in 
a few national clinical centres of excellence – with time, successful 
technologies, processes and work practices, as well as the personnel trained 
in them, can then migrate to the rest of the health system’.336 IT, he argues, 
can be a powerful enabler, but if poorly implemented or used, can result in 
patient harm.336 Australia’s investment in IT can best be protected if such 
advice is heeded. It is the most reliable way to ensure that quality of patient 
care is improved and not diminished. 
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CHAPTER 9 
 
CONCLUSION 
In this thesis I have attempted to determine whether the use of a computer as 
a clinical tool has affected the practice behaviour or the quality of care 
provided by a representative national sample of physicians working in 
Australian general practice. The quality of care provided by Australian GPsŦ 
appears neither to have improved nor deteriorated as a result of the 
introduction of computers to clinical practice. At a time when general practice 
is time poor and understaffed, GPs are being pressured to adopt technology 
about which they appear to have misgivings, at least in regard to stability and 
reliability. The reported ‘double’ record keeping indicates that technology does 
not appear to have reduced the amount of paper work and in many practices, 
the use of hybrid records has increased the possibility of harm to the patient, 
litigation for the clinician, and poorer quality of patient information.  
The few differences observed in their practice behaviour are not easily 
explainable and appear to exist in isolation. The two groups differed on only 
eight of forty-two quality indicators, performing ‘better’ on four and ‘worse’ on 
four, and overall do not appear to differ to any degree in the quality of care 
they provide to their patients. The exposure to advertising embedded in their 
clinical software also appears to have had little (if any) effect on the 
prescribing behaviour of GPs so exposed. 
I would have liked to examine the records of GPs who stated they were fully 
computerised (paperless), and compare those with the paper records they 
used to keep, or the records of those who stated they were not fully 
computerised, to see if there were differences in the quality or completeness 
of their notes, and indeed, differences in their overall practice behaviour. This 
objective was ultimately beyond the scope of this thesis, but it is worthy of 
further investigation and should be undertaken soon. There were only 188 
GPs in the group who did not use a computer for clinical activity. Whether or 
not clinical computer use ultimately affects the quality of patient care may not 
be completely assess until full computerisation of general practice is 
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achieved, but such assessment will be difficult without a non-user group for 
comparison. Other research methods will need to be developed. 
There are GPs who have fully adopted technology and are finding it an asset 
to the running of their practice but still have reservations about fully 
connecting with the larger health system. In general, however, GPs have seen 
little evidence to date that the cost in either time or money will produce a long 
term benefit to either the running of their practice or the quality of care their 
patients receive, and I have produced none either. I believe this is one of the 
major reasons for resistance by many clinicians to fully embracing IT.  
There is evidence of some benefits to the use of a computer as a clinical tool, 
and an assumption that others may eventuate. There is however, emerging 
evidence that harm can also result from their use. Until more evidence 
emerges that computerisation will improve the quality of care for their patients 
GPs will err on the side of caution – because one day they took an oath to 
‘abstain from whatever is harmful’.337  
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Appendix 2:  
Letter of invitation to participate in BEACH 
 
 
 
 
 
 
 
«Letter» 
 
«ID» 
«Title» «Firstname» «Surname» 
«Address1» 
«Address2» 
«Suburb»  «State»  «Pcode» 
 
Dear «Title» «Surname» 
 
BETTERING THE EVALUATION AND CARE OF HEALTH (BEACH ©) 
 
A NATIONAL SURVEY OF MORBIDITY AND ITS MANAGEMENT IN GENERAL PRACTICE 
 
Your name was drawn from a random sample of all practising recognised GPs in Australia and we 
invite you to work with us on this study.  BEACH © is a continuous data collection program now in its 
seventh year and is recognised as a quality assurance option by the RACGP’s QA program. 
Participation in BEACH © earns you a total of 65 Clinical Audit points. Participants can also earn 
ACCRM points.  BEACH© is free of charge because this National survey is funded by a consortium. 
 
Why do we need to carry out this study?  There are over 100 million consultations conducted in 
Australia by general practitioners every year. National general practice data is vital to the future of 
general practice in its negotiations with government. The General Practice Statistics and 
Classification Unit is a collaborating Unit of the University of Sydney and the Australian Institute 
of Health and Welfare. The Unit’s major objective is to ensure sufficient information is available 
about the problems managed and treatments provided in general practice in Australia.  To that end 
we are collecting de-identified data from a “rolling” random sample of GPs across the country at a 
rate of 20 per week – about 1,000 GPs per year. Over the past six years, the BEACH© programme has 
become recognised as the definitive source of general practice data in Australia. 
 
What would you gain from the study?  In return for your time you will receive 35 CA points plus 
a report containing a detailed profile of your practice, a comparison with nine other de-identified 
participants and the average results from all participants. When you fill in a short questionnaire 
about this report, the RACGP will allocate another 15 CA points. We will also provide resource 
material on alcohol consumption and smoking plus some tally sheets which you can use six months 
later if you wish to take part in the final stage of BEACH©, worth another 15 CA points. 
 
What would you need to do?  Complete a form for each of 100 consecutive patients, recording 
such details as age and sex, reasons for encounter, diagnoses, medications and other treatments 
provided at each encounter (not patient’s complete medical history).  In this study we are also 
gathering extremely valuable data on the health status of patients attending general practice, so at 
the bottom of each form there are a few varying questions to ask the patient. 
 
page 1 of 2 BEACH © 
 
 
 
The University of Sydney 
at Westmead Hospital 
General Practice Statistics and Classification Unit
  Family Medicine Research Centre 
    
Australian Institute of 
Health and Welfare 
a collaborating unit of the 
An example of a recording form is enclosed for your information.  Please do not be daunted by its 
seeming complexity.  Although there are four boxes for problems managed, at most encounters you 
will have only one or two to record.   Likewise, although there are four spaces to record 
medications for each problem, in many cases there will be only one or two, or in fact none, to 
record.  From past participants it is estimated that each form would take you about two or three 
minutes to complete.  A clear and comprehensive set of instructions will be included with your pad 
of forms.   
 
The large de-identified BEACH data-base which has been building since 1998 is put to various 
uses.  A report on the activities of general practice is published each year and papers are published 
in medical journals both in Australia and internationally. We now plot changes and trends in 
morbidity and its management in general practice. The data are used by all organisations 
contributing to the BEACH © program costs. In order to support further research and development in 
general practice and to aid planning for better health, data are sometimes supplied to other 
interested parties.  Data are never supplied in a form that could identify an individual GP or patient. 
You can visit our web site at www.fmrc.org.au for more information and to see our annual reports.  
 
A research assistant from the Centre will soon contact you by telephone to ascertain your 
availability and willingness to take part in the study. If you prefer, please ring us on our toll free 
number 1800 62 73 75. 
 
Thank you for taking the time to read this letter.  BEACH depends on the goodwill of the general 
practitioner workforce and we are keenly aware of the effort GPs from all over Australia put in to 
the BEACH program. We would greatly appreciate your involvement. 
 
Yours sincerely 
 
 
 
Dr Helena Britt 
A/Professor & Director 
General Practice Statistics & Classification Unit, the University of Sydney     
 
 
The Beach© program is endorsed by the Royal Australian College of General 
Practitioners and the Australian Medical Association 
 
• This project has been approved by the Health Ethics Committee of the Australian Institute of Health and Welfare 
and the Human Ethics Committee of the University of Sydney.  
• The data is being collected under the AIHW ACT 1987 and in accordance with the Privacy Act 1988. 
• BEACH © is overseen by a Program Advisory Board comprising representatives of the University of Sydney, the 
AIHW, each contributing organisation, the RACGP, the AMA, Divisions of General Practice and the Consumer 
Health Forum.  
 
Organisations contributing to the considerable cost of the BEACH © program are: 
 )The Department of Health & Ageing         )AstraZeneca (Aust) Pty Ltd)       )Janssen-Cilag Pty Ltd     
 )Merck Sharp & Dohme (Aust) Pty Ltd              )Pfizer Australia Pty Ltd 
 
Research team:   Dr Helena Britt, Dr Graeme Miller,  Jan Charles,  Stephanie Knox,   
Joan Henderson,  Lisa Valenti, Ying Pan,  Clare Bayram,  Julie O’Halloran,  Christopher Harrison. 
Any person with concerns or complaints about the conduct of this study can contact the Manager 
for Ethics Administration, University of Sydney on (02) 9351 4811. 
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Appendix 4:  
BEACH data collection form (encounter form) 
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 Problem    :
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ASK THE PATIENT:
What is their height
(without shoes) ?
What is their weight
(unclothed) ?
(You are NOT REQUIRED
to weigh or measure the
patient, but if the patient is
unsure, you may either do
so or take information from
the medical records.)
 
Alcohol use
ASK THE PATIENT (if over 18 years old):
1. How often they have a drink containing alcohol?
2. How many standard drinks they have on a typical drinking day?
(Use the standard drinks chart supplied if necessary).
3. How often they have more than 6 standard drinks on one occasion?
PLEASE ANSWER ALL  3  ALCOHOL QUESTIONS.
or we cannot determine safety of drinking levels.
  
 
FINISH TIME
Record the time the
consultation FINISHED in
hours and mins and circle
whether the time was AM
or PM.
eg.  
 AM / PM
	

The shaded section of the following forms asks questions about TIME OF CONSULTATION, & PATIENT RISK FACTORS
(BMI, smoking & alcohol).
You may tear out this page as a guide to completing the following 40 forms.
START TIME
Record the time the consultation
STARTED in hours and mins and
circle whether the time was AM or
PM.
eg.      
             AM / PM
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ASK THE PATIENT
if over 18 years:
Which category best
describes their smoking
status?
Tick one box.
 
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Appendix 5:  
Research kit covering letter for participants 
 
12th January 2005 
 
«DOCID» 
«Title» «Firstname» «Surname» 
«Address1» 
«Address2» 
«Suburb»    «Pcode» 
 
Dear «Title» «Surname» 
  
BETTERING THE EVALUATION AND CARE OF HEALTH 
A NATIONAL STUDY OF GENERAL PRACTICE 
WEEK 323 -  «Recdate» 
Thank you for agreeing to take part in this national study of general practice.  The week 
allocated to you is shown above. As we are running behind schedule at the moment, that date 
may already have passed so please just begin as soon as you can and continue until you have 
completed the 100 consecutive consultations.  This phase of the BEACH study consists of: 
• The completion of a very short “GP Profile” which you should return with your 
completed forms.  At no time will we release your name or any other identifying 
information to anyone.  Some of these anonymous data will appear in your report together 
with that of the nine other doctors in your “batch” so that you will have an idea of the 
basic characteristics of the other doctors. 
• The recording of 102 consecutive patient encounters.  This includes the shaded area at the 
bottom of each form.  The first 100 complete and legible records will be analysed. 
Please return the forms and profile in the reply-paid envelope as soon as you have completed 
recording, so that you will be compared with the other doctors who have recorded at the same 
time as you. The RACGP will then be notified and will allocate you 35 Clinical Audit 
(Group 1) points.  You will receive from us a report of your results about eight weeks later 
and you can then answer the accompanying questionnaire on interpretation of your results. A 
reply paid envelope for its return will be sent to you with your report.  When that 
questionnaire is received here, the College will again be notified and a further 15 CA points 
allocated.  
If you then wish to take part in a short BEACH Re-Audit of patient smoking, drinking 
and BMI six months later which is worth another 15 CA points, please retain the 
laminated Patient Information Cards. Material for the Re-Audit will automatically be sent 
to you when you return the above-mentioned questionnaire. 
Once again our thanks for your valuable contribution to the overall results of this in-depth 
study of Australian general practice (see our website www.fmrc.org.au ). If you have any 
queries, please call me on Freecall 1800 62 73 75. 
Yours sincerely 
 
 
Jan Charles 
Project Director       
 
General Practice Statistics and Classification Unit
  Family Medicine Research Centre 
   
The University of Sydney 
a collaborating unit of 
Australian Institute of 
Health and Welfare 
GPSCU,  Acacia House,  Westmead Hospital, PO Box 533,WENTWORTHVILLE, 2145. 
Ph: 02 98458151 fax: 02 98458155       email: janc@med.usyd.edu.au      Web http://www.fmrc.org.au   
at Westmead Hospital 
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Appendix 6:  
BEACH program summary information sheet 
BETTERING THE EVALUATION AND CARE OF HEALTH (BEACH ©) 
 
 A NATIONAL SURVEY OF MORBIDITY AND ITS MANAGEMENT IN GENERAL PRACTICE 
 
Summary Information  
 
The General Practice Statistics and Classification Unit is a collaborating Unit of the University of Sydney 
and the Australian Institute of Health and Welfare. The Unit’s major objective is to ensure sufficient 
information is available about the problems managed and treatments provided in general practice in 
Australia.  To that end we are collecting de-identified data from a “rolling” random sample of GPs across 
the country at a rate of 20 per week – about 1,000 GPs per year. BEACH© follows the methods we used in 
the Australian Morbidity and Treatment Survey that we conducted in 1990-91. Each GP completes details 
about 100 consecutive encounters (wherever they may occur) on structured encounter forms and this will 
result in a database of 100,000 consultations per year.   
 
The uses to which this large de-identified database is put are varied.  The BEACH© report “General 
Practice Activity in Australia” is published each year and other reports, academic papers and media 
publications and programs are also based on the data.    We have investigated changes that have occurred 
in general practice since the last National study and since BEACH© began in 1998.   The data are used by 
all organisations contributing to the BEACH© program costs, and in order to support further research 
development in general practice, may be supplied to other interested parties.  At no time will any data be 
supplied in a form that could identify it as emanating from an individual GP. 
 
Participation in BEACH © earns a minimum of 35 and maximum of 65 clinical audit points.  
A detailed report of individual practice activity is also provided to each participant. 
 
• This project has been approved by the Health Ethics Committee of the Australian Institute of Health 
and Welfare and the Ethics Committee of the University of Sydney.  
 
• The data is being collected under the AIHW ACT 1987 and in accordance with the Privacy Act 1988 
(amended 2001). 
 
• BEACH © is overseen by a Program Advisory Committee comprising representatives of the University 
of Sydney, the AIHW, each contributing organisation, the RACGP, Divisions of General Practice and 
the Consumer Health Forum.  
 
Endorsed by the Australian Medical Association.            RACGP encourages GPs to participate. 
 
Organisations contributing to the considerable cost of the BEACH © program are: 
)The Commonwealth Department of Health and Ageing   )Merck Sharp & Dohme (Aust) Pty Ltd 
)AstraZeneca Pty Ltd )Roche Products Pty Ltd   )Janssen-Cilag Pty Ltd 
    
Research Team:  Dr Helena Britt    Jan Charles   Dr Graeme Miller    Joan Henderson    Lisa Valenti 
    Ying Pan    Stephanie Knox    Chris Harrison      Clare Bayram     Julie O’Halloran 
Further information:  
Ms Jan Charles or Dr Helena Britt   phone: (02) 9845 8151 
General Practice Statistics and Classification Unit, freecall: 1800 62 73 75 
The University of Sydney    fax: (02) 9845 8155  
Acacia House, Westmead Hospital   email: janc@med.usyd.edu.au 
Westmead  NSW  2145    Web http://www.fmrc.org.au   
 
Any person with concerns or complaints about the conduct of this study can contact the Manager for 
Ethics Administration, University of Sydney on (02) 9351 4811. 
 
 
page 1 of 1  BEACH ©  Summary Information 
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Appendix 7:  
Instructions for participating GPs 
B E A C H  -  Bettering the Evaluation And Care of Health
NATIONAL MORBIDITY AND TREATMENT STUDY
INSTRUCTIONS FOR PARTICIPATING DOCTORS
USING THESE INSTRUCTIONS
Use these instructions as a resource to complete the forms. While they may look
daunting, most of the form is self-explanatory. The instructions contain:
 ® an example consultation scenario
 ® a completed form for the example scenario
 ® detailed explanations for each question on the form.
Reading these instructions will:
 ® show you how to fill out the forms
 ® ultimately save you time
 ® decrease the variation among practitioners in their recording techniques.
When to complete the forms
Complete the forms during the course of the consultation as
 ® some information needs to be asked of the patient
 ® it will be faster and more accurate than going back to your records at the
end of the day. To show the full range of your clinical activity it is vital that
you take the pad with you to all hospital, home and nursing home visits.
Informing patients
In your research pack there are two copies of a laminated notice which tells
patients about the study and of their right to refuse to allow inclusion of their
unidentified data.  Please ask your reception staff to ensure your patients read
the notice.  Patients who consult with you in another language, should be made
aware of their options regarding the study.  For patients not seen, nursing home
visits and palliative care, please use your professional discretion in this matter.
Patient information questions at the bottom of the form
These vary and are presented in blocks within the pad, so please read carefully
the instructions relating to these questions.  When the questions change in the
pad, a green instruction sheet gives you instructions for the next block of forms.
EXAMPLE OF ONE TYPE OF RECORDED ENCOUNTER
This is a description of the data recorded on the sample recording form that
follows.
On April 30th 2004, Mr A comes to the surgery.  He has read the patient
information card while in the waiting room and agrees to be included in the
study.  The consultation starts at 9.10 am.  From the medical record you note Mr
A’s date of birth is 13/3/1945, his postcode is 2145 and that he carries a Health
Care Card.  You ask if he is from a Non English-Speaking Background or
identifies himself as an Aboriginal or Torres Strait Islander and he answers no.
You use the tick boxes to show his responses.
He is a regular patient suffering from hypertension and says he has almost run
out of Cardizem and requests a script.  After examination you feel Mr A is not
responding to medication and you refer him to a cardiologist but also provide
him with the required script for Cardizem CD 180mg tablets to be taken once a
day with two repeats.  You also recommend he try to lose weight, advise a low-fat
diet and send him for cholesterol screening.
Mr A then complains about his ribs. He says he slipped and bumped himself at
work the day before and his ribs are hurting. You send him for an x-ray and
advise him to take Panadol for the pain.
You tell him you have to ask him a couple of extra questions for the study.  He
says that he is 170 centimetres tall and weighs about 90 kilos.  He says he no
longer smokes and has a drink most nights but never more than one or two. You
show him the ‘standard drinks’ card and he confirms one or two standard drinks.
This has been a standard surgery consultation in the Item 23 category which
finishes at 9.28 am.
1
Diagnosis/
Drug Name AND Form for this problem
1.
2.
3.
4.
Procedures, other treatments, counselling this consult for this problem
1.        2.
Diagnosis/
Drug Name AND Form for this problem
1.
2.
3.
4.
Procedures, other treatments, counselling this consult for this problem
1.        2.
Diagnosis/
Drug Name AND Form for this problem
1.
2.
3.
4.
Procedures, other treatments, counselling this consult for this problem
1.        2.
BEACH (Bettering the Evaluation And Care of Health) - Morbidity and Treatment Survey - National
Encounter Number
Patient
Reasons for
Encounter
Date of encounter
 _____ /___ /___
Date of Birth
 ____ /___ /_ _ _ _
1.
2.
3.
Sex
 M         F
Patient Postcode
NEW REFERRALS, ADMISSIONS
                                                                  Problem(s)
1. _______________________________ 1 2 3 4
2. _______________________________ 1 2 3 4
IMAGING/Other tests   Body site Problem(s)
1. _________________ - ______________ 1 2 3 4
2. _________________ - ______________ 1 2 3 4
PATHOLOGY Problem(s) PATHOLOGY(cont) Problem(s)
1. ________________________________ 1 2 3 4
2. ________________________________ 1 2 3 4
3. ________________________________ 1 2 3 4
4. _______________________________ 1 2 3 4
5. _______________________________ 1 2 3 4
 Patient reported
    Height:
  cm
    Weight:
   kg
 FINISH Time
START Time
:
AM / PM
(please circle)
30   04   04 13   03    1945 4 2145
Script for hypertension tablets
Sore ribs
Cardiologist
   X-ray Ribs Cholesterol
  9  10
Ó BEACH General Practice & Statistics Classification Unit University of Sydney 1996
ÃProblem     :
Frequency No. of
Rpts
OTC Drug status
New  Cont.
GP
Supply
DoseStrength of
product
Frequency No. of
Rpts
OTC Drug status
New  Cont.
GP
Supply
DoseStrength of
product
 ÂProblem    :
Diagnosis/
Drug Name AND Form for this problem
1.
2.
3.
4.
Procedures, other treatments, counselling this consult for this problem
1.        2.
OTCDoseStrength of
product
Dietary advice
4Cardizem CD tablets          180mg   1 tab  1 daily   2
Problem     :À Hypertension
Frequency No. of
Rpts
Drug status
New  Cont.
GP
Supply
Injury - ribs
Panadol tablets                   500mg  2 tabs   q i d
Frequency No. of
Rpts
OTC Drug status
New  Cont.
GP
Supply
DoseStrength of
product
4
Problem     :Á
4
 170
 90
BA
:
AM / PM
(please circle)
  9  28
To the patient if 18+:
Which best describes your smoking
status?
Smoke daily ............................................
Smoke occasionally ...........................
Previous smoker ..................................
Never smoked ........................................
How often do you have 6 or more
standard drinks on one occasion?
Never ......................................................................
Less than monthly ..........................................
Monthly .................................................................
Weekly ...................................................................
Daily or almost daily .....................................
4
How many ‘standard’ drinks do you
have on a typical day when you are
dr inking?
2
To the patient if 18+:
How often do you have a drink
containing alcohol?
Never ..........................................................
Monthly or less ....................................
Once a week/fortnight. ....................
2-3 times a week ................................
4+ times a week .................................. 4
4
New Patient ......................................................
Health Care/Benefits Card ...................
Veterans Affairs Card ................................
NESB .......................................................................
Aboriginal ..........................................................
Torres Strait Islander .................................
Yes / No
4
4
4
4
4
4
Problem Status
New         Old
Work
related
Problem Status
New         Old
Work
related
4
Problem Status
New         Old
Work
related 4
Problem Status
New         Old
Work
related4
DOC ID
 PATIENT SEEN .....................  
 PATIENT NOT SEEN .....
4
Item No:  (if
applicable)
23
Workers comp paid ...
State Govt/Other paid
No charge .........................
BEACH (Bettering the Evaluation And Care of Health) - Morbidity and Treatment Survey - National
DATE:  Enter day,
month and year of
encounter.
These items ask about the type of renumeration claimable for the encounter.
Medicare Encounters
Item No:
® Write the item number when there is a charge through Medicare, bulk-billed or otherwise.
® When multiple item numbers are involved, record the consultation item, eg 23.  Procedures and tests are
recorded elsewhere on the form.
® If unsure of item number, please provide type and level of consultation e.g. NHV-B (nursing home visit - level B)
or diabetes care plan - C.
® Include item numbers (when applicable) for services when the patient is not seen e.g. case conferences,
extended primary care (EPC) items.
Non- Medicare
Workers Compensation paid: For consultations claimable through workers compensation.
State Govt / Other paid:  If the encounter is being paid for by a state government (eg, hospital or other state
agency), insurance company or other source. DOES NOT include additional cash payments made by patients
charged through Medicare, but would include ‘cash only’ patients eg overseas travellers.
No charge: For services you provide free - with no payment from ANY source.
ENCOUNTER NUMBER:
Pre-stamped with consecutive
encounter number 001-105. A
few extra forms allow for error -
please complete up to 102.  This
is not a patient identification
number. If you see the same
patient more than once during
the recording period, complete a
new form for each encounter.  No
linking of forms is required.
Ask the patient the following questions and tick either ‘Yes’ or ‘No’ for each item.
® New Patient: If this is the patient’s first visit to your practice, tick the ‘New’ box. If the patient has
been seen previously at this practice by you or one of your associates tick the ‘Old’ box.
® Health Care / Benefits Card Holder: eg unemployed, pensioner, low income earner.
® Veterans’ Affairs Card holder:  Indicate whether the patient has a Veterans Card. Patients may
hold both Veterans’ and Health Care cards.
® NESB:  Non-English Speaking Background i.e. primary language spoken at home is NOT English.
® Aboriginal / Torres Strait Islander: Ask the patient “Are you of Aboriginal or Torres Strait
Islander origin?”  The patient may answer “Yes” to either or both. If both, tick both ‘Yes’ boxes.
Otherwise, tick ‘Yes’ to whichever option the patient nominates and ‘No’ to the other, or tick ‘No’ for
both options if that is the patient’s response.
PATIENT
POSTCODE:
Postcode of
patient’s home
address.
SEX:  Tick
box for sex
of patient.
BIRTH:  Enter day,
month and FULL
YEAR of patient’s
birth.
3
Date of encounter
 _____ /___ /___
Date of Birth
 ____ /___ /_ _ _ _
Sex
 M         F
Patient Postcode
30   04   04 13   03    1945 4 2145
Encounter Number
Ó BEACH General Practice & Statistics Classification Unit, University of Sydney 1996 DOC ID
** This question was formally adopted in 1995 by the
Australian Bureau of Statistics as the standard for
measuring membership of the Indigenous population.
McLennan, W. & Madden, R. (1999) The health and welfare
of Australia’s Aboriginal and Torres Strait Islander Peoples
ABS 4704.0 p.149
**
4 PATIENT SEEN .....................  
 PATIENT NOT SEEN .....
Item No:  (if
applicable)
23
New Patient ......................................................
Health Care/Benefits Card ...................
Veterans Affairs Card ................................
NESB .......................................................................
Aboriginal ..........................................................
Torres Strait Islander .................................
Yes / No
4
4
4
4
4
4
PATIENT SEEN / NOT SEEN.
Tick ‘PATIENT SEEN’ if this is a
face-to-face encounter
Tick ‘PATIENT NOT SEEN’ if a
service is provided where a
patient related action results
in entry of information into the
patient’s record but the
patient is not seen e.g:
renewals for script/referral/
certificates, case
conferences/EPC items,
where the patient is not seen
face-to-face.
Workers comp paid ...
State Govt/Other paid
No charge .........................
DIAGNOSIS/PROBLEM:  Record at least one and up to four problems.
® Use one Diagnosis/problem box for each diagnosis/problem
® Only record problems actually dealt with at this encounter
® Include ill-defined conditions  (e.g. “cough”), preventive care (e.g.
“pap smear” or “checkup”), and social problems (e.g. “problems
with spouse”).
® Diagnose at the highest level possible with the information
available (e.g. for diabetes, differentiate between IDDM/NIDDM/
Type 1/Type 2 etc.)
® The order in which you record the problems is not significant - they
do not have to match the order of the RFEs.
® If more than four problems are managed at the consultation, record
the four problems that best describe the breadth of the
consultation.
PROBLEM STATUS:  Tick ‘New’ if:
® this is a new problem to the patient, or
® this is a new episode of a recurrent problem (e.g. URTI), or
® the patient has not been treated for that problem by any medical practitioner
before.
Tick ‘Old’ if the patient has been seen before by ANY medical practitioner for
this chronic problem or this episode of an acute problem.
PATIENT REASON FOR ENCOUNTER (RFE):
Record at least 1 and up to 3 patient reasons for the encounter.
® The reason for encounter is the patient’s view of the reasons he/she is
consulting you. The patient’s own words should be used. May include:
® symptoms e.g. “runny nose”,
® diagnoses e.g. “diabetes”,
® requests for service e.g. “script for BP”, “referral”.
® other examples  - “Worried about…”, “follow-up”, “check-up
circulatory”
® Specify the body system even when this is not stated by the patient but is
understood between you.
Patient
Reasons for
Encounter
Date of encounter
 _____ /___ /___
Date of Birth
 ____ /___ /_ _ _ _
1.
2.
3.
Sex
 M         F
Patient Postcode
Script for hypertension tablets
Sore ribs
4
Encounter Number
  9 : 10
(please circle)
AM / PM
START Time
START TIME
Record the time the consultation
STARTED in hours and mins and
circle whether the time was AM or
PM.
eg.      9: 10
             AM / PM
Diagnosis/
Drug Name AND Form for this problem
1.
2.
3.
4.
Procedures, other treatments, counselling this consult for this problem
1.        2.
Problem     :À Hypertension
Frequency No. of
Rpts
OTC Drug status
New  Cont.
GP
Supply
DoseStrength of
product
Dietary advice
4Cardizem CD tablets          180mg   1 tab  1 daily   2
PROCEDURES, OTHER TREATMENTS, COUNSELLING:
For each problem:
® Record up to two procedures, other treatments or counselling.
® Only include those ACTUALLY PROVIDED at the encounter.
® Include in this section actions such as
®pap smears, injections, excisions, ear syringe
®psychosocial counselling
®diet and exercise advice
®medical certificates
® Do NOT include in this section:
®history
®routine physical examinations e.g. blood pressure checks
®discussion
®referrals, imaging, or pathology ordered (there are sections for these).
4
Problem Status
New         Old
Work
related
WORK RELATED:   Irrespective of the source of payment for the encounter, tick if:
® it is likely in your view that the symptom or  problem has resulted from work-
related activity or workplace exposures.
® where there is uncertainty but it is more likely than not that the condition is
work-related
® if there is a pre-existing condition which is thought to have been significantly
exacerbated by work activity or workplace exposures.
Diagnosis/
Drug Name AND Form for this problem
Diagnosis/
Drug Name AND Form for this problem
1.
2.
3.
4.
Procedures, other treatments, counselling this consult for this problem
1.        2.
OTCDoseStrength of
product
Problem     :À Hypertension
Frequency No. of
Rpts
Drug status
New  Cont.
GP
Supply
MEDICATIONS: NB - Do NOT record medications that were not prescribed / advised / supplied at this encounter
Record medications when
· a prescription is written at this encounter,
· you recommend that the patient take an “over the counter” (OTC) medication.
· you administer or supply a medication/vaccine. eg. If ‘Immunisation’ is the problem managed, please enter drugs administered at
this encounter, (e.g. CDT, DTP) or any drug samples you provide.
5
Injury - ribs
Panadol tablets                   500mg 2 tabs  q i d
Frequency No. of
Rpts
OTC Drug status
New  Cont.
GP
Supply
DoseStrength of
product
4
Problem     :Á
4
Strength of product:
Please specify the
strength of the product you
are prescribing/supplying/
advising.
We are attempting to
differentiate between
product strengths, e.g.
250mg or 500mg of the
same product.
Frequency:
® how often the dose is to
be taken.
® record in accepted
abbreviations eg. “bd”,
“tds”, etc.
® if drug is to be taken “as
required”, write PRN.
No. of Rpts: for all prescriptions
please specify the number of
repeats ordered. If no repeats are
given, please write ‘0’ or ‘ - ’.
Please do not leave blank.
GP supply:  tick box if
medication is from the
practice supplies eg
drug sample or vaccine.
Otherwise, leave blank.
Drug status:  If the medication is being used for the
management of  this problem for the first time then
tick the ‘New’ box.  If it is a continuation or repeat
of previous therapy then tick the ‘Cont.’ box.
PLEASE RECORD
INFORMATION IN AS MUCH
DETAIL AS YOU WOULD WRITE
ON A PRESCRIPTION.
For OTCs, provide as much detail as
the patient would need to buy the
medication over the counter.
Drug name and Form:
the brand or generic
name of the medication
and its form eg
Cardizam CD tablets;
Panadol syrup; Ventolin
nebules etc.
Dose: the
quantity of
medication to
be taken
eg 2 tabs;
25 mls;
1 inj;
2 puffs etc.
4
Problem Status
New         Old
Work
related
Problem Status
New         Old 4
Work
related 4
OTC: tick if
the
medication
advised can
be bought
Over The
Counter i.e.
an S2 or S3
product.
Otherwise
leave blank.
Drug Name AND Form
1.
2.
3.
Drug Name AND Form
1.
Drug Name AND Form
2.
Drug Name AND Form
1.
2.   Warfarin tablets
Drug Name AND Form
1.
Drug Name AND Form
1.
2.   Panadol syrup
OTHER MEDICATION EXAMPLES
Syrups
Dose may be written in
“mg” or “ml” but strength
must be specified.
Creams
Specify the name, form,
strength and no. of applications
per day. There is no need to
specify pack size.
Injections
Tick  GP supply only if you have provided the
vaccine / medication yourself.
NB Please write ‘injection given’ in the
“Procedures, other treatments ...” section if you
have given the injection at this encounter.
Multiple strengths of same drug
If prescribing multiple strengths of the same
drug to achieve a particular dose, specify
both.
Insulin
Specify the number of units prescribed.
Inhaled medications
Specify the mode of delivery, e.g. inhaler,
turbuhaler, nebules, etc. and the strength.
ALWAYS  SPECIFY
NAME and FORM,
STRENGTH
D O S E   and
FREQUENCY
6
  Amoxil syrup                250mg/5ml  2.5ml   tds     0
120mg/5ml
Frequency No. of
Rpts
OTC Drug status
New  Cont.
GP
Supply
DoseStrength of
product
 10ml 4 4
4
4hrly
  Warfarin tablets                 1 mg      1 tab   mane     2
    2 mg
Frequency OTC Drug status
New  Cont.
GP
SupplyDose
Strength of
product
 1 tab 4
4
 mane     2
Fluvax inject                  0.5ml    1 inj     stat
Engerix B Adult inject     20mcg/ml  1 inj     stat
Frequency OTC Drug status
New  Cont.
GP
SupplyDose
Strength of
product
4
40
0
1.
tds     -Aristocort cream 0.02%
Frequency No. of
Rpts
OTC Drug status
New  Cont.
GP
Supply
DoseStrength of
product
4
  Pulmicort turbuhaler           400mcg   2 puffs    bd     1          4
  Prednisone tablets              25mg     ½ tab   1 daily   0  4
  Ventolin inhaler                  100mcg   2 puffs 4/24prn
Frequency No. of
Rpts
OTC Drug status
New  Cont.
GP
Supply
DoseStrength of
product
 bd     1Mixtard 30/70 inject
Frequency No. of
Rpts
OTC Drug status
New  Cont.
DoseStrength of
product
4 100iu/ml  20 units
44
GP
Supply
No. of
Rpts
No. of
Rpts
NEW REFERRALS/ADMISSIONS:
® Specify the type of specialist(s) or allied health
professional(s) to whom the referral has been made, eg:
dermatologist or hospital emergency etc.
® Record new referrals only. Do not include continuation
referrals.
® Indicate the problem or problems for which the referral
was made by circling the appropriate problem number.
® Include referrals for clinical measurements such as
spirometry and ECG
IMAGING/Other tests (+Body site):
Imaging
® write the name of the imaging (e.g. x-ray) and body site
® circle the number(s) of the Diagnosis/problem which is being
investigated
Other tests
® specify the type of test
® circle the relevant Diagnosis/problem number(s)
Lateralization is not required.
NEW REFERRALS, ADMISSIONS       Problem(s)
1. _______________________________________ 1 2 3 4
2. _______________________________________ 1 2 3 4
IMAGING/Other tests Body site Problem(s)
1. ______________________ - _________________ 1 2 3 4
2. ______________________ - _________________ 1 2 3 4
7
PATHOLOGY Problem(s) PATHOLOGY(cont) Problem(s)
1. ___________________ 1 2 3 4 4. __________________ 1 2 3 4
2. ___________________ 1 2 3 4 5. __________________ 1 2 3 4
3. ___________________ 1 2 3 4
X-ray                    Ribs Lipids
FBC
Cardiologist
PATHOLOGY:
® Give details of up to five pathology tests ordered or
undertaken at the encounter. Document one test per line.
Circle the associated Diagnosis/problem number(s).
® For single tests, write the test name (e.g. HBAIC, pap
smear).  If ordering a set of tests such as a FBC or LFT
or lipids or thyroid function, record them in this grouped
form. You don’t need to list each of the individual tests
incorporated in the set.
® Do not record simple urine dip stick tests.
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Appendix 8:  
Patient height/weight conversion chart 
BEACH       
       
Weight Conversion Chart - Stone/pounds (st lbs) - Kilograms (kg)  
       
Weight   Weight  Weight  Weight  Weight Weight 
st lbs kg  st lbs kg st lbs kg st lbs kg st lbs kg st lbs kg
1' 6  4' 25 7' 44 10' 64 13' 83 16' 102
1'1" 7  4'1" 26 7'1" 45 10'1" 64 13'1" 83 16'1" 102
1'2" 7  4'2" 26 7'2" 45 10'2" 64 13'2" 83 16'2" 103
1'3" 8  4'3" 27 7'3" 46 10'3" 65 13'3" 84 16'3" 103
1'4" 8  4'4" 27 7'4" 46 10'4" 65 13'4" 84 16'4" 103
1'5" 9  4'5" 28 7'5" 47 10'5" 66 13'5" 85 16'5" 104
1'6" 9  4'6" 28 7'6" 47 10'6" 66 13'6" 85 16'6" 104
1'7" 10  4'7" 29 7'7" 48 10'7" 67 13'7" 86 16'7" 105
1'8" 10  4'8" 29 7'8" 48 10'8" 67 13'8" 86 16'8" 105
1'9" 10  4'9" 29 7'9" 49 10'9" 68 13'9" 87 16'9" 106
1'10" 11  4'10" 30 7'10" 49 10'10" 68 13'10" 87 16'10" 106
1'11" 11  4'11" 30 7'11" 49 10'11" 68 13'11" 88 16'11" 107
1'12" 12  4'12" 31 7'12" 50 10'12" 69 13'12" 88 16'12" 107
1'13" 12  4'13" 31 7'13" 50 10'13" 69 13'13" 88 16'13" 108
2' 13  5' 32 8' 51 11' 70 14' 89 17' 108
2'1" 13  5'1" 32 8'1" 51 11'1" 70 14'1" 89 17'1" 108
2'2" 14  5'2" 33 8'2" 52 11'2" 71 14'2" 90 17'2" 109
2'3" 14  5'3" 33 8'3" 52 11'3" 71 14'3" 90 17'3" 109
2'4" 15  5'4" 34 8'4" 53 11'4" 72 14'4" 91 17'4" 110
2'5" 15  5'5" 34 8'5" 53 11'5" 72 14'5" 91 17'5" 110
2'6" 15  5'6" 34 8'6" 54 11'6" 73 14'6" 92 17'6" 111
2'7" 16  5'7" 35 8'7" 54 11'7" 73 14'7" 92 17'7" 111
2'8" 16  5'8" 35 8'8" 54 11'8" 73 14'8" 93 17'8" 112
2'9" 17  5'9" 36 8'9" 55 11'9" 74 14'9" 93 17'9" 112
2'10" 17  5'10" 36 8'10" 55 11'10" 74 14'10" 93 17'10" 112
2'11" 18  5'11" 37 8'11" 56 11'11" 75 14'11" 94 17'11" 113
2'12" 18  5'12" 37 8'12" 56 11'12" 75 14'12" 94 17'12" 113
2'13" 19  5'13" 38 8'13" 57 11'13" 76 14'13" 95 17'13" 114
3' 19  6' 38 9' 57 12' 76 15' 95 18' 114
3'1" 20  6'1" 39 9'1" 58 12'1" 77 15'1" 96 18'1" 115
3'2" 20  6'2" 39 9'2" 58 12'2" 77 15'2" 96 18'2" 115
3'3" 20  6'3" 39 9'3" 59 12'3" 78 15'3" 97 18'3" 116
3'4" 21  6'4" 40 9'4" 59 12'4" 78 15'4" 97 18'4" 116
3'5" 21  6'5" 40 9'5" 59 12'5" 78 15'5" 98 18'5" 117
3'6" 22  6'6" 41 9'6" 60 12'6" 79 15'6" 98 18'6" 117
3'7" 22  6'7" 41 9'7" 60 12'7" 79 15'7" 98 18'7" 117
3'8" 23  6'8" 42 9'8" 61 12'8" 80 15'8" 99 18'8" 118
3'9" 23  6'9" 42 9'9" 61 12'9" 80 15'9" 99 18'9" 118
3'10" 24  6'10" 43 9'10" 62 12'10" 81 15'10" 100 18'10" 119
3'11" 24  6'11" 43 9'11" 62 12'11" 81 15'11" 100 18'11" 119
3'12" 24  6'12" 44 9'12" 63 12'12" 82 15'12" 101 18'12" 120
3'13" 25  6'13" 44 9'13" 63 12'13" 82 15'13" 101 18'13" 120
 
 BEACH     
     
Height Conversion Table -  Feet/inches (ft in) - Centimetres (cm) 
 
     
Height    Height Height  
 ft in cm  ft in cm ft in cm
1'  30  3' 91 5'  152
 1" 33  1" 94 1" 155
 2" 36  2" 97 2" 157
 3" 38  3" 99 3" 160
 4" 41  4" 102 4" 163
 5" 43  5" 104 5" 165
 6" 46  6" 107 6" 168
 7" 48  7" 109 7" 170
 8" 51  8" 112 8" 173
 9" 53  9" 114 9" 175
 10" 56  10" 117 10" 178
 11" 58  11" 119 11" 180
2'  61  4' 122 6'  183
 1" 64  1" 124 1" 185
 2" 66  2" 127 2" 188
 3" 69  3" 130 3" 191
 4" 71  4" 132 4" 193
 5' 74  5" 135 5" 196
 6" 76  6" 137 6" 198
 7" 79  7" 140 7" 201
 8" 81  8" 142 8" 203
 9" 84  9" 145 9" 206
 10" 86  10" 147 10" 208
 11" 89  11" 150 11" 211
 
 
 
 
 
 
 
 
Prepared by Family Medicine Research Centre, 17/03/1998 
 325
 
Appendix 9:  
Standard drinks chart 
 STANDARD DRINKS 
Because drinks vary a lot in strength, it is useful to know how much alcohol is in each 
common drink. A STANDARD DRINK is one which contains about 10 grams of alcohol. 
In the table below, you can see that common servings of different kinds of alcoholic 
drinks in fact contain about the same amount of alcohol. 
Low alcohol beer  
2x285ml (2x10oz) 
Ordinary beer 
285ml (10oz) 
Spirits (nip)     
30ml (1oz) 
     Table wine  
    100 -120ml  
       (3 - 4oz) 
Fortified wine 
60 ml (2oz)  
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Appendix 10:  
Patient information sheet 
 
 
 
 
GPSCU,  Acacia House,  Westmead Hospital, PO Box 533,WENTWORTHVILLE, 2145. 
Ph: 02 98458151 fax: 02 98458155       email: janc@med.usyd.edu.au      Web http://www.fmrc.org.au   
General Practice Statistics and Classification Unit
  Family Medicine Research Centre 
The University of Sydney 
a collaborating unit of the 
Australian Institute of 
Health and Welfare 
at Westmead Hospital 
INFORMATION FOR PATIENTS 
 
The BEACH © Project  
 
Today your doctor is taking part in a National Survey of general practice called 
BEACH © (Bettering the Evaluation and Care of Health).  This study is being done by 
the General Practice Statistics and Classification Unit, University of Sydney, with 
the Australian Institute of Health and Welfare. 
 
Your Doctor will be recording information about each patient he/she sees (age, 
gender etc), the problems that you see the Doctor about and the treatments given 
to you.  There are no names on the forms so you cannot be identified.  The 
information about today's visit to the doctor will be one record in a set of 100,000 
records collected in general practices across Australia over the year. 
 
This information will be used by researchers to describe what happens in general 
practice and to look at different aspects of health care; by government 
departments to help them plan for our future health; and by pharmaceutical 
companies to gain a picture of the people who use their drugs and of the 
problems being treated with the drugs they produce. 
 
Remember: your name will not be on the form and no information will ever 
be released which could possibly let anyone know who you are.  However, if 
you do not wish your doctor to record any unidentified information about you or 
your visit please tell your Doctor as soon as you go in. Such a decision will not 
affect the care your doctor is providing in any way. 
 
SEE OVER FOR PROJECT DETAILS 
          (page 1 / 2) 
 
BEACH ©  Program Details 
This program has been approved by the Ethics Committees of the University of 
Sydney and the Australian Institute of Health and Welfare (AIHW). The data are 
being collected under the AIHW ACT 1987 and in accordance with the Privacy Act 
1988 (Amended 2001). 
BEACH is endorsed  
by  
the Royal Australian 
College 
BEACH is endorsed  
by  
the Australian Medical 
FURTHER INFORMATION:
General Practice Statistics and
Classification Unit
The University of Sydney
Acacia House, Westmead Hospital,
Westmead 2145
Phone: (02) 9845 8151
Fax: (02) 9845 8155
Email: janc@med.usyd.edu.au
Web: http://www.fmrc.org.au
Any person with concerns or complaints about the conduct of this study 
can contact the Manager for Ethics Administration, University of Sydney on 
(02) 9351 4811. 
            
(page 2/2)
Organisations contributing financially to the conduct of this study are: 
 
) The Australian Government Department of Health and Ageing 
) AstraZeneca Pty Ltd (Australia)    ) Janssen-Cilag Pty Ltd 
) Roche Products Pty Ltd     ) Merck Sharp & Dohme (Aust) Pty Ltd 
) Pfizer Australia Pty Ltd 
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Appendix 11:  
Computerised medical record follow-up questionnaire 
- are held on computer (through software); all 
other clinical patient information is recorded 
on paper. Tick as many as apply. We will 
assume that any item not ticked is held on 
paper. 
 (Please tick) 
Page 1 of 1. 
 
 
14th June 2005 
 
«DOCID» 
«Title» «Firstname» «Surname» 
«Address1» 
«Address2» 
«Suburb»    «Pcode» 
 
Dear «Title» «Surname» 
BEACH Follow-up query 
Thank you for participating in the Bettering the Evaluation and Care of Health Program during the past year. 
As part of this program you answered questions about how computers were used by you in your practice at the 
time you participated in the BEACH program. Through this letter, we hope to ascertain the specific type and 
quantity of patient information held in computerised medical records by the GPs who have indicated that they 
use a computer for clinical purposes.  
To provide this information, all you need to do is tick one of the options listed below and return this letter 
in the enclosed reply-paid envelope. If you wish to add any comments please feel free to write them on the 
bottom of the letter.  
Once again our thanks for your valuable contribution to the overall results of this study of Australian general 
practice. If you have any queries, please call Joan Henderson on Freecall 1800 62 73 75. 
Yours sincerely 
 
 
 
Dr Helena Britt 
Director.  
 
To what extent did you use a computerised medical record for your patients at the time you participated in 
BEACH? 
 
1. All clinical patient information (eg. patient history, diagnoses/problems, treatments, referrals, 
requests etc) generated by you is held on computer, i.e., no paper records generated. All test 
results and other external correspondence are imported or scanned into the computer record.  
 
2. All clinical patient information (eg. patient history, diagnoses/problems, treatments, referrals, 
requests etc) generated by you is held on computer, i.e., no paper records generated. All test 
results and other external correspondence are kept on paper.    
 
3. Patient history 
Current problems being managed 
Prescriptions 
    - problem for which script was given  
Tests ordered 
    - problem for which test was ordered             
 Referrals           
Immunisations 
Comments  _______________________________________________________________________ 
OR 
OR 
The University of Sydney 
at Westmead Hospital
General Practice Statistics and Classification Unit
  Family Medicine Research Centre 
a collaborating unit of the 
Australian Institute of 
Health and Welfare 
AGPSCC, Acacia House, Westmead Hospital, PO Box 533, WENTWORTHVILLE  2145. 
Ph: 02 98458151   Fax: 02 95-845 8155    email janc@med.usyd.edu.au    Web http://www.fmrc.org.au 
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Appendix 12:  
Other investigations inclusions — ICPC-2 PLUS codes 
and terms 
Appendix 12: Other investigations— 
ICPC–2 PLUS codes and terms 
ICPC–2 PLUS code  ICPC–2 PLUS term 
A40001 Endoscopy 
A40002 Laparoscopy 
D40001 Gastroscopy 
D40002 Proctoscopy 
D40004 Colonoscopy 
D40005 Oesophagoscopy 
D40007 Sigmoidoscopy 
D40009 Endoscopy; diagnostic; digestive 
D43002 Procedures; diagnostic; digest 
H39001 Test; audiometry 
H39003 Test; hearing 
H39007 Test; tympanometry 
K39002 Monitoring; BP 
K42001 Electrocardiogram; ambulatory 
K42002 Electrocardiogram 
K42003 Electrocardiogram; 24 
K42004 Electrocardiogram; exercise 
K42005 Holter 
K42010 Electrocardiogram; stress 
L40001 Arthroscopy 
L42001 Electrical 
L42002 Electromyogram 
L43001 Synovial 
N39001 Test; physical 
N42001 Electroencephalogram 
N43001 Procedures; diagnostic; neuro 
P39001 Test; physical 
R39002 Test; peak 
R39003 Test; pulmonary 
R39004 Test; spirometry 
R39005 Test; lung 
R39007 Test; physical 
R40001 Bronchoscopy 
R43001 Procedures; diagnostic; resp 
U39001 Test; physical 
U40001 Cystoscopy 
W42001 Monitoring; foetal 
X40001 Colposcopy 
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Appendix 13:  
Quality indicator inclusions — ICPC-2 PLUS codes 
and terms 
 
Appendix 13:  Quality indicators – ICPC-2 PLUS codes and labels 
 
Quality indicator ICPC-2 
rubric 
ICPC-2 PLUS code ICPC-2/ICPC-2 PLUS label 
Pap smear/100 encounters with female patients aged 15-70 yrs 
  X37001 Pap smear  
  X37005 Pap smear; thin prep 
  X37003 Test ;cytology; genital; F 
  X37002 Test; histopathology; genital; F 
  X37004 Vault smear 
All immunisations/100 encounters with patients aged <5 yrs 
 A44  Preventative 
Immunisation/Medication 
 D44  Preventative 
Immunisation/Medication 
Digestive 
 N44  Preventative 
Immunisation/Medication 
Neurological 
 R44  Preventative 
Immunisation/Medication 
Respiratory  
PSA tests/100 screening encounters with males >50 years 
  Y34003 Test; prostate specific antigen 
All lifestyle counselling/100 encounters 
  A45004 Advice/education; exercise 
  A45005 Advice/education; health 
  A45006 Advice/education; diet 
  A45009 Health promotion 
  A45010 Information; health 
  A45012 Advice/education; STD 
  A45026 Advice/education; hygiene 
  A58005 Counselling; exercise 
  A58006 Counselling; health 
  A58008 Counselling; STDs 
  P45004 Advice/education; smoking 
  P45005 Advice/education; alcohol 
  P45006 Advice/education; illicit drugs 
  P45007 Advice/education; relaxation 
  P45008 Advice/education; lifestyle 
  P45010 Advice/education; life stage 
  P58008 Counselling; smoking 
  P58009 Counselling; alcohol 
  P58010 Counselling; drug abuse 
  P58011 Counselling; relaxation 
  P58012 Counselling; lifestyle 
  P58017 Counselling; stress management 
  T45005 Advice/education; nutritional 
  T45007 Advice/education; weight mgt 
  T45010 Weight management 
  T58002 Counselling; weight management 
  X58004 Counselling; STDs; F 
  Y58004 Counselling; STDs; M 
HbA1c tests/100 encounters with patients with diabetes 
  T34010 Test;HbA1c 
  T34022 Test;HBA1 
(Continued) 
 
Quality indicator ICPC-2 
rubric 
ICPC-2 PLUS code ICPC-2/ICPC-2 PLUS label 
Referrals to ophthalmologists or allied health/100 encounters with patients with diabetes 
  -66 Referral to other provider/nurse/ 
therapist/social worker 
  -68 (excluding A68009; 
A68011; Z68003; 
Z68004; Z68007; 
768008) 
Other referrals NEC 
  Z67002 Referral; respite care 
 T89  Diabetes, insulin dependent 
 T90  Diabetes, non-insulin dependent 
 W85  Gestational Diabetes 
  F47002 Consult; ophthalmologist 
  F47001 Consult; specialist; eye 
  F67002 Referral; ophthalmologist 
ACE inhibitors/100 encounters with patients with LVF or IHD or diabetes or 
cerebrovascular  disease 
 K77  Heart failure 
 K74  Ischaemic heart disease with 
angina 
 K75  Acute ,myocardial infarction 
 K76  Ischaemic heart disease without 
Angina 
 K89  Transient cerebral ischaemia 
 K90  Stroke/ Cerebrovascular accident 
 K91  Cerebrovascular disease 
 
Aspirin or clopidogrel/100 encounters with patients with LVF or IHD or diabetes or 
cerebrovascular disease 
 K77  Heart failure 
 K74  Ischaemic heart disease with 
angina 
 K75  Acute ,myocardial infarction 
 K76  Ischaemic heart disease without 
Angina 
 K89  Transient cerebral ischaemia 
 K90  Stroke/ Cerebrovascular accident 
 K91  Cerebrovascular disease 
 
Warfarin/100 encounters with patients with AF 
 K78  Atrial fibrillation/ flutter 
Imaging tests/100 encounters with patients with low back pain or strain/sprain 
 L02  Back symptom/ complaint  
 L03  Low back symptom/ complaint 
 L84  Back Syndrome without radiating 
pain 
 L86  Back Syndrome with radiating 
pain 
 L77  Sprain/ strain of ankle 
 L78  Sprain/ strain of knee 
 L79  Sprain/ strain of Joint NOS 
  L19014 Strain; muscle(s) 
  L83023 Sprain; neck 
  L83024 Strain; neck 
Strain; back   L84020 
L84021 Sprain; back 
(Continued) 
 
Quality indicator ICPC-2 
rubric 
ICPC-2 PLUS code ICPC-2/ICPC-2 PLUS label 
NSAIDs/100 encounters with patients with all arthritis aged >65 yrs 
  L70009 Arthritis; pyogenic 
  L70010 Arthritis; viral 
  L70021 Arthritis; septic 
  L81003 Arthritis; traumatic 
  L83010 Arthritis; spine; cervical 
  L84003 Arthritis; spine 
  L84023 Arthritis; spine; thoracic 
  L84024 Arthritis; spine; lumbar 
  L84025 Arthritis; lumbosacral 
  L84026 Arthritis; sacroiliac 
  L89004 Arthritis; hip 
  L90004 Arthritis; knee 
  L91001 Osteoarthritis; degenerative 
  L91003 Osteoarthritis 
  L91007 Arthritis degenerative 
  L91008 Heberdens nodes 
  L91015 Osteoarthritis; wrist 
  L91009 Arthritis 
  L91010 Arthritis; acute 
  L91011 Arthritis; allergic 
  L91012 Polyarthritis 
  L91013 Arthritis; hand/finger(s) 
  L91014 Arthritis; wrist 
  L92006 Arthritis; shoulder 
  S91002 Arthritis; psoriatic 
  T99063 Arthritis; crystal (excl gout) 
  L83011 Osteoarthritis; spine; cervical 
  L84004 Osteoarthritis; spine 
  L84009 Osteoarthritis; spine; thoracic 
  L84010 Osteoarthritis; spine; lumbar 
  L84011 Osteoarthritis; lumbosacral 
  L84012 Osteoarthritis; sacroiliac 
  L89001 Osteoarthritis; hip 
  L90001 Osteoarthritis; knee 
  L92007 Osteoarthritis; shoulder 
 L88  Rheumatoid/ Seropositive arthritis 
Non NSAID analgesics/100 encounters with patients with all arthritis aged >65 yrs 
  L70009 Arthritis; pyogenic 
  L70010 Arthritis; viral 
  L70021 Arthritis; septic 
  L81003 Arthritis; traumatic 
  L83010 Arthritis; spine; cervical 
  L84003 Arthritis; spine 
  L84023 Arthritis; spine; thoracic 
  L84024 Arthritis; spine; lumbar 
  L84025 Arthritis; lumbosacral 
  L84026 Arthritis; sacroiliac 
  L89004 Arthritis; hip 
  L90004 Arthritis; knee 
  L91001 Osteoarthritis; degenerative 
  L91003 Osteoarthritis 
  L91007 Arthritis degenerative 
  L91008 Heberdens nodes 
  L91015 Osteoarthritis; wrist 
(Continued) 
 
Quality indicator ICPC-2 
rubric 
ICPC-2 PLUS code ICPC-2/ICPC-2 PLUS label 
  L91009 Arthritis 
  L91010 Arthritis; acute 
  L91011 Arthritis; allergic 
  L91012 Polyarthritis 
  L91013 Arthritis; hand/finger(s) 
  L91014 Arthritis; wrist 
  L92006 Arthritis; shoulder 
  S91002 Arthritis; psoriatic 
  T99063 Arthritis; crystal (excl gout) 
  L83011 Osteoarthritis; spine; cervical 
  L84004 Osteoarthritis; spine 
  L84009 Osteoarthritis; spine; thoracic 
  L84010 Osteoarthritis; spine; lumbar 
  L84011 Osteoarthritis; lumbosacral 
  L84012 Osteoarthritis; sacroiliac 
  L89001 Osteoarthritis; hip 
  L90001 Osteoarthritis; knee 
  L92007 Osteoarthritis; shoulder 
 L88  Rheumatoid/ Seropositive arthritis 
Antibiotics/100 encounters with URTI 
 R74  Upper Respiratory Infection, 
Acute 
Antibiotics/100 encounters with new URTI 
 R74  Upper Respiratory Infection, 
Acute 
Antibiotics/100 encounters with URTI in children <5 years 
 R74  Upper Respiratory Infection, 
Acute 
Counselling/100 encounters with patients with depression 
(inclusions same for ‘new’ depression) 
 A45  Observe/Health 
education/Advice/Diet 
 A58  Therapeutic counselling/ 
Listening 
 P45  Observe/Health 
education/Advice/Diet 
Psychological 
 P58  Therapeutic counselling/ 
Listening Psychological 
 Z45  Observe/Health 
education/Advice/Diet Social 
 Z58  Therapeutic counselling/ 
Listening Social 
 P03  Feeling depressed 
 P76  Depressive disorder 
Antidepressants/100 contacts with patients with depression 
 P03  Feeling depressed 
 P76  Depressive disorder 
Benzodiazepine/100 encounters with patients with insomnia 
 P06  Sleep disturbance 
 
 
